<!DOCTYPE html>
<!-- saved from url=(0098)https://www.embase.com/#advancedSearch/resultspage/history.9/page.1/200.items/orderby.date/source. -->
<html dir="ltr" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    
    <meta name="viewport" content="width=device-width">
    <title>Embase
    </title>
    <meta http-equiv="Pragma" content="no-cache">
    
<script type="text/javascript" src="./Embase  neuronal injury 01_files/3c836f97d2"></script><script src="./Embase  neuronal injury 01_files/nr-spa-1216.min.js.下载"></script><script async="" src="./Embase  neuronal injury 01_files/pendo.js.下载"></script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1588687625",accountID:"2095262",trustKey:"2038175",xpid:"VgYOVFRVChABUVZQAgUEUlAF",licenseKey:"3c836f97d2",applicationID:"1572543444"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><link rel="apple-touch-icon" sizes="57x57" href="https://www.embase.com/webfiles/images/apple-touch-icon-57x57.png?254">
    <link rel="apple-touch-icon" sizes="60x60" href="https://www.embase.com/webfiles/images/apple-touch-icon-60x60.png?254">
    <link rel="apple-touch-icon" sizes="72x72" href="https://www.embase.com/webfiles/images/apple-touch-icon-72x72.png?254">
    <link rel="apple-touch-icon" sizes="76x76" href="https://www.embase.com/webfiles/images/apple-touch-icon-76x76.png?254">
    <link rel="apple-touch-icon" sizes="114x114" href="https://www.embase.com/webfiles/images/apple-touch-icon-114x114.png?254">
    <link rel="apple-touch-icon" sizes="120x120" href="https://www.embase.com/webfiles/images/apple-touch-icon-120x120.png?254">
    <link rel="apple-touch-icon" sizes="144x144" href="https://www.embase.com/webfiles/images/apple-touch-icon-144x144.png?254">
    <link rel="apple-touch-icon" sizes="152x152" href="https://www.embase.com/webfiles/images/apple-touch-icon-152x152.png?254">
    <link rel="apple-touch-icon" sizes="180x180" href="https://www.embase.com/webfiles/images/apple-touch-icon-180x180.png?254">
    <link rel="icon" type="image/png" sizes="192x192" href="https://www.embase.com/webfiles/images/favicon-192.png?254">
    <link rel="icon" type="image/png" sizes="32x32" href="https://www.embase.com/webfiles/images/favicon-32.png?254">
    <link rel="icon" type="image/png" sizes="96x96" href="https://www.embase.com/webfiles/images/favicon-96.png?254">
    <link rel="icon" type="image/png" sizes="16x16" href="https://www.embase.com/webfiles/images/favicon-16.png?254">
    <link type="text/css" href="./Embase  neuronal injury 01_files/embase.css" rel="stylesheet">
    <!--[if IE 9]>
        <link type="text/css" href="/webfiles/css/embase_ie9.css?254" rel="stylesheet" />
        <![endif]-->
    <link type="text/css" href="./Embase  neuronal injury 01_files/print.css" rel="stylesheet prefetch" title="printNormal" media="print">
    <link type="text/css" href="./Embase  neuronal injury 01_files/print-dialog.css" rel="stylesheet alternate prefetch" title="printDialog" media="print">
    <link type="text/css" href="./Embase  neuronal injury 01_files/jquery-ui-1.12.1.min.css" rel="stylesheet subresource">
    <link type="text/css" href="./Embase  neuronal injury 01_files/daterangepicker.css" rel="stylesheet subresource">
    <!-- Adobe Analytics loader -->
    <script src="./Embase  neuronal injury 01_files/catalystproxy"></script><script src="./Embase  neuronal injury 01_files/AppMeasurement.min.js.下载" async=""></script><script src="./Embase  neuronal injury 01_files/AppMeasurement_Module_ActivityMap.min.js.下载" async=""></script><script>
function targetPageParams() {
  var env = {
    prod: {"at_property": "PROD"},
    dev:  {"at_property": "DEV"}
  }
  return (_satellite && _satellite.buildInfo && _satellite.buildInfo.environment &&
          _satellite.buildInfo.environment == 'production') ? env.prod : env.dev;
}

function targetPageParamsAll() {
  var dataElements = [
    "Page - Name",
    "Page - Product Name",
    "Page - Business Unit",
    "Page - Type",
    "Page - Language",
    "Search - Type",
    "Search - Total Results",
    "Search - Sort Type",
    "Search - Feature Used",
    "Visitor - User ID",
    "Visitor - Access Type",
    "Visitor - Account ID",
    "Visitor - Account Name"
  ];
  var targetParams = {};

  for(var i=0; i<dataElements.length; i++) {
    try {
      var ele = _satellite.getVar(dataElements[i]);
      if(ele) {
        targetParams[dataElements[i]] = ele;
      }
    } catch(e){}
  }

  return targetParams;
}
</script><script>
document.addEventListener(adobe.target.event.REQUEST_SUCCEEDED, function(e) {
  try {
    window.targetData = window.targetData || {};
    if(!(e.detail && e.detail.responseTokens)) {
      return;
    }

    e.detail.responseTokens.forEach(function(token) {
      window.targetData[token["activity.id"]] = token;
    });
  } catch(ex) {
    _satellite.logger.log(ex.getMessage());
  }
});
</script><script>
(function(apiKey){
    (function(p,e,n,d,o){var v,w,x,y,z;o=p[d]=p[d]||{};o._q=[];
    v=['initialize','identify','updateOptions','pageLoad'];for(w=0,x=v.length;w<x;++w)(function(m){
        o[m]=o[m]||function(){o._q[m===v[0]?'unshift':'push']([m].concat([].slice.call(arguments,0)));};})(v[w]);
        y=e.createElement(n);y.async=!0;y.src='https://cdn.pendo.io/agent/static/'+apiKey+'/pendo.js';
        z=e.getElementsByTagName(n)[0];z.parentNode.insertBefore(y,z);})(window,document,'script','pendo');
})('4d0dfb3d-9fc0-428d-7e95-939e53338845');
</script>
<script>
var pageDataTracker = {
    eventCookieName: 'eventTrack',
    debugCookie: 'els-aa-debugmode',
    debugCounter: 1,
    warnings: [],
    measures: {},
    timeoffset: 0

    ,trackPageLoad: function(data) {
        if (window.pageData && ((pageData.page && pageData.page.noTracking == 'true') || window.pageData_isLoaded)) {
            return false;
        }

        if (data) {
            window.pageData = data;
        }

        this.initWarnings();
        if(!(window.pageData && pageData.page && pageData.page.name)) {
            console.error('pageDataTracker.trackPageLoad() called without pageData.page.name being defined!');
            return;
        }

        this.processIdPlusData(window.pageData);

        if(document.readyState !== 'loading') {
            this.warnings.push('dtm2');
        } else {
            if(window.pageData && pageData.page && !pageData.page.loadTime) {
                pageData.page.loadTime = performance ? Math.round((performance.now())).toString() : '';
            }
        }

        if(window.pageData && pageData.page) {
            var localTime = new Date().getTime();
            if(pageData.page.loadTimestamp) {
                // calculate timeoffset
                var serverTime = parseInt(pageData.page.loadTimestamp);
                if(!isNaN(serverTime)) {
                    this.timeoffset = pageData.page.loadTimestamp - localTime;
                }
            } else {
                pageData.page.loadTimestamp = localTime;
            }
        }

        this.validateData(window.pageData);

        // measures
        try {
            var resources = performance.getEntriesByType("resource");
            var f = true;
            var dtotal = 0;
            for (var j = 0; j < resources.length; j++) {
                var d = resources[j].duration;
                if (resources[j].name.indexOf('satelliteLib') !== -1) {
                    if(d) {
                        dtotal = dtotal + d;
                    }
                }
                if((resources[j].name.indexOf('satellite-') !== -1) && d && f) {
                    f = false;
                    dtotal = dtotal + d;
                }
            }
            this.measures['du'] = Math.round(dtotal).toString();
            this.measures['lt'] = Math.round((performance.now())).toString();
        } catch(e) {
            this.warnings.push('dtm4');
        }

        try {
            var cookieTest = 'a73bp32';
            this.setCookie(cookieTest, cookieTest);
            if(this.getCookie(cookieTest) != cookieTest) {
                this.warnings.push('dtm5');
            }
            this.deleteCookie(cookieTest);
        } catch(e){
            this.warnings.push('dtm5');
        }

        this.registerCallbacks();
        this.setAnalyticsData();

        // handle any cookied event data
        this.getEvents();

        window.pageData_isLoaded = true;

        this.debugMessage('Init - trackPageLoad()', window.pageData);
      
        _satellite.track('initializePendo');
        _satellite.track('pageLoad');
    }

    ,trackEvent: function(event, data, callback) {
        if(!window.pageData_isLoaded) {
            if(this.isDebugEnabled()) {
                console.log('[AA] pageDataTracker.trackEvent() called without calling trackPageLoad() first.');
            }
            return false;
        }
        if (window.pageData && pageData.page && pageData.page.noTracking == 'true') {
            return false;
        }

        if (event) {
            this.initWarnings();
            if(document.readyState !== 'complete') {
                this.warnings.push('dtm3');
            }
            if(event === 'newPage') {
                // auto fillings
                if(data.page && !data.page.loadTimestamp) {
                    data.page.loadTimestamp = ''+(new Date().getTime() + this.timeoffset);
                }
                this.processIdPlusData(data);
            }

            window.eventData = data ? data : {};
            window.eventData.eventName = event;
            this.handleEventData(event, data);

            if(event === 'newPage') {
                this.validateData(window.pageData);
            }
            this.debugMessage('Event: ' + event, data);

            _satellite.track('eventDispatcher', JSON.stringify({
                eventName: event,
                eventData: window.eventData,
                pageData: window.pageData
            }));
        }

        if (typeof(callback) == 'function') {
            callback.call();
        }
    }

    ,processIdPlusData: function(data) {
        if(data && data.visitor && data.visitor.idPlusData) {
            var idPlusFields = ['userId', 'accessType', 'accountId', 'accountName'];
            for(var i=0; i < idPlusFields.length; i++) {
                if(typeof data.visitor.idPlusData[idPlusFields[i]] !== 'undefined') {
                    data.visitor[idPlusFields[i]] = data.visitor.idPlusData[idPlusFields[i]];
                }
            }
            data.visitor.idPlusData = undefined;
        }
    }

    ,validateData: function(data) {
        if(!data) {
            this.warnings.push('dv0');
            return;
        }

        // top 5
        if(!(data.visitor && data.visitor.accessType)) {
            this.warnings.push('dv1');
        }
        if(data.visitor && (data.visitor.accountId || data.visitor.accountName)) {
            if(!data.visitor.accountName) {
                this.warnings.push('dv2');
            }
            if(!data.visitor.accountId) {
                this.warnings.push('dv3');
            }
        }
        if(!(data.page && data.page.productName)) {
            this.warnings.push('dv4');
        }
        if(!(data.page && data.page.businessUnit)) {
            this.warnings.push('dv5');
        }
        if(!(data.page && data.page.name)) {
            this.warnings.push('dv6');
        }

        // rp mandatory
        if(data.page && data.page.businessUnit && (data.page.businessUnit.toLowerCase().indexOf('els:rp:') !== -1 || data.page.businessUnit.toLowerCase().indexOf('els:rap:') !== -1)) {
            if(!(data.page && data.page.loadTimestamp)) {
                this.warnings.push('dv7');
            }
            if(!(data.page && data.page.loadTime)) {
                this.warnings.push('dv8');
            }
            if(!(data.visitor && data.visitor.ipAddress)) {
                this.warnings.push('dv9');
            }
            if(!(data.page && data.page.type)) {
                this.warnings.push('dv10');
            }
            if(!(data.page && data.page.language)) {
                this.warnings.push('dv11');
            }
        }

        // other
        if(data.page && data.page.environment) {
            var env = data.page.environment.toLowerCase();
            if(!(env === 'dev' || env === 'cert' || env === 'prod')) {
                this.warnings.push('dv12');
            }
        }
        if(data.content && data.content.constructor !== Array) {
            this.warnings.push('dv13');
        }
    }

    ,initWarnings: function() {
        this.warnings = [];
        try {
            var hdn = document.head.childNodes;
            var libf = false;
            for(var i=0; i<hdn.length; i++) {
                if(hdn[i].src && (hdn[i].src.indexOf('satelliteLib') !== -1 || hdn[i].src.indexOf('launch') !== -1)) {
                    libf = true;
                    break;
                }
            }
            if(!libf) {
                this.warnings.push('dtm1');
            }
        } catch(e) {
        }
    }

    ,getMessages: function() {
        return this.warnings.join('|');
    }
    ,addMessage: function(message) {
        this.warnings.push(message);
    }

    ,getPerformance: function() {
        var copy = {};
        for (var attr in this.measures) {
            if(this.measures.hasOwnProperty(attr)) {
                copy[attr] = this.measures[attr];
            }
        }

        this.measures = {};
        return copy;
    }

    ,dtmCodeDesc: {
        dtm1: 'satellite-lib must be placed in the <head> section',
        dtm2: 'trackPageLoad() must be placed and called before the closing </body> tag',
        dtm3: 'trackEvent() must be called at a stage where Document.readyState=complete (e.g. on the load event or a user event)',
        dv1: 'visitor.accessType not set but mandatory',
        dv2: 'visitor.accountName not set but mandatory',
        dv3: 'visitor.accountId not set but mandatory',
        dv4: 'page.productName not set but mandatory',
        dv5: 'page.businessUnit not set but mandatory',
        dv6: 'page.name not set but mandatory',
        dv7: 'page.loadTimestamp not set but mandatory',
        dv8: 'page.loadTime not set but mandatory',
        dv9: 'visitor.ipAddress not set but mandatory',
        dv10: 'page.type not set but mandatory',
        dv11: 'page.language not set but mandatory',
        dv12: 'page.environment must be set to \'prod\', \'cert\' or \'dev\'',
        dv13: 'content must be of type array of objects'
    }

    ,debugMessage: function(event, data) {
        if(this.isDebugEnabled()) {
            console.log('[AA] --------- [' + (this.debugCounter++) + '] Web Analytics Data ---------');
            console.log('[AA] ' + event);
            console.groupCollapsed("[AA] AA Data: ");
            if(window.eventData) {
                console.log("[AA] eventData:\n" + JSON.stringify(window.eventData, true, 2));
            }
            if(window.pageData) {
                console.log("[AA] pageData:\n" + JSON.stringify(window.pageData, true, 2));
            }
            console.groupEnd();
            if(this.warnings.length > 0) {
                console.groupCollapsed("[AA] Warnings ("+this.warnings.length+"): ");
                for(var i=0; i<this.warnings.length; i++) {
                    var error = this.dtmCodeDesc[this.warnings[i]] ? this.dtmCodeDesc[this.warnings[i]] : 'Error Code: ' + this.warnings[i];
                    console.log('[AA] ' + error);
                }
                console.log('[AA] More can be found here: https://confluence.cbsels.com/display/AA/AA+Error+Catalog');
                console.groupEnd();
            }
            console.log("This mode can be disabled by calling 'pageDataTracker.disableDebug()'");
        }
    }

    ,getTrackingCode: function() {
        return window.sessionStorage ? sessionStorage.getItem('dgcid') : '';
    }

    ,isDebugEnabled: function() {
        if(typeof this.debug === 'undefined') {
            this.debug = (document.cookie.indexOf(this.debugCookie) !== -1) || (window.pageData && pageData.page && pageData.page.environment && pageData.page.environment.toLowerCase() === 'dev');
            //this.debug = (document.cookie.indexOf(this.debugCookie) !== -1);
        }
        return this.debug;
    }

    ,enableDebug: function(expire) {
        if (typeof expire === 'undefined') {
            expire = 86400;
        }
        console.log('You just enabled debug mode for Adobe Analytics tracking. This mode will persist for 24h.');
        console.log("This mode can be disabled by calling 'pageDataTracker.disableDebug()'");
        this.setCookie(this.debugCookie, 'true', expire, document.location.hostname);
        this.debug = true;
    }

    ,disableDebug: function() {
        console.log('Debug mode is now disabled.');
        this.deleteCookie(this.debugCookie);
        this.debug = false;
    }

    ,setAnalyticsData: function() {
        if(!(window.pageData && pageData.page && pageData.page.productName && pageData.page.name)) {
            return;
        }
        pageData.page.analyticsPagename = pageData.page.productName + ':' + pageData.page.name;

        var pageEls = pageData.page.name.indexOf(':') > -1 ? pageData.page.name.split(':') : [pageData.page.name];
        pageData.page.sectionName = pageData.page.productName + ':' + pageEls[0];
    }

    ,getEvents: function() {
        pageData.savedEvents = {};
        pageData.eventList = [];

        var val = this.getCookie(this.eventCookieName);
        if (val) {
            pageData.savedEvents = val;
        }

        this.deleteCookie(this.eventCookieName);
    }

    ,handleEventData: function(event, data) {
        var val;
        switch(event) {
            case 'newPage':
                if (data && typeof(data) === 'object') {
                    for (var x in data) {
                        if(data.hasOwnProperty(x) && data[x] instanceof Array) {
                            pageData[x] = data[x];
                        } else if(data.hasOwnProperty(x) && typeof(data[x]) === 'object') {
                            if(!pageData[x]) {
                                pageData[x] = {};
                            }
                            for (var y in data[x]) {
                                if(data[x].hasOwnProperty(y)) {
                                    pageData[x][y] = data[x][y];
                                }
                            }
                        }
                    }
                }
                this.setAnalyticsData();
            case 'saveSearch':
            case 'searchResultsUpdated':
                if (data) {
                    // overwrite page-load object
                    if (data.search && typeof(data.search) == 'object') {
                        window.eventData.search.resultsPosition = '';
                        pageData.search = pageData.search || {};
                        var fields = ['advancedCriteria', 'criteria', 'currentPage', 'dataFormCriteria', 'facets', 'resultsByType', 'resultsPerPage', 'sortType', 'totalResults', 'type', 'database',
                            'suggestedClickPosition','suggestedLetterCount','suggestedResultCount', 'autoSuggestCategory', 'autoSuggestDetails','typedTerm','selectedTerm', 'channel',
                            'facetOperation', 'details'];
                        for (var i=0; i<fields.length; i++) {
                            if (data.search[fields[i]]) {
                                pageData.search[fields[i]] = data.search[fields[i]];
                            }
                        }
                    }
                }
                this.setAnalyticsData();
                break;
            case 'navigationClick':
                if (data && data.link) {
                    window.eventData.navigationLink = {
                        name: ((data.link.location || 'no location') + ':' + (data.link.name || 'no name'))
                    };
                }
                break;
            case 'autoSuggestClick':
                if (data && data.search) {
                    val = {
                        autoSuggestSearchData: (
                            'letterct:' + (data.search.suggestedLetterCount || 'none') +
                            '|resultct:' + (data.search.suggestedResultCount || 'none') +
                            '|clickpos:' + (data.search.suggestedClickPosition || 'none')
                        ).toLowerCase(),
                        autoSuggestSearchTerm: (data.search.typedTerm || ''),
                        autoSuggestTypedTerm: (data.search.typedTerm || ''),
                        autoSuggestSelectedTerm: (data.search.selectedTerm || ''),
                        autoSuggestCategory: (data.search.autoSuggestCategory || ''),
                        autoSuggestDetails: (data.search.autoSuggestDetails || '')
                    };
                }
                break;
            case 'linkOut':
                if (data && data.content && data.content.length > 0) {
                    window.eventData.linkOut = data.content[0].linkOut;
                    window.eventData.referringProduct = _satellite.getVar('Page - Product Name') + ':' + data.content[0].id;
                }
                break;
            case 'socialShare':
                if (data && data.social) {
                    window.eventData.sharePlatform = data.social.sharePlatform || '';
                }
                break;
            case 'contentInteraction':
                if (data && data.action) {
                    window.eventData.action.name = pageData.page.productName + ':' + data.action.name;
                }
                break;
            case 'searchWithinContent':
                if (data && data.search) {
                    window.pageData.search = window.pageData.search || {};
                    pageData.search.withinContentCriteria = data.search.withinContentCriteria;
                }
                break;
            case 'contentShare':
                if (data && data.content) {
                    window.eventData.sharePlatform = data.content[0].sharePlatform;
                }
                break;
            case 'contentLinkClick':
                if (data && data.link) {
                    window.eventData.action = { name: pageData.page.productName + ':' + (data.link.type || 'no link type') + ':' + (data.link.name || 'no link name') };
                }
                break;
            case 'contentWindowLoad':
            case 'contentTabClick':
                if (data && data.content) {
                    window.eventData.tabName = data.content[0].tabName || '';
                    window.eventData.windowName = data.content[0].windowName || '';
                }
                break;
            case 'userProfileUpdate':
                if (data && data.user) {
                    if (Object.prototype.toString.call(data.user) === "[object Array]") {
                        window.eventData.user = data.user[0];
                    }
                }
                break;
            case 'videoStart':
                if (data.video) {
                    data.video.length = parseFloat(data.video.length || '0');
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.open(data.video.id, data.video.length, s.Media.playerName);
                    s.Media.play(data.video.id, data.video.position);
                }
                break;
            case 'videoPlay':
                if (data.video) {
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.play(data.video.id, data.video.position);
                }
                break;
            case 'videoStop':
                if (data.video) {
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.stop(data.video.id, data.video.position);
                }
                break;
            case 'videoComplete':
                if (data.video) {
                    data.video.position = parseFloat(data.video.position || '0');
                    s.Media.stop(data.video.id, data.video.position);
                    s.Media.close(data.video.id);
                }
                break;
            case 'addWebsiteExtension':
                if(data && data.page) {
                    val = {
                        wx: data.page.websiteExtension
                    }
                }
                break;
        }

        if (val) {
            this.setCookie(this.eventCookieName, val);
        }
    }

    ,registerCallbacks: function() {
        var self = this;
        if(window.usabilla_live) {
            window.usabilla_live('setEventCallback', function(category, action, label, value) {
                if(action == 'Campaign:Open') {
                    self.trackEvent('ctaImpression', {
                        cta: {
                            ids: ['usabillaid:' + label]
                        }
                    });
                } else if(action == 'Campaign:Success') {
                    self.trackEvent('ctaClick', {
                        cta: {
                            ids: ['usabillaid:' + label]
                        }
                    });
                }
            });
        }
    }

    ,getConsortiumAccountId: function() {
        var id = '';
        if (window.pageData && pageData.visitor && (pageData.visitor.consortiumId || pageData.visitor.accountId)) {
            id = (pageData.visitor.consortiumId || 'no consortium ID') + '|' + (pageData.visitor.accountId || 'no account ID');
        }

        return id;
    }

    ,getSearchClickPosition: function() {
        if (window.eventData && eventData.search && eventData.search.resultsPosition) {
            var pos = parseInt(eventData.search.resultsPosition), clickPos;
            if (!isNaN(pos)) {
                var page = pageData.search.currentPage ? parseInt(pageData.search.currentPage) : '', perPage = pageData.search.resultsPerPage ? parseInt(pageData.search.resultsPerPage) : '';
                if (!isNaN(page) && !isNaN(perPage)) {
                    clickPos = pos + ((page - 1) * perPage);
                }
            }
            return clickPos ? clickPos.toString() : eventData.search.resultsPosition;
        }
        return '';
    }

    ,getSearchFacets: function() {
        var facetList = '';
        if (window.pageData && pageData.search && pageData.search.facets) {
            if (typeof(pageData.search.facets) == 'object') {
                for (var i=0; i<pageData.search.facets.length; i++) {
                    var f = pageData.search.facets[i];
                    facetList += (facetList ? '|' : '') + f.name + '=' + f.values.join('^');
                }
            }
        }
        return facetList;
    }

    ,getSearchResultsByType: function() {
        var resultTypes = '';
        if (window.pageData && pageData.search && pageData.search.resultsByType) {
            for (var i=0; i<pageData.search.resultsByType.length; i++) {
                var r = pageData.search.resultsByType[i];
                resultTypes += (resultTypes ? '|' : '') + r.name + (r.results || r.values ? '=' + (r.results || r.values) : '');
            }
        }
        return resultTypes;
    }

    ,getJournalInfo: function() {
        var info = '';
        if (window.pageData && pageData.journal && (pageData.journal.name || pageData.journal.specialty || pageData.journal.section || pageData.journal.issn || pageData.journal.issueNumber || pageData.journal.volumeNumber)) {
            var journal = pageData.journal;
            return (journal.name || 'no name') + '|' + (journal.specialty || 'no specialty') + '|' + (journal.section || 'no section') + '|' + (journal.issn || 'no issn') + '|' + (journal.issueNumber || 'no issue #') + '|' + (journal.volumeNumber || 'no volume #');
        }
        return info;
    }

    ,getBibliographicInfo: function(doc) {
        if (!doc || !(doc.publisher || doc.indexTerms || doc.publicationType || doc.publicationRights || doc.volumeNumber || doc.issueNumber || doc.subjectAreas || doc.isbn)) {
            return '';
        }

        var terms = doc.indexTerms ? doc.indexTerms.split('+') : '';
        if (terms) {
            terms = terms.slice(0, 5).join('+');
            terms = terms.length > 100 ? terms.substring(0, 100) : terms;
        }

        var areas = doc.subjectAreas ? doc.subjectAreas.split('>') : '';
        if (areas) {
            areas = areas.slice(0, 5).join('>');
            areas = areas.length > 100 ? areas.substring(0, 100) : areas;
        }

        var biblio	= (doc.publisher || 'none')
            + '^' + (doc.publicationType || 'none')
            + '^' + (doc.publicationRights || 'none')
            + '^' + (terms || 'none')
            + '^' + (doc.volumeNumber || 'none')
            + '^' + (doc.issueNumber || 'none')
            + '^' + (areas || 'none')
            + '^' + (doc.isbn || 'none');

        return this.stripProductDelimiters(biblio).toLowerCase();
    }

    ,getContentItem: function() {
        var docs = window.eventData && eventData.content ? eventData.content : pageData.content;
        if (docs && docs.length > 0) {
            return docs[0];
        }
    }

    ,getFormattedDate: function(ts) {
        if (!ts) {
            return '';
        }

        var d = new Date(parseInt(ts) * 1000);

        // now do formatting
        var year = d.getFullYear()
            ,month = ((d.getMonth() + 1) < 10 ? '0' : '') + (d.getMonth() + 1)
            ,date = (d.getDate() < 10 ? '0' : '') + d.getDate()
            ,hours = d.getHours() > 12 ? d.getHours() - 12 : d.getHours()
            ,mins = (d.getMinutes() < 10 ? '0' : '') + d.getMinutes()
            ,ampm = d.getHours() > 12 ? 'pm' : 'am';

        hours = (hours < 10 ? '0' : '') + hours;
        return year + '-' + month + '-' + date;
    }

    ,getVisitorId: function() {
        var orgId = '4D6368F454EC41940A4C98A6@AdobeOrg';
        if(Visitor && Visitor.getInstance(orgId)) {
            return Visitor.getInstance(orgId).getMarketingCloudVisitorID();
        } else {
            return ''
        }
    }

    ,setProductsVariable: function() {
        var prodList = window.eventData && eventData.content ? eventData.content : pageData.content
            ,prods = [];
        if (prodList) {
            for (var i=0; i<prodList.length; i++) {
                if (prodList[i].id || prodList[i].type || prodList[i].publishDate || prodList[i].onlineDate) {
                    if (!prodList[i].id) {
                        prodList[i].id = 'no id';
                    }
                    var prodName = (pageData.page.productName || 'xx').toLowerCase();
                    if (prodList[i].id.indexOf(prodName + ':') != 0) {
                        prodList[i].id = prodName + ':' + prodList[i].id;
                    }
                    prodList[i].id = this.stripProductDelimiters(prodList[i].id);
                    var merch = [];
                    if (prodList[i].format) {
                        merch.push('evar17=' + this.stripProductDelimiters(prodList[i].format.toLowerCase()));
                    }
                    if (prodList[i].type) {
                        var type = prodList[i].type;
                        if (prodList[i].accessType) {
                            type += ':' + prodList[i].accessType;
                        }
                        merch.push('evar20=' + this.stripProductDelimiters(type.toLowerCase()));
                    }
                    if(!prodList[i].title) {
                        prodList[i].title = prodList[i].name;
                    }
                    if (prodList[i].title) {
                        merch.push('evar75=' + this.stripProductDelimiters(prodList[i].title.toLowerCase()));
                    }
                    if (prodList[i].breadcrumb) {
                        merch.push('evar63=' + this.stripProductDelimiters(prodList[i].breadcrumb).toLowerCase());
                    }
                    var nowTs = new Date().getTime()/1000;
                    if (prodList[i].onlineDate && !isNaN(prodList[i].onlineDate)) {
                        if(prodList[i].onlineDate > 32503680000) {
                            prodList[i].onlineDate = prodList[i].onlineDate/1000;
                        }
                        merch.push('evar122=' + this.stripProductDelimiters(pageDataTracker.getFormattedDate(prodList[i].onlineDate)));
                        var onlineAge = Math.floor((nowTs - prodList[i].onlineDate) / 86400);
                        onlineAge = (onlineAge === 0) ? 'zero' : onlineAge;
                        merch.push('evar128=' + onlineAge);
                    }
                    if (prodList[i].publishDate && !isNaN(prodList[i].publishDate)) {
                        if(prodList[i].publishDate > 32503680000) {
                            prodList[i].publishDate = prodList[i].publishDate/1000;
                        }
                        merch.push('evar123=' + this.stripProductDelimiters(pageDataTracker.getFormattedDate(prodList[i].publishDate)));
                        var publishAge = Math.floor((nowTs - prodList[i].publishDate) / 86400);
                        publishAge = (publishAge === 0) ? 'zero' : publishAge;
                        merch.push('evar127=' + publishAge);
                    }
                    if (prodList[i].onlineDate && prodList[i].publishDate) {
                        merch.push('evar38=' + this.stripProductDelimiters(pageDataTracker.getFormattedDate(prodList[i].onlineDate) + '^' + pageDataTracker.getFormattedDate(prodList[i].publishDate)));
                    }
                    if (prodList[i].mapId) {
                        merch.push('evar70=' + this.stripProductDelimiters(prodList[i].mapId));
                    }
                    if (prodList[i].relevancyScore) {
                        merch.push('evar71=' + this.stripProductDelimiters(prodList[i].relevancyScore));
                    }
                    if (prodList[i].status) {
                        merch.push('evar73=' + this.stripProductDelimiters(prodList[i].status));
                    }
                    if (prodList[i].previousStatus) {
                        merch.push('evar111=' + this.stripProductDelimiters(prodList[i].previousStatus));
                    }
                    if (prodList[i].entitlementType) {
                        merch.push('evar80=' + this.stripProductDelimiters(prodList[i].entitlementType));
                    }
                    if (prodList[i].recordType) {
                        merch.push('evar93=' + this.stripProductDelimiters(prodList[i].recordType));
                    }
                    if (prodList[i].exportType) {
                        merch.push('evar99=' + this.stripProductDelimiters(prodList[i].exportType));
                    }
                    if (prodList[i].importType) {
                        merch.push('evar142=' + this.stripProductDelimiters(prodList[i].importType));
                    }
                    if (prodList[i].section) {
                        merch.push('evar100=' + this.stripProductDelimiters(prodList[i].section));
                    }
                    if (prodList[i].detail) {
                        merch.push('evar104=' + this.stripProductDelimiters(prodList[i].detail.toLowerCase()));
                    } else if(prodList[i].details) {
                        merch.push('evar104=' + this.stripProductDelimiters(prodList[i].details.toLowerCase()));
                    }
                    if (prodList[i].position) {
                        merch.push('evar116=' + this.stripProductDelimiters(prodList[i].position));
                    }
                    if (prodList[i].publicationTitle) {
                        merch.push('evar129=' + this.stripProductDelimiters(prodList[i].publicationTitle));
                    }
                    if (prodList[i].specialIssueTitle) {
                        merch.push('evar130=' + this.stripProductDelimiters(prodList[i].specialIssueTitle));
                    }
                    if (prodList[i].specialIssueNumber) {
                        merch.push('evar131=' + this.stripProductDelimiters(prodList[i].specialIssueNumber));
                    }
                    if (prodList[i].referenceModuleTitle) {
                        merch.push('evar139=' + this.stripProductDelimiters(prodList[i].referenceModuleTitle));
                    }
                    if (prodList[i].referenceModuleISBN) {
                        merch.push('evar140=' + this.stripProductDelimiters(prodList[i].referenceModuleISBN));
                    }
                    if (prodList[i].volumeTitle) {
                        merch.push('evar132=' + this.stripProductDelimiters(prodList[i].volumeTitle));
                    }
                    if (prodList[i].publicationSection) {
                        merch.push('evar133=' + this.stripProductDelimiters(prodList[i].publicationSection));
                    }
                    if (prodList[i].publicationSpecialty) {
                        merch.push('evar134=' + this.stripProductDelimiters(prodList[i].publicationSpecialty));
                    }
                    if (prodList[i].issn) {
                        merch.push('evar135=' + this.stripProductDelimiters(prodList[i].issn));
                    }
                    if (prodList[i].id2) {
                        merch.push('evar159=' + this.stripProductDelimiters(prodList[i].id2));
                    }
                    if (prodList[i].id3) {
                        merch.push('evar160=' + this.stripProductDelimiters(prodList[i].id3));
                    }
                    if (prodList[i].provider) {
                        merch.push('evar164=' + this.stripProductDelimiters(prodList[i].provider));
                    }
                    if (prodList[i].citationStyle) {
                        merch.push('evar170=' + this.stripProductDelimiters(prodList[i].citationStyle));
                    }

                    var biblio = this.getBibliographicInfo(prodList[i]);
                    if (biblio) {
                        merch.push('evar28=' + biblio);
                    }

                    if (prodList[i].turnawayId) {
                        pageData.eventList.push('product turnaway');
                    }

                    var price = prodList[i].price || '', qty = prodList[i].quantity || '', evts = [];
                    if (price && qty) {
                        qty = parseInt(qty || '1');
                        price = parseFloat(price || '0');
                        price = (price * qty).toFixed(2);

                        if (window.eventData && eventData.eventName && eventData.eventName == 'cartAdd') {
                            evts.push('event20=' + price);
                        }
                    }

                    var type = window.pageData && pageData.page && pageData.page.type ? pageData.page.type : '', evt = window.eventData && eventData.eventName ? eventData.eventName : '';
                    if (type.match(/^CP\-/gi) !== null && (!evt || evt == 'newPage' || evt == 'contentView')) {
                        evts.push('event181=1');
                    }
                    if (evt == 'contentDownload' || type.match(/^CP\-DL/gi) !== null) {
                        evts.push('event182=1');
                    }
                    if (evt == 'contentExport') {
                        evts.push('event184=1');
                    }
                    if (this.eventFires('recommendationViews')) {
                        evts.push('event264=1');
                    }

                    if(prodList[i].datapoints) {
                        evts.push('event239=' + prodList[i].datapoints);
                    }
                    if(prodList[i].documents) {
                        evts.push('event240=' + prodList[i].documents);
                    }
                    if(prodList[i].discountAmount) {
                        evts.push('event301=' + prodList[i].discountAmount);
                    }

                    prods.push([
                        ''					// empty category
                        ,prodList[i].id		// id
                        ,qty				// qty
                        ,price				// price
                        ,evts.join('|')		// events
                        ,merch.join('|')	// merchandising eVars
                    ].join(';'));
                }
            }
        }

        return prods.join(',');
    }
    ,eventFires: function(eventName) {
        var evt = window.eventData && eventData.eventName ? eventData.eventName : '';
        if(evt == eventName) {
            return true;
        }
        // initial pageload and new pages
        if((!window.eventData || evt == 'newPage') && window.pageData && window.pageData.trackEvents) {
            var tEvents = window.pageData.trackEvents;
            for(var i=0; i<tEvents.length; i++) {
                if(tEvents[i] == eventName) {
                    return true;
                }
            }
        }
        return false;
    }

    ,md5: function(s){function L(k,d){return(k<<d)|(k>>>(32-d))}function K(G,k){var I,d,F,H,x;F=(G&2147483648);H=(k&2147483648);I=(G&1073741824);d=(k&1073741824);x=(G&1073741823)+(k&1073741823);if(I&d){return(x^2147483648^F^H)}if(I|d){if(x&1073741824){return(x^3221225472^F^H)}else{return(x^1073741824^F^H)}}else{return(x^F^H)}}function r(d,F,k){return(d&F)|((~d)&k)}function q(d,F,k){return(d&k)|(F&(~k))}function p(d,F,k){return(d^F^k)}function n(d,F,k){return(F^(d|(~k)))}function u(G,F,aa,Z,k,H,I){G=K(G,K(K(r(F,aa,Z),k),I));return K(L(G,H),F)}function f(G,F,aa,Z,k,H,I){G=K(G,K(K(q(F,aa,Z),k),I));return K(L(G,H),F)}function D(G,F,aa,Z,k,H,I){G=K(G,K(K(p(F,aa,Z),k),I));return K(L(G,H),F)}function t(G,F,aa,Z,k,H,I){G=K(G,K(K(n(F,aa,Z),k),I));return K(L(G,H),F)}function e(G){var Z;var F=G.length;var x=F+8;var k=(x-(x%64))/64;var I=(k+1)*16;var aa=Array(I-1);var d=0;var H=0;while(H<F){Z=(H-(H%4))/4;d=(H%4)*8;aa[Z]=(aa[Z]| (G.charCodeAt(H)<<d));H++}Z=(H-(H%4))/4;d=(H%4)*8;aa[Z]=aa[Z]|(128<<d);aa[I-2]=F<<3;aa[I-1]=F>>>29;return aa}function B(x){var k="",F="",G,d;for(d=0;d<=3;d++){G=(x>>>(d*8))&255;F="0"+G.toString(16);k=k+F.substr(F.length-2,2)}return k}function J(k){k=k.replace(/rn/g,"n");var d="";for(var F=0;F<k.length;F++){var x=k.charCodeAt(F);if(x<128){d+=String.fromCharCode(x)}else{if((x>127)&&(x<2048)){d+=String.fromCharCode((x>>6)|192);d+=String.fromCharCode((x&63)|128)}else{d+=String.fromCharCode((x>>12)|224);d+=String.fromCharCode(((x>>6)&63)|128);d+=String.fromCharCode((x&63)|128)}}}return d}var C=Array();var P,h,E,v,g,Y,X,W,V;var S=7,Q=12,N=17,M=22;var A=5,z=9,y=14,w=20;var o=4,m=11,l=16,j=23;var U=6,T=10,R=15,O=21;s=J(s);C=e(s);Y=1732584193;X=4023233417;W=2562383102;V=271733878;for(P=0;P<C.length;P+=16){h=Y;E=X;v=W;g=V;Y=u(Y,X,W,V,C[P+0],S,3614090360);V=u(V,Y,X,W,C[P+1],Q,3905402710);W=u(W,V,Y,X,C[P+2],N,606105819);X=u(X,W,V,Y,C[P+3],M,3250441966);Y=u(Y,X,W,V,C[P+4],S,4118548399);V=u(V,Y,X,W,C[P+5],Q,1200080426);W=u(W,V,Y,X,C[P+6],N,2821735955);X=u(X,W,V,Y,C[P+7],M,4249261313);Y=u(Y,X,W,V,C[P+8],S,1770035416);V=u(V,Y,X,W,C[P+9],Q,2336552879);W=u(W,V,Y,X,C[P+10],N,4294925233);X=u(X,W,V,Y,C[P+11],M,2304563134);Y=u(Y,X,W,V,C[P+12],S,1804603682);V=u(V,Y,X,W,C[P+13],Q,4254626195);W=u(W,V,Y,X,C[P+14],N,2792965006);X=u(X,W,V,Y,C[P+15],M,1236535329);Y=f(Y,X,W,V,C[P+1],A,4129170786);V=f(V,Y,X,W,C[P+6],z,3225465664);W=f(W,V,Y,X,C[P+11],y,643717713);X=f(X,W,V,Y,C[P+0],w,3921069994);Y=f(Y,X,W,V,C[P+5],A,3593408605);V=f(V,Y,X,W,C[P+10],z,38016083);W=f(W,V,Y,X,C[P+15],y,3634488961);X=f(X,W,V,Y,C[P+4],w,3889429448);Y=f(Y,X,W,V,C[P+9],A,568446438);V=f(V,Y,X,W,C[P+14],z,3275163606);W=f(W,V,Y,X,C[P+3],y,4107603335);X=f(X,W,V,Y,C[P+8],w,1163531501);Y=f(Y,X,W,V,C[P+13],A,2850285829);V=f(V,Y,X,W,C[P+2],z,4243563512);W=f(W,V,Y,X,C[P+7],y,1735328473);X=f(X,W,V,Y,C[P+12],w,2368359562);Y=D(Y,X,W,V,C[P+5],o,4294588738);V=D(V,Y,X,W,C[P+8],m,2272392833);W=D(W,V,Y,X,C[P+11],l,1839030562);X=D(X,W,V,Y,C[P+14],j,4259657740);Y=D(Y,X,W,V,C[P+1],o,2763975236);V=D(V,Y,X,W,C[P+4],m,1272893353);W=D(W,V,Y,X,C[P+7],l,4139469664);X=D(X,W,V,Y,C[P+10],j,3200236656);Y=D(Y,X,W,V,C[P+13],o,681279174);V=D(V,Y,X,W,C[P+0],m,3936430074);W=D(W,V,Y,X,C[P+3],l,3572445317);X=D(X,W,V,Y,C[P+6],j,76029189);Y=D(Y,X,W,V,C[P+9],o,3654602809);V=D(V,Y,X,W,C[P+12],m,3873151461);W=D(W,V,Y,X,C[P+15],l,530742520);X=D(X,W,V,Y,C[P+2],j,3299628645);Y=t(Y,X,W,V,C[P+0],U,4096336452);V=t(V,Y,X,W,C[P+7],T,1126891415);W=t(W,V,Y,X,C[P+14],R,2878612391);X=t(X,W,V,Y,C[P+5],O,4237533241);Y=t(Y,X,W,V,C[P+12],U,1700485571);V=t(V,Y,X,W,C[P+3],T,2399980690);W=t(W,V,Y,X,C[P+10],R,4293915773);X=t(X,W,V,Y,C[P+1],O,2240044497);Y=t(Y,X,W,V,C[P+8],U,1873313359);V=t(V,Y,X,W,C[P+15],T,4264355552);W=t(W,V,Y,X,C[P+6],R,2734768916);X=t(X,W,V,Y,C[P+13],O,1309151649);Y=t(Y,X,W,V,C[P+4],U,4149444226);V=t(V,Y,X,W,C[P+11],T,3174756917);W=t(W,V,Y,X,C[P+2],R,718787259);X=t(X,W,V,Y,C[P+9],O,3951481745);Y=K(Y,h);X=K(X,E);W=K(W,v);V=K(V,g)}var i=B(Y)+B(X)+B(W)+B(V);return i.toLowerCase()}
    ,stripProductDelimiters: function(val) {
        if (val) {
            return val.replace(/\;|\||\,/gi, '-');
        }
    }

    ,setCookie: function(name, value, seconds, domain) {
        domain = document.location.hostname;
        var expires = '';
        var expiresNow = '';
        var date = new Date();
        date.setTime(date.getTime() + (-1 * 1000));
        expiresNow = "; expires=" + date.toGMTString();

        if (typeof(seconds) != 'undefined') {
            date.setTime(date.getTime() + (seconds * 1000));
            expires = '; expires=' + date.toGMTString();
        }

        var type = typeof(value);
        type = type.toLowerCase();
        if (type != 'undefined' && type != 'string') {
            value = JSON.stringify(value);
        }

        // fix scoping issues
        // keep writing the old cookie, but make it expire
        document.cookie = name + '=' + value + expiresNow + '; path=/';

        // now just set the right one
        document.cookie = name + '=' + value + expires + '; path=/; domain=' + domain;
    }

    ,getCookie: function(name) {
        name = name + '=';
        var carray = document.cookie.split(';'), value;

        for (var i=0; i<carray.length; i++) {
            var c = carray[i];
            while (c.charAt(0) == ' ') {
                c = c.substring(1, c.length);
            }
            if (c.indexOf(name) == 0) {
                value = c.substring(name.length, c.length);
                try {
                    value = JSON.parse(value);
                } catch(ex) {}

                return value;
            }
        }

        return null;
    }

    ,deleteCookie: function(name) {
        this.setCookie(name, '', -1);
        this.setCookie(name, '', -1, document.location.hostname);
    }

    ,mapAdobeVars: function(s) {
        var vars = {
            pageName		: 'Page - Analytics Pagename'
            ,channel		: 'Page - Section Name'
            ,campaign		: 'Campaign - ID'
            ,currencyCode	: 'Page - Currency Code'
            ,purchaseID		: 'Order - ID'
            ,prop1			: 'Visitor - Account ID'
            ,prop2			: 'Page - Product Name'
            ,prop4			: 'Page - Type'
            ,prop6			: 'Search - Type'
            ,prop7			: 'Search - Facet List'
            ,prop8			: 'Search - Feature Used'
            ,prop12			: 'Visitor - User ID'
            ,prop13			: 'Search - Sort Type'
            ,prop14			: 'Page - Load Time'
            ,prop15         : 'Support - Topic Name'
            ,prop16			: 'Page - Business Unit'
            ,prop21			: 'Search - Criteria'
            ,prop24			: 'Page - Language'
            ,prop25			: 'Page - Product Feature'
            ,prop28         : 'Support - Search Criteria'
            ,prop30			: 'Visitor - IP Address'
            ,prop33         : 'Page - Product Application Version'
            ,prop34         : 'Page - Website Extensions'
            ,prop60			: 'Search - Data Form Criteria'
            ,prop65         : 'Page - Online State'
            ,prop67         : 'Research Networks'

            ,eVar3			: 'Search - Total Results'
            ,eVar7			: 'Visitor - Account Name'
            ,eVar15			: 'Event - Search Results Click Position'
            ,eVar19			: 'Search - Advanced Criteria'
            ,eVar21			: 'Promo - Clicked ID'
            ,eVar22			: 'Page - Test ID'
            ,eVar27			: 'Event - AutoSuggest Search Data'
            ,eVar157		: 'Event - AutoSuggest Search Typed Term'
            ,eVar156		: 'Event - AutoSuggest Search Selected Term'
            ,eVar162		: 'Event - AutoSuggest Search Category'
            ,eVar163		: 'Event - AutoSuggest Search Details'
            ,eVar33			: 'Visitor - Access Type'
            ,eVar34			: 'Order - Promo Code'
            ,eVar39			: 'Order - Payment Method'
            ,eVar41			: 'Visitor - Industry'
            ,eVar42			: 'Visitor - SIS ID'
            ,eVar43			: 'Page - Error Type'
            ,eVar44			: 'Event - Updated User Fields'
            ,eVar48			: 'Email - Recipient ID'
            ,eVar51			: 'Email - Message ID'
            ,eVar52			: 'Visitor - Department ID'
            ,eVar53			: 'Visitor - Department Name'
            ,eVar60			: 'Search - Within Content Criteria'
            ,eVar61			: 'Search - Within Results Criteria'
            ,eVar62			: 'Search - Result Types'
            ,eVar74			: 'Page - Journal Info'
            ,eVar76			: 'Email - Broadlog ID'
            ,eVar78			: 'Visitor - Details'
            ,eVar80         : 'Visitor - Usage Path Info'
            ,eVar102		: 'Form - Name'
            ,eVar103        : 'Event - Conversion Driver'
            ,eVar105        : 'Search - Current Page'
            ,eVar106        : 'Visitor - App Session ID'
            ,eVar107        : 'Page - Secondary Product Name'
            ,eVar117        : 'Search - Database'
            ,eVar126        : 'Page - Environment'
            ,eVar141        : 'Search - Criteria Original'
            ,eVar143        : 'Page - Tabs'
            ,eVar161        : 'Search - Channel'
            ,eVar169        : 'Search - Facet Operation'
            ,eVar173        : 'Search - Details'
            ,eVar174        : 'Campaign - Spredfast ID'
            ,eVar175        : 'Visitor - TMX Device ID'
            ,eVar176        : 'Visitor - TMX Request ID'
            ,eVar148        : 'Visitor - Platform Name'
            ,eVar149        : 'Visitor - Platform ID'
            ,eVar152        : 'Visitor - Product ID'
            ,eVar153        : 'Visitor - Superaccount ID'
            ,eVar154        : 'Visitor - Superaccount Name'
            ,eVar177        : 'Page - Context Domain'
            ,eVar189    : 'Page - Experimentation User Id'
            ,eVar190    : 'Page - Identity User'

            ,list2			: 'Page - Widget Names'
            ,list3			: 'Promo - IDs'
        };

        for (var i in vars) {
            s[i] = s[i] ? s[i] : _satellite.getVar(vars[i]);
        }
    }
};

</script>
    <!--[if lt IE 9]>
    <script type="text/javascript">
        document.createElement('header');
        document.createElement('nav');
        document.createElement('section');
        document.createElement('article');
        document.createElement('aside');
        document.createElement('footer');
    </script>
    <![endif]-->
    <script type="text/javascript">
        var buildVersion = "254";
        window.require = {waitSeconds: 60};

        /*
          PROBLEM: the default (home) page of the Embase is quick search. Whole legacy app is hosted in the root, and routing is handled via hash fragment.
          This means there is no way on server to redirect to react ONLY for the root, because hash is purely front-end feature, not available on server.
          SOLUTION: do a redirect on front-end as early as possible.
         */
        (function () {
            // Redirect to react as soon as possible (for the root only)
            if (window.location.pathname === '/' && ['', '#', '#/'].indexOf(window.location.hash) !== -1) {
                window.location.href = window.location.origin + '/search/quick';
            }
        })();
    </script>

    <script src="./Embase  neuronal injury 01_files/launch-30cae8c5a597.min.js.下载"></script>
    <script src="./Embase  neuronal injury 01_files/require-2.1.9.min.js.下载" data-main="/webfiles/javascript/application/app.concat.js?254" type="text/javascript" defer=""></script>

<script type="text/javascript" charset="utf-8" async="" data-requirecontext="_" data-requiremodule="/webfiles/javascript/application/app.concat.js?254" src="./Embase  neuronal injury 01_files/app.concat.js.下载"></script><script type="text/javascript" charset="utf-8" async="" data-requirecontext="_" data-requiremodule="/webfiles/javascript/vendor/d3.min.js" src="./Embase  neuronal injury 01_files/d3.min.js.下载"></script><script src="./Embase  neuronal injury 01_files/RC58c977ad96b340368747fa69a94b2356-source.min.js.下载" async=""></script><script src="./Embase  neuronal injury 01_files/RCe4cc29d2d167492b8c088a4314c62022-source.min.js.下载" async=""></script><script src="./Embase  neuronal injury 01_files/RCae399f9ba1584e1c8bc22f4475109d2f-source.min.js.下载" async=""></script><style type="text/css">.jqstooltip { position: absolute;left: 0px;top: 0px;visibility: hidden;background: rgb(0, 0, 0) transparent;background-color: rgba(0,0,0,0.6);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr=#99000000, endColorstr=#99000000);-ms-filter: "progid:DXImageTransform.Microsoft.gradient(startColorstr=#99000000, endColorstr=#99000000)";color: white;font: 10px arial, san serif;text-align: left;white-space: nowrap;padding: 5px;border: 1px solid white;z-index: 10000;}.jqsfield { color: white;font: 10px arial, san serif;text-align: left;}</style><link type="text/css" rel="stylesheet" href="./Embase  neuronal injury 01_files/guide.-323232.1669194385134.css" id="_pendo-css_"></head>

<body>
    <!-- access navigation -->
    <div class="accessNav">
        <strong>Access navigation</strong>
        <ul>
            <li><a href="https://www.embase.com/#contentBlock">Go to the content</a></li>
            <li><a href="https://www.embase.com/#headerBlock">Go to main navigation</a></li>
            <li><a href="https://www.embase.com/#footer">Go to footer navigation</a></li>
        </ul>
    </div>
    <div class="overlay" id="overlay" style="display: none;"></div>
    
    <div id="abxw" style="display: none;"></div>
    <div id="a2bxw" style="margin: auto; display: none;"><div id="processSearchDialog" class="dialog info" style="display: block;"><h2 class="process-dialog">Please wait</h2><br><div class="clearfix"><p class="login"><span>Processing search...</span></p><br><div class="floatRight"><span class="basebutton emb-btn-small cancel" id="ok_button"><span class="emb-button-text">Cancel</span></span></div></div></div></div>
    <!-- wrapper -->
    <div id="wrapper">
        <div id="headerBlock"><div id="header-holder"><header id="header" class="els-header"><!-- Brand --><div class="els-header-brand-holder"><a id="header-brand" class="els-header-brand" href="https://www.embase.com/"><span class="els-header-logo els-header-logo-reduce-s"><svg xmlns="http://www.w3.org/2000/svg" role="img" version="1.1" width="54" height="48" viewBox="0 0 54 48" enable-background="new 0 0 54 48" xml:space="preserve" focusable="false"><title id="els-header-logo">Elsevier</title><path xmlns="http://www.w3.org/2000/svg" d="M15.04 22.48c.58-.3.91-.68.97-1.11.09-.4-.26-.36-.35-.28-.32.26-.74.66-1.14.93a4.19 4.19 0 0 0-.56.07c-.05-.02-.1-.1-.08-.12.37-.23.77-.46 1.03-.77.17-.2.1-.37-.23-.41-.37-.06-.8.1-1.13.39-.57.48-.84 1.55-.9 2.23-.11.12-.15.12-.27.17a2.83 2.83 0 0 1 .3-2.2c.05-.14.01-.37-.2-.43-.11-.05-.17-.02-.22.1-.28.81-.77 1.15-1.45 1.66-.06.05-.68.39-.83.48-.54-.17-1.15-1.17-1.66-1.93a.47.47 0 0 0-.45-.2c-1.11.13-1.94.05-2.54-.83-.27-.36-.39-.43-.72-.11-.38.39-.75.69-1.12 1-.2.13-.34.09-.42-.16a7.04 7.04 0 0 1-.37-2.35c0-.33.04-.84.05-1.16a2.87 2.87 0 0 0-.71-.48C1.1 16.53 0 15.5 0 15.17c0-.07.06-.25.32-.4 1.36-.6 2.43-.1 2.83-.16.35-.03.46-.28.4-.77a2.7 2.7 0 0 1 .88-2.42c.46-.5.43-1.04.32-1.65-.06-.28-.12-.35-.4-.32-.75.16-.71.18-.85.83-.08.42-.23.85-.47 1.2-.3.47-.7.87-1.05 1.29-.12.17-.26.17-.44.05A2.44 2.44 0 0 1 .6 9.74c.12-.32.3-.67.49-.84l.1.03c0 .06 0 .13-.03.19l-.22.69c-.28.8-.23 1.57.3 2.26.18.22.34.29.44.19.34-.35.7-.67 1-1.05.36-.42.47-.93.36-1.46a9.27 9.27 0 0 0-.1-.6c-.05-.3-.18-.27-.32-.1-.33.34-.49.61-.65 1.23a.48.48 0 0 1-.15.23.65.65 0 0 1-.08-.33c.1-.56.22-1.05.58-1.41.23-.26.17-.4-.05-.46-.8-.22-1.49-.45-2.1-1.2a.67.67 0 0 1-.16-.4c0-.16.08-.28.26-.41.7-.48 1.42-.99 2.11-1.14l.57-.09C2.62 4.1 2.3 2.9 2.1 1.81c0-.23.16-.84.25-1.02.15-.02.34-.02.62.08.32.12.62.32.92.5.29.17.37.17.56-.09.32-.47.7-.89 1.19-1.14.17-.08.28-.14.39-.14.16 0 .28.1.44.34.27.43.5.93.74 1.4.28.47.58.5 1 .19.48-.32.91-.63 1.35-.99.4-.32.52-.32.97 0 .4.27.83.78 1.05 1.23.04.08.97-.42 1-.64.04-.4.15-.7.3-1.02.2-.4.47-.51.73-.51.23 0 .67.26 1 .47l.7.4c.37.2.39.2.61-.13.25-.4.47-.47.99-.47 1.02 0 1.95.26 2.66 1.1.13.17.25.2.41.04.29-.3.56-.41 1.1-.41h.95c.21 0 .35.01.55-.26.26-.38.55-.74.97-.74.67 0 1.55.94 2 1.75l-.24.12a4.76 4.76 0 0 0-1.75-1.1c-.4-.17-.58 0-.53.42.06.5.19 1 .3 1.49.15.46.55.86 1 1.05l.02.17c-.07-.02-.16-.05-.28-.06a2.04 2.04 0 0 0-.87.03c-.56.14-1.07.38-1.57.6-.25.12-.25.18-.04.39.28.26.54.56.86.79.9.68 1.8.54 2.79.16l.46-.16c.42-.08.87.1 1.21.4l1 .91c.32.3.4.58.2.96-.33.64-.7 1.3-1.06 1.92a.62.62 0 0 1-.23.24c-.12-.1-.23-.33-.11-.53.44-.56.72-1.34.82-1.87.09-.52-.19-.77-.68-.64l-.42.16c-.18.07-.24 0-.28-.18-.07-.16-.15-.26-.2-.43-.12-.28-.28-.37-.52-.19-.42.26-.71.52-.96.93a3.53 3.53 0 0 0-.4 2.17c.01.1.09.16.14.22a.4.4 0 0 0 .19-.2c.13-.32.21-.64.27-1 .03-.2.06-.54.12-.72.05-.1.2-.06.28-.03.21.08.3.19.33.34-.42.53-.68 1.32-.96 2.02-.05.1-.23.22-.34.22-.13-.01-.3-.12-.34-.23-.17-.45-.47-.89-.59-1.34-.3-1.51-.4-1.6-.46-1.69a9.32 9.32 0 0 0-2.26-2.57c-.07-.07-.1-.16-.16-.22.08-.04.15-.11.23-.14l.88-.34c.38-.13.64-.37.8-.71.1-.2.25-.4.36-.59.16-.28.14-.43-.07-.67a1.44 1.44 0 0 0-1.47-.45c-.57.14-.92.54-1.1 1.08-.07.2-.09.4-.09.61 0 .3.1.37.35.21.41-.34.88-.62 1.33-.92-.2.48-.5.85-.92 1.12-.28.18-.55.32-.83.48-.24.17-.32.1-.4-.18-.06-.3-.03-.6-.03-.9A1.97 1.97 0 0 0 18 .9l-.74-.3a.7.7 0 0 0-.28.64c.06.8.18 1.4.32 2.08.13.28.44.4.75.45.19-.1.34-.36.09-.76l-.37-.72c-.03-.1-.08-.18-.1-.28-.02-.04-.04-.1 0-.15.04.02.09.02.18.11.46.5.84 1.07 1.08 1.78.1.28 0 .39-.26.42-.62.05-1.24.1-1.84.22-.97.2-1.3.56-1.65 1.21-.15.28-.23.46-.24.62.35.03.74.01 1.3-.09a3.7 3.7 0 0 0 1.34-.44c.26-.3.46-.61.85-.89.12-.08.38-.11.48-.05a5.12 5.12 0 0 1 2.56 2.5c.04.12.15.23.2.32.11.13.07.18-.09.17-.22-.06-.47-.12-.67-.2-.08-.04-.15-.17-.19-.26l-.2-.58c-.11-.23-.17-.23-.4-.15l-.45.19c-.17.06-.25.09-.29-.1-.05-.28-.13-.55-.2-.8-.1-.31-.22-.38-.52-.23a2.8 2.8 0 0 0-1.25 1.28c-.26.54-.36.9-.12 2.34.06.28.28.62.54.7l2.42.75c.12 0 .2.14.05.24-.3.2-.63.38-.94.57-.15.1-.24.05-.31-.1a1.9 1.9 0 0 0-1-.9c-.16-.08-.24-.05-.3.12-.12.26-.24.64-.34.91-.06.14-.12.2-.28.1-.69-.58-1.41-.61-2.26-.5-.42.06-.61.17-.51.59.23 1.16 1.25 1.7 2.11 2.07a.59.59 0 0 0 .3-.23c.13-.19.1-.37-.1-.54-.33-.29-1.04-.62-1.39-.94-.06-.19.34-.35.56-.21.63.28 1.11.8 1.62 1.3.26.25.38.22.46-.14.1-.28.19-.7.27-1.03.05-.16.15-.1.19 0 .06.24.14.55.14.83 0 .3-.1.56-.19.84-.05.28-.27.43-.5.37-1.07-.1-1.88.4-2.54.42-.15 0-.47-.1-.62-.17-.24-.18.1-.2.18-.2.28 0 .7 0 .92-.12-.06-.1-.18-.2-.29-.27-.6-.49-1.26.03-1.77.29-.3.16-.31.2-.19.5.19.46.52.64.98.64.26 0 .51.04.78.03a.93.93 0 0 0 .37-.1c.35-.12.65-.3.97-.43.4-.06.38.14.2.33l-.79.49c-.08.04-.17.07-.23.13-.11.08-.25.22-.23.28.05.1.17.21.3.26.37.11.74.17 1.1.25.57.11.81-.05.97-.62.08-.31.19-.6.34-.9.09-.18.2-.2.31-.02.4.73.8 1.44 1.22 2.14.08.16 0 .24-.15.22-.9-.1-1.8-.2-2.7-.34-.3-.04-.6-.24-.9-.37a3.2 3.2 0 0 0-1.47-.39c-.45 0-.72.28-.56.72.2.62.44 1.26.7 1.89.17.42.59.58 1.04.62.22.03.14-.12.09-.22l-.75-1.61c-.1-.27-.02-.31.13-.09.41.62.84 1.2 1.21 1.83.23.39-.05.5-.33.5-.94-.09-1.8-.41-2.7-.76-.1-.03-.22-.23-.2-.31.17-.16.38 0 .56 0 .22.04.3-.06.22-.22a.86.86 0 0 0-.45-.42 5.56 5.56 0 0 0-1.34-.49c-.28-.05-.47.07-.41.32.07.32.22.61.39.95.05.1.05.22.02.31-.17 0-.37.05-1.07-.25-.7-.29-.7-.48-.7-1.34 0-.18 0-.55.03-.71.07-.24.1-.28.3-.25.73.15 1.47.35 2.18.7.22.09.42.27.65.36.18.06.27 0 .25-.19a.65.65 0 0 0-.41-.56c-.77-.32-1.53-.69-2.3-1-.18-.07-.24-.15-.14-.35.3-.5.46-1.09.33-1.72 0-.05.06-.11.12-.17a.47.47 0 0 1 .34.43c.06.54.42.91.77 1.28.72.74.72.74 1.72.5.13-.02.23-.11.34-.19-.1-.07-.19-.2-.32-.26-.18-.1-.39-.15-.6-.23-.66-.25-.86-.73-.64-1.43a24.2 24.2 0 0 0 .63-1.95c.07-.3.1-.63.11-.96 0-.18.14-.18.25-.2l1.46-.1c.37-.02.8-.46.94-.71l.49-.8a1.01 1.01 0 0 0-1-.14c.11-.36.26-.7.26-1.05 0-.23-.05-.5-.15-.73-.1-.22-.25-.26-.44-.12-.35.3-.65.65-.76 1.14-.11.48-.31 1.36-.21 1.52.22-.17.52-.39.71-.45.1-.02.26 0 .34.06-.33.3-.72.56-1.08.75-.27.12-.37-.04-.33-.3.32-1.21.12-1.3.02-1.9a6.98 6.98 0 0 0-.9-2.09c-.13-.16-.34-.1-.61.23-.45.54-.56 1-.8 1.92l-.05.19-.32.28-.14-.16c.12-.43.25-.68.25-1.02 0-.42-.18-.72-.46-.95-.35.22-.66.5-.75.65a.92.92 0 0 0 .02 1.06c.36.62.3 1.25.19 1.98l-.1-.03a8.26 8.26 0 0 0-.25-1.41c-.08-.3-.27-.55-.43-.8-.16-.24-.3-.74-.17-.95.19-.32.77-.5 1-.79.23-.35.12-.5.41-.82.18-.21.56-.65.84-.5.84.42 1.73.51 2.67.39.4-.06.49-.05.6-.45.1-.33.14-.1.47-.22.57-.19.87-.7.87-1.3 0-.34.02-.68-.02-1.03-.03-.3-.14-.58-.23-.85-.08-.18-.2-.14-.28-.01-.23.3-.63.9-.84 1.24l-.33.6c-.05.16-.13.2-.27.05a3.03 3.03 0 0 0-.49-.43c-.3-.2-.33-.81-.21-1.2.13.07.22.22.3.42.12.26.17.56.38.65.27.14.54-.42.5-.8a.6.6 0 0 0-.1-.28C14.77.83 14.1.4 13.68.4c-.48 0-.8.6-.6 1.16.06.15.12.26.2.4-1.15.6-1.46.99-1.92 1.52-.05.07-.1.25-.05.34.21.41.13.55-.31.8-.2.1-.46.21-.67.27-.03.02-.08-.02-.14-.03a.28.28 0 0 1 .06-.11c.28-.63.58-1.22.84-1.86.28-.68-.33-1.3-.88-1.52-.36-.14-.65-.06-.9.27-.6.72-.73 1.9.12 3.02.13.19.1.26-.12.28-.49.04-.97.1-1.47.12a1.95 1.95 0 0 0-1.5.8c-.1.16-.25.2-.41.09-.38-.24-.7-.18-1.1.05a4.9 4.9 0 0 1-1.84.62c-.07 0-.15-.06-.2-.12.03-.05.09-.13.23-.18.4-.1.72-.2 1.08-.3.06-.06.09-.22.13-.29-.07-.1-.2-.21-.31-.22a4.91 4.91 0 0 0-1.02 0c-.88.08-1.53.5-2.09 1.01-.26.26-.28.53 0 .75.65.46 1.35.93 2.23.7.62-.2 1-.66 1.4-1.1.33-.36.74-.77 1.13-.33.57.65.68 1.33 1.61 1.21.36-.04.5-.16.6-.5l.07-.4c.03-.25-.1-.38-.36-.28-.17.06-.31.15-.48.19-.1.02-.2-.01-.3-.04 0-.1.02-.22.08-.28.17-.11.38-.2.56-.29.7-.18 1.36-.32 2.05-.46a.6.6 0 0 1 .21 0l-.06.2c-.25.57-.59.75-1.04.86-.06.05-.17.18-.25.44a2.6 2.6 0 0 0 .5 2.57c.22.25.5.46.79.63.48.28.61.75.79 1.24.11.31.23.62.37.92-.39.28-.71.6-.94 1-.1.1-.17.06-.22-.05l-.27-.66c-.24-.58-.65-.96-1.3-1.01-.24-.02-.47-.06-.7-.09-.26-.02-.44.1-.53.4-.37 1.12-.02 2.09 1.05 2.68-.86.22-1.56.56-2 1.16.04.17.3.39.64.53.84.34 1.7.3 2.49.04.46-.17.48-.06.56.28l.24 1.04c.05.25-.09.39-.32.3-1.28-.37-2.8-.98-3.9-1.72a5.77 5.77 0 0 0-1.43-.43c-.17.1-.31.22-.46.2a8.16 8.16 0 0 1-1.38-.5c-.22-.12-.23-.19.05-.23.43 0 1.21.19 1.61.19.4-.12.4-.19.15-.35-.94-.75-2-.57-3.05-.4-.38.08-.4.26-.19.56 1.36 1.53 2.36 1.52 4.02 1.33 1.08.68 2.16 1.3 3.42 1.7l.02.18c-.9.06-1.75.21-2.56.38-.41.08-.5.33-.27.7.33.54.86.8 1.47.94.43.13.87.1 1.3-.08.5-.23.83-.65 1.3-.91.28-.15.75.02 1.03.1.42.13.83.32 1.27.38 1.73.24 3.57.4 5.18.26-.2.38-.33.73-.46 1.1-.09.22-.01.27.22.25.34 0 .67-.2.81-.46.03-.26.03-.5.08-.76.03-.14.07-.33.16-.35.07-.01.47.06.42.17-.14.4-.26.71-.43 1.11.15.03.31.06.47.06.65 0 .75-.1.72-.74a2.7 2.7 0 0 0-.08-.55c-.08-.49.02-.82.44-1.05.4-.2.84-.14 1.25-.09a7.63 7.63 0 0 1 3.52 1.6c.51.4.07.97.07 1.74 0 .49-.1.99-.09 1.24.02.4.19.61.34.73.45.34.94.68 1.41 1 .49.3.73.5 1.3.7.14.04.3.04.42.03a1.49 1.49 0 0 0-.03-.6c-.28-.19-.67-.28-1.12-.43-.08-.03-.17-.14-.21-.24a.84.84 0 0 1 .32-.19l.73-.15c.05-.02.15-.1.18-.16-.03-.07-.09-.15-.14-.16-.3-.1-.7-.16-.94-.22-.1-.03-.14-.12-.22-.2a.91.91 0 0 1 .36-.19l.74-.09a.4.4 0 0 0 .2-.12c-.03-.07-.07-.17-.13-.2-.15-.07-.92-.35-1-.43-.07-.07-.08-.16-.11-.28.1-.05.25-.1.35-.08l.62.01a.4.4 0 0 0 .26-.12.56.56 0 0 0-.17-.2c-.3-.18-.41-.3-.75-.46-.15-.1-.23-.18-.26-.38.12-.03.28-.05.42-.02.23.06.35.13.59.17.06.02.18-.01.26-.03a.26.26 0 0 0-.07-.18c-.09-.1-.21-.14-.32-.23-.17-.11-.46-.39-.63-.53-.05-.04-.02-.18-.03-.23h.18c.23.05.56.15.75.18.33.06.29.01.15-.23-.2-.18-.42-.3-.62-.52-.05-.07-.03-.2-.03-.3.32.02.65.17.94.17.02-.05.04-.1.04-.17a4.75 4.75 0 0 0-.23-.55c-.08-.22.03-.3.19-.24.22.1.57.28.81.34.1.03.22 0 .34-.05-.11-.22-.24-.4-.4-.62-.02-.06 0-.14.06-.2.38.1.77.37 1.11.46.16.06.26 0 .3-.08.03-.09-.25-.37-.23-.48 0-.07.02-.1.06-.14l.65.2c.48.13.75.17.82.06.1-.03 0-.25-.15-.51.38-.03.42.15 1.08.28.25.06 3.74-.43 5.16-.87.56-.18 1.2-.46 1.73-.7l.17.03c.4 1.03 1.24 1.34 2.1 1.44l.8.05c.25 0 .3-.06.23-.31a4.47 4.47 0 0 0-1.3-2.2l-.55-.35c-.24-.25-.21-.54.05-.74.44-.3 1.04-.59 1.49-.87.65-.41.87-1.06.83-1.74a.58.58 0 0 0-.24-.45.73.73 0 0 0-.33.23c-.18.37-.36.68-.51 1-.13.07-.26.1-.37.15-.03-.12-.1-.23-.06-.34.2-.58.7-1.04 1.04-1.41.14-.24-.07-.33-.17-.31-.37.08-.78.22-1.06.54a7.5 7.5 0 0 0-1.47 3.04c-.06.29-.19.4-.28.66-.12.41-.11.5.24.76.52.33 1.19.64 1.67.98.2.22.1.3-.11.3a1.93 1.93 0 0 1-1.4-.63c-.18-.2-.34-.34-.56-.37-.5.14-1.2.34-1.72.41-.3.06-.53.18-.69.46-.1.23-.31.28-.56.19-.37-.1-.74-.24-1.11-.32a4.19 4.19 0 0 0-1.86.13c-.25.04-.31-.02-.24-.26.07-.3.17-.6.23-.9 0-.13.03-.33-.1-.4-.12.06-.3.09-.35.17-.2.3-.34.6-.53.92-.12.25-.17.25-.43.14a4.75 4.75 0 0 1-1.05-.65c-.25-.4-.52-.73-.65-1.08-.05-.09.1-.16.21-.16.28.22.62.5.87.74.17.19.22.37.33.61.03.06.3.05.35-.05.04-.1.08-.23.12-.43.1-.37.03-.88-.3-1.22-.42-.42-.7-.5-1.26-.9-.71-.48-.81-.45-1.07.03-.2.39-.35.82-.35 1.3.19 1.14.46 1.6 1.83 2.3a.38.38 0 0 1-.1.2c-.1.07-.15.11-.3.11-.49-.01-1.17-.02-1.7-.07-.15 0-.24-.06-.28-.14a6.98 6.98 0 0 1 .62-5.02.84.84 0 0 1 .33-.37c.29-.15.75-.34 1.03-.46.16-.08.25-.02.32.15.12.44.17.76.2 1.14.02.23.03.47.13.51.22.1.42-.09.53-.28.42-.68.53-1.44.22-2.26-.03-.07.04-.22.12-.27.95-.38 1.83-.77 2.8-1.14.53-.03 1.22.03 2.18.18.16.02.5.3.84.5-.44.22-1.08.69-1.53 1.11-.12.13-.28.3-.17.66.38-.02.56-.13.84-.2.43-.13.7-.2 1.04-.2a1.86 1.86 0 0 1 .28.04.51.51 0 0 1-.13.29c-.12.11-.31.1-.45.17-.14.1-.28.23-.19.4.07.11.25.24.38.22.45-.03.86-.08 1.32-.22.2-.17.99-1.2.54-1.29-.25-.05-.79-.09-1.02-.21a.47.47 0 0 1 .28-.32c.24.04.52.11.9.15a5.5 5.5 0 0 0 1.83-.08c.25-.1.33-.19.25-.35a2.88 2.88 0 0 0-1.7-1.48c-.34-.1-.75-.02-1.1-.02l-3-.03c-.06 0-.13-.06-.2-.1.06-.04.12-.1.17-.12.28-.17.6-.31.89-.5.42-.3.7-.71.81-1.25a.51.51 0 0 0 0-.28c-.28-1.03-.83-1.77-2-1.9l-.57-.1c-.22-.01-.3.08-.3.27 0 .37.02.56 0 .94 0 .18.1.25.3.27a7.17 7.17 0 0 1 1.59.46c.3.12.37.3 0 .62l-.84.6c-.15.1-.21.02-.23-.12-.02-.22-.02-.47-.06-.68a.47.47 0 0 0-.12-.21.61.61 0 0 0-.45.37c-.1.3-.18.57-.23.86a.91.91 0 0 1-.64.75c-.17.04-.32-.02-.29-.18a4 4 0 0 1 .12-.56c.27-.65.41-1.2.36-1.82a13.12 13.12 0 0 1-.1-1.29.38.38 0 0 1 .28-.4c.5-.2.98-.4 1.5-.56.19-.07.33 0 .47.18l1.07 1.25c.27.3.35.29.6-.05.21-.31.46-.6.81-.8.19-.09.19-.27-.03-.35-.4-.15-.8-.23-1.22-.37-.09-.03-.2-.03-.3-.07-.06-.03-.14-.11-.14-.17 0-.05.08-.14.14-.16.77-.27 1.4-.52 2.08-.79.19-.08.28-.23.25-.42-.02-.25-.1-.47-.13-.71-.04-.22-.19-.4-.42-.42-.93-.1-1.49.17-2.12.82a.58.58 0 0 0-.15.51c.11.02.2.02.29 0a3.8 3.8 0 0 0 1-.43c.16-.18.3-.37.39-.37.05 0 .15.23.18.32-.09.1-.18.22-.92.54a21.25 21.25 0 0 1-4.07 1.4c-.2.02-.18-.1-.13-.18.26-.46.55-.93.84-1.42.28-.17.36-.1.25.17a5 5 0 0 1-.3.58c-.03.18.05.23.16.21a1.56 1.56 0 0 0 1.16-1.39c0-.23-.11-.31-.36-.3-.35.02-.74.05-1.08.16-.66.16-1.05.62-1.26 1.21-.1.28-.15.56-.2.85-.06.3-.32.42-.6.57-.45.28-.68.22-1.07.3a6.42 6.42 0 0 0-.98.22c0-.11-.03-.21 0-.28.22-.35.42-.7.65-1.02.33-.48.24-.75-.28-.93a1.94 1.94 0 0 0-2.23.78c-.28.44-.48.98-.68 1.46-.12.29 0 .46.3.53.48.08 1.05-.1 1.48-.21-.03.14-.04.67-.09.79l-.27.6c-.18.3-.38.4-.7.24a14.7 14.7 0 0 1-1.46-.79 3.37 3.37 0 0 0-1.73-.56.84.84 0 0 1-.18-.01c-.2-.05-.22-.12-.1-.25.16-.15.17-.31.08-.5l-.64-1.2a3.26 3.26 0 0 1-.3-.7c.15-.03.74.17.74.28.04.65.24 1.12.58 1.53.26.26.5.1.53-.17.05-.34-.42-.9.19-2.19C26.7 1 27.5 0 28.02 0c.28 0 .51.12.68.53.1.19.16.63.24.82.08.19.17.28.37.26.5-.07 1.2-.37 1.77-.45.36-.05.64.85.82 1.18.28.48.41.9.73.38.54-.75.79-1.58 1.36-1.85a4.03 4.03 0 0 1 2.35-.4c.25.03.33.13.27.38-.05.15-.06.3-.1.46-.05.18.1.24.3.1.27-.16.47-.38.66-.62.48-.52.96-.78 1.91-.78.45 0 .8.1 1.2.23.3.11.35.16.26.47l-.27.9c-.09.4-.02.46.34.66.32.19.57.32.76.56a.65.65 0 0 0 .4-.14A4.81 4.81 0 0 1 43.8.74c.3-.16.38-.14.5.14.25.64.39 1.19.43 1.78.34-.39.73-.8 1-1.12C46.74.6 47.74.6 49.09.94c.33.1.07.43-.12.69l-.26.39c-.09.14-.15.15-.26.03-.17-.2-.34-.54-.5-.71-.31-.3-.85-.13-1.22.1a5 5 0 0 0-1.81 1.84 9.77 9.77 0 0 1-1.58 1.88c-.24.09-.24.08-.19-.17a6.65 6.65 0 0 0 1.1-3.45.83.83 0 0 0-.64.14c-.93.52-1.4 2.37-1.53 3.6-.03.27-.03.47-.26.6-.39.22-.54.32-.93.5-.1.01-.15 0-.23-.01.18-.82.05-1.4-.42-2.17-.08-.15-.19-.23-.36-.17-.1.06-.19.13-.4.3a3.5 3.5 0 0 0-1.1 2.69c0 .18.18.18.31.09.17-.14.26-.25.36-.43.23-.39.43-.8.65-1.19.04-.1.15-.16.23-.19.05.1.05.2.03.28l-.17.75a2.33 2.33 0 0 1-.74 1.02c-.07.1-.11.26.07.28.8.04 1.27-.05 1.96-.42.72-.37 1.2-.68 1.52-.64.22.03 1.3.34 1.4.42-.06.11-.14.15-.2.22-.12.1-.65.38-.88.58-.37.3-.5.45-.43 1.07.04.28.09.54.15.8.03.1.1.21.15.23.1 0 .19-.07.24-.14l.9-1.15a.7.7 0 0 1 .19-.11c0 .07.02.14 0 .18-.07.46-.3.8-.58 1.14l-.18.23c-.24.35-.26.4-.02.75.28.4.32.86.23 1.3-.06.32-.17.8-.23 1.28-.59.27-1.18.65-1.68.99-.31.28-.37.5-.37.57.15.18.29.21.58.33.4.13 1.17-.03 1.31-.46.05-.1.1-.3.1-.48.14.03.27.03.31.15.15.47.28.78.58 1.09-.04.12-.1.21-.23.4-.17.3-.32.55-.57.5-.1-.02-.2-.04-.31-.04-.19 0-.37 0-.35.33.04.43.1.62 0 1.06-.05.24-.13.5-.37.5-.58-.05-.97-.48-1.53-.47a2.2 2.2 0 0 1-1.07-.19c-.3-.15-.51-.32-.65-.4-2.36.38-4.96.86-6.97 1.3-.22.04-.2.18-.25.4-.1.52-.3 1.02-.39 1.53-.02.09.1.19.15.26.06-.05.14-.09.2-.16.12-.18.2-.39.34-.56.24-.26.88.02.99.37.1.21-.2.32-.19.56.02.2.32.39.32.65 0 .23-.1.38-.13.5.87.56 1.09 1.03 1.11 1.75.03.22.03.34.15.47.12.12.32.3.4.4.41.48.79 1.23 1.06 1.3.14.06.5.08.77.06l.05.14c-.09.22-.33.48-.56.55-.64.2-.95-.75-1.3-1.3a4.65 4.65 0 0 0-.54-.72c-.28.31-.74 1.55-.7 2.13.18.8.65 1.58.95 2.15.22.35.64.47 1.05.63.34.12.6.18.95.08.18-.04.25-.05.33-.12v-.72c.08-1.3.29-2.6.37-3.72 0-.3.23-.8.6-1.06.4-.28.57-.65.55-1.13a.88.88 0 0 1 .09-.46c.13-.26-.12-.26-.37-.3-.28-.04-.35-.15-.2-.4.25-.44.63-.8.92-1.23.19-.3.28-.5.35-.69-.08-.36-.05-.9.31-.92 1.19-.14 1.68-.03 2.43.53.05.08.06.19.06.28 0 .1.21.17.61.57.31.29.6 1.1.09 2.35.26.15.25.4.22.68-.02.24.06.27.28.36.28.1.43.26.66.84.2.55.81 2.01 1.16 5.6a14.92 14.92 0 0 1-.48 2.87c.24 1.72.51 3.84.73 6.73.17 2.74.22 4.14.27 5.27.49.04.64.14.74-.27l.1-.38c.09-.27.36-.18.37-.03l.3.87c.06.26.13.41.23.66.32.44.46.05.46-.27.04-.28.04-.52.04-.77.05-.32.22-.34.34-.12l.43 1.02c.16.35.33.44.4.23.05-.29.06-.8.05-1.21-.07-.23-.17-.49-.2-.69 0-.28.22-.22.27-.14a32.48 32.48 0 0 1 1.52 1.98c.28.17.45-.12.37-.23-.02-.11-.16-.25-.16-.47.04-.36.37-.2.45-.07.3.3.51.7.69 1.03a.65.65 0 0 0 .28.14c.06-.09.09-.23.08-.32-.02-.11-.15-.38-.19-.5.13-.21.4.06.48.14.1.1.19.25.3.45.17.26.45.48 1.07.57l.03.18c-.08.06-.22.12-.6.19a7.6 7.6 0 0 1-2.32.05 2.7 2.7 0 0 0-1.71.37c-.37.21-.74.18-1.18.17-.84-.04-1.68-.04-2.53-.06-1.77-.05-2.66.3-4.66.41-.65 0-2-.34-2-.75 0-.3.16-.53.16-.68 0-.19-.04-.24-.2-.28-1.43-.25-2.83.07-4.13.31-1.1.17-1.67 0-2.25-.46a2.91 2.91 0 0 1-.8-.85 11.37 11.37 0 0 0-2.22-2.11c-.93-.74-2.11-2.1-2.85-3.02-.17-.2-.46-1.15-.56-1.42a2.85 2.85 0 0 1-.13-1.23c.11-.1.25-.2.36-.21.62-.02 1.4-.32 1.42-.5.06-.14-.04-.26-.16-.23-.33.06-.77.06-1.1 0-.18-.03-.4-.1-.5-.2.12-.14.2-.24.32-.31a3.27 3.27 0 0 0 1.45-.56.35.35 0 0 0-.04-.18c-.4-.02-.72-.02-1.18-.13a1.05 1.05 0 0 1-.45-.26.72.72 0 0 1 .34-.28c.52-.17.9-.42 1.25-.75v-.2a7.1 7.1 0 0 1-1.42-.15c-.21-.11-.23-.13 0-.4.34-.08.96-.13 1.3-.24.24-.13.2-.35-.05-.42a7.63 7.63 0 0 1-1.21-.13c-.25-.23-.28-.25.04-.4l1.07-.22c.41-.14.35-.4 0-.5-.32-.04-.55-.11-.87-.17-.43-.21-.42-.23-.08-.37l.68-.19c.19-.04.38-.12.41-.26a.2.2 0 0 0-.02-.14c-.28-.08-.87-.02-1.13-.1-.1-.03-.19-.13-.24-.25l.25-.14c.32-.07.67-.21.92-.35a.81.81 0 0 0 .1-.24.6.6 0 0 0-.18-.09c-.34-.1-.53-.17-.87-.3-.19-.23-.18-.28.08-.38l.48-.13a3.1 3.1 0 0 0-.24-.48.48.48 0 0 0-.17-.17c-.28-.17-.68-.33-.98-.53-.56-.34-1.14-.68-1.58-1.12a3.63 3.63 0 0 1-1.17-1.91c-.09-.47-.1-.96-.01-1.42.05-.35.25-.72.44-1.06.07-.12.13-.23.05-.33-.28-.36-.51-.6-.86-.93a1.47 1.47 0 0 0-.55-.28c-1.11-.2-1.79-.42-2.3-.36a1.77 1.77 0 0 0-.42.64c.1.38.28.95.29 1.43.4.04.9.18 1.4.46.4.26.49.4.65.9.34 1.11.43 2.54.68 4.06.2 1.46-.55 2.66-2.02 2.71-.8.04-1.46-.12-1.67-.66-.26-.76-.46-1.4-.7-2.17-1.05.26-2.15.62-3.26 1.16-.98.46-1.78.9-2.81 1.33-1.97.8-4.14 1.3-6.08 1.3a8.6 8.6 0 0 1-2.96-.52c-.7-.28-.96-.57-1.12-1.46a8.48 8.48 0 0 1-.03-2.3c.09-.74.21-1.26.72-2.65.22-.62.51-.9.99-1.15a5.21 5.21 0 0 1 2.57-.5c.3.01.7.06.98.18.56.2.64.65.66 1.2 0 .33.02.66 0 .98-.03.26-.02.37-.02.47.7.1 2.18.06 2.88-.1.58-.11.81-.2 1.86-.7.73-.33 1.71-1.06 2.86-1.66zm22.28 12.45c.06.13.22.83.22 1.07 0 .57-.05 1.1-.11 1.98-.1 1.15.03 2.32-.13 3.46-.07.56-.2 1.42-.16 2.19 0 .3.06.39.23.42.56.13.93.19 1.21.19.86 0 1.42-.39 1.34-.87a11.63 11.63 0 0 1-.4-3.2l.23-.01c.31 1.3.58 1.94.67 2.62.12.61 0 1.67.13 2.2 1.43.16 3.14.02 3.66-.09.13-1.17.1-2.37-.42-2.82-.21-.2-.85-.68-1.13-.86a6.41 6.41 0 0 1-1.53-1.7c-.61-.96-.78-1.27-1.32-2.21-.5-.88-.84-1.63-1.18-2.14-.22-.35-.4-.56-.5-.65a6.58 6.58 0 0 0-1.3-.25c-.6-.06-1-.13-1.35-.5-.3-.3-.42-.55-.24-.95.1-.21-.03-.36-.18-.54-.18-.22-.13-.46.09-.63a3.55 3.55 0 0 1 1.72-.97l-.11-.48c-.28.04-.59.12-1.15.12-.77 0-1.47-.32-1.75-1.33-.1-.36-.55-1.39-.68-1.84-.1-.28 0-.63.14-1.03-.25-.3-.45-.63-.66-.91-.41-.18-.92-.35-1.25-.76-.14-.17-.2-.18-.33-.1-.11.09-.14.2-.3.35-.14.13-.45.14-.74.02-.28-.11-.42-.4-.41-.68.03-.37.21-.7.05-.85-.3-.3-.56-.65-.22-.9.1-.08.31-.06.44-.12a.93.93 0 0 0 .45-1.04c-.08-.31-.25-.45-.55-.48-.44-.03-.64-.25-.64-.54 0-.37.33-.53.63-.46.12.02.29.09.39.18.03.14.1.34.2.32.5-.06.9-.58.9-1.07 0-.17-.11-.25-.44-.18-.6.1-1.34.32-2.08.57-.4.14-.46.46-.24.84.08.08.13.18.19.28.1.14.05.26-.1.34l-.18.14c-.22.17-.25.35-.11.6.04.1.1.16.17.23.16.15.16.28 0 .46a.7.7 0 0 0-.14.76c.06.21.23 1.42.23 1.65-.01.63.11 1.25.07 1.84-.02.42.19.8.6 1.26.45.5.77.94 1.38 1.53.71.68 1.1 1.49 1.17 2.48.03.47.25.64.7.88.94.26 1.26.79 1.37 1.5.19 1.28-.43 2.52-1.58 2.4-.58-.05-.87-.4-.87-.71 0-.33.16-.65.43-.74.05-.02.22 0 .26 0a.56.56 0 0 1 .02.2c0 .08-.1.13-.15.3-.02.1-.02.33.09.47.12.16.33.22.56.14.26-.08.43-.3.55-.54.54-.96.27-2.1-.75-2.34-.32-.1-.79-.14-1.09.03-.63.4-1.17.62-1.7 1.1a.4.4 0 0 0-.13.3 52.05 52.05 0 0 0 .45 6.34c0 .45.33 1.02.46 1.1.37-.27.47-.54.8-1.06.15-.09.22-.03.27.1 0 .48-.1.94-.05 1.35.03.12.17.23.27.31.22-.2.23-.5.32-.74.25-.26.3.03.32.1-.02.3 0 .59.03.75 0 .12.12.14.22.17.27-.54.61-1.02 1.05-1.32.26-.19.43-.03.28.23a6.6 6.6 0 0 0-.6 1.58.93.93 0 0 0 .26-.03c.06-.02.14-.04.17-.19.19-.46.29-.52.5-.18.1.31.24.54.42.63.28-.08.3-.41.41-.65.3.02.32.34.47.5.1.08.95.11 1.1.1l-.02-.5c-.02-.99 0-1.78.06-2.76.08-1.02.19-2.07.24-2.97.04-.75.13-1.88.2-2.77zM51.26 15.9c-.23-.03-1.16-.09-1.4-.09-.21 0-.77 0-.79.29 0 .08.11.23.24.32.68.46 2.58.54 3.35.41.02-.18 0-.4-.06-.56-.19-.57-.89-1.07-1.53-1.28a5.26 5.26 0 0 0-2.06-.07l-.14-.35c.23-1 .2-1.93.06-2.67-.08-.4-.19-.6-.4-.93-.14-.18-.29-.18-.46-.04-.1.1-.22.22-.41.47-.65.78-.62 1.3-.5 2.48.07.05.15.1.37.1.2 0 .3-.09.32-.37.02-.39.11-.8.17-1.16.1.03.26.14.28.2.04.61-.16 1.24-.3 1.81.03.07.47.26.4.45-.05.14-.74.31-1.22.35a2.46 2.46 0 0 0-1.14-.94c-.28-.11-.59-.2-.36-.39l.38-.15c.65-.27.43-.64.4-1.27-.02-.24-.12-.31-.34-.3-.33.02-.54.05-.8.19-.5.3-.87.79-1.22 1.19-.06.06-.2.03-.32.03l.62-1.75c.06-.18.15-.37.35-.32 1 .23 2.03.04 2.74-.67.3-.32.3-.47-.09-.74a2.36 2.36 0 0 0-2.14-.46c-.3.12-.5.3-.55.61-.03.19.9-.07 1.22-.04.1 0 .16.09.23.14-.6.26-1.29.39-1.86.55-.19.05-.26 0-.3-.18a.81.81 0 0 1 .3-.82c.43-.37.78-.81.87-1.4.06-.31-.2-.79-.34-1.06-.02-.07.02-.13.02-.18.37.09.88.33 1.19.55a2.63 2.63 0 0 0 1.83 2.03c.33.11.66.24 1.01.34.32.1.56 0 .54-.34l-.01-.46c.27-.12.6-.22.67-.2.53.07 1.07.33 1.61.5.38.2.2.32-.07.28-.4-.06-.81-.18-1.2-.28-.25-.05-.46.06-.5.3.17.3.94.65 1.22.77.4.14 1.95.32 1.93-.1a5.45 5.45 0 0 0-.18-1.23c-.1-.34-.4-.54-.72-.62a8.38 8.38 0 0 0-2.07-.24c-.16 0-.46.1-.74.24l-.09-.46c-.14-.62-.44-.77-.9-.93.02-.18.02-.3.02-.5.41-.23.91-.62 1.1-.95-.16-.16-.46-.24-.62-.3-.63-.22-.7-.46-1.12-.65a2.8 2.8 0 0 0-1-.25c-.32 0-.75.08-.84.2-.05.08 0 .21.18.34.28.22.87.37 1.16.58.18.1.09.15-.03.17a2.88 2.88 0 0 1-1.14-.33c-.21-.11-.28-.2-.43-.26-.28-.1-.33-.02-.52.3-.14.24.03.36.23.47.67.37 1.16.59 2 .68.1.1.12.25.15.44-.84-.11-1.12-.12-1.64-.3-.83-.45-1.49-.8-2.29-1.07-.15-.06-.2-.16-.04-.26.84-.5 1.64-1.12 2.49-1.58.12-.07.31-.04.46-.01.41.07.55.2.96.32.24.1.48.16.52-.06.12-.61.32-1.07.5-1.33.37-.57.9-.87 1.6-1.3C50.33.9 51.18 0 51.49 0c.84 0 1.67 1.53 1.84 2.1.11.4-.56.76-.1.76.38 0 .74.06.74.4a2.9 2.9 0 0 1-.46 1.6c-.32.44-.65.9-1.08 1.19l.03.15c.72.54 1.51.93 1.51 1.75 0 .43-.12.74-.37.96-.2.16-.35.33-.33.58.03.57.06.89.03 1.44-.03.38-1.17.45-1.33.62a4.65 4.65 0 0 1-.31 2.83l.23.43c1.15.8 1.3 1.54 1.47 2.17-.32.31-.84.57-1.02.57-.75 0-2.4-.56-2.72-.6-.13.23-.06.44.11.9.15.43.43.72.43 1.1 0 .2-.03.49-.56.57a3.74 3.74 0 0 1-2.48-.68c-.15-.08-.28-.18-.43-.25-.25-.14-.57-.03-.65.25l-.17.56c-.1.31-.25.34-.67.25-1.18-.25-1.73-1.52-1.73-2.65.05-.23.24-.14.28-.03.07.55.31 1.08.49 1.53.22.43.5.66.97.72.1 0 .22-.18.33-.38.25-.53.49-.88.41-1.5-.03-.22-.09-.52-.25-.72-.07-.1-.2-.16-.33-.28.06-.1.16-.21.25-.18.52.18.91.18 1.24 0 .2-.1.3-.25.43-.42.45-.12 1.18-.28 1.8-.37.84 0 1.58.12 2.2.4zM19.4 36.32c.45 0 .99.22.98.7l-.1.25a.25.25 0 0 1-.1-.03c-.17-.36-.44-.57-.88-.48-.4.08-.76.29-1.02.58-.18.18.18.3.4.41l.47.28c0 .25-.63 2.01-.31 2.07.8.14 1.86-.96 1.97-2.51-.03-.56.29-.84.9-1.05.73-.27 1.07-.6.95-1.4-.06-.38.17-.27.38-.6l.24-.26c.04.11.12.38.1.49-.17.64-.04 1.14.28 1.72l.6 1.54c.13.15.26.03.4.19.51 1.03 1.09 2.58 1.87 3.24.64.53 1.32 1.46 1.93 2.02.35.31.6 1.1 1.04 1.25.32.12.3.28.26.57-.06.35.1.42.22.42.22-.03.42-.08.65-.1.48.1.37.44.01.5-.24.02-.47-.03-.71-.03-.09.02-.17.06-.25.1.02.09.06.18.13.24.39.21.67.24 1.05.32.07 0 .13.06.21.09-.03.06-.1.21-.18.25-.12.02-.28.02-.43 0-.35-.08-.66-.23-.99-.37-.11-.04-.18-.16-.29-.24l-.28-.08c0 .11-.03.21-.02.3.07.16.23.42.16.47-.02.05-.25.19-.31.15-.28-.13-.5-.45-.77-.6-.33-.2-.64-.2-.95.01-.33.23-.62.42-.93.6-.38.25-.79.65-1.24.65-.25 0-.88-.38-1.16-.46-.52-.17-.69-.19-1.24-.31-.47-.11-.88.06-1.35.22-.58.18-1.21.25-1.84.37-.35.06-.76 0-1.13-.02-.56-.02-1.1-.07-1.65-.06-.37 0-.76.07-1.12.19-.16.04-.34.07-.49.07-.25 0-.5-.06-.72-.22a1.06 1.06 0 0 0-.8-.15c-.26.05-.77.15-.98-.05-.26-.26-.89-.78-1.24-.71-1.1.18-1.64.81-2.72.53-.76-.2-1.26-.38-2-.13-.2.07-.68-.04-.87-.01-.28.03-.37-.02-.34-.3l.03-.15c.05-.29-.23-.5-.51-.4-.3.1-.49.41-.77.56-.53.26-1.03.18-1.6-.04-.4-.17-.8-.1-1.17.1-.24.12-.63.7-.9.7-.08 0-.22-.16-.27-.29v-.27a1.86 1.86 0 0 1 .61-.56 3.49 3.49 0 0 1 2.13-.28c.33.05.7.09 1.01-.04.25-.11.51-.13.74-.25.42-.23.79-.42 1.26-.25.35-.16.53-.27.7-.53.1-.42-.06-.86.05-1.27.09-.37.25-.84.37-1.2.07-.18.2-.16.32-.14.34.5.75.96.54 1.41-.14.32.59.54.47.86-.12.24-.07.4.18.42l.18.02c.22 0 .22-.14.22-.41 0-1.53-.49-2.59-1.01-3.79a1.77 1.77 0 0 1 0-1.4l.3-.94c.18-.45.55-.84.97-1 .05-.02.21.05.25.12.68.96.93 2.12.6 3.28-.1.34-.17.7-.24 1.08-.02.09.01.18.03.28.06-.06.15-.12.2-.19.34-.5.68-1 .95-1.54.26-.52.7-.73 1.23-.83.59-.12.75-.05.6.52-.09.33-.19.67-.3.97a1.93 1.93 0 0 1-.99 1.2c-.33.18-.64.43-.93.65-.11.15-.14.14-.02.29.11.14.28.05.42-.03.55-.4 1.12-.72 1.68-1.03.2-.09.27-.01.25.23-.03.28-.07.66-.35.76-.3.1-.71.15-.98.28a1.86 1.86 0 0 0-.47.4c-.18.28-.18.47-.33.76-.03.07 0 .18 0 .28.1-.03.2-.03.26-.07.36-.26.56-.56.92-.84.28-.21.34-.19.45.16.04.11.13.2.24.3.1-.07.23-.13.31-.25.33-.48.53-1.45.96-2.09.08 0 .17.06.23.08.09.22-.03.95-.01 1.11 0 .45.15.54.55.34.32-.16.6-.33.92-.5.33-.16.6-.03.4.23-.1.16-.25.28-.35.44-.05.1-.04.26-.05.38.09 0 .22.01.31-.03.25-.07.49-.18.73-.28.32-.15.66-.1 1.02 0 .35.12.7.2 1.03.3.27.06.56-.06.8-.17a8.64 8.64 0 0 1 1.48-.57 4.75 4.75 0 0 0 1.83-1.05c.12-.13.3-.2.45-.33.1-.09.2-.53.21-.67.1-.37-.06-1.24.02-1.63.05-.1.12-.3.18-.4l.16.04c.05.14.11.36.11.47-.02.67-.03 2.16-.1 2.8 0 .16-.27.4-.42.46-1.17.42-2.35.87-3.53 1.2-.53.15-1.12.07-1.68.08-.44 0-.88-.07-1.32-.04-.34.03-.84.35-1.19.4-.97.15-1.8.09-2.76.26-.89.17-1.74.41-2.58.65-.23.06-.35.13-.53.26-.07.05-.09.15-.11.22.09.05.18.11.27.1.22-.03.4.04.62.01.52-.08 1.04-.14 1.58-.19.11 0 .26.08.36.15a1 1 0 0 0 .82.17c.32-.07.6.01.88.21.48.4.6.41 1.16.1.43-.23.9-.23 1.38-.2 1.06.05 2.05.2 3 .38a2.05 2.05 0 0 0 1.98-.76c.27-.34.53-.68.74-1.01.18-.24.37-.4.65-.4.6 0 1.21-.14 1.8-.1.33.02.5.33.5.52-.03.2-.1.32-.33.31-.46-.03-.9-.05-1.34-.11-.47-.04-.84.1-1.12.45-.15.16-.11.28.11.33.1.01.22.06.32.07.24.02.35.14.42.36.04.14.33.28.82.3.62.04.94.04 1.48-.13.23-.08.38-.34.53-.53.36-.51.6-.65 1.23-.51.45.08.75-.4 1.15-.37.73.1-.1-1.38-.56-1.87-.64-.47-1.15-1.41-1.71-2.11-.41-.51-.9-.7-1.26-1.33-.68-1.13-1.24-2.5-2-3.4-.29-.31-.93-.1-1.25.07a.88.88 0 0 0-.37.26c.91.77.95 1.84.63 2.63-.09.25-.18.24-.44.14a9.6 9.6 0 0 1-.72-.29c-.16-.08-.3-.04-.46.06-.7.42-1.54.98-1.68.84-.28-.27-.73-1.11-.7-1.54.02-.35.14-.65.27-.85a6.98 6.98 0 0 1-.9-.57v-.31c.58-.56 1.36-1.1 1.96-1.1zm-17.42-8.1c.08.55.3 1 .84 1.2.76.32 1.77.5 2.62.52 1.02.03 2.13-.06 3.32-.28a21.59 21.59 0 0 0 5.36-1.87 14.83 14.83 0 0 1 3.25-1.24 7.37 7.37 0 0 1 3.6-.1c.54.13.65.13.57-.25-.03-.26-.1-.5-.15-.77-.13-.89-.09-1.73-.42-2.5a1.03 1.03 0 0 0-.5-.45 2.94 2.94 0 0 0-.85-.26 6.05 6.05 0 0 0-1.8 0 9.06 9.06 0 0 0-2.73.84c-.93.46-1.86.97-2.55 1.39a7.35 7.35 0 0 1-3.78 1.09c-.89 0-1.47-.03-2.36-.13a8.41 8.41 0 0 1-3.47-.95c-.24-.12-.37-.09-.46.16a7.79 7.79 0 0 0-.47 3.6zM43.38 38c-.3.04-.94.13-1.32.15a1.77 1.77 0 0 1-.36-.05c.06-.11.1-.15.16-.18.45-.23.94-.45 1.27-.7.19-.15.15-.28.1-.4-.63.27-1.21.4-1.87.5-.05 0-.08-.04-.1-.07.51-.38 1.2-.69 1.57-1.02.25-.2.06-.26-.02-.35-.54.19-1.08.37-1.65.52a.65.65 0 0 1-.26-.02c0-.11.11-.16.2-.22a8.68 8.68 0 0 0 1.59-1.04l-.03-.14-.19-.02c-.44.08-1.4.22-1.93.27-.26 0-.22-.15-.17-.18.42-.19.74-.41 1.05-.74.11-.12.1-.23.06-.29-.5.24-1.08.24-1.42.28-.06-.08.02-.18.06-.22.4-.16.5-.29.7-.43.14-.1.44-.3.5-.4.04-.05.03-.16 0-.2a6.51 6.51 0 0 1-1.24.3.62.62 0 0 1-.22-.03c.03-.1.05-.17.1-.2.59-.3.9-.42 1.3-.67a1 1 0 0 0 .28-.36l-.04-.06-1.42.44c-.1-.02-.14-.08-.22-.14a.57.57 0 0 1 .16-.17 7.6 7.6 0 0 0 2.64-1.52c.22-.18.42-.4.5-.56l-.06-.11a13.7 13.7 0 0 1-2.9 1.63c-.22-.02-.18-.15-.1-.2.1-.1.37-.41.6-.7a8.4 8.4 0 0 0 2.43-1.41c.06-.06.09-.22.05-.32-.48.21-1.2.62-1.83.86l-.12-.04c.02-.11.08-.22.14-.33a8.11 8.11 0 0 0 1.53-1.24c.02-.07.05-.15 0-.23-.4.22-.85.37-1.26.51-.14-.09.03-.33.05-.39.59-.48.87-.8 1.15-1.2.06-.1.06-.18 0-.33-.32.23-.79.37-1.15.51l-.1-.03c-.02-.12 0-.1.04-.18.42-.4.79-.7 1.05-1.15.02-.05.02-.17-.03-.25-.35.12-.62.22-1 .32a.3.3 0 0 1-.14-.03c.02-.12 0-.15.05-.24.26-.23.52-.53.76-.9.07-.09.06-.18.01-.25-.18.05-.52.1-.69.11-.07.02-.16-.06-.21-.15l.65-.46a.56.56 0 0 0 .11-.18c-.08-.04-.15-.08-.2-.06-.28.03-.54.06-.82.12-.61.13-.61.21-.67.39a13.61 13.61 0 0 1-.68 2.03c-.08.18-.19.36-.37.43-.26.14-.2.27-.28.53-.11.5-.19.46-.4.95a2.7 2.7 0 0 1-.57.94h-.14l-.05-.7c-.05-.47-.14-.37-.22-.84-.05-.42.06-.87.11-1.23.05-.42.1-1.14.1-1.55-.04-.03-.08-.1-.13-.13a.4.4 0 0 0-.13.18c-.09.32-.24.82-.28 1.15-.1.76.05 1.5 0 2.27a8.65 8.65 0 0 0-.1 2.4c.25-.03.24-.06.59-.2.46-.18.8-.25 1.27-.67.34-.28.28-.85.4-1.32.16-.56.38-.76.6-.85.07-.02.13 0 .2.02l-.33.82c-.11.3-.22.77.1.82l.23.04c.01.06.01.14-.03.19-.3.28-.54.63-1.91 1.02-.16.05-.5.46-.52.62-.03.22-.03.47.02.82.14 1.37.82 2.65 1.58 3.92.64 1.08 1.12 1.9 1.81 2.6.33.3.67.53 1.21.27.3-.13.66-.36.75-.44.04-.06.05-.15.04-.23zm-18.6-19.7c.03.54-.07.68-.76.5-.73-.22-1.06-.14-1.53-.67-.28-.33-.63-.33-.93-.02-.14.17-.24.33-.46.37-.04-.07-.09-.18-.06-.26.08-.32.27-.56.57-.7.21-.12.47-.2.7-.26.64-.25.95-.63.95-1.38 0-.43.14-.86.14-1.3 0-.32-.12-.43-.42-.32-.53.2-1.03.4-1.56.63a.64.64 0 0 0-.37.35c-.15.28-.24.56-.37.84-.12.16-.23.08-.26.02-.25-.4-.56-.82-.82-1.16-.23-.28-.23-.38.03-.57l.86-.76c.43-.4.6-.93.64-1.52v-.81c-.01-.35.06-.46.41-.41.25.03.5.1.71.2.4.17.78.4 1.17.6.2.13.36.3.38.57 0 .3-.2.5-.47.39a8.56 8.56 0 0 0-1.31-.46c-.23-.05-.45.07-.49.28-.09.51.35.54.31.68-.11.36-.7.47-.78.8-.07.3-.07.5.2.45.74-.15 1.46-.6 2.02-.84.49-.2.74-.13.8.41.26 1.58.5 2.94.68 4.35zm11.44-5.02c.14.04.32.12.43.22.27.63.84 1.32 1.57 1.7.23.12.46.16.65.18.07-.28.19-.74.19-1.25 0-.4-.12-.84-.5-1.21a4.84 4.84 0 0 0-1.11-.84.47.47 0 0 0-.55.05c-.01.09-.01.23.04.31.18.3.6.59.8.88.06.3.04.28-.2.18a4.7 4.7 0 0 1-1.33-1.16c-.21-.24-.35-.24-.5.02a4.5 4.5 0 0 0-.67 2 2.05 2.05 0 0 0 1.11 2.14c.35.15.6.11.77-.21.17-.33.3-.61.4-.97.06-.19.06-.26-.08-.43a6.15 6.15 0 0 0-.56-.62.81.81 0 0 0-.28-.23.37.37 0 0 0-.07.24c.01.28.06.58.07.87 0 .07-.01.19-.06.25a.57.57 0 0 1-.32-.37c-.18-.69-.15-1.3.2-1.75zM4.06 3.15l.54.64c.22.42.34.8.45 1.13.1.34.24.34.45.19a.76.76 0 0 0 .32-.65 2.17 2.17 0 0 0-.12-.59c-.2-.72-.06-1.34.57-1.8.22-.14.37-.39.3-.65-.1-.36-.19-.7-.33-1.04C6.2.23 5.98.2 5.84.27c-.7.37-1.54 1.44-.9 2.34.03.05 0 .22-.05.31-.6-.58-1.74-1.78-2.09-1.75-.1.17-.17.51-.1 1.21.1.68.27 1.38.78 2.33.13.21.25.34.44.5.12.1.37.22.56.22.06-.14.07-.39.03-.55-.17-.64-.34-1.12-.55-1.7zm47 2.68c.49-.1.89-.24 1.07-.31.8-.3 1.33-.82 1.5-1.7.07-.23-.07-.36-.33-.42l-.52-.14c-.5-.15-.61.06-.8.56-.16.37-.31.8-.71 1.11-.12.1-.54-.2-.66-.28a4.26 4.26 0 0 0 1.68-2.1c.1-.17 0-.34-.18-.4-.25-.07-.5-.1-.8-.07a4.01 4.01 0 0 0-2.88 2.14c-.04.1 0 .31.06.34.11.05.4.02.52-.03.07 0 .1-.11.15-.18.33-.58.88-.93 1.51-1.21.19-.1.25-.03.15.18-.12.16-1.26.96-1.28 1.07-.15.33.07.37.26.37l.34-.09c.12.6.48.99.9 1.16zm-17.22-.1c-.02.28-.12.44-.38.35-.52-.23-.83-.8-1.42-.99-.21-.07-.34.12-.37.32-.1.6-.19 1.12-.19 1.35 0 .82.44 1.26.88 1.7.13.11.13.19-.01.25l-1.8 1c-.17.12-.37.14-.56 0-.17-.15-.23-.35-.17-.54.21-.9.36-1.84.6-2.72.36-1.4.97-1.87 1.98-2 .37-.06.64-.06.92-.06.3 0 .42.06.46.33.04.18.05.39.05 1.01zm1.36 6.17c0-.68-.55-.87-.79-1.45-.22-.57-.42-.57-.88-.16-.52.5-.84.92-1.02 1.63a3.9 3.9 0 0 0 .01 1.96c.05.2.16.41.38.35a.37.37 0 0 0 .27-.37c0-.58.05-1.14.34-1.51.13-.17.19-.2.26-.25.1.14.06.3.06.33-.09.43-.15.87-.24 1.3-.06.28-.06.44.09.7.17.26.3.3.42.12.53-.85 1.1-2.07 1.1-2.65zM6.14 13.78a5.21 5.21 0 0 0-.37-1.67c-.22-.53-.56-.84-.78-.84-.2 0-.68.56-.84 1.01-.4 1.15-.19 2.08.48 3.18.09.14.27.4.53.14.2-.24.36-.4.55-.65.26-.31.44-.75.43-1.17zm25.07 17.96c-.12-.96-.84-1.89-2.05-2.7-.25-.1-.27.07-.27.28.12 1.33.27 2.67.44 3.86.05.26.17.33.41.2.36-.17.7-.34 1.05-.54.32-.19.52-.36.42-1.1zm10.96-10.89c-.2-.46-.5-.66-.97-.7-.47-.05-.86-.11-1.35-.19-.28.04-.47.26-.63.63.01.08.04.17.1.19.16.06.44.11.48.14.06.04.24.23.28.38-.04.13-.2.27-.42.3-.28.06-.28.29-.23.58.04.28.14.5.36.8.19-.1.28-.15.42-.3a.63.63 0 0 0 .19-.54c-.04-.6.3-1.04.71-1.44l.1.05c-.07.35-.25.6-.3.94-.08.7-.32 1.3-1.02 1.78.22.28.75.07.92-.1.29-.26.52-.58.63-.98l.11-.35a.28.28 0 0 1 .1.02c.13.26-.06.8.03 1.18a.87.87 0 0 0 .35-.28c.26-.62.39-1.53.14-2.1zm8.76-14.33c-.12 0-.6.01-.74.04-.11.03-.17.29-.11.34.13.09.22.16.33.2.44.05.63.05 1.14.13.08.01.18.06.25.14-.05.04-.1.1-.19.12-.93.11-1.2.1-1.86-.34-.18-.08-.24.05-.19.22.1.32.36.58.84.77.38.17.75.37 1.15.37.6-.02 1.02-.06 1.51-.14.26-.04.52-.19.56-.32.05-.13 0-.42-.15-.6l-.35-.36c-.56-.59-.92-.96-1.75-.87-.11 0-.28.3-.44.3zm.58 6.2c0-.34-.05-.6-.14-.9a1.58 1.58 0 0 0-1.38-1.14c-.34 0-.51.06-.37.38.04.1.34.43.46.7.16.31.31.64.31.91a.93.93 0 0 1-.08.38c-.2-.11-.32-.37-.37-.49-.09-.3-.1-.47-.2-.64-.08-.15-.19-.19-.23-.19-.13 0-.19.05-.2.23a2.67 2.67 0 0 0 1.46 2.67c.26.1.33.03.41-.2a5.58 5.58 0 0 0 .33-1.7zM5.58 9.12c-.13.5-.15.83-.14 1.1.01.36.19.66.52.8a6.23 6.23 0 0 0 3.1.5c.03 0 .13-.07.13-.1-.02-.22-.14-.25-.33-.3-.44-.16-1.61-.47-1.77-.66-.12-.17-.06-.34.13-.37a1 1 0 0 1 .51.08c.3.14.54.33.84.5.1.05.2.15.32 0 .08-.14.16-.27-.02-.4l-.69-.55c-.6-.47-1.49-.7-2.6-.6zm21.29 7.71c-.05.1-.14.2-.25.33-.1-.11-.22-.19-.27-.3a22.36 22.36 0 0 1-1.12-3.73c-.02-.24.07-.33.28-.32.53.06 1 .3 1.46.54.07.06.13.22.14.33.1 1.05-.04 2.23-.24 3.15zM3.95 18.97l-.08-.03c.05-.64.37-1.54.25-1.77a1.3 1.3 0 0 0-.64.06c-.22.1-.32.32-.36.7-.06.82.07 1.67.25 2.41.05.28.17.31.37.11.53-.48 1.03-1.1 1.43-1.57.28-.36.33-.7.22-1.05-.1-.29-.29-.4-.5-.4-.24 0-.32.18-.38.35-.13.46-.34.79-.56 1.19zm42.97-1.9c.42 0 .76.08.88.12.5.18.72.4.81.58.1.17.1.26.1.34a.9.9 0 0 1-.83-.17c-.45-.42-1.1-.6-1.49-.42.03.3.3.65.54.84.78.6 1.47.7 2.3.51.15-.05.2-.25.2-.42-.03-.54 0-1.11-.5-1.58-.57-.53-1.37-.51-1.92-.28-.09.05-.23.11-.3.19.02.06.09.2.21.28zM27.56 2.32c.17-.04.1.03.05.18-.1.48-.37.85-.7 1.19-.2.16-.23.42-.1.55.24.23.52.03.7-.15.38-.41.61-.93.83-1.43.26-.62.2-1.4-.1-1.92-.15-.22-.4-.25-.58-.08a3.23 3.23 0 0 0-1.14 2.23c0 .13.01.35.1.4.42-.2.68-.66.93-.96zm11.36 22.52c.04-.04.12 0 .15.02 0 .5.12 1.1.18 1.28a.58.58 0 0 0 .19-.13l.14-.68c.31-.96.08-1.72-.32-2.6-.07-.16-.18-.18-.35-.1-.12.05-.23.13-.12.3.09.14.08.25 0 .4-.13.24-.23.51-.37.81-.05.19-.06.33-.08.56l-.14 3.44c.06.19.17.15.23.04.08-.19.13-.36.17-.56.1-.54.25-.56.28-1.1.05-.56.05-1.11.03-1.67zM7.39 3.57c-.01-.05 0-.18.02-.21l.57.1c.28.05.42.01.52-.2.15-.41.07-.78-.36-.87-.65-.12-1.3.1-1.86.22-.36.13-.45.5-.18.77.41.4.81.8 1.25 1.15.36.29.77.36 1.18.28.19-.05.35-.17.35-.33a.47.47 0 0 0-.14-.34 1.26 1.26 0 0 0-.33-.18zM6.8 28.63c-.03.19-.12.35-.43.33a3.83 3.83 0 0 1-.83-.12c-.3-.08-.38-.2-.4-.3-.1-.57-.04-1.33.09-1.85.04-.1.35-.28.48-.35.4.04.72.1 1 .18.12.07.34.4.36.45.06.18.06.37.06.56-.11.46-.25.86-.33 1.1zm31.08 16.8c.75.28 1.33.36 1.55.32a.45.45 0 0 0 .34-.5c0-.2-.1-.38-.37-.45-.57-.12-1.15-.2-1.7-.4-.3-.1-.55-.09-.83.13-.43.32-.84.5-1.37.6a.65.65 0 0 0-.34.12c-.15.2-.11.33.12.46.92.08 1.79-.1 2.6-.28zm3.07 1.83c.46 0 .8-.1 1.12-.3a2.8 2.8 0 0 1 1.35-.6c.2-.04.41-.25.43-.42 0-.23-.19-.26-.34-.31-.45-.14-.98-.12-1.44-.24-.15-.02-.36-.02-.48.07-.96.97-1.15.74-1.6 1.22-.12.16-.12.35.21.44.26.06.6.12.75.14zM25 10.86c0-.23.43-.6.67-.57.04.02.09.05.13.1l.09.5c.03.2.1.37.2.37.48.04 1.05-.3 1.32-.72.28-.44.49-.95.73-1.44.22-.53.57-.2.45.12-.31.92-.7 1.86-.99 2.77-.1.33-.14.35-.46.24l-1.54-.55a.8.8 0 0 1-.6-.81zM36.8 33.85c.25.12.23.07.56-.12a.76.76 0 0 0 .3-.54l-.1-2.01c0-.07-.09-.17-.12-.17-.28 0-.62-.06-.84.06-.43.24-.8.57-1.18.88-.15.15-.01.3.21.28.19-.08.4-.17.59-.27l.35-.19c0 .07 0 .12-.03.17-.34.37-.6.82-1.05 1.06-.12.02-.09.32.09.33.14-.02.42-.17.5-.25.29-.22.4-.36.69-.6.1.15.16.26.02.38l-.75.67c-.11.11-.03.22.1.2.2-.02.38-.1.53-.2.2-.12.35-.29.52-.47 0 .02.1.13.09.13-.14.22-.3.42-.48.66zm-23.82-23.4c-.11 1.12-.39 2.25-.9 2.77-.4-.79-.68-1.7-.96-2.5.22-.28.5-.7.62-1.02.06-.16.15-.19.3-.08.33.31.62.56.94.82zm1.33 16.04a.93.93 0 0 1-.5.64c-.2.1-.52.23-.88.23-.17 0-.3-.04-.32-.19l-.3-1.5c0-.12.1-.28.2-.38.32-.3.74-.39 1.18-.41.1 0 .4.13.45.2.09.47.14.9.17 1.4zm-4.06-6.03c-.6.1-1.12.63-1.03.84.01.47.1.91.36 1.31.15.24.27.3.52.13a4.47 4.47 0 0 0 1.78-1.82c.12-.22-.12-.29-.34-.4-.3-.14-.61-.14-.78-.06-.17.09-.23.27-.26.4-.19.68-.23.7-.43.94a1.8 1.8 0 0 1 .18-1.34zM14.28 46c.03-.08.05-.13.12-.14.1-.02.37-.02.4 0 .53.15 1.02-.23 1.51-.3.11-.02.24-.04.37-.02.32.01.65.02 1.01-.07.15-.06.34.02.51.1.57.24 1.12.38 1.67.06.29-.2.58-.38.88-.53.51-.2.56.14.58.33a.48.48 0 0 1-.28.29c-1.77.63-3.3.64-5.28.4a4.47 4.47 0 0 1-1.5-.12zM3.2 27.39c-.04.24.04.6.23.8l.09.08-.05.15a4.19 4.19 0 0 1-.91-.12c-.13-.05.23-.24.26-.47.06-.45.19-1.2.19-1.75 0-.1-.24-.2-.24-.28a.34.34 0 0 1 .11-.19c.66.16.75.15.88.46.13.28.25.74.45 1.08.03-.02.09-.04.12-.07.03-.3.02-.75.03-.96.01-.17.09-.25.27-.25.13 0 .48.01.62.04.02.03.02.05.02.1 0 .08-.11.11-.14.12-.31.11-.33.14-.47 1l-.15.98c-.02.08-.03.23-.08.33-.08 0-.23 0-.26-.08-.21-.52-.5-1.08-.76-1.55h-.1c-.07.2-.07.4-.12.59zm20.47 4.59c.03-.2.03-.4 0-.57-.1-.32-.25-.63-.2-.9.14-.49.24-1 .2-1.5a6.27 6.27 0 0 1 .05-1.86c.17.06.3.17.34.28.04.2.09.4.09.57.06.53.02 1.04-.01 1.56-.08 1-.17 1.93-.14 2.92.02.15.05.34.1.48.12.3.06.63-.18.97l-.15-.07c-.11-.41-.4-.98-.51-1.43-.02-.08 0-.15.1-.17.2-.03.31-.15.32-.28zm9.68-7.4c-.4-.04-.83-.4-.8-1.05-.2.27-.45.55-.68.66.02.22.57.54.95.7.22.28.37.42.65.74.17-.43.38-.8.44-1.03a3.3 3.3 0 0 0-.32-1.51c-.31-.35-.8-.63-1.27-.94-.23.25.06.79.64 1.11-.13.36-.11.9.46 1.21zm-27.82-1c.29-.02.6-.06.94-.11.22-.06.47-.11.48-.4.02-.24-.28-.38-.48-.44a4.43 4.43 0 0 0-2.93.3c-.25.13-.46.27-.6.42-.22.24-.18.39 0 .52.18.14.45.29.8.37.04-.2.08-.54.15-.74.32-.52 1.21-.62 1.83-.64.15.03.15.22.03.26-.18.14-.53.1-.62.26 0 .15.15.21.4.2zm1.99 5.4c-.01-.11.12-.25.13-.33.03-.15.03-.35.03-.5.02-.4-.07-1.06-.07-1.45l.22-.14c.07-.03.13.02.21.1.19.18.6.64.8.82.02 0 .05-.05.06-.06v-.3c0-.2-.04-.35-.1-.57-.07-.25-.25-.43-.05-.45l.76-.05c-.07.15-.13.26-.16.48-.03.3-.1.59-.1.88.04.44.13.89.17 1.26 0 .03-.06.07-.11.1a.7.7 0 0 1-.22-.14c-.37-.38-.63-.72-1.11-1.18a.4.4 0 0 0-.07.2c.1.3.21.62.41.9.12.16.15.21-.16.33-.17.05-.45.13-.63.09zm13.6.08c.44-.27.62-1.17.5-1.6a.58.58 0 0 0-.14-.31c-.14-.14-.3-.1-.37.14-.09.35-.13.72-.17 1.05a3.26 3.26 0 0 0-.99-.03c-.33.05-.98.24-.98.64 0 .65 1.5.5 2.15.11zm2.63-4.5a.74.74 0 0 0 .18.52c.67.7 1.6 1.42 2.18 1.56.52.14.96.45 1.28.87l.3.42c.23.28.52.46.9.52.07.02.16 0 .23 0-.06-.23-.06-.26-.22-.43-1.38-1.23-2.84-2.19-4.26-3.18-.14-.09-.4-.25-.6-.28zM9.36 40.38v-.02c-.14-.59-.3-1.15-.44-1.72-.12-.2-.32-.06-.3.03-.15.41-.3.83-.43 1.27a.61.61 0 0 0 0 .4c.22.6.43 1.21.67 1.83.04.08.15.13.21.18.06-.07.14-.16.16-.23zm2.44-14.6c.04.12.1.26.11.39.01.1.01.17-.02.22 0 .03-.06.02-.12 0-.29-.14-.61-.32-.87-.15-.1.07-.06.24.06.3l.82.33c.37.14.47.3.4.74-.07.42-.38.59-.74.69-.15.04-.31.06-.51.04-.03.13 0 .28-.09.33-.06.04-.08.03-.15.06a3.6 3.6 0 0 1-.28-1.02c0-.08.03-.09.06-.12.12.04.23.2.42.38.22.08.6.14.66.08.11-.14.16-.23.16-.28 0-.1-.13-.19-.25-.23-.28-.16-.44-.22-.74-.34-.28-.11-.33-.36-.33-.6 0-.25.14-.52.54-.65l.46-.13c.04-.08.07-.36.07-.41.06-.01.18-.03.2.01zM6 8.26c-.57 0-.92-.14-1.48-.09-.4.03-.79.2-1.18.35-.23.12-.19.22.02.3.2.1.34.15.54.14l3.6-.33c.07-.1.12-.17.19-.32-.44-.29-1-.23-1.54-.39zm13.24 17.23c-.05.03-.13.1-.27.24a.73.73 0 0 1-.23.17l-.16-.1.26-.6c.09-.23.18-.26.4-.11l.2.17c.18.14.4.25.6.16.2-.1.1-.38-.1-.48-.3-.19-.53-.24-.9-.46-.21-.13-.3-.33-.3-.61 0-.23.15-.51.45-.54.11-.03.25-.03.4-.03.2 0 .33-.03.45-.2.1-.11.2-.19.23-.06.07.34.03.7-.06.91-.06-.01-.1-.01-.17-.04-.17-.28-.4-.41-.6-.38-.19.02-.28.16-.14.31.25.26.6.4.9.57.43.23.4.56.35.8a.6.6 0 0 1-.63.5c-.22 0-.43-.06-.68-.22zm-.84-.86c.04.72-.54.98-.95.97-.38 0-.6-.08-.74-.46-.06-.23-.14-.9-.18-1.16-.08-.1-.2-.13-.4-.18-.1-.02-.1-.1-.12-.18.14-.07.39-.14.56-.17.41-.06.41-.04.48.34.05.42.12.87.2 1.3.14.42.59.33.59-.03 0-.33.02-.71 0-1.07-.07-.08-.19-.26-.32-.38-.16-.19-.16-.24.06-.33.52-.2.56-.33.63.36.03.26.19.66.19 1zm.48 3.67l1.3-.3c.35-.1.54-.47.52-.8-.04-.25-.19-.39-.45-.44a3.54 3.54 0 0 0-1.68.23c-.04.44.12.93.31 1.3zM6.91 23.66c-.16 0-.39.04-.55.09-.33.08-.5.11-.82.08-.19-.02-.49-.14-.66-.18-.2.01-.4.2-.47.47-.04.28.13.48.44.53.62.14 1.2.25 1.79.25.22 0 .25-.03.26-.21.02-.35.01-.65.01-1.03zm14.9-13.3a3.77 3.77 0 0 1-.82-.25c-.09-.03-.15-.26-.15-.38.02-.32-.06-.65 0-1 .02-.18.13-.23.3-.2l.73.19c.32.13.79 1 .65 1.31-.14.28-.39.32-.7.34zM16.42 25.6a.93.93 0 0 1-.26.25c-.3.2-.86.33-1.24.58-.19.13-.1-.32-.11-.49l-.2-1.04a1.36 1.36 0 0 0-.34-.56c-.1-.13.2-.18.37-.23l.6-.19c.23-.07.28.09.22.14-.31.22-.28.32-.25.6.05.29.05.6.06.83.05.11.11.26.2.36.18-.05.39-.2.39-.25l.04-.6c.23-.27.26-.14.3-.01.1.22.14.36.22.61zm.93-6.6c-.13-.4-.26-.83-.36-1.24-.03-.17.11-.27.27-.24.56.12 1.1.25 1.67.4.18.04.18.19.06.31-.36.37-.74.69-1.24.91-.26.14-.26.04-.4-.15zm24.1-14.77a4.1 4.1 0 0 0-.63-1.54c-.26-.32-.56-.35-.84-.06-.1.1-.18.19-.24.28-.28.36-.26.47.16.67.64.19 1 .56 1.45 1.03zM11.9 40.4a2.6 2.6 0 0 0-.83.74l-.58 1c-.07.16-.18.55-.22.8l.1.1a4.65 4.65 0 0 0 .83-.6c.47-.46.58-.9.84-1.83l.05-.11zM52.9 2.13c-.25-.52-.71-1.22-.9-1.47-.26-.32-.38-.34-.66-.06l-.25.28c-.28.35-.45.78 0 .84.4.07.93 0 1.18.18l.54.36zm-47.18 25c-.07.69-.05.69-.05 1.16 0 .26.12.26.35.28.21 0 .28-.19.33-.44l.14-.94c.03-.3.05-.48-.13-.51-.35-.05-.6.17-.64.46zm3.63-12.58a3.6 3.6 0 0 1-.87-.3c-.47-.24-.91-.75-.84-1.21.04-.22.16-.28.34-.18.36.26.66.65.92.93.21.22.37.47.46.76zm3.5 11.06c0 .19.16.74.22 1.05.02.17.06.3.3.27.32-.05.43-.18.38-.44-.03-.28-.1-.57-.16-.87-.06-.28-.18-.44-.43-.43-.26.03-.35.12-.32.42zM26.66 8.05c-.2.35-.37.7-.6 1.01-.18.26-.46.41-.71.63-.24.06-.25.04-.17-.2.36-.6.7-1.06 1.1-1.57.28-.15.38-.03.37.13zm18.67 9.66c0 .22-.04.43-.11.64l-.06.03c-.29-.73-.99-1.9-.94-2.02-.02-.08.17-.13.25-.11l.32.13c.18.43.37.84.54 1.33zm2.03-15.42c.03 0 .15.04.23.11.14.11.16.24-.03.32-.44.2-1.17.6-1.65.77-.09.05-.2.06-.15-.11.09-.28 1.2-1.1 1.6-1.1zM31.44 22.5c-.3 0-.56.24-.56.48 0 .27.35.56.66.56.28 0 .47-.18.47-.46.02-.34-.22-.58-.57-.58zM6.91 46c-.06 0-.18.2-.28.21-.38.03-.5.07-.5.23 0 .21.1.32.28.27.56-.17.69-.15 1.42-.1l.25-.3c-.09-.07-.15-.16-.25-.19A4.16 4.16 0 0 0 6.9 46zM39.7 19.21c-.12.07-.22.15-.19.29l.1.22c.21-.04.45-.06.68-.04.3.1.8.2 1.11.26.08.02.17-.06.23-.14l-.07-.12c-.43-.43-1.14-.44-1.86-.46zM19.19 9.8l-.76-.34c-.05-.02-.08-.16-.03-.22.17-.25.34-.48.52-.7.1-.1.17-.09.21.03l.38.95c.08.19 0 .26-.32.28zM9.18 19.15c.18-.04.27.08.25.24-.02.1-.05.13-.2.2-.58.19-1.1.18-1.7.06-.18-.02-.3-.06-.33-.1a.35.35 0 0 1 .22-.16zm5.34-14.93c-.06.01-.12.06-.16.03-.5-.28-1.2-.65-1.65-.94-.1-.15-.04-.2.1-.18.37.12 1 .3 1.36.44.24.12.31.33.35.65zm7.58 10.86c.06.09.11.17-.04.42-.26.4-.32.8-.49 1.33-.04.12-.11.24-.17.32-.05.06-.14.08-.2.11-.02-.06-.06-.15-.05-.2l.5-1.64c.08-.2.23-.3.45-.34zM40.28 9.6a9.03 9.03 0 0 1-1.96-.68c-.21-.19-.17-.18.1-.19l1.84.5c.35.26.28.25.02.37zM32.7 21.25a.62.62 0 0 0-.28-.35c-.1-.05-.27-.03-.37.06-.1.06-.22.16-.3.26-.14.2-.05.39.17.55.18.13.39.12.51-.06.11-.14.21-.24.27-.46zm-12.26-9c-.07.15-.09.29-.18.39-.25.3-.53.58-.8.87-.27.12-.28-.04-.25-.17.25-.47.6-.86.93-1.24.03-.04.14-.07.18-.04.05.03.08.1.12.19zM9.93 9.7c-.07.04-1.05-1.5-1.17-1.8 0-.06.16-.18.24-.24.06.04.14.1.17.15.31.67.86 1.8.82 1.85zm-.42 6.13l-.42-.19c-.3.07-.56.2-.9.25-.36.02-.51-.05-.65-.14.05-.12.25-.23.54-.28.17-.03.9-.1 1.54-.04zM47.4 8l1.08.81c.1.08.09.23.13.32l-.24-.03c-.46-.23-.95-.42-1.25-.87-.26-.39.16-.34.28-.23zM20.04 9.34l-.12.19c-.04-.06-.1-.11-.14-.19-.09-.18-.09-.4-.1-.6-.06-.46-.04-.7.24-.99.12-.13.2-.05.2.07.03.58 0 .95-.08 1.52zm-6.92-1.7c.1.05.28 1.15.4 1.72.03.13.02.3 0 .42-.05.13-.1.16-.2.05-.19-.59-.28-1.18-.38-1.74-.03-.17-.03-.35.18-.44zm31.57 6.74c.44.25.96.7 1.18.96.05.05.03.2 0 .31-.08-.03-.16-.03-.22-.08-.37-.23-.71-.5-1.06-.74-.04-.03-.05-.3-.09-.36a.4.4 0 0 1 .19-.1zM24.34 4.79c.07.05.1.1.15.16a.4.4 0 0 1-.15.17c-.32.12-1.06.12-1.36-.06a.95.95 0 0 1-.16-.18l.21-.12c.44-.1.93-.06 1.3.04zm8.37 1.79c.3.46.43.91.56 1.41 0 .03-.02.04-.02.12-.07-.05-.11-.06-.14-.1a2.6 2.6 0 0 1-.74-1.23c-.04-.1-.02-.2.12-.28a.5.5 0 0 1 .22.08zm-5.79 31.85c.36-.2.46-.36.77-.55.13-.08.12-.1.05-.22-.07-.14-.14-.14-.32-.1-.35.13-.49.21-.84.35-.15.06-.2.12-.05.24zm-10.9-33c.43-.3.9-.45 1.37-.63.08-.02.19.01.27.09l-.16.14c-.38.27-.75.47-1.1.68-.11 0-.28-.03-.38-.06a.28.28 0 0 1 0-.22zM4.9 14.55c-.1-.5-.24-1.11-.15-1.56.02-.1.09-.19.2-.28.08.09.18.15.19.23.09.53-.06 1.12-.1 1.6zM29.13 3.32c.32-.26.86-.54 1.25-.73a4.7 4.7 0 0 1-1.28 1.37c-.03-.2-.1-.53.03-.64zm-5.96 19.44c0 .2.1.43.26.59.1-.08.17-.22.17-.28.04-.4.06-.8.06-1.2.05-.16-.18-.2-.24-.04-.09.3-.24.62-.25.93zm20.44 16.1l-1.72.58c.4.45 1.56.08 1.72-.58zM18.26 7.6c.03.46-.06 1.03-.3 1.45-.04.05-.1.09-.18.14-.02-.08-.1-.14-.09-.2.1-.47.21-1.02.33-1.49.01-.03.09-.05.13-.06zm24.1 32.9c.37 0 .73 0 1-.08.26-.16.25-.49.33-.71l-.1-.03-.4.37a5.8 5.8 0 0 1-.84.17c-.05.06-.1.1-.13.17.05.06.1.11.15.12zm-3.44-18.43c.12-.27.23-.52.32-.77.02-.05-.06-.2-.16-.29a.73.73 0 0 0-.2.1 3.72 3.72 0 0 0-.55.82c.04.06.22.06.58.14zm-28.81-7.3l.36-.92c.06-.02.12-.02.17 0 .05.29 0 .73-.02.91-.06.25-.15.4-.37.51a1.52 1.52 0 0 1-.14-.5zm21 6.84c-.25 0-.45.15-.47.37 0 .19.2.36.43.36.24-.01.41-.18.43-.39 0-.22-.14-.34-.39-.34zm-.22 2.29c0-.25-.15-.42-.42-.42-.22 0-.37.14-.37.33 0 .23.23.45.46.43.2 0 .33-.15.33-.34zm-.94-2.35c0 .2-.13.33-.33.33-.26 0-.46-.16-.46-.4a.4.4 0 0 1 .38-.37c.2-.02.4.16.4.44zm.16.93c-.22 0-.37.14-.37.33 0 .2.2.37.42.37.17 0 .33-.18.33-.37 0-.18-.16-.33-.38-.33zm-2.44 16.64c-.3 0-.54.14-.53.3.01.16.24.37.41.37.2 0 .3-.2.3-.44-.02-.19 0-.23-.18-.23zM9.93 3.9a3.23 3.23 0 0 1 .06-1.63c.24.48.26 1.27-.06 1.63zm20.94 16.3c-.15.1-.28.25-.26.31.02.11.14.21.21.33a.6.6 0 0 0 .25-.3c.03-.07-.1-.19-.21-.34z" fill="#53565a"></path></svg></span><span class="els-header-brand-name els-header-brand-name-reduce-fs">Embase</span></a></div><!-- Nav --><div id="header-nav-holder" class="els-header-nav-holder els-header-has-mobile-panel"><ul id="app-header-nav" class="els-header-nav els-header-nav-horizontal"><li class="u-margin-m-left"><a class="anchor " id="nav-search" href="https://www.embase.com/search/quick"><span class="anchor-text">Search</span></a></li><li class="u-margin-m-left"><a class="anchor " id="nav-emtree" href="https://www.embase.com/#emtreeSearch/default"><span class="anchor-text">Emtree</span></a></li><li class="u-margin-m-left"><a class="anchor " id="nav-journals" href="https://www.embase.com/journals"><span class="anchor-text">Journals</span></a></li><li class="u-margin-m-left"><a class="anchor els-header-anchor-active" id="nav-results" href="https://www.embase.com/#advancedSearch/resultspage"><span class="anchor-text">Results</span></a></li><li class="u-margin-m-left"><a class="anchor " id="nav-tools" href="https://www.embase.com/#clipboard/default"><span class="anchor-text">My tools</span></a></li></ul></div><!-- Utils --><div id="header-nav-utils-holder" class="els-header-nav-utils-holder els-header-has-mobile-panel"><ul id="app-header-nav-utils" class="els-header-nav els-header-nav-horizontal"><li class="u-margin-s-left"><a id="header-btn-help" class="button-link els-header-icon-holder-paren-hover button-link-primary" href="https://service.elsevier.com/app/home/supporthub/embase/" target="_blank" title="Go to the help files"><span class="button-link-text"><span class="els-header-icon-holder els-header-icon-holder-has-hover els-header-icon-holder-reduce-s"><svg focusable="false" viewBox="0 0 114 128" width="21.375" height="24" class="icon icon-help els-header-icon"><path d="m57 8c-14.7 0-28.5 5.72-38.9 16.1-10.38 10.4-16.1 24.22-16.1 38.9 0 30.32 24.68 55 55 55 14.68 0 28.5-5.72 38.88-16.1 10.4-10.4 16.12-24.2 16.12-38.9 0-30.32-24.68-55-55-55zm0 1e1c24.82 0 45 20.18 45 45 0 12.02-4.68 23.32-13.18 31.82s-19.8 13.18-31.82 13.18c-24.82 0-45-20.18-45-45 0-12.02 4.68-23.32 13.18-31.82s19.8-13.18 31.82-13.18zm-0.14 14c-11.55 0.26-16.86 8.43-16.86 18v2h1e1v-2c0-4.22 2.22-9.66 8-9.24 5.5 0.4 6.32 5.14 5.78 8.14-1.1 6.16-11.78 9.5-11.78 20.5v6.6h1e1v-5.56c0-8.16 11.22-11.52 12-21.7 0.74-9.86-5.56-16.52-16-16.74-0.39-0.01-0.76-0.01-1.14 0zm-4.86 5e1v1e1h1e1v-1e1h-1e1z"></path></svg></span></span></a></li><li class="u-margin-s-left"><div class="popover" id="header-popover-institution"><div id="popover-trigger-header-popover-institution"><button class="button-link els-header-icon-holder-paren-hover button-link-primary" id="header-btn-institution" type="button"><span class="button-link-text"><span class="els-header-icon-holder els-header-icon-holder-has-hover els-header-icon-holder-reduce-s els-header-icon-holder-dark"><svg focusable="false" viewBox="0 0 106 128" width="19.875" height="24" class="icon icon-institution els-header-icon"><path d="m84 98h1e1v1e1h-82v-1e1h1e1v-46h14v46h1e1v-46h14v46h1e1v-46h14v46zm-72-61.14l41-20.84 41 20.84v5.14h-82v-5.14zm92 15.14v-21.26l-51-25.94-51 25.94v21.26h1e1v36h-1e1v3e1h102v-3e1h-1e1v-36h1e1z"></path></svg></span></span></button></div><div id="popover-content-header-popover-institution" class="popover-content popover-align-right" style="width: 350px;"><div class="popover-content-inner"><p class="u-margin-m-bottom u-text++ u-clr-grey7">Brought to you by</p><div class="els-header-institution-info"><span class="u-margin-s-right"><span class="els-header-icon-holder els-header-icon-holder-dark"><svg focusable="false" viewBox="0 0 106 128" width="19.875" height="24" class="icon icon-institution els-header-icon"><path d="m84 98h1e1v1e1h-82v-1e1h1e1v-46h14v46h1e1v-46h14v46h1e1v-46h14v46zm-72-61.14l41-20.84 41 20.84v5.14h-82v-5.14zm92 15.14v-21.26l-51-25.94-51 25.94v21.26h1e1v36h-1e1v3e1h102v-3e1h-1e1v-36h1e1z"></path></svg></span></span><span class="els-header-institution-info-text">Zhejiang University Library, IP_Zhejiang University</span></div></div></div></div></li></ul></div><!-- Profile --><div id="header-profile-holder" class="els-header-profile-holder els-header-has-mobile-panel"><button id="header-btn-sign-in" class="button button-primary els-header-btn-reduce-s" type="button"><span class="button-text">Sign in</span></button></div><!-- Mobile panel --><div id="header-mobile-panel-holder" class="els-header-mobile-panel-holder"><div id="header-mobile-panel" class="els-mobile-panel "><button id="header-btn-open-mobile-panel" class="els-mobile-panel__open-btn"><span class="els-header-icon-holder els-header-icon-holder-reduce-s els-header-icon-holder-has-hover"><svg focusable="false" viewBox="0 0 104 128" width="19.5" height="24" class="icon icon-list els-header-icon"><path d="m2e1 95a9 9 0 0 1 -9 9 9 9 0 0 1 -9 -9 9 9 0 0 1 9 -9 9 9 0 0 1 9 9zm0-3e1a9 9 0 0 1 -9 9 9 9 0 0 1 -9 -9 9 9 0 0 1 9 -9 9 9 0 0 1 9 9zm0-3e1a9 9 0 0 1 -9 9 9 9 0 0 1 -9 -9 9 9 0 0 1 9 -9 9 9 0 0 1 9 9zm14 55h68v1e1h-68zm0-3e1h68v1e1h-68zm0-3e1h68v1e1h-68z"></path></svg></span></button><div class="els-mobile-panel__content"><button id="header-btn-close-mobile-panel" class="els-mobile-panel__close-btn"><span class="els-header-icon-holder els-header-icon-holder-has-hover"><svg focusable="false" viewBox="0 0 70 128" width="13.125" height="24" class="icon icon-cross els-header-icon"><path d="m68.94 36.12l-6.94-7.12-27 27-27-27-7 7 27 27-27 27 7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></span></button><div class="u-padding-m"><!-- Profile --><div class="u-margin-m-bottom u-margin-l-right"><button id="m-header-btn-sign-in" class="button button-primary els-header-full-width" type="button"><span class="button-text">Sign in</span></button></div><!-- Nav --><ul id="m-app-header-mobile-nav" class="els-header-nav els-header-nav-vertical"><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-search" href="https://www.embase.com/search/quick"><span class="anchor-text">Search</span></a></div><div class="u-margin-s-top u-margin-m-left"><ul id="m-app-header-mobile-nav-nav-search" class="els-header-nav els-header-nav-vertical"><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-quick-search" href="https://www.embase.com/search/quick"><span class="anchor-text">Quick</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-pico" href="https://www.embase.com/search/pico"><span class="anchor-text">PICO</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-pw-wizard" href="https://www.embase.com/#PVwizard/default"><span class="anchor-text">PV Wizard</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-medical-device" href="https://www.embase.com/search/medical-device"><span class="anchor-text">Medical device</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-advanced" href="https://www.embase.com/#advancedSearch/default"><span class="anchor-text">Advanced</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-drug" href="https://www.embase.com/#drugSearch/default"><span class="anchor-text">Drug</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-disease" href="https://www.embase.com/#diseaseSearch/default"><span class="anchor-text">Disease</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-device" href="https://www.embase.com/#deviceSearch/default"><span class="anchor-text">Device</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-citation-information" href="https://www.embase.com/search/citation-information"><span class="anchor-text">Citation information</span></a></div></li></ul></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-emtree" href="https://www.embase.com/#emtreeSearch/default"><span class="anchor-text">Emtree</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-journals" href="https://www.embase.com/journals"><span class="anchor-text">Journals</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 els-header-anchor-active" id="m-nav-results" href="https://www.embase.com/#advancedSearch/resultspage"><span class="anchor-text">Results</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-tools" href="https://www.embase.com/#clipboard/default"><span class="anchor-text">My tools</span></a></div><div class="u-margin-s-top u-margin-m-left"><ul id="m-app-header-mobile-nav-nav-tools" class="els-header-nav els-header-nav-vertical"><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-clipboard" href="https://www.embase.com/#clipboard/default"><span class="anchor-text">Clipboard</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-saved-clipboards" href="https://www.embase.com/#savedclipboards/default"><span class="anchor-text">Saved Clipboards</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-email-alerts" href="https://www.embase.com/tools/alerts"><span class="anchor-text">Email Alerts</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-saved-searches" href="https://www.embase.com/#saved/default"><span class="anchor-text">Saved Searches</span></a></div></li><li class="u-margin-s-bottom"><div><a class="anchor u-clr-grey7 " id="m-nav-preferences" href="https://www.embase.com/tools/preferences"><span class="anchor-text">Preferences</span></a></div></li></ul></div></li></ul><!-- Account settings / Utils --><ul id="m-app-header-nav-utils" class="els-header-nav els-header-nav-vertical"><li class="u-margin-s-bottom"><a id="m-header-help" class="anchor els-header-icon-holder-paren-hover" href="https://embase.com/" target="_blank" title="Go to the help files"><span class="anchor-text">Help</span></a></li></ul><!-- Institution --><p class="u-margin-m-bottom u-text++ u-clr-grey7">Brought to you by</p><div class="els-header-institution-info"><span class="u-margin-s-right"><span class="els-header-icon-holder els-header-icon-holder-dark"><svg focusable="false" viewBox="0 0 106 128" width="19.875" height="24" class="icon icon-institution els-header-icon"><path d="m84 98h1e1v1e1h-82v-1e1h1e1v-46h14v46h1e1v-46h14v46h1e1v-46h14v46zm-72-61.14l41-20.84 41 20.84v5.14h-82v-5.14zm92 15.14v-21.26l-51-25.94-51 25.94v21.26h1e1v36h-1e1v3e1h102v-3e1h-1e1v-36h1e1z"></path></svg></span></span><span class="els-header-institution-info-text">Zhejiang University Library, IP_Zhejiang University</span></div><!-- Profile --></div></div><div id="els-mobile-panel-overlay" class="els-mobile-panel__overlay"></div></div></div></header></div><div id="page-bar-holder"><div id="page-bar"><h3 id="page-title">Results</h3><div class="page-bar-google-translate-holder"><div id="google-translate-element"></div></div></div></div><div id="sub-nav-holder"></div></div>
        <div id="content">
            <div id="contentBlock" class="content"><div id="searchFeedback" class="feedbackBar" style="display: block;"></div>			<!-- Row1 -->			<div id="searchResultSearchBLock" style="display: block;"><article class="SearchForm" id="SearchForm"><div id="searchForm" class="formWrapper formWrapperNextToTitle"><fieldset class="searchField"><div class="container searchFormContainer" style="visibility: visible;"><div class="expertMode"><input type="checkbox" id="expertSearch"><label for="expertSearch" class="emb-checkbox">Expert mode (allows for multiline queries)</label></div><textarea name="searchField" id="searchField" class="searchFieldSettings text" autocomplete="off" type="text" maxlength="200000" autofocus="autofocus" required="" placeholder="searches free-text by default – add /exp to explode" style="height: 30px;"></textarea><div class="autoComplete" style="display: none;"><ul class="resultsList notranslate"></ul></div></div><div id="extendedSearchBLock"><fieldset class="extensiveSearch"><div class="buttonBar"><a class="emb-btn-primary " id="submit_search" type="submit" value="submit"><span class="emb-button-text">Search</span></a><a href="https://www.embase.com/#/tab/advancedTab" type="tab" data-tracking="mapping" class="barbutton  barbuttonTab" id="advancedTab">Mapping<i class="bar-icon" id="advancedTab"></i></a><a href="https://www.embase.com/#/tab/basicsTab" type="tab" data-tracking="date" class="barbutton  barbuttonTab" id="basicsTab">Date<i class="bar-icon" id="basicsTab"></i></a><a href="https://www.embase.com/#/tab/sourcesTab" type="tab" data-tracking="sources" class="barbutton  barbuttonTab" id="sourcesTab">Sources<i class="bar-icon" id="sourcesTab"></i></a><a href="https://www.embase.com/#/tab/fieldLabelsTab" type="tab" data-tracking="fields" class="barbutton  barbuttonTab" id="fieldLabelsTab">Fields<i class="bar-icon" id="fieldLabelsTab"></i></a><a href="https://www.embase.com/#/tab/quickLimits" type="tab" data-tracking="quickLimits" class="barbutton  barbuttonTab" id="quickLimits">Quick limits<i class="bar-icon" id="quickLimits"></i></a><a href="https://www.embase.com/#/tab/search_ebm" type="tab" data-tracking="ebm" class="barbutton  barbuttonTab" id="search_ebm">EBM<i class="bar-icon" id="search_ebm"></i></a><a href="https://www.embase.com/#/tab/search_articletype" type="tab" data-tracking="pubTypes" class="barbutton  barbuttonTab" id="search_articletype">Pub. types<i class="bar-icon" id="search_articletype"></i></a><a href="https://www.embase.com/#/tab/search_language" type="tab" data-tracking="languages" class="barbutton  barbuttonTab" id="search_language">Languages<i class="bar-icon" id="search_language"></i></a><a href="https://www.embase.com/#/tab/search_gender" type="tab" data-tracking="gender" class="barbutton  barbuttonTab" id="search_gender">Gender<i class="bar-icon" id="search_gender"></i></a><a href="https://www.embase.com/#/tab/search_agetype" type="tab" data-tracking="age" class="barbutton  barbuttonTab" id="search_agetype">Age<i class="bar-icon" id="search_agetype"></i></a><a href="https://www.embase.com/#/tab/search_animaltype" type="tab" data-tracking="animal" class="barbutton  barbuttonTab" id="search_animaltype">Animal<i class="bar-icon" id="search_animaltype"></i></a><a href="https://www.embase.com/#/tab/search_tips" type="tab" data-tracking="searchtips" class="barbutton search-tips barbuttonTab" id="search_tips">Search tips<i class="bar-icon" id="search_tips"></i></a><span class="buttonBarEndBlock tabSheetButtonBar">&nbsp;</span></div>    </fieldset></div></fieldset><div id="journalsBrowse" class="browseForms notranslate" style="display: none;"></div><div id="authorsBrowse" class="browseForms" style="display: none;"></div></div></article></div><div class="content-wrap" style="display: block;"><!-- START OF CONCRETE THING -->	<div class="columns" id="resultsTwoCol">		<!-- col1 -->		<div id="filterBlock" style="display: block;"><article id="filters" class=""><nav class="filterActions"><div class="filtersTitle">Results Filters</div><ul> <li><a class="Expand textButton" href="https://www.embase.com/#action-expand" id="expandAllFilters" title="Expand"><span class="collapse-plus">+</span>Expand</a></li><li class="last-child"><a class=" textButton" href="https://www.embase.com/#action-collapse" id="collapseAllFilters" title="Collapse"><span class="collapse-minus">—</span>Collapse all</a></li></ul><a class="pushButton disabled" href="https://www.embase.com/#"><span class="push-btn-text">Apply</span></a><!--END of pushButton--><!--END of pushButton--><!--END of pushButton--></nav><ul id="filterCategories"><li class="filterCategory notranslate" id="SOURCES"><div class="translate filterHeader" id="SOURCES"><a href="javascript:void(0);" data-tracking="SOURCES" class="filterTitle toggle-nav-SOURCES" id="SOURCES"><span class="filter-title-name" id="SOURCES" data-tracking="SOURCES">Sources</span><i class="filter-nav" id="SOURCES" data-tracking="SOURCES"></i></a></div><div id="SOURCESGraphical" groupid="SOURCES"></div></li><li class="filterCategory notranslate" id="DRUG"><div class="translate filterHeader" id="DRUG"><a href="javascript:void(0);" data-tracking="DRUG" class="filterTitle toggle-nav-DRUG" id="DRUG"><span class="filter-title-name" id="DRUG" data-tracking="DRUG">Drugs</span><i class="filter-nav" id="DRUG" data-tracking="DRUG"></i></a></div><div id="DRUGStandard" groupid="DRUG"></div></li><li class="filterCategory notranslate" id="DISEASE"><div class="translate filterHeader" id="DISEASE"><a href="javascript:void(0);" data-tracking="DISEASE" class="filterTitle toggle-nav-DISEASE" id="DISEASE"><span class="filter-title-name" id="DISEASE" data-tracking="DISEASE">Diseases</span><i class="filter-nav" id="DISEASE" data-tracking="DISEASE"></i></a></div><div id="DISEASEStandard" groupid="DISEASE"></div></li><li class="filterCategory notranslate" id="MEDICAL_DEVICE"><div class="translate filterHeader" id="MEDICAL_DEVICE"><a href="javascript:void(0);" data-tracking="MEDICAL_DEVICE" class="filterTitle toggle-nav-MEDICAL_DEVICE" id="MEDICAL_DEVICE"><span class="filter-title-name" id="MEDICAL_DEVICE" data-tracking="MEDICAL_DEVICE">Devices</span><i class="filter-nav" id="MEDICAL_DEVICE" data-tracking="MEDICAL_DEVICE"></i></a></div><div id="MEDICAL_DEVICEStandard" groupid="MEDICAL_DEVICE"></div></li><li class="filterCategory notranslate" id="SUBHEADINGS"><div class="translate filterHeader" id="SUBHEADINGS"><a href="javascript:void(0);" data-tracking="SUBHEADINGS" class="filterTitle toggle-nav-SUBHEADINGS" id="SUBHEADINGS"><span class="filter-title-name" id="SUBHEADINGS" data-tracking="SUBHEADINGS">Floating Subheadings</span><i class="filter-nav" id="SUBHEADINGS" data-tracking="SUBHEADINGS"></i></a></div><div id="SUBHEADINGSStandard" groupid="SUBHEADINGS"></div></li><li class="filterCategory notranslate" id="AGE"><div class="translate filterHeader" id="AGE"><a href="javascript:void(0);" data-tracking="AGE" class="filterTitle toggle-nav-AGE" id="AGE"><span class="filter-title-name" id="AGE" data-tracking="AGE">Age</span><i class="filter-nav" id="AGE" data-tracking="AGE"></i></a></div><div id="AGEStandard" groupid="AGE"></div></li><li class="filterCategory notranslate" id="GENDER"><div class="translate filterHeader" id="GENDER"><a href="javascript:void(0);" data-tracking="GENDER" class="filterTitle toggle-nav-GENDER" id="GENDER"><span class="filter-title-name" id="GENDER" data-tracking="GENDER">Gender</span><i class="filter-nav" id="GENDER" data-tracking="GENDER"></i></a></div><div id="GENDERGraphical" groupid="GENDER"></div></li><li class="filterCategory notranslate" id="STUDYTYPE"><div class="translate filterHeader" id="STUDYTYPE"><a href="javascript:void(0);" data-tracking="STUDYTYPE" class="filterTitle toggle-nav-STUDYTYPE" id="STUDYTYPE"><span class="filter-title-name" id="STUDYTYPE" data-tracking="STUDYTYPE">Study types</span><i class="filter-nav" id="STUDYTYPE" data-tracking="STUDYTYPE"></i></a></div><div id="STUDYTYPEStandard" groupid="STUDYTYPE"></div></li><li class="filterCategory notranslate" id="PUBTYPE"><div class="translate filterHeader" id="PUBTYPE"><a href="javascript:void(0);" data-tracking="PUBTYPE" class="filterTitle toggle-nav-PUBTYPE" id="PUBTYPE"><span class="filter-title-name" id="PUBTYPE" data-tracking="PUBTYPE">Publication types</span><i class="filter-nav" id="PUBTYPE" data-tracking="PUBTYPE"></i></a></div><div id="PUBTYPEStandard" groupid="PUBTYPE"></div></li><li class="filterCategory notranslate" id="JOURNAL"><div class="translate filterHeader" id="JOURNAL"><a href="javascript:void(0);" data-tracking="JOURNAL" class="filterTitle toggle-nav-JOURNAL" id="JOURNAL"><span class="filter-title-name" id="JOURNAL" data-tracking="JOURNAL">Journal titles</span><i class="filter-nav" id="JOURNAL" data-tracking="JOURNAL"></i></a></div><div id="JOURNALStandard" groupid="JOURNAL"></div></li><li class="filterCategory notranslate" id="PUBYEAR"><div class="translate filterHeader" id="PUBYEAR"><a href="javascript:void(0);" data-tracking="PUBYEAR" class="filterTitle toggle-nav-PUBYEAR" id="PUBYEAR"><span class="filter-title-name" id="PUBYEAR" data-tracking="PUBYEAR">Publication years</span><i class="filter-nav" id="PUBYEAR" data-tracking="PUBYEAR"></i></a></div><div id="PUBYEARStandard" groupid="PUBYEAR"></div></li><li class="filterCategory notranslate" id="AUTHOR"><div class="translate filterHeader" id="AUTHOR"><a href="javascript:void(0);" data-tracking="AUTHOR" class="filterTitle toggle-nav-AUTHOR" id="AUTHOR"><span class="filter-title-name" id="AUTHOR" data-tracking="AUTHOR">Authors</span><i class="filter-nav" id="AUTHOR" data-tracking="AUTHOR"></i></a></div><div id="AUTHORStandard" groupid="AUTHOR"></div></li><li class="filterCategory notranslate" id="CONFERENCES"><div class="translate filterHeader" id="CONFERENCES"><a href="javascript:void(0);" data-tracking="CONFERENCES" class="filterTitle toggle-nav-CONFERENCES" id="CONFERENCES"><span class="filter-title-name" id="CONFERENCES" data-tracking="CONFERENCES">Conference Abstracts</span><i class="filter-nav" id="CONFERENCES" data-tracking="CONFERENCES"></i></a></div><div id="CONFERENCESStandard" groupid="CONFERENCES"></div></li><li class="filterCategory notranslate" id="DRUG_TRADENAMES"><div class="translate filterHeader" id="DRUG_TRADENAMES"><a href="javascript:void(0);" data-tracking="DRUG_TRADENAMES" class="filterTitle toggle-nav-DRUG_TRADENAMES" id="DRUG_TRADENAMES"><span class="filter-title-name" id="DRUG_TRADENAMES" data-tracking="DRUG_TRADENAMES">Drug Trade Names</span><i class="filter-nav" id="DRUG_TRADENAMES" data-tracking="DRUG_TRADENAMES"></i></a></div><div id="DRUG_TRADENAMESStandard" groupid="DRUG_TRADENAMES"></div></li><li class="filterCategory notranslate" id="DRUG_MANUFACTURERS"><div class="translate filterHeader" id="DRUG_MANUFACTURERS"><a href="javascript:void(0);" data-tracking="DRUG_MANUFACTURERS" class="filterTitle toggle-nav-DRUG_MANUFACTURERS" id="DRUG_MANUFACTURERS"><span class="filter-title-name" id="DRUG_MANUFACTURERS" data-tracking="DRUG_MANUFACTURERS">Drug Manufacturers</span><i class="filter-nav" id="DRUG_MANUFACTURERS" data-tracking="DRUG_MANUFACTURERS"></i></a></div><div id="DRUG_MANUFACTURERSStandard" groupid="DRUG_MANUFACTURERS"></div></li><li class="filterCategory notranslate" id="MEDICAL_DEVICE_TRADENAMES"><div class="translate filterHeader" id="MEDICAL_DEVICE_TRADENAMES"><a href="javascript:void(0);" data-tracking="MEDICAL_DEVICE_TRADENAMES" class="filterTitle toggle-nav-MEDICAL_DEVICE_TRADENAMES" id="MEDICAL_DEVICE_TRADENAMES"><span class="filter-title-name" id="MEDICAL_DEVICE_TRADENAMES" data-tracking="MEDICAL_DEVICE_TRADENAMES">Device Trade Names</span><i class="filter-nav" id="MEDICAL_DEVICE_TRADENAMES" data-tracking="MEDICAL_DEVICE_TRADENAMES"></i></a></div><div id="MEDICAL_DEVICE_TRADENAMESStandard" groupid="MEDICAL_DEVICE_TRADENAMES"></div></li><li class="filterCategory notranslate" id="MEDICAL_DEVICE_MANUFACTURERS"><div class="translate filterHeader" id="MEDICAL_DEVICE_MANUFACTURERS"><a href="javascript:void(0);" data-tracking="MEDICAL_DEVICE_MANUFACTURERS" class="filterTitle toggle-nav-MEDICAL_DEVICE_MANUFACTURERS" id="MEDICAL_DEVICE_MANUFACTURERS"><span class="filter-title-name" id="MEDICAL_DEVICE_MANUFACTURERS" data-tracking="MEDICAL_DEVICE_MANUFACTURERS">Device Manufacturers</span><i class="filter-nav" id="MEDICAL_DEVICE_MANUFACTURERS" data-tracking="MEDICAL_DEVICE_MANUFACTURERS"></i></a></div><div id="MEDICAL_DEVICE_MANUFACTURERSStandard" groupid="MEDICAL_DEVICE_MANUFACTURERS"></div></li></ul><a class="pushButton disabled" href="https://www.embase.com/#"><span class="push-btn-text">Apply</span></a><!--END of pushButton--><!--END of pushButton--><!--END of pushButton--></article></div>		<!--// col1 -->		<!-- col2 -->		<div class="" id="resultsRight">			<!--// Row1 -->           <div id="searchHistoryBlock" class="resultsHistory sessionResults"><form action="https://www.embase.com/" method="post" id="printPopupForm" onsubmit="window.open(&#39;&#39;, &#39;foo&#39;, &#39;width=450,height=300,status=yes,resizable=yes,scrollbars=yes&#39;)"><div><input type="hidden" name="recordId"><input type="hidden" name="subaction"></div></form><form action="https://www.embase.com/" method="post" id="historySubactionForm"><div><input type="hidden" name="recordId"><input type="hidden" name="subaction"></div></form><form id="sessionsearches" action="https://www.embase.com/search/results" method="post" onsubmit=""><div class="message" style="display:none"><ul id="message" style="display:none"><li>&nbsp;</li></ul></div><div class="resultHeader mainHead"><div style="display: none;" class="header searchMainHead" id="searchMainHead">History</div><ul class="tools_history" id="tools_history" style="visibility: visible;"><li class="normalSize normal-size-history"><input type="checkbox" value="" class="checkbox" id="table-selectall"><label for="table-selectall" class="emb-checkbox emb-checkbox-result"></label></li><li class="normalSize headerLabelHistory"><span class="section-headings">History&nbsp;&nbsp;</span></li><li class="ajaxSessionSaveSearchPopup"><span class="textButton">Save</span> |</li><li class="ajaxSessionDeleteSearch"><span class="textButton">Delete</span> |</li><li class="printHistory"><span class="textButton">Print view</span> |</li><li class="exportHistorySubmit"><span class="textButton">Export</span> |</li><li class="emailHistorySubmit"><span class="textButton">Email</span></li></ul><div class="extraNav exterNavSH" id="exterNavSH" style="visibility: visible;"><span id="combineBasicInput"><a id="combineSimple" class="emb-btn-small emb-btn-disabled"><span class="emb-button-text">Combine</span></a><span class="text moreSpace notranslate"><span class="using translate">using</span><input type="radio" id="and_radio_bottom" checked="checked" value="and" name="combined_operator" class="radio"><label for="and_radio_bottom" class="emb-radio-button emb-radio-button-history"><span class="and-or-radio-button translate">And </span></label><input type="radio" id="or_radio_bottom" value="or" name="combined_operator" class="radio"><label for="or_radio_bottom" class="emb-radio-button emb-radio-button-history"><span class="and-or-radio-button translate">Or </span></label></span></span></div><div class="toggle-history"><span id="anchorToggleTop" data="3" class="displaySetting">Collapse</span><span class="history-expand" data="3" style="display: none;">v</span><span class="history-collapse" data="3" style="display: block;">v</span></div></div><div id="scrollableList" class="tableView notranslate" style="visibility: visible;"><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row  table-row-even table-row-active"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="9" id="9"><label for="9" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#9</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND (<span class="term">'neuronal injury'</span> OR (<span class="term">neuronal</span> AND (<span class="term">'injury'</span>/exp OR <span class="term">injury</span>)))</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">223</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_9" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-odd"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="8" id="8"><label for="8" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#8</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND (<span class="term">'neurotoxicity'</span>/exp OR <span class="term">neurotoxicity</span>)</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">685</a></div><div class="table-row-dropdown" id="dropdown"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_8" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-even"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="7" id="7"><label for="7" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#7</div><div class="query table-row-text"><div class="queryContent"><span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span></div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">25,968</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_7" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-odd"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="6" id="6"><label for="6" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#6</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND <span class="term">memory</span>:ti,ab,kw</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">570</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_6" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-even"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="5" id="5"><label for="5" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#5</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND <span class="term">learning</span>:ti,ab,kw</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">451</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_5" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-odd"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="4" id="4"><label for="4" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#4</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND <span class="term">'neurocognative development'</span>:ti,ab,kw</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">0</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_4" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-even"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="3" id="3"><label for="3" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#3</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND <span class="term">'neuronal injury'</span>:ti,ab,kw</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">53</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_3" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-odd"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="2" id="2"><label for="2" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#2</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND <span class="term">neurotoxicity</span>:ti,ab,kw</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">486</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_2" class="query table-row-subcontent"></div></div></div><div><div id="rowcontainer" class="table-row-contianer"><div id="table_row" class="table-row   table-row-even"><div class="selectors cur-d table-row-checkbox"><input type="checkbox" name="ss_checkbox" class="checkbox" value="1" id="1"><label for="1" class="emb-checkbox emb-checkbox-result"></label></div><div class="search-number table-row-rownumber">#1</div><div class="query table-row-text"><div class="queryContent">(<span class="term">'sevoflurane'</span>/exp OR <span class="term">sevoflurane</span>) AND <span class="term">neurotoxicity</span>:ti,ab,kw</div><div class="editBox"></div></div><div class="metaData table-row-hitcount"><a class="reloadHistory" href="https://www.embase.com/#">486</a></div><div class="table-row-dropdown" id="dropdown" style="display: none;"><div><ul><li><a href="https://www.embase.com/#" class="edit">Edit</a></li><li><a href="https://www.embase.com/#" class="email">Email alert</a></li><li><a href="https://www.embase.com/#" class="rss">RSS feed</a></li></ul></div></div></div><div id="subqueries_1" class="query table-row-subcontent"></div></div></div></div></form></div>			<!-- Row2 -->			<div id="searchResultListBLock">               <div id="ppInteropWrapper" style="display: none;"></div>               <div id="ResultList" class=""><div class="searchHitsText" id="searchHitsText"><h3 class="search-hitcounts">223 results for search #9</h3></div><a id="setEmailAlertForLatest" class="textButton" style="margin-left: 20px;"><span class="ss-alarmclock" style="margin-right: 5px; font-size: 20px; color: #007398; vertical-align: middle;"></span>Set email alert</a><a id="setRSSFeedForLatest" class="textButton"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 -256 1792 1792" version="1.1" width="19" height="19" style="display: inline-block; margin-right: 5px; vertical-align: top;"><g transform="matrix(1,0,0,-1,212.61017,1346.1695)"><path d="M 384,192 Q 384,112 328,56 272,0 192,0 112,0 56,56 0,112 0,192 q 0,80 56,136 56,56 136,56 80,0 136,-56 56,-56 56,-136 z M 896,69 Q 898,41 879,21 861,0 832,0 H 697 Q 672,0 654,16.5 636,33 634,58 612,287 449.5,449.5 287,612 58,634 33,636 16.5,654 0,672 0,697 v 135 q 0,29 21,47 17,17 43,17 h 5 Q 229,883 375,815.5 521,748 634,634 748,521 815.5,375 883,229 896,69 z m 512,-2 Q 1410,40 1390,20 1372,0 1344,0 H 1201 Q 1175,0 1156.5,17.5 1138,35 1137,60 1125,275 1036,468.5 947,662 804.5,804.5 662,947 468.5,1036 275,1125 60,1138 35,1139 17.5,1157.5 0,1176 0,1201 v 143 q 0,28 20,46 18,18 44,18 h 3 Q 329,1395 568.5,1288 808,1181 994,994 1181,808 1288,568.5 1395,329 1408,67 z" fill="#007398"></path></g></svg>Set RSS feed</a><a class="toggleSearchDetails textButton"><span class="ss-file" style="margin-right: 5px; font-size: 20px; color: #007398; vertical-align: middle;"></span>Search details</a><a class="toggleTermSelector textButton"><span class="indexMinerIcon" style="margin-right: 5px; vertical-align: top;"></span>Index miner</a><div id="searchDetails" style="display: none; position: relative; margin: 0.5em 0 1em; background: #f5f5f5; border-top: 1px solid #dcdcdc; border-bottom: 1px solid #dcdcdc;"><div style="padding: 1em;"><span style="display: inline-block; width: 100px;">Sources</span><span id="searchDetailsSources" class="notranslate"></span></div><div style="padding: 1em;"><span style="display: inline-block; width: 100px;">Query</span><span id="searchDetailsQuery" class="notranslate"></span></div><div style="padding: 1em;"><span style="display: inline-block; width: 100px;">Mapped terms</span><span id="searchDetailsMapped" class="notranslate"></span></div><span class="toggleSearchDetails" style="cursor: pointer; font-size: 24px; position: absolute; top: 0.5em; right: 0.5em;">×</span></div><form action="https://www.embase.com/" method="post" id="subactionPopupForm" onsubmit="window.open(&#39;&#39;, &#39;foo&#39;, &#39;width=450,height=300,status=yes,resizable=yes,scrollbars=yes&#39;)"><div><input type="hidden" name="recordId"><input type="hidden" name="subaction"><input type="hidden" name="searchType"><input type="hidden" name="page"><input type="hidden" name="orderBy" value=""><input type="hidden" name="pageSize" value="200"><input type="hidden" name="recordSelection"><input type="hidden" name="recordSelectionWithRows"></div></form><form action="https://www.embase.com/" method="post" id="subactionForm"><div><input type="hidden" name="recordId"><input type="hidden" name="subaction"><input type="hidden" name="searchType"><input type="hidden" name="page"><input type="hidden" name="orderBy" value=""><input type="hidden" name="pageSize" value="200"><input type="hidden" name="recordSelection"><input type="hidden" name="recordSelectionWithRows"></div></form><form id="search_results" action="https://www.embase.com/search/results" method="post"><div class="fieldset"><input type="hidden" name="page" value="1" id="page"><input type="hidden" name="pageFrom" value="" id="pageFrom"><input type="hidden" name="pageSize" value="200" id="pageSize"><input type="hidden" name="rand" value="" id="rand"><!-- edged container --><div class="resultHeader actionBar"><ul><li class="checkAllbox"><input title="Select all on page" type="checkbox" class="checkbox" id="selectAllOnPage" name="selectAllOnPage"><label for="selectAllOnPage" class="emb-checkbox emb-checkbox-result"></label></li><li class="headerLabel"><span class="section-headings">Results</span></li><li class=" viewSubmit"><a class="textButton" href="javascript:void(0);" id="viewSubmitAction">View</a> |</li><li><span class="exportSubmit textButton" data="false">Export</span> |</li><li><span class="emailSubmit textButton" data="false">Email</span> |</li><li><a class="textButton" href="javascript:void(0);" id="addToClipboardAction">Add to Clipboard</a></li></ul><div class="hitcount-abstract"><div class="extraNav"><span class="text"><span class="hitStart">1</span> — <span class="hitEnd">200</span> </span><a class="emb-btn-result-nav next"><span class="emb-btn-nxt"></span></a></div></div></div><!--// edged container --><!-- result list tools --><table cellspacing="0" class="resultList" summary="Search Results List"><colgroup><col class="selectable"><col><col></colgroup><tbody><tr class="resultListTools"><td class="resultsSelect nowrap" id="toLeft"><select id="selectionAmount"><option id="initialNone" selected="selected" value="none">Select number of items</option><option id="initialSmall" value="1">100</option><option id="initialMiddle" value="2">223</option><option id="initialLarge" value="3" disabled="disabled">5,000</option><option id="initialHuge" value="4" disabled="disabled">1 - 10,000</option><option id="secondHuge" value="5" disabled="disabled">10,001 - 20,000</option><option id="thirdHuge" value="6" disabled="disabled">20,001 - 30,000</option><option id="fourthHuge" value="7" disabled="disabled">30,001 - 40,000</option><option id="fifthHuge" value="8" disabled="disabled">40,001 - 50,000</option><option id="sixthHuge" value="9" disabled="disabled">50,001 - 60,000</option></select>&nbsp;&nbsp;<input type="hidden" id="recordSelection" name="recordSelection" value="">Selected:  <label for="manualSelection" id="getSelectedNumber">0</label> (<a id="clearSelection" href="javascript:void(0)">clear</a>)</td><td class="nowrap notranslate" id="toRight"><div class="translate displayAllAbstracts "><a title="Hide all abstracts" class="showAllAbstracts hideThem">Hide all abstracts</a></div><span class="sort-result-title translate">Sort by: </span><input type="radio" id="orderby1" class="radio changeSortOrder" name="orderby" value="relevance"><label for="orderby1" class="emb-radio-button"><span class="sort-result translate"> Relevance </span></label><input type="radio" id="orderby2" class="radio changeSortOrder" name="orderby" value="author"><label for="orderby2" class="emb-radio-button"><span class="sort-result translate"> Author </span></label><input type="radio" id="orderby3" class="radio changeSortOrder" name="orderby" value="date" checked="checked"><label for="orderby3" class="emb-radio-button"><span class="sort-result translate"> Publication Year</span></label><input type="radio" id="orderby4" class="radio changeSortOrder" name="orderby" value="loaddate"><label for="orderby4" class="emb-radio-button"><span class="sort-result translate"> Entry Date</span></label></td></tr></tbody></table><!--// result list tools --><div class="clearfix"><ul id="recordsFound"><li>    <div id="embaseRecord_L2021164956" class="resultPreviewItem first"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2021164956" type="checkbox" id="record_checkbox_L2021164956"><label for="record_checkbox_L2021164956" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">1</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=1&amp;page=1&amp;id=L2021164956" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Corrigendum to “<span class="hit">Sevoflurane</span> up-regulates miR-7a to protect against ischemic brain <span class="hit">injury</span> in rats by down-regulating ATG7 and reducing <span class="hit">neuronal</span> autophagy” [Brain Res. Bull. 188 (2022) 214–222, (S0361923022001666), (10.1016/j.brainresbull.2022.07.003)]</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tan</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yuan</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">Brain Research Bulletin</span>&nbsp;<span class="journal-publication-year">2023</span>&nbsp;<span class="journal-volume">192</span><span class="journal-pages">&nbsp;(80-82)</span>&nbsp;<span class="cited-by" id="CTB-L2021164956"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-1"><a href="https://www.embase.com/#" class="showAbstract" data="1" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="1"></i> Abstract</a></li><li class="ui-tab" id="indexTab-1"><a href="https://www.embase.com/#" class="showIndexTerms" data="1" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="1"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.brainresbull.2022.11.004" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="0">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-0"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The authors regret an inadvertent error in the preparation of Fig. 4 where Fig. 2F and Fig. 4E are repeated. The correct figure is shown below. [Formula presented] The authors also regret mistakes in the following text. The revised text is here with bold to highlight corrections: In the Method part, 2.4 Neurological score, the sentence: “According to the Zea Longa scoring, no neurological deficit symptoms were scored as 0 point; rats with slight neurological deficit and the right upper limb unable to fully extend were scored as 1 point; rats turning to the right when walking with moderate focal neurological deficit were scored as 2 points; rats inclining to the right with severe focal neurological deficit were scored as 3 points; rats unable to walk spontaneously with reduced consciousness were scored as 4 points.” should be revised as: “According to the Zea Longa scoring, no neurological deficit symptoms were scored as 0 point; rats with slight neurological deficit and the left upper limb unable to fully extend were scored as 1 point; rats turning to the left when walking with moderate focal neurological deficit were scored as 2 points; rats inclining to the left with severe focal neurological deficit were scored as 3 points; rats unable to walk spontaneously with reduced consciousness were scored as 4 points.” In the Method part, 3.2 <span class="hit">Sevoflurane</span> alleviated ischemic brain <span class="hit">injury</span> in rats by reducing autophagy of neurons, the sentence: “Immunofluorescence results revealed that the MCAO-operated rats exhibited a markedly higher proportion of NeuN-(LC3B-II/Ⅰ) double-stained positive cells in the left hippocampus, increased number of the ratio of microglia Iba1-(LC3B-II/I) double staining positive cells when compared to the sham-operated rats. <span class="hit">Sevoflurane</span> treatment was observed to diminish the proportion of NeuN-(LC3B-II/I) double-stained positive cells in the left hippocampus and decreased number of the ratio of microglia Iba1-(LC3B-II/I) double staining positive cells in MCAO-operated rats (Fig. 2B, C and Fig. S1A, B), suggesting that <span class="hit">Sevoflurane</span> treatment led to the inhibition of autophagy in the neurons and microglia of the left hippocampus of the rats following ischemic brain <span class="hit">injury</span>.” should be revised as: “Immunofluorescence results revealed that the MCAO-operated rats exhibited a markedly higher proportion of NeuN-(LC3B-II/Ⅰ) double-stained positive cells in the right hippocampus, increased number of the ratio of microglia Iba1-(LC3B-II/I) double staining positive cells when compared to the sham-operated rats. <span class="hit">Sevoflurane</span> treatment was observed to diminish the proportion of NeuN-(LC3B-II/I) double-stained positive cells in the right hippocampus and decreased number of the ratio of microglia Iba1-(LC3B-II/I) double staining positive cells in MCAO-operated rats (Fig. 2B, C and Fig. S1A, B), suggesting that <span class="hit">Sevoflurane</span> treatment led to the inhibition of autophagy in the neurons and microglia of the right hippocampus of the rats following ischemic brain <span class="hit">injury</span>.” The authors would like to apologize for any inconvenience caused.</p><p class="hitsHighlighted">© 2022 Elsevier Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015089589" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015089589" type="checkbox" id="record_checkbox_L2015089589"><label for="record_checkbox_L2015089589" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">2</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=2&amp;page=1&amp;id=L2015089589" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">The neuroprotective mechanism of <span class="hit">sevoflurane</span> in rats with traumatic brain <span class="hit">injury</span> via FGF2</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yuan</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wei</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xing</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xing</span> <span class="given-name notranslate">N.</span></span><br><span class="article-in-press">[In Process] </span><span class="journal-title">Journal of Neuroinflammation</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">19</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 51</span>&nbsp;<span class="cited-by" id="CTB-L2015089589"><a href="https://lls.reaxys.com/redir?pid=scp:85124779491" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-2"><a href="https://www.embase.com/#" class="showAbstract" data="2" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="2"></i> Abstract</a></li><li class="ui-tab" id="indexTab-2"><a href="https://www.embase.com/#" class="showIndexTerms" data="2" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="2"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1186/s12974-021-02348-z" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="1">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-1"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Traumatic brain injury (TBI) is a kind of acquired brain injury, which is caused by external mechanical forces. Moreover, the neuroprotective role of sevoflurane (Sevo) has been identified in TBI. Therefore, this research was conducted to figure out the mechanism of Sevo in TBI via FGF2. Methods: The key factors of neuroprotective effects of Sevo in TBI rats were predicted by bioinformatics analysis. A TBI model was induced on rats that then inhaled Sevo for 1&nbsp;h and grouped via lentivirus injection. Modified Neurological Severity Score was adopted to evaluate neuronal damage in rats, followed by motor function and brain water content measurement. FGF2, EZH2, and HES1 expression in brain tissues was evaluated by immunofluorescence staining, and expression of related genes and autophagy factors by RT-qPCR and Western blot analysis. Methylation-specific PCR was performed to assess HES1 promoter methylation level, and ChIP assay to detect the enrichment of EZH2 in the HES1 promoter. Neuronal damage was assessed by cell immunofluorescence staining, and neuronal apoptosis by Nissl staining, TUNEL staining, and flow cytometry. Results: Sevo diminished brain edema, improved neurological scores, and decreased neuronal apoptosis and autophagy in TBI rats. Sevo preconditioning could upregulate FGF2 that elevated EZH2 expression, and EZH2 bound to the HES1 promoter to downregulate HES1 in TBI rats. Also, FGF2 or EZH2 overexpression or HES silencing decreased brain edema, neurological deficits, and neuronal autophagy and apoptosis in Sevo-treated TBI rats. Conclusions: Our results provided a novel insight to the neuroprotective mechanism of Sevo in TBI rats by downregulating HES1 via FGF2/EZH2 axis activation.</p><p class="hitsHighlighted">© 2022, The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018487485" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018487485" type="checkbox" id="record_checkbox_L2018487485"><label for="record_checkbox_L2018487485" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">3</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=3&amp;page=1&amp;id=L2018487485" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lei</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wen</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qin</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">L.</span></span><br><span class="journal-title">Journal of Headache and Pain</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">23</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 98</span>&nbsp;<span class="cited-by" id="CTB-L2018487485"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-3"><a href="https://www.embase.com/#" class="showAbstract" data="3" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="3"></i> Abstract</a></li><li class="ui-tab" id="indexTab-3"><a href="https://www.embase.com/#" class="showIndexTerms" data="3" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="3"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1186/s10194-022-01469-x" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="2">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-2"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: The pathogenesis of chronic migraine remains unresolved. Recent studies have affirmed the contribution of GLUA1-containing AMPA receptors to chronic migraine. The dopamine D2 receptor, a member of G protein-coupled receptor superfamily, has been proven to have an analgesic effect on pathological headaches. The present work investigated the exact role of the dopamine D2 receptor in chronic migraine and its effect on GLUA1-containing AMPA receptor trafficking. Methods: A chronic migraine model was established by repeated inflammatory soup stimulation. Mechanical, periorbital, and thermal pain thresholds were assessed by the application of von Frey filaments and radiant heat. The mRNA and protein expression levels of the dopamine D2 receptor were analyzed by qRT‒PCR and western blotting. Colocalization of the dopamine D2 receptor and the GLUA1-containing AMPAR was observed by immunofluorescence. A dopamine D2 receptor agonist (quinpirole) and antagonist (sulpiride), a PI3K inhibitor (LY294002), a PI3K pathway agonist (740YP), and a GLUA1-containing AMPAR antagonist (NASPM) were administered to confirm the effects of the dopamine D2 receptor, the PI3K pathway and GULA1 on central sensitization and the GLUA1-containing AMPAR trafficking. Transmission electron microscopy and Golgi-Cox staining were applied to assess the impact of the dopamine D2 receptor and PI3K pathway on synaptic morphology. Fluo-4-AM was used to clarify the role of the dopamine D2 receptor and PI3K signaling on <span class="hit">neuronal</span> calcium influx. The Src family kinase (SFK) inhibitor PP2 was used to explore the effect of Src kinase on GLUA1-containing AMPAR trafficking and the PI3K signaling pathway. Results: Inflammatory soup stimulation significantly reduced pain thresholds in rats, accompanied by an increase in PI3K-P110β subunit expression, loss of dopamine receptor D2 expression, and enhanced GLUA1-containing AMPA receptor trafficking in the trigeminal nucleus caudalis (TNC). The dopamine D2 receptor colocalized with the GLUA1-containing AMPA receptor in the TNC; quinpirole, LY294002, and NASPM alleviated pain hypersensitivity and reduced GLUA1-containing AMPA receptor trafficking in chronic migraine rats. Sulpiride aggravated pain hypersensitivity and enhanced GLUA1 trafficking in CM rats. Importantly, the anti-<span class="hit">injury</span> and central sensitization-mitigating effects of quinpirole were reversed by 740YP. Both quinpirole and LY294002 inhibited calcium influx to neurons and modulated the synaptic morphology in the TNC. Additional results suggested that DRD2 may regulate PI3K signaling through Src family kinases. Conclusion: Modulation of GLUA1-containing AMPA receptor trafficking and central sensitization by the dopamine D2 receptor via the PI3K signaling pathway may contribute to the pathogenesis of chronic migraine in rats, and the dopamine D2 receptor could be a valuable candidate for chronic migraine treatment.</p><p class="hitsHighlighted">© 2022, The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018962004" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018962004" type="checkbox" id="record_checkbox_L2018962004"><label for="record_checkbox_L2018962004" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">4</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=4&amp;page=1&amp;id=L2018962004" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Ferroptosis is involved in regulating perioperative neurocognitive disorders: emerging perspectives</a><br><span class="author fn notranslate"><span class="family-name notranslate">Song</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xue</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">P.</span></span><br><span class="journal-title">Journal of Neuroinflammation</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">19</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 219</span>&nbsp;<span class="cited-by" id="CTB-L2018962004"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-4"><a href="https://www.embase.com/#" class="showAbstract" data="4" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="4"></i> Abstract</a></li><li class="ui-tab" id="indexTab-4"><a href="https://www.embase.com/#" class="showIndexTerms" data="4" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="4"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1186/s12974-022-02570-3" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="3">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-3"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Since the twenty-first century, the development of technological advances in anesthesia and surgery has brought benefits to human health. However, the adverse neurological effects of perioperative-related factors (e.g., surgical trauma, anesthesia, etc.) as stressors cannot be ignored as well. The nervous system appears to be more “fragile” and vulnerable to damage in developing and aging individuals. Ferroptosis is a novel form of programmed cell death proposed in 2012. In recent years, the regulation of ferroptosis to treat cancer, immune system disorders, and neurodegenerative diseases have seen an unprecedented surge of interest. The association of ferroptosis with perioperative neurocognitive disorders has also received much attention. Cognitive impairment can not only affect the individual’s quality of life, but also impose a burden on the family and society. Therefore, the search for effective preventive and therapeutic methods to alleviate cognitive impairment caused by perioperative-related factors is a challenge that needs to be urgently addressed. In our review, we first briefly describe the connection between iron accumulation in neurons and impairment of brain function during development and aging. It is followed by a review of the pathways of ferroptosis, mainly including iron metabolism, amino acid metabolism, and lipid metabolism pathway. Furthermore, we analyze the connection between ferroptosis and perioperative-related factors. The surgery itself, general anesthetic drugs, and many other relevant factors in the perioperative period may affect <span class="hit">neuronal</span> iron homeostasis. Finally, we summarize the experimental evidence for ameliorating developmental and degenerative neurotoxicity by modulating ferroptosis. The suppression of ferroptosis seems to provide the possibility to prevent and improve perioperative neurocognitive impairment.</p><p class="hitsHighlighted">© 2022, The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2019429216" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2019429216" type="checkbox" id="record_checkbox_L2019429216"><label for="record_checkbox_L2019429216" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">5</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=5&amp;page=1&amp;id=L2019429216" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Cathepsin L-containing exosomes from α-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor</a><br><span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zheng</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cao</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">npj Parkinson's Disease</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">8</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 127</span>&nbsp;<span class="cited-by" id="CTB-L2019429216"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-5"><a href="https://www.embase.com/#" class="showAbstract" data="5" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="5"></i> Abstract</a></li><li class="ui-tab" id="indexTab-5"><a href="https://www.embase.com/#" class="showIndexTerms" data="5" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="5"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1038/s41531-022-00394-9" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="4">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-4"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Uncontrolled microglial activation is pivotal to the pathogenesis of Parkinson’s disease (PD), which can secrete Cathepsin L (CTSL) to affect the survival of neurons in the PD patients; however, the precise mechanism has yet to be determined. We demonstrated for the first time that CTSL was mostly released by exosomes derived from α-Syn-activated microglia, resulting in <span class="hit">neuronal</span> damage and death. The elevation of CTSL activity was blocked by GW4869, suggesting a critical role for exosomes in mediating CTSL release. Furthermore, the P2X7R/PI3K/AKT signalling pathway was identified as the underlying molecular mechanism since specific antagonists of this signalling pathway, P2X7R knockdown and exosome release inhibitors significantly reduced the <span class="hit">injury</span> to cultured mouse cortical neurons. Our study suggests that increased extracellular release of CTSL from α-Syn-activated microglia through exosomes amplifies and aggravates of the neurotoxic effect of microglia, implying that CTSL may be involved in a fresh mechanism of PD pathogenesis, and serve as a potential biomarker and a target for PD drug development.</p><p class="hitsHighlighted">© 2022, The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2020460946" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2020460946" type="checkbox" id="record_checkbox_L2020460946"><label for="record_checkbox_L2020460946" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">6</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=6&amp;page=1&amp;id=L2020460946" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">PHLDA1 promotes <span class="hit">sevoflurane</span>-induced pyroptosis of <span class="hit">neuronal</span> cells in developing rats through TRAF6-mediated activation of Rac1</a><br><span class="author fn notranslate"><span class="family-name notranslate">Shu</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Du</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">NeuroToxicology</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">93</span><span class="journal-pages">&nbsp;(140-151)</span>&nbsp;<span class="cited-by" id="CTB-L2020460946"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-6"><a href="https://www.embase.com/#" class="showAbstract" data="6" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="6"></i> Abstract</a></li><li class="ui-tab" id="indexTab-6"><a href="https://www.embase.com/#" class="showIndexTerms" data="6" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="6"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.neuro.2022.09.007" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="5">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-5"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> anesthesia induces neurocognitive impairment and pyroptosis in the developing brain. Pleckstrin homology-like domain, family A, member 1 (PHLDA1) was involved in <span class="hit">neuronal</span> apoptosis, oxidative stress and inflammation during ischemic stroke. The role of PHLDA1 in <span class="hit">sevoflurane</span>-induced pyroptosis in developing rats was investigated. Firstly, neonatal rats at day 7 was exposed to 2.0% <span class="hit">sevoflurane</span> for 6 h to induce neurotoxicity. Pathological analysis showed that <span class="hit">sevoflurane</span> anesthesia induced hippocampal <span class="hit">injury</span> and reduced the number of neurons. The expression of PHLDA1 was elevated in hippocampus of <span class="hit">sevoflurane</span>-treated rats. Secondly, <span class="hit">sevoflurane</span> anesthesia-treated neonatal rats were injected with adeno-associated virus serotype (AAV) to mediate knockdown of PHLDA1. Injection with AAV-shPHLDA1 ameliorated <span class="hit">sevoflurane</span>-induced hippocampal <span class="hit">injury</span> and neurocognitive impairment in rats. Moreover, knockdown of PHLDA1 increased the number of neurons in <span class="hit">sevoflurane</span>-treated rats. Silence of PHLDA1 suppressed <span class="hit">neuronal</span> apoptosis, and inhibited pyroptosis in <span class="hit">sevoflurane</span>-treated rats. Thirdly, PHLDA1 was also elevated in <span class="hit">sevoflurane</span>-treated primary <span class="hit">neuronal</span> cells. Loss of PHLDA1 also enhanced cell viability and suppressed pyroptosis of <span class="hit">sevoflurane</span>-treated primary <span class="hit">neuronal</span> cells. Lastly, silence of PHLDA1 reduced protein expression of TRAF6 and p-Rac1 in <span class="hit">sevoflurane</span>-treated rats and <span class="hit">neuronal</span> cells. Over-expression of TRAF6 attenuated PHLDA1 silence-induced increase of cell viability and decreased pyroptosis in <span class="hit">neuronal</span> cells. In conclusion, loss of PHLDA1 protected against <span class="hit">sevoflurane</span>-induced pyroptosis in developing rats through inhibition of TRAF6-mediated activation of Rac1.</p><p class="hitsHighlighted">© 2022 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2019948695" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2019948695" type="checkbox" id="record_checkbox_L2019948695"><label for="record_checkbox_L2019948695" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">7</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=7&amp;page=1&amp;id=L2019948695" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> exposure causes <span class="hit">neuronal</span> apoptosis and cognitive dysfunction by inducing ER stress via activation of the inositol 1, 4, 5-trisphosphate receptor</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yin</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xian</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hou</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Q.</span></span><br><span class="journal-title">Frontiers in Aging Neuroscience</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">14</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 990679</span>&nbsp;<span class="cited-by" id="CTB-L2019948695"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-7"><a href="https://www.embase.com/#" class="showAbstract" data="7" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="7"></i> Abstract</a></li><li class="ui-tab" id="indexTab-7"><a href="https://www.embase.com/#" class="showIndexTerms" data="7" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="7"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3389/fnagi.2022.990679" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="6">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-6"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The role of the inositol 1, 4, 5-trisphosphate receptor (IP3R) in hippocampal <span class="hit">neuronal</span> apoptosis and cognitive dysfunction induced by <span class="hit">sevoflurane</span> is currently unclear. Therefore, in this study, we investigated the role of the IP3R in endoplasmic reticulum (ER) stress and hippocampal <span class="hit">neuronal</span> apoptosis induced by <span class="hit">sevoflurane</span> in aged rats and isolated hippocampal neurons using both in vivo and in vitro experiments, including bioinformatics, functional enrichment analysis, gene set enrichment analysis, hematoxylin, and eosin staining, TUNEL assay, flow cytometry, western blot analysis and transmission electron microscopy. Furthermore, behavioral assessment was performed with the Morris water maze test. We identified 232 differentially expressed genes induced by <span class="hit">sevoflurane</span> exposure, including 126 upregulated genes and 106 downregulated genes. <span class="hit">Sevoflurane</span> exposure caused cognitive impairment and <span class="hit">neuronal injury</span>, and increased p-IP3R levels and ER stress. An IP3R inhibitor, 2-APB, suppressed these changes, while an IP3R agonist, FK-506, aggravated these changes. Together, these findings suggest that <span class="hit">sevoflurane</span> exposure causes marked cognitive dysfunction in aged rats and <span class="hit">neuronal injury</span> in isolated hippocampal neurons by activating the IP3R and inducing cytoplasmic calcium overload, thereby resulting in ER stress and hippocampal <span class="hit">neuronal</span> apoptosis. (Figure presented.)</p><p class="hitsHighlighted">Copyright © 2022 Zhang, Li, Wang, Yin, Zhou, Guo, Zhao, Xian, Hou and Wang.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018764627" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018764627" type="checkbox" id="record_checkbox_L2018764627"><label for="record_checkbox_L2018764627" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">8</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=8&amp;page=1&amp;id=L2018764627" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Systemic inflammation exacerbates developmental neurotoxicity induced by <span class="hit">sevoflurane</span> in neonatal rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Useinovic</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Maksimovic</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liechty</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cabrera</span> <span class="given-name notranslate">O.H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Quillinan</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jevtovic-Todorovic</span> <span class="given-name notranslate">V.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">129</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(555-566)</span>&nbsp;<span class="cited-by" id="CTB-L2018764627"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-8"><a href="https://www.embase.com/#" class="showAbstract" data="8" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="8"></i> Abstract</a></li><li class="ui-tab" id="indexTab-8"><a href="https://www.embase.com/#" class="showIndexTerms" data="8" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="8"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bja.2022.05.008" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="7">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-7"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: General anaesthesia in the neonatal period has detrimental effects on the developing mammalian brain. The impact of underlying inflammation on anaesthesia-induced developmental neurotoxicity remains largely unknown. Methods: Postnatal day 7 (PND7) rats were randomly assigned to receive <span class="hit">sevoflurane</span> (3 vol% for 3 h) or carrier gas 12 h after bacterial lipopolysaccharide (LPS; 1 μg g<sup>−1</sup>) or vehicle injection. Pharmacological inhibition of caspase-1 by Vx-765 (two doses of 50 μg g<sup>−1</sup> body weight) was used to investigate mechanistic pathways of <span class="hit">neuronal injury</span>. Histomorphological <span class="hit">injury</span> and molecular changes were quantified 2 h after the end of anaesthesia. Long-term functional deficits were tested at 5–8 weeks of age using a battery of behavioural tests in the memory and anxiety domains. Results: <span class="hit">Sevoflurane</span> or LPS treatment increased activated caspase-3 and caspase-9 expression in the hippocampal subiculum and CA1, which was greater when <span class="hit">sevoflurane</span> was administered in the setting of LPS-induced inflammation. <span class="hit">Neuronal injury</span> induced by LPS+<span class="hit">sevoflurane</span> treatment resulted in sex-specific behavioural outcomes when rats were tested at 5–8 weeks of age, including learning and memory deficits in males and heightened anxiety-related behaviour in females. Hippocampal caspase-1 and NLRP1 (NLR family pyrin domain containing 1), but not NLRP3, were upregulated by LPS or LPS+<span class="hit">sevoflurane</span> treatment, along with related proinflammatory cytokines, interleukin (IL)-1β, and IL-18. Pretreatment with Vx-765, a selective caspase-1 inhibitor, led to reduced IL-1β in LPS and LPS+<span class="hit">sevoflurane</span> groups. Caspase-1 inhibition by Vx-765 significantly decreased activated caspase-3 and caspase-9 immunoreactivity in the subiculum. Conclusions: Systemic inflammation promotes developmental neurotoxicity by worsening anaesthesia-induced <span class="hit">neuronal</span> damage with sex-specific behavioural outcomes. This highlights the importance of studying anaesthesia-induced neurotoxicity in more clinically relevant settings.</p><p class="hitsHighlighted">© 2022 British Journal of Anaesthesia</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2019768328" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2019768328" type="checkbox" id="record_checkbox_L2019768328"><label for="record_checkbox_L2019768328" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">9</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=9&amp;page=1&amp;id=L2019768328" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> up-regulates miR-7a to protect against ischemic brain <span class="hit">injury</span> in rats by down-regulating ATG7 and reducing <span class="hit">neuronal</span> autophagy</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tan</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yuan</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">Brain Research Bulletin</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">188</span><span class="journal-pages">&nbsp;(214-222)</span>&nbsp;<span class="cited-by" id="CTB-L2019768328"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-9"><a href="https://www.embase.com/#" class="showAbstract" data="9" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="9"></i> Abstract</a></li><li class="ui-tab" id="indexTab-9"><a href="https://www.embase.com/#" class="showIndexTerms" data="9" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="9"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.brainresbull.2022.07.003" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="8">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-8"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The current study aimed to elucidate the effects of <span class="hit">Sevoflurane</span> on <span class="hit">neuronal</span> autophagy and ischemic brain <span class="hit">injury</span> by regulating miR-7a/ATG7 axis. The rat model of middle cerebral artery occlusion (MCAO) was established by thread embolization. The expression pattern of microRNA-7a (miR-7a) and autophagy-related gene 7 (ATG7) was subsequently determined in <span class="hit">Sevoflurane</span>-treated MCAO rats with their relation and effects on <span class="hit">neuronal</span> autophagy and ischemic brain <span class="hit">injury</span> further analyzed. Bioinformatics analysis confirmed that miR-7a could target to inhibit ATG7 in ischemic brain <span class="hit">injury</span> samples. <span class="hit">Sevoflurane</span> could alleviate ischemic brain <span class="hit">injury</span> in rats by reducing the level of <span class="hit">neuronal</span> autophagy-related factors. The expression of miR-7a was up-regulated and ATG7 was down-regulated in the brain tissues of MCAO rats after <span class="hit">Sevoflurane</span> treatment. ATG7 was found to induce <span class="hit">neuronal</span> autophagy during autophagy in the brain tissues of MCAO rats. In summary, <span class="hit">Sevoflurane</span> exerts protective effects on ischemic brain <span class="hit">injury</span> via inhibiting autophagy of neurons and microglia through the miR-7a-mediated downregulation of ATG7.</p><p class="hitsHighlighted">© 2022 Elsevier Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2020221790" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2020221790" type="checkbox" id="record_checkbox_L2020221790"><label for="record_checkbox_L2020221790" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">10</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=10&amp;page=1&amp;id=L2020221790" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">PURA syndrome</a><br><span class="author fn notranslate"><span class="family-name notranslate">Rubin</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sigler</span> <span class="given-name notranslate">E.</span></span><br><span class="journal-title">Anasthesiologie und Intensivmedizin</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">63</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(S257-S262)</span>&nbsp;<span class="cited-by" id="CTB-L2020221790"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-10"><a href="https://www.embase.com/#" class="showAbstract" data="10" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="10"></i> Abstract</a></li><li class="ui-tab" id="indexTab-10"><a href="https://www.embase.com/#" class="showIndexTerms" data="10" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="10"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.19224/ai2022.s257" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="9">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-9"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Disease summary: Genetic mutations of the gene coding for purine-rich element binding protein A (PURA, 5q31.2) lead to a developmental disorder, named PURA syndrome. PURA is thought to play a role in the control of DNA replication and transcription, neuron proliferation, dendrite maturation, and mRNA transportation to translation sites during <span class="hit">neuronal</span> development. The gene is relevant in brain development and may be involved in the automatic regulation of breathing by the brainstem. PURA defects affect the development of neurons and may also affect the formation of maturation of myelination, leading to developmental problems and seizures, although the exact mechanism is unclear. Early signs of this disorder include hypotonia, hypothermia, swallowing disorders, seizures, central and obstructive sleep apnoea. Later manifestations include neurodevelopmental delay, speech delay or absence, delayed and impaired gross motor development, intellectual disability, and seizure disorder. Challenges for an anaesthesiologist are multifold and the proposed approach is deduced from the above-mentioned clinical problems and from the anaesthetic implications of other phenotypically similar neurodevelopmental disorders. Primary anaesthetic concerns focus on the respiratory, cardiovascular, and neurologic functions of the child as these patients could show an increased sensitivity to sedative medications.</p><p class="hitsHighlighted">© 2022 DIOmed Verlags GmbH. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L638669921" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L638669921" type="checkbox" id="record_checkbox_L638669921"><label for="record_checkbox_L638669921" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">11</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=11&amp;page=1&amp;id=L638669921" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> post-treatment mitigates oxygen-glucose deprivation-induced pyroptosis of hippocampal neurons by regulating the Mafb/DUSP14 axis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zuo</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Current neurovascular research</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="cited-by" id="CTB-L638669921"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-11"><a href="https://www.embase.com/#" class="showAbstract" data="11" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="11"></i> Abstract</a></li><li class="ui-tab" id="indexTab-11"><a href="https://www.embase.com/#" class="showIndexTerms" data="11" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="11"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.2174/1567202619666220802104426" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="10">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-10"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND: Ischemic brain <span class="hit">injury</span> often results in irreversible pyroptosis of neurons. <span class="hit">Sevoflurane</span> (Sevo) post-treatment exerts an alleviative role in neuroinflammation. OBJECTIVES: This work evaluated the mechanism of Sevo post-treatment in oxygen-glucose deprivation (OGD)-induced pyroptosis of rat hippocampal neurons. METHODS: Rat hippocampal neuron cell line H19-7 was treated with OGD, followed by post-treatment of 2% Sevo. The expression patterns of MAF bZIP Transcription Factor B (Mafb) and dual-specificity phosphatase 14 (DUSP14) were determined via quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting methods. H19-7 cell viability and the release of lactate dehydrogenase (LDH) were examined via cell counting kit-8 and LDH assay kit. Levels of pyroptosis-related proteins and cytokines NOD-like receptor family, pyrin domain containing 3 (NLRP3), N-term cleaved Gasdermin-D (GSDMD-N), cleaved-caspase-1, interleukin (IL)-1β, and IL-18 were also examined. The binding relation between Mafb and the DUSP14 promoter were detected. Besides, the roles of Mafb/DUSP14 in OGD-induced pyroptosis of rat hippocampal neurons were investigated through functional rescue experiments. RESULTS: Mafb and DUSP14 expression levels were decreased in OGD-induced hippocampal neurons. Sevo post-treatment up-regulated Mafb and DUSP14, facilitated H19-7 cell viability, inhibited LDH release, and reduced levels of NLRP3, GSDMD-N, cleaved-caspase-, IL-1β, and IL-18. Mafb increased DUSP14 expression via binding to the DUSP14 promoter. Repressing Mafb or DUSP14 exacerbated pyroptosis of hippocampal neurons. CONCLUSION: Sevo post-treatment increased Mafb and DUSP14 expressions, which repressed OGD-induced pyroptosis of hippocampal neurons.</p><p class="hitsHighlighted">Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018197847" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018197847" type="checkbox" id="record_checkbox_L2018197847"><label for="record_checkbox_L2018197847" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">12</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=12&amp;page=1&amp;id=L2018197847" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of toxic apolipoprotein E fragments on Tau phosphorylation and cognitive impairment in neonatal mice under <span class="hit">sevoflurane</span> anesthesia</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhuang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pan</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Brain and Behavior</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">12</span><span class="journal-issue">:8</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number e2702</span>&nbsp;<span class="cited-by" id="CTB-L2018197847"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-12"><a href="https://www.embase.com/#" class="showAbstract" data="12" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="12"></i> Abstract</a></li><li class="ui-tab" id="indexTab-12"><a href="https://www.embase.com/#" class="showIndexTerms" data="12" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="12"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1002/brb3.2702" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="11">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-11"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Anesthesia induces Tau phosphorylation and cognitive impairment in young, but not adult, mice. Apolipoprotein E (ApoE) may play a protective role in <span class="hit">neuronal</span> activity and <span class="hit">injury</span> repair, whereas its toxic fragments are reported to induce neurodegeneration and neurocognitive impairment in patients with Alzheimer's disease (AD). Therefore, we set out to test the hypothesis that the difference in ApoE fragments, but not the full-length ApoE, contributes to the difference in Tau phosphorylation and neurocognitive functions following <span class="hit">sevoflurane</span> anesthesia in young mice. Methods: <span class="hit">Sevoflurane</span> was administered to wild-type (WT), ApoE-knockout (ApoE-KO), ApoE3-targeted replacement (ApoE3 expresses both full-length and fragmented ApoE), and ApoE2-targeted replacement (ApoE2 only expresses full-length ApoE) mice. The mRNA and protein levels of ApoE, phosphorylated Tau (pTau), and cognitive function were tested in the mice. Results: <span class="hit">Sevoflurane</span> anesthesia enhanced ApoE mRNA, total ApoE, full-length ApoE, ApoE fragments, Tau phosphorylation (AT8 and PHF1), and cognitive impairment in young mice, but not in adult mice. ApoE2, but not ApoE3 or ApoE-KO, mice showed reduced <span class="hit">sevoflurane</span>-induced pTau elevation and cognitive impairment. Conclusion: These data suggest that elevated ApoE fragments rather than full-length ApoE might be one of the underlying mechanisms of age-dependent Tau phosphorylation and cognitive impairment in young mice following <span class="hit">sevoflurane</span> anesthesia.</p><p class="hitsHighlighted">© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2014714624" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2014714624" type="checkbox" id="record_checkbox_L2014714624"><label for="record_checkbox_L2014714624" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">13</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=13&amp;page=1&amp;id=L2014714624" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">USP18 alleviates neurotoxicity induced by <span class="hit">sevoflurane</span> via AKT and NF-κB pathways</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yao</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lu</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Molecular and Cellular Toxicology</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">18</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(431-438)</span>&nbsp;<span class="cited-by" id="CTB-L2014714624"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-13"><a href="https://www.embase.com/#" class="showAbstract" data="13" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="13"></i> Abstract</a></li><li class="ui-tab" id="indexTab-13"><a href="https://www.embase.com/#" class="showIndexTerms" data="13" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="13"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s13273-021-00217-7" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="12">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-12"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: <span class="hit">Sevoflurane</span> has obvious side effects during anesthesia, which caused <span class="hit">neuronal</span> apoptosis and neuroinflammation. How to reduce <span class="hit">sevoflurane</span>-induced neurotoxicity is an urgent problem to be solved. Objective: To assess the role of USP18 in anesthetic <span class="hit">sevoflurane</span>-induced neurotoxicity, detect its effects on neuroinflammation, oxidative stress, and apoptosis, and explore the related potential signaling pathway. Results: USP18 alleviated <span class="hit">sevoflurane</span>-induced learning and memory dysfunction and changed distribution of neurons. USP18 also reduced <span class="hit">sevoflurane</span>-induced neuroinflammation. We further found that USP18 reduced the <span class="hit">sevoflurane</span>-induced oxidative stress in the mice model. USP18 also attenuated <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis. Mechanically, USP18 reduced <span class="hit">sevoflurane</span>-induced neurotoxicity via AKT and NF-κB pathway. Conclusion: USP18 was involved in the pathology of <span class="hit">sevoflurane</span>-induced neurotoxicity.</p><p class="hitsHighlighted">© 2022, The Author(s) under exclusive licence to The Korean Society of Toxicogenomics and Toxicoproteomics.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2017964260" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2017964260" type="checkbox" id="record_checkbox_L2017964260"><label for="record_checkbox_L2017964260" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">14</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=14&amp;page=1&amp;id=L2017964260" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">miRNA-384-3p alleviates <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span> by inhibiting Aak1 kinase in neonatal rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pei</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Brain and Behavior</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">12</span><span class="journal-issue">:7</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number e2556</span>&nbsp;<span class="cited-by" id="CTB-L2017964260"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-14"><a href="https://www.embase.com/#" class="showAbstract" data="14" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="14"></i> Abstract</a></li><li class="ui-tab" id="indexTab-14"><a href="https://www.embase.com/#" class="showIndexTerms" data="14" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="14"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1002/brb3.2556" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="13">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-13"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: <span class="hit">Sevoflurane</span> is a common anesthetic and is widely used in pediatric clinical surgery to induce and maintain anesthesia through inhalation. Increasing studies have revealed that <span class="hit">sevoflurane</span> has neurotoxic effects on neurons, apoptosis, and memory impairment. miR-384 is involved in the process of neurological diseases. However, the role of miRNA-384-3p in <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span> is not clear. This study focused on exploring the roles and mechanisms of miRNA-384-3p in <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span>. Methods: Seven-day-old rats were exposed to 2.3% <span class="hit">sevoflurane</span> to induce nerve <span class="hit">injury</span>. The morphological changes in neurons in the hippocampal CA1 region were detected by HE staining and Nissl staining. <span class="hit">Neuronal</span> apoptosis was detected by TUNEL and Western blot assays. Spatial memory and learning ability were detected by the Morris water maze assay. The target gene of miRNA-384-3p was verified through a luciferase reporter assay. A rescue experiment was used to confirm the miRNA-384-3p pathway in <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span>. Results: <span class="hit">Sevoflurane</span> reduced miRNA-384-3p expression in the rat hippocampus. miRNA-384-3p alleviated <span class="hit">sevoflurane</span>-induced morphological changes in hippocampal neurons and apoptosis of neurons in the hippocampal CA1 region. Meanwhile, miRNA-384-3p attenuated the decline in spatial memory and learning ability induced by <span class="hit">sevoflurane</span>. miRNA-384-3p alleviated <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span> by inhibiting the expression of adaptor-associated kinase 1 (Aak1). Conclusion: Our findings revealed the role and mechanism of miRNA-384-3p in <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span>, suggesting that miRNA-384-3p could be a novel and promising strategy for reducing <span class="hit">sevoflurane</span>-induced neurotoxicity.</p><p class="hitsHighlighted">© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018632673" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018632673" type="checkbox" id="record_checkbox_L2018632673"><label for="record_checkbox_L2018632673" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">15</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=15&amp;page=1&amp;id=L2018632673" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">IN BRAIN POST-ISCHEMIC PLASTICITY, Na<sup>+</sup>/Ca<sup>2+</sup> EXCHANGER 1 AND Ascl1 INTERVENE IN MICROGLIA-DEPENDENT CONVERSION OF ASTROCYTES INTO <span class="hit">NEURONAL</span> LINEAGE</a><br><span class="author fn notranslate"><span class="family-name notranslate">Casamassa</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cuomo</span> <span class="given-name notranslate">O.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pannaccione</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cepparulo</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Laudati</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Valsecchi</span> <span class="given-name notranslate">V.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Annunziato</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pignataro</span> <span class="given-name notranslate">G.</span></span><br><span class="journal-title">Cell Calcium</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">105</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 102608</span>&nbsp;<span class="cited-by" id="CTB-L2018632673"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-15"><a href="https://www.embase.com/#" class="showAbstract" data="15" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="15"></i> Abstract</a></li><li class="ui-tab" id="indexTab-15"><a href="https://www.embase.com/#" class="showIndexTerms" data="15" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="15"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.ceca.2022.102608" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="14">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-14"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The intricate glia interaction occurring after stroke strongly depend on the maintenance of intraglial ionic homeostasis. Among the several ionic channels and transporters, the plasmamembrane Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX) represents a key player in maintaining astroglial Na<sup>+</sup> and Ca<sup>2+</sup> homeostasis. Here, using a combined in vitro, in vivo and ex vivo experimental strategy we evaluated whether microglia responding to ischemic <span class="hit">injury</span> may influence the morphological and the transcriptional plasticity of post-ischemic astrocytes. Astrocyte plasticity was monitored by the expression of the transcription factor Acheate-scute like 1 (Ascl1), which plays a central role in the commitment of astrocytes towards the <span class="hit">neuronal</span> lineage. Furthermore, we explored the implication of NCX1 expression and activity in mediating Ascl1-dependent post-ischemic astrocyte remodeling. We demonstrated that: (a) in astrocytes co-cultured with microglia the exposure to oxygen and glucose deprivation followed by 7 days of reoxygenation induced a prevalence of bipolar astrocytes overexpressing Ascl1 and NCX1, whereas this did not occur in monocultured astrocytes; (b) the reoxygenation of anoxic astrocytes with the conditioned medium derived from IL-4 stimulated microglia strongly elicited the astrocytic co-expression of Ascl1 and NCX1; (c) Ascl1 expression in anoxic astrocytes was dependenton NCX1 since its silencing prevented Ascl1 expression both in in vitro and in post-ischemic ex vivo experimental conditions. Collectively, the results of our study support the idea that, after brain ischemia, astrocyte-microglia crosstalk can influence astrocytic morphology and its Ascl1 expression. This phenomenon is strictly dependent on ischemia-induced increase of NCX1 which in turn induces Ascl1 overexpression possibly through astrocytic Ca<sup>2+</sup> elevation.</p><p class="hitsHighlighted">© 2022</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015245007" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015245007" type="checkbox" id="record_checkbox_L2015245007"><label for="record_checkbox_L2015245007" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">16</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=16&amp;page=1&amp;id=L2015245007" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Electro-Acupuncture Pretreatment Ameliorates Anesthesia and Surgery-Induced Cognitive Dysfunction Via Inhibiting Mitochondrial <span class="hit">Injury</span> and nEuroapoptosis in Aged Rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yin</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yan</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Q.</span></span><br><span class="journal-title">Neurochemical Research</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">47</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(1751-1764)</span>&nbsp;<span class="cited-by" id="CTB-L2015245007"><a href="https://lls.reaxys.com/redir?pid=scp:85125960944" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-16"><a href="https://www.embase.com/#" class="showAbstract" data="16" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="16"></i> Abstract</a></li><li class="ui-tab" id="indexTab-16"><a href="https://www.embase.com/#" class="showIndexTerms" data="16" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="16"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s11064-022-03567-3" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="15">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-15"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Abstract: Postoperative cognitive dysfunction (POCD) remains one of the most common complications following anesthesia and surgery (AS) in the elderly population. Calcium-mediated mitochondrial injury has been proved to induce cognitive impairment in a variety of neurologic diseases. In the current study we determined whether electro-acupuncture (EA) pretreatment ameliorated AS-induced POCD in aged rats, as well as the underlying mechanism. Eighty SD rats (18&nbsp;months, male) were randomly assigned into four groups (n = 20): C, C + EA, POCD and EA + POCD. Rats in Group POCD and EA + POCD were subjected to exploratory laparotomy under sevoflurane anesthesia. Rats of Group C + EA and EA + POCD received a 5-day EA stimulation at Hegu, Neiguan and Zusanli acupoints before AS. At 3rd day after AS, open field test along with Morris water maze test were employed to examine the cognitive function of aged rats. Then hippocampal tissues were stripped and hippocampal neuronal amount, expression level of cleaved caspase-9 level, cytochrome c (Cyt C), cleaved caspase-3 level, Bcl-2, Bax, ROS expression level, apoptosis rate, mitochondrial membrane potential (MMP), cytosolic calcium concentration ([Ca<sup>2+</sup>]c), opening level of mitochondrial permeability transition pore (mPTP) and ultrastructure of hippocampal neurons were detected separately. EA pretreatment inhibited AS-induced cognitive dysfunction. Furthermore, EA pretreatment decreased level of [Ca<sup>2+</sup>]c, MMP, mPTP, ROS and hippocampal mitochondrial disruption and enhanced neuronal amount. In addition, EA pretreatment notably reduced the AS-induced increased level of cleaved caspase-9, cleaved caspase-3 and expression of Cyt c, Bax/Bcl-2 ratio, as well as neuronal apoptosis rate in aged rats. EA pretreatment ameliorates AS-induced POCD in aged rats, the potential mechanism may be associated with inhibiting calcium overload and ameliorating mitochondrial injury and neuroapoptosis in hippocampal neurons. Graphical Abstract: [Figure not available: see fulltext.]</p><p class="hitsHighlighted">© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L638557638" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L638557638" type="checkbox" id="record_checkbox_L638557638"><label for="record_checkbox_L638557638" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">17</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=17&amp;page=1&amp;id=L638557638" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Sub-dose anesthesia combined with chloride regulator protects the brain resist chronic ischemia-hypoxia <span class="hit">injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Journal of Cerebral Blood Flow and Metabolism</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">42</span><span class="journal-issue">:1</span>&nbsp;<span class="journal-suppl">Supplement</span><span class="journal-pages">&nbsp;(292-)</span>&nbsp;<span class="cited-by" id="CTB-L638557638"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-17"><a href="https://www.embase.com/#" class="showAbstract" data="17" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="17"></i> Abstract</a></li><li class="ui-tab" id="indexTab-17"><a href="https://www.embase.com/#" class="showIndexTerms" data="17" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="17"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1177/0271678X221099127" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="16">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-16"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Cerebral ischemia-hypoxia leads to excitotoxicity-mediated <span class="hit">neuronal</span> damage and cognitive dysfunction, especially in the elderly. Excessive intracellular [Cl <sup>-</sup> ] <sub>i</sub> accumulation weakens γ-aminobutyric acid (GABA) compensatory effects. Sub-anesthetic dose of propofol protected the brain against ischemia-hypoxia, which was abolished by blocking Cl <sup>-</sup> efflux transporter K <sup>+</sup> /Cl <sup>-</sup> cotransporter 2 (KCC2). We aimed to determine whether low dose anesthetic combined with [Cl - ] <sub>i</sub> regulators could restore the compensatory GABAergic system and improve cognitive function. Methods: Chronic cerebral hypoxia (CCH) model was established by bilateral carotid artery ligation in aged rats. Sub dose of anesthetics (propofol and <span class="hit">sevoflurane</span>) with or without KCC2 agonist N-ethylmaleimide (NEM) or Na <sup>+</sup> /K <sup>+</sup> /Cl <sup>-</sup> cotransporter 1 (NKCC1) antagonist bumetanide (BTN) were administered systemically 30 days post-surgery. Primary rat hippocampal <span class="hit">neuronal</span> cultures were subjected to hypoxic <span class="hit">injury</span> with or without drug treatment. Memory function, hippocampal <span class="hit">neuronal</span> survival, GABAergic system functioning and brain-derived neurotrophic factor (BDNF) expressions were evaluated. Results/Conclusions: Sub-anesthetic dose of combined propofol (1.2 μg/ml) and <span class="hit">sevoflurane</span> [0.7 MAC (minimum alveolar concentration)] did not aggravate the hypoxic brain <span class="hit">injury</span> in rats or cell damage in <span class="hit">neuronal</span> cultures. Adding either BTN or NEM protected against hypoxic <span class="hit">injury</span>, associated with improved cognitive function in vivo, less intracellular accumulation of [Cl <sup>-</sup> ] <sub>i</sub>, reduced cell death, restored GABAergic compensation, and increased BDNF expression both in vivo and in vito. Sub-anesthetic dose of propofol and <span class="hit">sevoflurane</span> is a recommended anesthesia regimen in at-risk patients. Restoration of [Cl <sup>-</sup> ]<sub>i</sub> homeostasis and GABAergic could further reduce the brain damage caused by ischemiahypoxia.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015076182" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015076182" type="checkbox" id="record_checkbox_L2015076182"><label for="record_checkbox_L2015076182" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">18</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=18&amp;page=1&amp;id=L2015076182" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Hypercholesterolemia aggravates <span class="hit">sevoflurane</span>‑induced cognitive impairment in aged rats by inducing neurological inflammation and apoptosis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Long</span> <span class="given-name notranslate">B.</span></span><br><span class="article-in-press">[In Process] </span><span class="journal-title">Journal of Biochemical and Molecular Toxicology</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">36</span><span class="journal-issue">:5</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number e23009</span>&nbsp;<span class="cited-by" id="CTB-L2015076182"><a href="https://lls.reaxys.com/redir?pid=scp:85124734497" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-18"><a href="https://www.embase.com/#" class="showAbstract" data="18" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="18"></i> Abstract</a></li><li class="ui-tab" id="indexTab-18"><a href="https://www.embase.com/#" class="showIndexTerms" data="18" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="18"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1002/jbt.23009" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="17">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-17"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">We aimed to explore the effects of hypercholesterolemia on <span class="hit">sevoflurane</span>-induced cognitive impairment in aged rats and the underlying mechanism(s). Aged rats were administrated with high-fat diet, <span class="hit">sevoflurane</span>, or both. Thereafter, the plasma levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were evaluated. The Morris water maze task was performed to evaluate the spatial learning and memory ability of rats. Moreover, Nissl and Evans blue staining were conducted to test nerve damage and detect the blood–brain barrier permeability, respectively. The percentage of apoptotic cells was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The messenger RNA expression of inflammatory factors and protein expression of microglial activation markers and apoptosis-related proteins were tested by real-time polymerase chain reaction, enzyme-linked immunosorbent assay, or western blot analysis, respectively. High-fat diet induced high levels of TC, TG, and LDL but decreased levels of HDL. However, <span class="hit">sevoflurane</span> had no effects on these levels. In contrast, <span class="hit">sevoflurane</span> significantly induced the impairment of learning and memory, nerve damage, neuroinflammatory damage, and <span class="hit">neuronal</span> apoptosis. Hypercholesterolemia exacerbated the <span class="hit">sevoflurane</span>‑induced impairment in aged rats. These results suggested that hypercholesterolemia aggravates <span class="hit">sevoflurane</span>‑induced cognitive impairment in aged rats, possibly by inducing neurological inflammation and apoptosis.</p><p class="hitsHighlighted">© 2022 Wiley Periodicals LLC.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2016923508" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2016923508" type="checkbox" id="record_checkbox_L2016923508"><label for="record_checkbox_L2016923508" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">19</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=19&amp;page=1&amp;id=L2016923508" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neurotoxic 18-kDa apolipoprotein E fragment production contributes to anesthetic <span class="hit">sevoflurane</span>-induced tau phosphorylation and neuroinflammation in vitro</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhuang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pan</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Feng</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Human and Experimental Toxicology</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">41</span><span class="journal-pages"></span>&nbsp;<span class="cited-by" id="CTB-L2016923508"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-19"><a href="https://www.embase.com/#" class="showAbstract" data="19" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="19"></i> Abstract</a></li><li class="ui-tab" id="indexTab-19"><a href="https://www.embase.com/#" class="showIndexTerms" data="19" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="19"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1177/09603271221102519" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="18">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-18"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Anesthesia may induce <span class="hit">neuronal</span> tau phosphorylation and neurotoxicity in the developing brain. Apolipoprotein E (ApoE) may play a protective role in <span class="hit">neuronal</span> activity and <span class="hit">injury</span> repair, whereas its 18-kDa fragments are reported to induce neurodegeneration and neuroinflammation in Alzheimer’s disease patients. We aimed to test the hypothesis that differences in 18-kDa ApoE fragment levels, but not full-length ApoE, in primary neurons contribute to differences in tau phosphorylation and neuroinflammation with or without <span class="hit">sevoflurane</span> administration. Neurons extracted from wild-type (WT), ApoE knockout (ApoE-KO), and ApoE ε3-and ε2-targeted replacement (ApoE ε3, ApoE ε2) mice were divided into control and <span class="hit">sevoflurane</span> groups. Neurons in the <span class="hit">sevoflurane</span> group were treated with 21% O<sub>2</sub>, 5% CO<sub>2</sub>, and 4.1% <span class="hit">sevoflurane</span>, whereas those in the control group were treated with 21% O<sub>2</sub> and 5% CO<sub>2</sub> only on day 5 of <span class="hit">neuronal</span> culture. ApoE mRNA, full-length ApoE, 18-kDa ApoE fragments, Tau-PS202/PT205 (AT8), Tau-PSer396/404 (PHF1), tumor necrosis factor (TNF)-α, and interleukin (IL)-6 and IL-1β levels were measured. The data showed that <span class="hit">sevoflurane</span>-induced AT8 and PHF1 increases, and TNF-α, IL-6, and IL-1β increases in WT or ApoE ε3 neurons (both expressing full-length and 18-kDa fragmented ApoE) could be mitigated in ApoE ε2 (only expressing full-length ApoE), but not in ApoE-KO neurons, indicating that differences in 18-kDa ApoE fragments, but not full-length ApoE, in primary mouse neurons contributed to differences in tau phosphorylation and neuroinflammation with or without 4.1% <span class="hit">sevoflurane</span> administration.</p><p class="hitsHighlighted">© The Author(s) 2022.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2017854396" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2017854396" type="checkbox" id="record_checkbox_L2017854396"><label for="record_checkbox_L2017854396" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">20</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=20&amp;page=1&amp;id=L2017854396" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">4.8% <span class="hit">sevoflurane</span> induces activation of autophagy in human neuroblastoma SH-SY5Y cells by the AMPK/mTOR signaling pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lv</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cheng</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yao</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jin</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">NeuroToxicology</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">90</span><span class="journal-pages">&nbsp;(256-264)</span>&nbsp;<span class="cited-by" id="CTB-L2017854396"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-20"><a href="https://www.embase.com/#" class="showAbstract" data="20" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="20"></i> Abstract</a></li><li class="ui-tab" id="indexTab-20"><a href="https://www.embase.com/#" class="showIndexTerms" data="20" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="20"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.neuro.2022.04.008" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="19">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-19"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Prolonged <span class="hit">sevoflurane</span> exposure leads to neurotoxicity. Autophagy plays an important role in promoting cell survival in different conditions. However, the role and mechanism of autophagy in <span class="hit">sevoflurane</span>-induced neurotoxicity were not fully elucidated. We attempted to indicate whether <span class="hit">sevoflurane</span> could activate the AMP-activated protein kinase (AMPK)/mechanistic target of rapamycin (mTOR)-mediated autophagy to attenuate anesthetics-induced <span class="hit">neuronal injury</span> in this study. <span class="hit">Sevoflurane</span> treatment significantly decreased the cell viability and induced apoptosis of SH-SY5Y cells. The expression level of Bcl-2 decreased, while that of Bax remarkably increased. Meanwhile, autophagy was activated by <span class="hit">sevoflurane</span> exposure as evidenced by increased expression levels of autophagy-related proteins (LC3-II and Atg5), decreased expression level of autophagic substrate P62, and increased autophagosomes and autolysosomes. Further autophagosomes and fewer autolysosomes were observed in the presence of Bafilomycin A1, an autolysosomes degradation inhibitor, suggesting that <span class="hit">sevoflurane</span> induced autophagic flux rather than inhibiting degradation of autophagy. Activation of autophagy by rapamycin partly reversed the <span class="hit">sevoflurane</span>-decreased cell viability. In contrast, inhibition of autophagy by 3-Methyladenine (3-MA) or Atg5-targeted small interfering RNA (siRNA) aggravated the <span class="hit">sevoflurane</span>-induced neurotoxicity. Further examination revealed that <span class="hit">sevoflurane</span>-induced autophagy was mediated by the AMPK/mTOR signaling pathway, with increased p-AMPK expression and decreased p-mTOR expression. Collectively, these results indicated that <span class="hit">sevoflurane</span> activates autophagy by regulating the AMPK/mTOR signaling pathway, which is protective against <span class="hit">sevoflurane</span>-induced damage in SH-SY5Y cells. Our results may assist clinicians to develop further promising therapeutic strategies for the neurotoxicity induced by inhaled anesthetics.</p><p class="hitsHighlighted">© 2022 The Authors</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018686036" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018686036" type="checkbox" id="record_checkbox_L2018686036"><label for="record_checkbox_L2018686036" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">21</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=21&amp;page=1&amp;id=L2018686036" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Repeated Neonatal Exposure to <span class="hit">Sevoflurane</span> Induces Age-Dependent Impairments in Cognition and Synaptic Plasticity in Mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shi</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Du</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pan</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Developmental Neuroscience</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">44</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(153-161)</span>&nbsp;<span class="cited-by" id="CTB-L2018686036"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-21"><a href="https://www.embase.com/#" class="showAbstract" data="21" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="21"></i> Abstract</a></li><li class="ui-tab" id="indexTab-21"><a href="https://www.embase.com/#" class="showIndexTerms" data="21" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="21"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1159/000523730" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="20">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-20"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: <span class="hit">Sevoflurane</span> is a volatile anesthetic that is widely used in pediatric anesthesia due to its low toxicity. However, whether neonatal exposure to <span class="hit">sevoflurane</span> induces long-lasting cognitive impairment remains unclear. It has been reported that <span class="hit">neuronal injury</span> is the main cause of <span class="hit">sevoflurane</span>-induced learning and memory disabilities in the development of brain. But, the specific mechanism is not well elucidated. The <span class="hit">injury</span> of synapse occurs earlier than that of <span class="hit">neuronal</span> cell in brain <span class="hit">injury</span>. The synaptic plasticity is involved in learning and memory. Methods: We compared the learning and memory ability of neonatal mice to <span class="hit">sevoflurane</span> for once or three times in vitro and synaptic plasticity as well as <span class="hit">neuronal</span> excitability in vivo. In this study, neonatal C57BL/6J mice were exposed to 3% <span class="hit">sevoflurane</span> for 2 h on postnatal day 7 (P7) or once daily for 3 consecutive days (P7/8/9). The Morris water maze test was performed to evaluate the cognitive performance on P31 and P61, respectively. Theta burst stimulation-induced long-term potentiation (LTP) was measured in acute hippocampal slices from P38 and P68 mice to assess the synaptic plasticity. Primary hippocampal neurons were isolated from 24-h-old mice and exposed to different doses of <span class="hit">sevoflurane</span> (1, 2, and 3 minimum alveolar anesthetic concentration [MAC]) for 6 h to examine the <span class="hit">neuronal</span> excitability. Results: The results showed that compared with the control, repeated exposure to <span class="hit">sevoflurane</span> resulted in significant cognitive impairment in adolescent mice, while showing no effect on adult mice. Repeated exposure to <span class="hit">sevoflurane</span> remarkably attenuated hippocampal LTP of adolescent mice, which turned to normal in adult mice. No significant difference of LTP was observed between control mice and one-dose <span class="hit">sevoflurane</span>-treated mice both in adolescent and adult mice. In primary hippocampal neurons, 2 MAC and 3 MAC <span class="hit">sevoflurane</span> delayed <span class="hit">neuronal</span> excitation and dose-dependently reduced the number of evoked action potentials compared with control. These effects disappeared after a 24-h recovery. Conclusions: These data suggested that <span class="hit">sevoflurane</span> may impair cognitive performance and <span class="hit">neuronal</span> plasticity when administered repeatedly or in a high MAC during infancy, which is noticeable during adolescence but alleviates during adulthood.</p><p class="hitsHighlighted">© 2022 S. Karger AG, Basel. Copyright: All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L638416740" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L638416740" type="checkbox" id="record_checkbox_L638416740"><label for="record_checkbox_L638416740" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">22</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=22&amp;page=1&amp;id=L638416740" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">A Rare Case of Acute Toxic Leukoencephalopathy: Is <span class="hit">Sevoflurane</span> the Culprit?</a><br><span class="author fn notranslate"><span class="family-name notranslate">Al Mawed</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Al-Ghazawi</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Patel</span> <span class="given-name notranslate">N.</span></span><br><span class="journal-title">Neurology</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">98</span><span class="journal-issue">:18 SUPPL</span><span class="journal-pages"></span>&nbsp;<span class="cited-by" id="CTB-L638416740"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-22"><a href="https://www.embase.com/#" class="showAbstract" data="22" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="22"></i> Abstract</a></li><li class="ui-tab" id="indexTab-22"><a href="https://www.embase.com/#" class="showIndexTerms" data="22" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="22"></i> Index Terms</a></li><li><span id="FTL-L638416740" class="fulltext" data="{&quot;recno&quot;:&quot;L638416740&quot;,&quot;issn&quot;:&quot;1526632X&quot;,&quot;volume&quot;:&quot;98&quot;,&quot;issue&quot;:&quot;18 SUPPL&quot;,&quot;startpage&quot;:&quot;&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="21">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-21"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: To present a patient with rare acute toxic leukoencephalopathy (ATL) after elective surgery. Background: ATL is an uncommon condition that results from white matter damage, often secondary to chemotherapeutic agents, environmental toxins, and drug abuse. <span class="hit">Sevoflurane</span> can cause neurocognitive and developmental impairments, especially in infants and children. In animal models, it has been shown to cause alteration in normal brain function and <span class="hit">neuronal</span> cell apoptosis. However, it has not been previously reported to cause ATL. Design/Methods: NA Results: We present a healthy 22-year-old female who underwent elective plastic surgery with an uneventful intraoperative course. Postoperatively, she had no spontaneous respiration or response to stimuli. Initial CT brain showed subtle basal ganglia hypodensities. MRI brain completed a few hours later revealed restricted diffusion involving the bilateral basal ganglia, perirolandic and occipital cortices, and brainstem with left basal ganglia hemorrhage. Repeat MRI brain and C/T-spine after 48 hours showed significant evolution of this acute process resulting in restricted diffusion throughout the bilateral subcortical white matter extending into the brainstem, cerebellum and spinal cord. <span class="hit">Sevoflurane</span> was the only inhaled anesthetic used. Sufentanil, Dexmedetomidine, and Versed were used in minimal doses. Vitamin B12, thiamine, drug screen, heavy metals, alcohol and hypercoagulable labs were normal. Plasma amino acids, urine organic acids, and acylcarnitine profile were concerning for hepatocellular impairment but without apparent metabolic disorder. Imaging and labs did not show hepatic <span class="hit">injury</span>. Wholeexome sequencing and neuropathologic correlation remain underway. Conclusions: To our knowledge, this is the first reported case of ATL after an elective surgery. We hypothesize that ATL resulted from an idiosyncratic reaction to <span class="hit">Sevoflurane</span> in the setting of a genetic predilection. Our case highlights what we believe to be an adverse reaction to a traditionally safe anesthetic. Further research is needed to identify this mechanism of <span class="hit">injury</span> in a potentially at-risk population.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015421068" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015421068" type="checkbox" id="record_checkbox_L2015421068"><label for="record_checkbox_L2015421068" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">23</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=23&amp;page=1&amp;id=L2015421068" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> protects mice from cerebral ischaemic <span class="hit">injury</span> by regulating microRNA-203-3p/HDAC4/Bcl-2 axis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Song</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">He</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shen</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">European Journal of Neuroscience</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">55</span><span class="journal-issue">:7</span><span class="journal-pages">&nbsp;(1695-1708)</span>&nbsp;<span class="cited-by" id="CTB-L2015421068"><a href="https://lls.reaxys.com/redir?pid=scp:85127300172" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-23"><a href="https://www.embase.com/#" class="showAbstract" data="23" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="23"></i> Abstract</a></li><li class="ui-tab" id="indexTab-23"><a href="https://www.embase.com/#" class="showIndexTerms" data="23" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="23"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/ejn.15622" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="22">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-22"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> (Sevo) is neuroprotective in ischaemic <span class="hit">injury</span>, but its specific mechanism in the disease from microRNA-203-3p/histone deacetylases 4/B-cell lymphoma 2 (miR-203-3p/HDAC4/Bcl-2) axis asks for a comprehensive explanation. A middle cerebral artery occlusion (MCAO) mouse model was established by nylon suture method. miR-203-3p and HDAC4 expression was measured in mouse brain tissues. The MCAO mice were exposed to Sevo or injected with miR-203-3p- or HDAC4-related plasmids. In response to Sevo treatment or plasmid interference, neurological function, brain pathology, <span class="hit">neuronal</span> apoptosis and inflammation were determined. The interactions of miR-203-3p and HDAC4, and HDAC4 and Bcl-2 were verified. MCAO mice presented down-regulated miR-203-3p and up-regulated HDAC4. Sevo improved neurological function, brain pathological damage and reduced <span class="hit">neuronal</span> apoptosis and inflammation in MCAO mice, while overexpressing miR-203-3p further enhanced those effects. HDAC4 overexpression antagonized the impacts of miR-203-3p up-regulation on MCAO mice. The targeting relation existed between miR-203-3p and HDAC4, as well as between HDAC4 and Bcl-2. It is clearly elucidated that miR-203-3p enhances the protective effects of Sevo on MCAO mice through elevating Bcl-2 and down-regulating HDAC4, potentially and clinically offering an effective treatment method with Sevo for cerebral ischaemic <span class="hit">injury</span>.</p><p class="hitsHighlighted">© 2022 Federation of European Neuroscience Societies and John Wiley &amp; Sons Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018124033" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018124033" type="checkbox" id="record_checkbox_L2018124033"><label for="record_checkbox_L2018124033" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">24</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=24&amp;page=1&amp;id=L2018124033" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">C1q/tumor necrosis factor (TNF)-associated protein 6 (CTRP6) ameliorates the cognitive dysfunction induced by <span class="hit">sevoflurane</span> by activating AMPK/SIRT1 pathway in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Nie</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Tropical Journal of Pharmaceutical Research</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">21</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(549-554)</span>&nbsp;<span class="cited-by" id="CTB-L2018124033"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-24"><a href="https://www.embase.com/#" class="showAbstract" data="24" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="24"></i> Abstract</a></li><li class="ui-tab" id="indexTab-24"><a href="https://www.embase.com/#" class="showIndexTerms" data="24" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="24"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.4314/tjpr.v21i3.14" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="23">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-23"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Purpose: To evaluate the possible effects of C1q/tumor necrosis factor (TNF)-associated protein 6 (CTRP6) on postoperative cognitive dysfunction (POCD), including the potentially-related signaling pathway. Methods: Behavioral analysis and cognitive impairment were assessed in each group. Immunoblots were used to determine the level of CTRP6 following <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span>. Hippocampal neurons were identified using Nissl staining, while inflammatory response following <span class="hit">neuronal injury</span> was monitored by enzyme-linked immunosorbent assay (ELISA) and quantitative polymerase chain reaction (qPCR). The involvement of adenosine monophosphate-activated protein kinase (AMPK)/sirtuin 1 (SIRT1) pathway was determined using immunoblot. Results: CTRP6 alleviated <span class="hit">sevoflurane</span>-induced cognitive dysfunction in rats (p &lt; 0.001). Moreover, CTRP6 reduced <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span> and inflammation in rats (p &lt; 0.05). Conclusion: CTRP6 ameliorates <span class="hit">sevoflurane</span>-induced cognitive dysfunction by activating AMPK/SIRT1 pathway, thus offering a novel target for POCD treatment.</p><p class="hitsHighlighted">© 2022 The authors.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2016569785" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2016569785" type="checkbox" id="record_checkbox_L2016569785"><label for="record_checkbox_L2016569785" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">25</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=25&amp;page=1&amp;id=L2016569785" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">GPR68 Improves Nerve Damage and Myelination in an Immature Rat Model Induced by <span class="hit">Sevoflurane</span> Anesthesia by Activating cAMP/CREB to Mediate BDNF</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zeng</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">ACS Chemical Neuroscience</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">13</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(423-431)</span>&nbsp;<span class="cited-by" id="CTB-L2016569785"><a href="https://lls.reaxys.com/redir?pid=scp:85123366038" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-25"><a href="https://www.embase.com/#" class="showAbstract" data="25" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="25"></i> Abstract</a></li><li class="ui-tab" id="indexTab-25"><a href="https://www.embase.com/#" class="showIndexTerms" data="25" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="25"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1021/acschemneuro.1c00830" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="24">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-24"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Ovarian cancer G-protein-coupled receptor 1 (OGR1, also known as GPR68) is a member of proton-sensing G-protein-coupled receptors, involved in cardiovascular physiology, tumor biology, and asthma, and exerts a neuroprotective effect against brain ischemia. The effects of GPR68 on anesthesia-induced nerve damage and myelination were investigated in this study. First, 2-day old postnatal rats were exposed to 4.9% <span class="hit">sevoflurane</span> for 2 h. Data from hematoxylin and eosin staining and Nissl staining showed that <span class="hit">sevoflurane</span> induced pathological changes in the hippocampus with a reduced number of neurons. GPR68 was downregulated in the hippocampus of <span class="hit">sevoflurane</span>-induced rats. Second, <span class="hit">sevoflurane</span>-induced rats were injected with adeno-associated virus (AAV)-mediated overexpression of GPR68, and overexpression of GPR68 ameliorated <span class="hit">sevoflurane</span>-induced pathological changes, enhanced the number of neurons, and improved the learning and memory function. Moreover, overexpression of GPR68 increased the number of BrdU-positive and Olig2-positive cells and enhanced protein expression of Olig2 in <span class="hit">sevoflurane</span>-induced rats. Third, the number of myelin basic protein (MBP) positive cells and protein expression of MBP in <span class="hit">sevoflurane</span>-induced rats were also enhanced by injection with AAV-GPR68. Overexpression of GPR68 attenuated <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis and oxidative stress in rats. Lastly, overexpression of GPR68 upregulated protein expression of the brain-derived neurotrophic factor (BDNF) by increasing cAMP and phosphorylated cAMP response element-binding protein (CREB). In conclusion, GPR68 alleviated <span class="hit">sevoflurane</span>-induced nerve damage and myelination through BDNF-mediated activation of the cAMP/CREB pathway.</p><p class="hitsHighlighted">© 2022 American Chemical Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2013644921" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2013644921" type="checkbox" id="record_checkbox_L2013644921"><label for="record_checkbox_L2013644921" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">26</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=26&amp;page=1&amp;id=L2013644921" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">The Role of Klotho Protein Against <span class="hit">Sevoflurane</span>-Induced <span class="hit">Neuronal Injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Lian</span> <span class="given-name notranslate">W.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lu</span> <span class="given-name notranslate">Z.-P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zou</span> <span class="given-name notranslate">J.-Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lu</span> <span class="given-name notranslate">Z.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">L.-B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lei</span> <span class="given-name notranslate">H.-Y.</span></span><br><span class="journal-title">Neurochemical Research</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">47</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(315-326)</span>&nbsp;<span class="cited-by" id="CTB-L2013644921"><a href="https://lls.reaxys.com/redir?pid=scp:85114439915" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-26"><a href="https://www.embase.com/#" class="showAbstract" data="26" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="26"></i> Abstract</a></li><li class="ui-tab" id="indexTab-26"><a href="https://www.embase.com/#" class="showIndexTerms" data="26" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="26"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s11064-021-03444-5" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="25">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-25"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The effects of general anesthetics on the developing brain have aroused much attention in recent years. Sevoflurane, a commonly used inhalation anesthetic especially in pediatric anesthesia, can induce developmental neurotoxicity. In this study, the differentially expressed mRNAs in the hippocampus of newborn rats exposed to 3% sevoflurane for 6&nbsp;h were detected by RNA-Sequencing. Those data indicated that the mRNA of Klotho was increased after exposure to sevoflurane. Moreover, the protein expression of Klotho was assayed by Western Blot. Besides&nbsp;over-expression and under-expression of Klotho protein, we also detected changes of cell proliferation, ROS, JC-1, and Bcl-2/Bax ratio in PC12 cells exposed to sevoflurane. After exposure to 3% sevoflurane, the expression of Klotho protein increased in the hippocampus of neonatal rats. In PC12 cells, exposure to sevoflurane could increase cellular ROS level, reduce mitochondrial membrane potential and Bcl-2/Bax ratio. While overexpression of Klotho alleviated the above changes, knockdown of Klotho aggravated the injury of sevoflurane. Klotho protein could reduce oxidative stress and mitochondrial injury induced by sevoflurane in the neuron.</p><p class="hitsHighlighted">© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015581412" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015581412" type="checkbox" id="record_checkbox_L2015581412"><label for="record_checkbox_L2015581412" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">27</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=27&amp;page=1&amp;id=L2015581412" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">General Anesthesia and the Young Brain: The Importance of Novel Strategies with Alternate Mechanisms of Action</a><br><span class="author fn notranslate"><span class="family-name notranslate">Maksimovic</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Useinovic</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Quillinan</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Covey</span> <span class="given-name notranslate">D.F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Todorovic</span> <span class="given-name notranslate">S.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jevtovic-Todorovic</span> <span class="given-name notranslate">V.</span></span><br><span class="journal-title">International Journal of Molecular Sciences</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">23</span><span class="journal-issue">:3</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 1889</span>&nbsp;<span class="cited-by" id="CTB-L2015581412"><a href="https://lls.reaxys.com/redir?pid=scp:85124172469" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-27"><a href="https://www.embase.com/#" class="showAbstract" data="27" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="27"></i> Abstract</a></li><li class="ui-tab" id="indexTab-27"><a href="https://www.embase.com/#" class="showIndexTerms" data="27" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="27"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3390/ijms23031889" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="26">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-26"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Over the past three decades, we have been grappling with rapidly accumulating evidence that general anesthetics (GAs) may not be as innocuous for the young brain as we previously believed. The growing realization comes from hundreds of animal studies in numerous species, from nematodes to higher mammals. These studies argue that early exposure to commonly used GAs causes widespread apoptotic neurodegeneration in brain regions critical to cognition and socio-emotional development, kills a substantial number of neurons in the young brain, and, importantly, results in lasting disturbances in <span class="hit">neuronal</span> synaptic communication within the remaining <span class="hit">neuronal</span> networks. Notably, these outcomes are often associated with long-term impairments in multiple cognitive-affective domains. Not only do preclinical studies clearly demonstrate GA-induced neurotoxicity when the exposures occur in early life, but there is a growing body of clinical literature reporting similar cognitive-affective abnormalities in young children who require GAs. The need to consider alternative GAs led us to focus on synthetic neuroactive steroid analogues that have emerged as effective hypnotics, and analgesics that are apparently devoid of neurotoxic effects and long-term cognitive impairments. This would suggest that certain steroid analogues with different cellular targets and mechanisms of action may be safe alternatives to currently used GAs. Herein we summarize our current knowledge of neuroactive steroids as promising novel GAs.</p><p class="hitsHighlighted">© 2022 by the authors. Licensee MDPI, Basel, Switzerland.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015391553" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015391553" type="checkbox" id="record_checkbox_L2015391553"><label for="record_checkbox_L2015391553" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">28</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=28&amp;page=1&amp;id=L2015391553" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Triiodothyronine attenuates neurocognitive dysfunction induced by <span class="hit">sevoflurane</span> in the developing brain of neonatal rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Journal of Affective Disorders</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">297</span><span class="journal-pages">&nbsp;(455-462)</span>&nbsp;<span class="cited-by" id="CTB-L2015391553"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-28"><a href="https://www.embase.com/#" class="showAbstract" data="28" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="28"></i> Abstract</a></li><li class="ui-tab" id="indexTab-28"><a href="https://www.embase.com/#" class="showIndexTerms" data="28" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="28"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.jad.2021.10.086" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="27">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-27"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Whilst concerns have been raised about the detrimental effects of general anaesthetics on the brain's development and function in the young, reports have indicated that thyroid hormones are able to promote neurogenesis in the developing brain. This present study aimed to investigate the effects of triiodothyronine (T3) on the neonatal rat brain, following <span class="hit">sevoflurane</span> exposure. Methods: Postnatal day 7 (P7) ratpups were treated with Triiodothyronine (T3) (1 µg/100 g body weight, i.p. injection, once/day for 3 days) after 2% <span class="hit">sevoflurane</span> exposure for 6 h. They were sacrificed at either P7 (immediately), P15 or P30 and their brains were harvested to assess cell death, proliferation in the hippocampus, N-methyl-D-aspartate (NMDA) receptor subunit A and B, and a post-synaptic protein (PSD-95 in the hippocampus,). Neuro-behavioral changes in other cohorts between P27 and P30 were evaluated with Morris water maze and open field tests. Results: <span class="hit">Sevoflurane</span> exposure caused cell death and suppressed the proliferation of astrocytes and neurons, as well as the dendritic growth of neurons in the hippocampus which were all reversed by the administration of T3. Moreover, cognitive function, including learning, memory, and adaptability to a new environment, were impaired by <span class="hit">sevoflurane</span> exposure, which was also negated by T3 treatment. Furthermore, <span class="hit">sevoflurane</span> decreased the expression of NMDA receptor subunits NR2A and NR2B, as well as PSD-95 in the hippocampus at P15 and those effects of <span class="hit">sevoflurane</span> were abolished by T3 administration. Conclusions: A potential therapeutic role of T3 in protecting general anesthetic induced <span class="hit">neuronal injury</span> in the developing brain is likely to occur through enhancing expression of PSD-95 and the NMDA NR2A and NR2B expression.</p><p class="hitsHighlighted">© 2021</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015297342" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015297342" type="checkbox" id="record_checkbox_L2015297342"><label for="record_checkbox_L2015297342" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">29</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=29&amp;page=1&amp;id=L2015297342" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Phosphoinositide-3-Kinase/Akt–Endothelial Nitric Oxide Synthase Signaling Pathway Mediates the Neuroprotective Effect of <span class="hit">Sevoflurane</span> Postconditioning in a Rat Model of Hemorrhagic Shock and Resuscitation</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">World Neurosurgery</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">157</span><span class="journal-pages">&nbsp;(e223-e231)</span>&nbsp;<span class="cited-by" id="CTB-L2015297342"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-29"><a href="https://www.embase.com/#" class="showAbstract" data="29" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="29"></i> Abstract</a></li><li class="ui-tab" id="indexTab-29"><a href="https://www.embase.com/#" class="showIndexTerms" data="29" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="29"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.wneu.2021.09.143" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="28">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-28"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Although extensive reports have demonstrated the neuroprotection of <span class="hit">sevoflurane</span> postconditioning in cases of focal and global cerebral ischemia/reperfusion, the underlying mechanisms are not completely elucidated. This study investigated whether this effect is related to endothelial nitric oxide synthase (eNOS) and mediated by the phosphoinositide-3-kinase pathway in a rat model of hemorrhagic shock and resuscitation. Methods: Adult male Sprague Dawley rats were subjected to hemorrhagic shock for 60 minutes and then resuscitation for 30 minutes in experimental groups. <span class="hit">Sevoflurane</span> postconditioning was performed at the beginning of resuscitation to completion. At 24 hours after resuscitation, the brain infarct volume was evaluated by 2,3,5-triphenyltetrazolium chloride staining. The <span class="hit">neuronal</span> morphological changes and apoptosis were determined by hematoxylin and eosin staining and immunohistochemistry analysis, respectively. The activity of phosphorylated Akt and eNOS was evaluated by Western blot analysis. Results: Brain injuries such as the cerebral infarct volume and pathological <span class="hit">neuronal</span> changes as well as cell apoptosis were observed in the hippocampus after hemorrhagic shock and resuscitation. Postconditioning with 2.4% <span class="hit">sevoflurane</span> significantly attenuated brain injuries. Wortmannin prevented the improvements of <span class="hit">neuronal</span> characteristics elicited by <span class="hit">sevoflurane</span> postconditioning as well as the hyperactivity of eNOS and phosphorylated Akt. Conclusions: <span class="hit">Sevoflurane</span> postconditioning could attenuate brain <span class="hit">injury</span> induced by hemorrhagic shock and resuscitation, and this neuroprotective effect may be partly by upregulation of eNOS through the phosphoinositide-3-kinase/Akt signaling pathway.</p><p class="hitsHighlighted">© 2021 Elsevier Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015659557" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015659557" type="checkbox" id="record_checkbox_L2015659557"><label for="record_checkbox_L2015659557" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">30</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=30&amp;page=1&amp;id=L2015659557" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Docosahexaenoic acid supplementation alleviates behavioral memory impairment caused via repeated administration of <span class="hit">sevoflurane</span> in aged rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Tian</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">Experimental and Therapeutic Medicine</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">23</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 10968</span>&nbsp;<span class="cited-by" id="CTB-L2015659557"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-30"><a href="https://www.embase.com/#" class="showAbstract" data="30" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="30"></i> Abstract</a></li><li class="ui-tab" id="indexTab-30"><a href="https://www.embase.com/#" class="showIndexTerms" data="30" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="30"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/etm.2021.10968" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="29">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-29"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Elderly patients often need repeated surgical intervention, so it is important to determine the impact of repeated exposure to anesthetics on learning and memory. Docosahexaenoic acid (DHA) is considered to be an essential nutrient for maintaining brain health. The aim of the present study was to explore the potential effects of DHA on memory impairment induced by repeated <span class="hit">sevoflurane</span> anesthesia in aged rats. A total of 54 Sprague Dawley aged rats (18 months) were randomly divided into the following six groups: i) Control group; ii) <span class="hit">sevoflurane</span> group (Sev, 2.5% for 5 min); iii) DHA group (3 g/kg); iv) Sev + DHA (0.3 g/kg) group; v) Sev + DHA (1 g/kg) group; and vi) Sev + DHA (3 g/kg) group. Morris water maze experiment was performed to evaluate the learning and memory ability of the rats following treatment. H&amp;E staining was used to observe any histological changes. Superoxide dismutase, malondialdehyde and glutathione peroxidase levels were detected using ELISA. Immunohistochemistry and western blotting were used to determine nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1) protein expression levels. Following repeated sevo- flurane anesthesia, rats exhibited a prolonged escape latency. The number of times rats crossed the platform and the time spent in the target quadrant were also significantly reduced by repeated <span class="hit">sevoflurane</span> anesthesia. However, rats treated with Sev + DHA exhibited a reduced escape latency, whilst the number of times they crossed the platform and the time spent in the target quadrant increased compared with Sev treatment alone. Histopathological examination revealed that DHA treatment ameliorated the disordered neuron arrange- ment, deep staining of the <span class="hit">neuronal</span> nucleus pyknosis and cell edema observed in the brain tissue induced by repeated <span class="hit">sevoflurane</span> anesthesia. Furthermore, the protein expression levels of Nrf2 and HO-1 were demonstrated to be significantly increased in rats treated with DHA and exposed to repeated <span class="hit">sevoflurane</span> anesthesia compared with those in untreated rats that underwent repeated <span class="hit">sevoflurane</span> anesthesia. In conclusion, the present study revealed that DHA exerted protective effects against impairments in learning and memory induced by repeated <span class="hit">sevoflurane</span> anesthesia in aged rats, which may be associated with the Nrf2/HO-1 signaling pathway.</p><p class="hitsHighlighted">© 2022 Spandidos Publications. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2017581916" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2017581916" type="checkbox" id="record_checkbox_L2017581916"><label for="record_checkbox_L2017581916" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">31</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=31&amp;page=1&amp;id=L2017581916" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">EFFECTS OF DEXMEDETOMIDINE ON POSTOPERATIVE OXIDATIVE STRESS, INFLAMMATORY CYTOKINES AND COGNITIVE FUNCTION IN ELDERLY PATIENTS UNDERGOING NEUROSURGERY UNDER GENERAL ANESTHESIA</a><br><span class="author fn notranslate"><span class="family-name notranslate">Luo</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Luo</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ning</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">L.</span></span><br><span class="journal-title">Acta Medica Mediterranea</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">38</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(1349-1354)</span>&nbsp;<span class="cited-by" id="CTB-L2017581916"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-31"><a href="https://www.embase.com/#" class="showAbstract" data="31" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="31"></i> Abstract</a></li><li class="ui-tab" id="indexTab-31"><a href="https://www.embase.com/#" class="showIndexTerms" data="31" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="31"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.19193/0393-6384_2022_2_205" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="30">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-30"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Introduction: To explore the effect of dexmedetomidine infusion on postoperative oxidative stress and cognitive function in elderly patients under general anesthesia after neurosurgery. Materials and methods: A total of 128 elderly patients undergoing neurosurgery under general anesthesia from January 2019 to December 2019 were selected. Medication factors (level 2: dexmedetomidine, normal saline) were randomly divided into observation group and control group, with 64 cases in each group. The subjects underwent the same anesthesia, surgery, and intraoperative analgesia. Peripheral blood was collected on the 3rd day after operation, and the contents of superoxide dismutase (SOD) and reactive oxygen species (ROS) as well as the contents of neuron-specific enolase (NSE) and autophagy marker molecule (LC3 II) in excised brain tissues were detected by enzyme-linked immunosorbent assay (ELISA). The plasma cortisol (COR) and interleukin-6 (IL-6) levels of the two groups of patients were measured. The Rey Auditory Verbal Learning Test and the Beck Depression Inventory (BDI) were used for early neuropsychological assessment. Results: The use of different analgesics in the neurosurgery of patients had different effects on the oxidative stress and cognitive function after the operation. Those treated with dexmedetomidine showed less oxidative stress and better cognitive function. There was no statistically significant effect of the medication method and the operation time course on the observation indicators. Medication factors exerted an impact on the NSE and LC3 II contents in the brain tissues of the subjects. The NSE content in the brain tissues of the subjects receiving dexmedetomidine was lower than that of the saline patients. The levels of COR and IL-6 in the observation group were significantly lower than those in the control group, and the differences were statistically significant (P&lt;0.05). Conclusion: Infusion of dexmedetomidine under general anesthesia reduces the oxidative stress of elderly patients after neurosurgery and improves their cognitive function, and the mechanism of dexmedetomidine to reduce perioperative brain <span class="hit">injury</span> may be related to the inhibition of <span class="hit">neuronal</span> autophagy.</p><p class="hitsHighlighted">© 2022 A. CARBONE Editore. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2018098779" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2018098779" type="checkbox" id="record_checkbox_L2018098779"><label for="record_checkbox_L2018098779" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">32</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=32&amp;page=1&amp;id=L2018098779" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> Improves Hemorrhagic Shock and Resuscitation-Induced Cognitive Impairments and Mitochondrial Dysfunctions through SIRT1-Mediated Autophagy</a><br><span class="author fn notranslate"><span class="family-name notranslate">Shu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liao</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qian</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">C.</span></span><br><span class="article-in-press">[In Process] </span><span class="journal-title">Oxidative Medicine and Cellular Longevity</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">2022</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 9771743</span>&nbsp;<span class="cited-by" id="CTB-L2018098779"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-32"><a href="https://www.embase.com/#" class="showAbstract" data="32" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="32"></i> Abstract</a></li><li class="ui-tab" id="indexTab-32"><a href="https://www.embase.com/#" class="showIndexTerms" data="32" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="32"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1155/2022/9771743" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="31">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-31"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Cerebral ischemia reperfusion <span class="hit">injury</span> (IRI) induced by hemorrhagic shock and reperfusion (HSR) is the main cause of death following trauma. Previous studies indicated the neuroprotective effect of <span class="hit">sevoflurane</span> postconditioning (SP) in cerebral IRI. However, the mechanisms still remain elusive. Cerebral IRI models with SP were established by using HSR with C57BL/6 mice (male, 3-month-old) in vivo and by using oxygen glucose deprivation and reoxygenation (OGD/R) with HT22 cells in vitro. Postoperative cognition was evaluated by the Morris water maze, novel object recognition, and elevated plus maze tests. The role of SIRT1 was determined by using siRNA, a sensitive inhibitor (EX527), or an overexpression shRNA-GFP lentivirus. IRI caused significant disabilities of spatial learning and memory associated with enhanced cerebral infarct and <span class="hit">neuronal</span> apoptosis, which were effectively attenuated by SP. IRI also made a significant decrease of SIRT1 accompanied by oxidative stress, mitochondria dysfunction, and inactivated autophagy. SP or genetically overexpressing SIRT1 significantly suppressed defective autophagy, mitochondrial oxidative <span class="hit">injury</span>, and <span class="hit">neuronal</span> death caused by HSR or OGD/R. However, genetic suppression or pharmacological inhibition of SIRT1 significantly reversed the impact of SP treatment on mitochondrial DNA transcription ability and autophagy. Our results demonstrate that the loss of SIRT1 causes a sequential chain of mitochondrial dysfunction, defective autophagy, and <span class="hit">neuronal</span> apoptosis after IRI in the preclinical stroke models. <span class="hit">Sevoflurane</span> postconditioning treatment could effectively attenuate pathophysiological signatures induced by noxious stimuli, which maybe mediated by SIRT1.</p><p class="hitsHighlighted">© 2022 Jianwei Shu et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2019520214" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2019520214" type="checkbox" id="record_checkbox_L2019520214"><label for="record_checkbox_L2019520214" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">33</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=33&amp;page=1&amp;id=L2019520214" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">mTORC1-Dependent and GSDMD-Mediated Pyroptosis in Developmental <span class="hit">Sevoflurane</span> Neurotoxicity</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wen-Yuan</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wan-Qing</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qi-Yun</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu-Si</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shao-Jie</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jin-Tao</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hui</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hui-Ling</span> <span class="given-name notranslate">Y.</span></span><br><span class="article-in-press">[In Process] </span><span class="journal-title">Molecular Neurobiology</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="cited-by" id="CTB-L2019520214"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-33"><a href="https://www.embase.com/#" class="showAbstract" data="33" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="33"></i> Abstract</a></li><li class="ui-tab" id="indexTab-33"><a href="https://www.embase.com/#" class="showIndexTerms" data="33" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="33"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12035-022-03070-4" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="32">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-32"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Developmental <span class="hit">sevoflurane</span> exposure leads to <span class="hit">neuronal</span> cell death, and subsequent learning and memory cognitive defects. The underlyi\ng mechanism remains to be elucidated. Gasdermin D (GSDMD)-mediated pyroptosis is a form of inflammatory cell death and participates in a variety of neurodegenerative diseases. Several studies illustrated that dysregulation of mTOR activity is involved in pyroptotic cell death. The current study was designed to interrogate the role of GSDMD-mediated pyroptosis and mTOR activity in developmental <span class="hit">sevoflurane</span> exposure. We found that inhibition of GSDMD pore formation with Disulfiram (DSF) or Necrosulfonamide (NSA) significantly attenuated <span class="hit">sevoflurane</span> neurotoxicity in vitro. In addition, treatment with DSF or NSA also mitigated damage-associated molecular patterns (DAMPs) release and subsequent plasma membrane rupture (PMR) induced by <span class="hit">sevoflurane</span> challenge. Further investigation showed that the overactivation of mTOR signaling is involved in <span class="hit">sevoflurane</span> induced pyroptosis both in vivo and in vitro. Intriguingly, we found that the DAMPs release and subsequent PMR triggered by developmental <span class="hit">sevoflurane</span> priming were compromised by knocking down the expression of mTORC1 component Raptor, but not mTORC2 component Rictor. Moreover, <span class="hit">sevoflurane</span> induced pyroptosis could also be restored by suppressing mTOR activity or knocking down the expressions of Ras-related small GTPases RagA or RagC. Finally, administration of DSF or NSA dramatically improved the spatial and emotional cognitive disorders without alternation of locomotor activity. Taken together, these results indicate that mTORC1-dependent and GSDMD-mediated pyroptosis contributes to the developmental <span class="hit">sevoflurane</span> neurotoxicity. Characterizing these processes may provide experimental evidence for the possible prevention of developmental <span class="hit">sevoflurane</span> neurotoxicity.</p><p class="hitsHighlighted">© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2019656615" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2019656615" type="checkbox" id="record_checkbox_L2019656615"><label for="record_checkbox_L2019656615" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">34</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=34&amp;page=1&amp;id=L2019656615" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Down-regulation of miR-204-5p ameliorates <span class="hit">sevoflurane</span>-induced brain <span class="hit">injury</span> in neonatal rats through targeting VCAM1</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xie</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Toxicology Mechanisms and Methods</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="cited-by" id="CTB-L2019656615"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-34"><a href="https://www.embase.com/#" class="showAbstract" data="34" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="34"></i> Abstract</a></li><li class="ui-tab" id="indexTab-34"><a href="https://www.embase.com/#" class="showIndexTerms" data="34" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="34"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1080/15376516.2022.2128705" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="33">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-33"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">To confirm the regulation of miR-204-5p on VCAM1 and its effect on <span class="hit">sevoflurane</span>-induced brain <span class="hit">injury</span> in neonatal rats. We adopted the <span class="hit">sevoflurane</span>-induced brain <span class="hit">injury</span> model, and the double luciferase reporter gene assay was applied to explore the targeting relationship between vascular adhesion factor 1 (VCAM1) and miR-204-5p. RT-qPCR was applied to assess the levels of miR-204-5. VCAM1, LC3, P62 and cleaved-caspase 3 levels in the hippocampus were estimated by western blot. The number of autophagosomes in the cerebral cortex was assessed via Transmission electron microscopy (TEM), and histopathological changes within the hippocampus by HE staining. miR-204-5p levels were remarkably increased, but VCAM1 expression was decreased after neonatal rat brain <span class="hit">injury</span>. Furthermore, miR-204-5p directly targeted VCAM1. The escape latency, swimming distance, autophagosome number, <span class="hit">neuronal</span> apoptosis ratio, LC3 II and Cleaved-caspase 3 expression were reduced after miR-204-5p inhibition interference, whereas crossing times, and P62 expression increased in the <span class="hit">sevoflurane</span>-induced brain <span class="hit">injury</span> model. Furthermore, down-regulation of VCAM1 reversed the trend of these indices. These results suggest that down-regulation of miR-204-5p ameliorates <span class="hit">sevoflurane</span>-induced cognitive impairment and hippocampal pathology and inhibits <span class="hit">neuronal</span> autophagy and apoptosis by targeting VCAM1.</p><p class="hitsHighlighted">© 2022 Informa UK Limited, trading as Taylor &amp; Francis Group.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2019940594" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2019940594" type="checkbox" id="record_checkbox_L2019940594"><label for="record_checkbox_L2019940594" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">35</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=35&amp;page=1&amp;id=L2019940594" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Lin28A Reduced <span class="hit">Sevoflurane</span>-Induced Nerve <span class="hit">Injury</span> and Cognitive Dysfunction by Inhibiting Tau Acetylation and Phosphorylation via Activating SIRT1 in Elderly Rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Q.</span></span><br><span class="journal-title">Neurotoxicity Research</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="cited-by" id="CTB-L2019940594"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-35"><a href="https://www.embase.com/#" class="showAbstract" data="35" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="35"></i> Abstract</a></li><li class="ui-tab" id="indexTab-35"><a href="https://www.embase.com/#" class="showIndexTerms" data="35" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="35"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12640-022-00594-4" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="34">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-34"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> (Sev) might cause neurotoxicity in elderly rats. However, the role of Lin28A in Sev-induced neurotoxicity remains unclear in elderly rats. In this study, elderly rats were used to construct an Sev-induced nerve <span class="hit">injury</span> model. Learning and memory abilities were assessed by Morris water maze (MWM) trainings; pathological alterations in hippocampal region were assessed by HE staining; <span class="hit">neuronal</span> apoptosis was assessed by TUNEL; related protein expression was analyzed by immunofluorescence, immunohistochemistry, and Western blotting. Results of this study showed that Sev treatment caused nerve <span class="hit">injury</span> and cognitive dysfunction in elderly rats, with increased <span class="hit">neuronal</span> apoptosis and decreased Lin28A levels. Pathological impairment and learning and memory abilities of elderly rats were significantly improved after forced overexpression of Lin28A using AAV, accompanied by decreased expression of CD68, Iba-1, and GFAP. TUNEL analysis showed that Lin28A overexpression significantly reversed Sev-induced <span class="hit">neuronal</span> apoptosis. Further mechanistic analysis showed that Lin28A significantly promoted SIRT1 expression, which further reversed Sev-induced Tau acetylation at lysine 280 and 686 and Tau hyperphosphorylation, thereby alleviating nerve <span class="hit">injury</span> and cognitive dysfunction in elderly rats. The introduction of SIRT1 inhibitor EX527 further confirmed the involvement of SIRT1 in the regulation of Lin28A in elderly rats. In conclusion, our findings demonstrated that Lin28A reduced <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span> and cognitive dysfunction by inhibiting Tau acetylation and phosphorylation via activating SIRT1 in elderly rats.</p><p class="hitsHighlighted">© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2020486132" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2020486132" type="checkbox" id="record_checkbox_L2020486132"><label for="record_checkbox_L2020486132" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">36</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=36&amp;page=1&amp;id=L2020486132" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> dose and postoperative delirium: a prospective cohort analysis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Taylor</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Payne</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Casey</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kunkel</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Parker</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rivera</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zetterberg</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Blennow</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pearce</span> <span class="given-name notranslate">R.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lennertz</span> <span class="given-name notranslate">R.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">McCulloch</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gaskell</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sanders</span> <span class="given-name notranslate">R.D.</span></span><br><span class="article-in-press">[In Process] </span><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="cited-by" id="CTB-L2020486132"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-36"><a href="https://www.embase.com/#" class="showAbstract" data="36" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="36"></i> Abstract</a></li><li class="ui-tab" id="indexTab-36"><a href="https://www.embase.com/#" class="showIndexTerms" data="36" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="36"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bja.2022.08.022" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="35">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-35"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Recent trials are conflicting as to whether titration of anaesthetic dose using electroencephalography monitoring reduces postoperative delirium. Titration to anaesthetic dose itself might yield clearer conclusions. We analysed our observational cohort to clarify both dose ranges for trials of anaesthetic dose and biological plausibility of anaesthetic dose influencing delirium. Methods: We analysed the use of <span class="hit">sevoflurane</span> in an ongoing prospective cohort of non-intracranial surgery. Of 167 participants, 118 received <span class="hit">sevoflurane</span> and were aged &gt;65 yr. We tested associations between age-adjusted median <span class="hit">sevoflurane</span> (AMS) minimum alveolar concentration fraction or area under the <span class="hit">sevoflurane</span> time×dose curve (AUC-S) and delirium severity (Delirium Rating Scale-98). Delirium incidence was measured with 3-minute Diagnostic Confusion Assessment Method (3D-CAM) or CAM-ICU. Associations with previously identified delirium biomarkers (interleukin-8, neurofilament light, total tau, or S100B) were tested. Results: Delirium severity did not correlate with AMS (Spearman's ρ=–0.014, P=0.89) or AUC-S (ρ=0.093, P=0.35), nor did delirium incidence (AMS Wilcoxon P=0.86, AUC-S P=0.78). Further sensitivity analyses including propofol dose also demonstrated no relationship. Linear regression confirmed no association for AMS in unadjusted (log (IRR)=–0.06 P=0.645) or adjusted models (log (IRR)=–0.0454, P=0.735). No association was observed for AUC-S in unadjusted (log (IRR)=0.00, P=0.054) or adjusted models (log (IRR)=0.00, P=0.832). No association of anaesthetic dose with delirium biomarkers was identified (P&gt;0.05). Conclusion: <span class="hit">Sevoflurane</span> dose was not associated with delirium severity or incidence. Other biological mechanisms of delirium, such as inflammation and <span class="hit">neuronal injury</span>, appear more plausible than dose of <span class="hit">sevoflurane</span>. Clinical trial registration: NCT03124303, NCT01980511.</p><p class="hitsHighlighted">© 2022 British Journal of Anaesthesia</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2020781366" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2020781366" type="checkbox" id="record_checkbox_L2020781366"><label for="record_checkbox_L2020781366" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">37</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=37&amp;page=1&amp;id=L2020781366" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Identification and Validation of Ferroptosis-Related Genes in <span class="hit">Sevoflurane</span>-Induced Hippocampal Neurotoxicity</a><br><span class="author fn notranslate"><span class="family-name notranslate">Miao</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zeng</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Han</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fu</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">Oxidative Medicine and Cellular Longevity</span>&nbsp;<span class="journal-publication-year">2022</span>&nbsp;<span class="journal-volume">2022</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 4435161</span>&nbsp;<span class="cited-by" id="CTB-L2020781366"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-37"><a href="https://www.embase.com/#" class="showAbstract" data="37" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="37"></i> Abstract</a></li><li class="ui-tab" id="indexTab-37"><a href="https://www.embase.com/#" class="showIndexTerms" data="37" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="37"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1155/2022/4435161" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="36">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-36"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background. <span class="hit">Sevoflurane</span> is one of the most popular inhalational anesthetics during perioperative period but presenting neurotoxicity among pediatric and aged populations. Recent experiments in vivo and in vitro have indicated that ferroptosis may contribute to the neurotoxicity of <span class="hit">sevoflurane</span> anesthesia. However, the exact mechanism is still unclear. Methods. In current study, we explored the differential expressed genes (DEGs) in HT-22 mouse hippocampal <span class="hit">neuronal</span> cells after <span class="hit">sevoflurane</span> anesthesia using RNA-seq. Differential expressed ferroptosis-related genes (DEFRGs) were screened and analyzed by Gene Ontology (GO) and pathway enrichment analysis. Protein-to-protein interaction (PPI) network was constructed by the Search Tool for the Retrieval of Interacting Genes (STRING). Significant modules and the hub genes were identified by using Cytoscape. The Connectivity Map (cMAP) was used for screening drug candidates targeting the identified DEFRGs. Potential TF-gene network and drug-gene pairs were established towards the hub genes. In final, we validated these results in experiments. Results. A total of 37 ferroptosis-related genes (18 upregulated and 19 downregulated) after <span class="hit">sevoflurane</span> exposure in hippocampal <span class="hit">neuronal</span> cells were finally identified. These differentially expressed genes were mainly involved into the biological processes of cellular response to oxidative stress. Pathway analysis indicated that these genes were involved in ferroptosis, mTOR signaling pathway, and longevity-regulating pathway. PPI network was constructed. 10 hub genes including Prkaa2, Chac1, Arntl, Tfrc, Slc7a11, Atf4, Mgst1, Lpin1, Atf3, and Sesn2 were found. Top 10 drug candidates, gene-drug networks, and TFs targeting these genes were finally identified. These results were validated in experiments. Conclusion. Our results suggested that ferroptosis-related genes play roles in <span class="hit">sevoflurane</span> anesthesia-related hippocampal neuron <span class="hit">injury</span> and offered the hub genes and potential therapeutic agents for investigating and treatment of this neurotoxicity after <span class="hit">sevoflurane</span> exposure. Finally, therapeutic effect of these drug candidates and function of potential ferroptosis targets should be further investigated for treatment and clarifying mechanisms of <span class="hit">sevoflurane</span> anesthesia-induced neuron <span class="hit">injury</span> in future research.</p><p class="hitsHighlighted">© 2022 Mengrong Miao et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2011867435" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2011867435" type="checkbox" id="record_checkbox_L2011867435"><label for="record_checkbox_L2011867435" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">38</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=38&amp;page=1&amp;id=L2011867435" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroprotective strategies in the perioperative period: A systematic review</a><br><span class="author fn notranslate"><span class="family-name notranslate">Safari</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zali</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pezeshgi</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bastanhagh</span> <span class="given-name notranslate">E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jahangirifard</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Akhlaghdoust</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">Journal of Cellular and Molecular Anesthesia</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">6</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(50-65)</span>&nbsp;<span class="cited-by" id="CTB-L2011867435"><a href="https://lls.reaxys.com/redir?pid=scp:85104921274" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-38"><a href="https://www.embase.com/#" class="showAbstract" data="38" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="38"></i> Abstract</a></li><li class="ui-tab" id="indexTab-38"><a href="https://www.embase.com/#" class="showIndexTerms" data="38" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="38"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.22037/jcma.v6i1.33072" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="37">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-37"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Surgery and anesthetics may cause brain damage, and the resulting neurological defect can impair the patient's cognitive function. This disorder is one of the most common complications after surgery and causes disorders in several cognitive areas of the patient. The mechanism of this disorder is not fully understood, but <span class="hit">neuronal</span> inflammation is one of the main causes of this disorder. The purpose of this systematic review was to evaluate neuroprotective drug strategies for the treatment or prevention of surgical disorders associated with anesthesia. We searched the keywords "neuroprotective", "neuroprotection", "postoperative" and "perioperative" in the databases of the web of science, Scopus, PubMed, ScienceDirect, and Google Scholar with a 5-year time limit. At first, 492 articles were obtained, and finally, after a detailed survey based on exclusion and inclusion criteria, 31 studies were selected to extract data. Findings from studies show that medication and treatment strategies used in a group of mice and rats under surgery with treatment can improve <span class="hit">Neuronal</span> inflammation and brain damage compared to mice and rats with surgery only and reduce the side effects of surgery and anesthetics.</p><p class="hitsHighlighted">© 2021 Journal of Cellular and Molecular Anesthesia. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2014757592" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2014757592" type="checkbox" id="record_checkbox_L2014757592"><label for="record_checkbox_L2014757592" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">39</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=39&amp;page=1&amp;id=L2014757592" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Contemporary neuroprotection strategies during cardiac surgery: State of the art review</a><br><span class="author fn notranslate"><span class="family-name notranslate">Motshabi-Chakane</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mogane</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Moutlana</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Leballo-Mothibi</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dingezweni</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mpanya</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tsabedze</span> <span class="given-name notranslate">N.</span></span><br><span class="journal-title">International Journal of Environmental Research and Public Health</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">18</span><span class="journal-issue">:23</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 12747</span>&nbsp;<span class="cited-by" id="CTB-L2014757592"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-39"><a href="https://www.embase.com/#" class="showAbstract" data="39" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="39"></i> Abstract</a></li><li class="ui-tab" id="indexTab-39"><a href="https://www.embase.com/#" class="showIndexTerms" data="39" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="39"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3390/ijerph182312747" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="38">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-38"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Open-heart surgery is the leading cause of <span class="hit">neuronal injury</span> in the perioperative state, with some patients complicating with cerebrovascular accidents and delirium. Neurological fallout places an immense burden on the psychological well-being of the person affected, their family, and the healthcare system. Several randomised control trials (RCTs) have attempted to identify therapeutic and interventional strategies that reduce the morbidity and mortality rate in patients that experience perioperative neurological complications. However, there is still no consensus on the best strategy that yields improved patient outcomes, such that standardised neuroprotection protocols do not exist in a significant number of anaesthesia departments. This review aims to discuss contemporary evidence for preventing and managing risk factors for <span class="hit">neuronal injury</span>, mechanisms of <span class="hit">injury</span>, and neuroprotection interventions that lead to improved patient outcomes. Furthermore, a summary of existing RCTs and large observational studies are examined to determine which strategies are supported by science and which lack definitive evidence. We have established that the overall evidence for pharmacological neuroprotection is weak. Most neuroprotective strategies are based on animal studies, which cannot be fully extrapolated to the human population, and there is still no consensus on the optimal neuroprotective strategies for patients undergoing cardiac surgery. Large multicenter studies using universal standardised neurological fallout definitions are still required to evaluate the beneficial effects of the existing neuroprotective techniques.</p><p class="hitsHighlighted">© 2021 by the authors. Licensee MDPI, Basel, Switzerland.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2015593229" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2015593229" type="checkbox" id="record_checkbox_L2015593229"><label for="record_checkbox_L2015593229" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">40</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=40&amp;page=1&amp;id=L2015593229" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Anesthetics mediated the immunomodulatory effects via regulation of TLR signaling</a><br><span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xing</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">International Immunopharmacology</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">101</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 108357</span>&nbsp;<span class="cited-by" id="CTB-L2015593229"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-40"><a href="https://www.embase.com/#" class="showAbstract" data="40" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="40"></i> Abstract</a></li><li class="ui-tab" id="indexTab-40"><a href="https://www.embase.com/#" class="showIndexTerms" data="40" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="40"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.intimp.2021.108357" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="39">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-39"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Anesthetics have been widely used in surgery and found to suppress inflammatory <span class="hit">injury</span> and affect the outcomes of the surgery and diseases. In contrast, anesthetics are also found to induce <span class="hit">neuronal injury</span> and inflammation. However, the immune-modulation mechanism of anesthetics is still not clear. Recent studies have shown that the immune-modulation of anesthetics is associated with the regulation of toll-like receptor (TLR)-mediated signaling. Moreover, the regulation of anesthetics in TLR signaling is related to modulations of non-coding RNAs (nc RNAs). Consistently, nc RNAs are mainly divided into micro RNAs (miRs) and long non-coding RNAs (lnc RNAs), which have been found to exert regulatory effects on the immune system. In this review, we summarize the immunomodulatory functions of the widely used anesthetic agents, which are associated with regulation of TLR signaling. In addition, we also focus on the roles of nc RNAs induced by anesthetics in regulations of TLR signaling.</p><p class="hitsHighlighted">© 2021 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L636973732" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L636973732" type="checkbox" id="record_checkbox_L636973732"><label for="record_checkbox_L636973732" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">41</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=41&amp;page=1&amp;id=L636973732" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Changes of <span class="hit">Neuronal</span> Plasticity in Postoperative Cognitive Dysfunction (POCD)</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span><br><span class="article-in-press">[In Process] </span><span class="journal-title">Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">17</span>&nbsp;<span class="journal-suppl">Supplement 2</span><span class="journal-pages">&nbsp;(e058460-)</span>&nbsp;<span class="cited-by" id="CTB-L636973732"><a href="https://lls.reaxys.com/redir?pid=scp:85123037008" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-41"><a href="https://www.embase.com/#" class="showAbstract" data="41" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="41"></i> Abstract</a></li><li class="ui-tab" id="indexTab-41"><a href="https://www.embase.com/#" class="showIndexTerms" data="41" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="41"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1002/alz.058460" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="40">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-40"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND: Postoperative cognitive dysfunction (POCD) is defined as a prolonged cognitive function impairment that occurs within weeks to months of a surgical procedure. Clinically this is a well-known risk of the surgical experience in the elderly, having been described as a consequence of anesthesia. The medial prefrontal cortex (mPFC) plays a critical role in remote, recent, and short-term memories over a broad range of tasks. The effect of POCD on <span class="hit">neuronal</span> plasticity in mPFC remains controversial. The present study investigates the impact of laparotomy on cognition and synaptic functions. METHOD: Mice were induced with 5% <span class="hit">sevoflurane</span> and maintained with 3 - 4% <span class="hit">sevoflurane</span> continuously for 30 mins. Under <span class="hit">sevoflurane</span> anesthesia, a 2.5 cm longitudinal midline incision was made. Approximately 10 cm of intestine was exteriorized and vigorously rubbed for 2 min and stay outside the abdominal cavity for 1 min. Novel Object Recognition (NOR) test was performed 1hour and 24 hours for the short-term and long-term memory seven days after the surgery. Open field test (OFT) and The Elevated Plus Maze test, was performed to exclude motor dysfunction and anxiety. The miniature excitatory postsynaptic currents (mEPSC) and miniature inhibitory postsynaptic currents (mIPSC) were recorded on the 7 or 14 days after surgery. RESULT: In the NOR test, mice with undergone laparotomy surgery had worse cognitive performance than the control group. There was no significance between the laparotomy group and the control group in the OFT test and Elevated Plus Maze test. There was no significance in the amplitude of the mEPSC between laparotomy and control group. However, the frequency increased significantly in the laparotomy group than the control group, which can last for 14 days. There was no significance of mIPSC in the amplitude and frequency between the laparotomy group and the control group. CONCLUSION: These findings demonstrated that laparotomy surgery under <span class="hit">sevoflurane</span> leads to learning and memory impairment in adolescent mice without altering motor dysfunction and anxiety. The increase in the presynapse release ability indicated the glutamatergic neuron abnormalities without altering the GABAergic neuron's function. Our result suggested that postoperative cognitive dysfunctions may be related to surgical trauma and glutamate neurons abnormalities.</p><p class="hitsHighlighted">© 2021 the Alzheimer's Association.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2006052306" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2006052306" type="checkbox" id="record_checkbox_L2006052306"><label for="record_checkbox_L2006052306" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">42</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=42&amp;page=1&amp;id=L2006052306" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> Post-Conditioning Ameliorates <span class="hit">Neuronal</span> Deficits and Axon Demyelination After Neonatal Hypoxic Ischemic Brain <span class="hit">Injury</span>: Role of Microglia/Macrophage</a><br><span class="author fn notranslate"><span class="family-name notranslate">Xue</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">Q.-S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Z.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Niu</span> <span class="given-name notranslate">J.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">P.</span></span><br><span class="journal-title">Cellular and Molecular Neurobiology</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">41</span><span class="journal-issue">:8</span><span class="journal-pages">&nbsp;(1801-1816)</span>&nbsp;<span class="cited-by" id="CTB-L2006052306"><a href="https://lls.reaxys.com/redir?pid=scp:85090131558" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;8</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-42"><a href="https://www.embase.com/#" class="showAbstract" data="42" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="42"></i> Abstract</a></li><li class="ui-tab" id="indexTab-42"><a href="https://www.embase.com/#" class="showIndexTerms" data="42" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="42"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s10571-020-00949-5" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="41">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-41"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Microglia/macrophages have been identified to be highly polarized after ischemia. Interestingly, the polarization of these microglia/macrophages varies immensely under differing disease conditions. Post-conditioning using sevoflurane, a volatile anesthetic, could provide long-term neuroprotection to neonatal rats after hypoxic-ischemic brain injury (HIBI). Thus, the current study aimed at investigating the effects of sevoflurane post-conditioning (SPC) on microglia/macrophage polarization after HIBI induction in neonatal rats. Additionally, we aimed at identifying the underpinning mechanisms specifically related to autophagy and lysosomal protease enzyme, cathepsin B. To develop a HIBI model, 7-day-old Sprague–Dawley rats underwent left common carotid artery ligation followed by 2&nbsp;h of hypoxia. The role of microglia/macrophages in the neuroprotection conferred by SPC was examined by left-side intra-cerebroventricular injection with adenovirus vector carrying catB-GFP or rapamycin. The number of interleukin (IL)-1β<sup>+</sup> cells, cathepsin B<sup>+</sup> cells, light chain 3B positive (LC3B<sup>+</sup>) cells among ionized calcium binding adaptor molecule 1(Iba1<sup>+</sup>)cells to investigate microglia polarization, neuronal apoptosis to assess neuronal death in the acute phase were tested at 24&nbsp;h after HIBI. Behavioral tests including suspension test, Morris water maze tests were performed to investigate the long-term effects of SPC, at 21 to 34&nbsp;days post HIBI. Nissl staining and myelin basic protein (MBP) immunostaining to assess the long-term neuronal and myelin damage were performed at 34&nbsp;days after HIBI. Based on the obtained results post HIBI, we observed the cells that were positive for IL-1β, cathepsin B, and LC3B among Iba1 positive cell population in the hippocampus were significantly decreased after SPC treatment. SPC significantly attenuated the HIBI-induced increase in neuronal apoptosis, improved long-term cognitive function, and attenuated HI-induced decrease of Nissl-positive cells and MBP expression. However, these trends were reversed by injection of adenovirus vector carrying catB-GFP and rapamycin. SPC attenuated microglia polarization towards neurotoxic phenotypes, alleviates neuronal death and axon demyelination after HIBI in neonatal rats by regulating microglia autophagy and cathepsin B expression, and therefore provided long-term cognitive, learning and memory protection.</p><p class="hitsHighlighted">© 2020, Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2014025955" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2014025955" type="checkbox" id="record_checkbox_L2014025955"><label for="record_checkbox_L2014025955" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">43</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=43&amp;page=1&amp;id=L2014025955" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: Evidence from in vitro and in vivo studies</a><br><span class="author fn notranslate"><span class="family-name notranslate">Unchiti</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Leurcharusmee</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Samerchua</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pipanmekaporn</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chattipakorn</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chattipakorn</span> <span class="given-name notranslate">S.C.</span></span><br><span class="journal-title">European Journal of Neuroscience</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">54</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(7006-7047)</span>&nbsp;<span class="cited-by" id="CTB-L2014025955"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-43"><a href="https://www.embase.com/#" class="showAbstract" data="43" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="43"></i> Abstract</a></li><li class="ui-tab" id="indexTab-43"><a href="https://www.embase.com/#" class="showIndexTerms" data="43" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="43"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/ejn.15474" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="42">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-42"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Neurological disorders following brain injuries and neurodegeneration are on the rise worldwide and cause disability and suffering in patients. It is crucial to explore novel neuroprotectants. Dexmedetomidine, a selective α2-adrenoceptor agonist, is commonly used for anxiolysis, sedation and analgesia in clinical anaesthesia and critical care. Recent studies have shown that dexmedetomidine exerts protective effects on multiple organs. This review summarized and discussed the current neuroprotective effects of dexmedetomidine, as well as the underlying mechanisms. In preclinical studies, dexmedetomidine reduced <span class="hit">neuronal injury</span> and improved functional outcomes in several models, including hypoxia-induced <span class="hit">neuronal injury</span>, ischaemic-reperfusion <span class="hit">injury</span>, intracerebral haemorrhage, post-traumatic brain <span class="hit">injury</span>, anaesthetic-induced <span class="hit">neuronal injury</span>, substance-induced <span class="hit">neuronal injury</span>, neuroinflammation, epilepsy and neurodegeneration. Several mechanisms are associated with the neuroprotective function of dexmedetomidine, including neurotransmitter regulation, inflammatory response, oxidative stress, apoptotic pathway, autophagy, mitochondrial function and other cell signalling pathways. In summary, dexmedetomidine has the potential to be a novel neuroprotective agent for a wide range of neurological disorders.</p><p class="hitsHighlighted">© 2021 Federation of European Neuroscience Societies and John Wiley &amp; Sons Ltd</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2014456047" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2014456047" type="checkbox" id="record_checkbox_L2014456047"><label for="record_checkbox_L2014456047" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">44</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=44&amp;page=1&amp;id=L2014456047" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Up-regulated microRNA-132 reduces the cognition-damaging effect of <span class="hit">sevoflurane</span> on Alzheimer's disease rats by inhibiting FOXA1</a><br><span class="author fn notranslate"><span class="family-name notranslate">Cong</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cong</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Feng</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Genomics</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">113</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(3644-3652)</span>&nbsp;<span class="cited-by" id="CTB-L2014456047"><a href="https://lls.reaxys.com/redir?pid=scp:85114411563" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;4</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-44"><a href="https://www.embase.com/#" class="showAbstract" data="44" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="44"></i> Abstract</a></li><li class="ui-tab" id="indexTab-44"><a href="https://www.embase.com/#" class="showIndexTerms" data="44" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="44"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.ygeno.2021.08.011" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="43">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-43"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: Some studies have implied the damaging effect of <span class="hit">sevoflurane</span> (sevo) on cognitive function in Alzheimer's disease (AD). This research was conducted to explore the effect of microRNA (miR)-132/forkhead-box A1 (FOXA1) axis on cognitive ability of sevo-treated AD rats. Methods: The condensed-matter Aβ<sub>1</sub><sub>–</sub><sub>40</sub>-induced AD rats were injected with miR-132- or FOXA1-related plasmids, followed by inhalation with 3% sevo. Then, the cognitive functions of AD rats were assessed. miR-132 and FOXA1 levels in hippocampal tissues of AD rats, and their interaction were identified. Results: miR-132 expression was reduced and FOXA1 mRNA and protein levels were elevated in AD rats. miR-132 targeted FOXA1. Sevo treatment impaired cognitive function in AD rats. Elevated miR-132 or inhibited FOXA1 attenuated sevo-mediated <span class="hit">injury</span> in AD rats. Overexpressed FOXA1 rescued the effect of elevated miR-132 in AD rats with sevo treatment. Conclusion: Up-regulated miR-132 reduces the cognition-damaging effect of sevo on AD rats by inhibiting FOXA1.</p><p class="hitsHighlighted">© 2021</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2013074187" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2013074187" type="checkbox" id="record_checkbox_L2013074187"><label for="record_checkbox_L2013074187" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">45</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=45&amp;page=1&amp;id=L2013074187" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> Postconditioning Ameliorates <span class="hit">Neuronal</span> Migration Disorder Through Reelin/Dab1 and Improves Long-term Cognition in Neonatal Rats After Hypoxic-Ischemic <span class="hit">Injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xue</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">P.</span></span><br><span class="journal-title">Neurotoxicity Research</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">39</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(1524-1542)</span>&nbsp;<span class="cited-by" id="CTB-L2013074187"><a href="https://lls.reaxys.com/redir?pid=scp:85109299303" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;3</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-45"><a href="https://www.embase.com/#" class="showAbstract" data="45" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="45"></i> Abstract</a></li><li class="ui-tab" id="indexTab-45"><a href="https://www.embase.com/#" class="showIndexTerms" data="45" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="45"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12640-021-00377-3" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="44">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-44"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Sevoflurane postconditioning (SPC) has been widely reported to attenuate brain injury after hypoxia–ischemia encephalopathy (HIE) by inhibiting neural necrosis and autophagy. Moreover, recent reports revealed that sevoflurane facilitated hippocampal reconstruction via regulating migration. Yet, it remains unclear whether the promotion of neural migration by SPC repairs the hippocampal injury after HIE. Here, we hypothesize that SPC exerts a neuroprotective effect by ameliorating neuronal migration disorder after HIE and regulating Reelin expression. Furthermore, the downstream Reelin/Dab1 pathway may be involved. The classical Rice–Vannucci model of hypoxia–ischemia was performed on postnatal day 7 rat pups, which was followed by SPC at 1 minimum alveolar concentration (MAC 2.5%) for 30&nbsp;min. Piceatannol, causing Reelin aggregation in vivo, was used to detect whether Reelin/Dab1 was involved in the neuroprotection effect of SPC. Hippocampal-dependent learning ability tests were conducted to assess the long-term effects on locomotor activity and spatial learning ability. Our findings suggest that hypoxia–ischemia injury inhibited neurons migrated outward from the basal zone of dentate gyrus, disrupted cytoarchitecture of the dentate gyrus (DG), and led to long-term cognition deficits. However, SPC could relieve the restricted hippocampal neurons and repair the hippocampal-dependent memory function damaged after HIE by attenuating the overactivation of the Reelin/Dab1 pathway. These results demonstrate that SPC plays a pivotal role in ameliorating neuronal migration disorder and maintaining normal cytoarchitecture of the DG via inhibiting overactivated Reelin expression. This process may involve overactivated Reelin/Dab1 signaling pathway and spatial learning ability by regulating the Reelin expression which may associate with its neuroprotection.</p><p class="hitsHighlighted">© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L635435639" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L635435639" type="checkbox" id="record_checkbox_L635435639"><label for="record_checkbox_L635435639" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">46</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=46&amp;page=1&amp;id=L635435639" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Protective effects of <span class="hit">sevoflurane</span> in cerebral ischemia reperfusion <span class="hit">injury</span>: A narrative review</a><br><span class="author fn notranslate"><span class="family-name notranslate">Liang</span> <span class="given-name notranslate">T.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Peng</span> <span class="given-name notranslate">S.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">H.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">G.</span></span><br><span class="journal-title">Medical Gas Research</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">11</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(152-154)</span>&nbsp;<span class="cited-by" id="CTB-L635435639"><a href="https://lls.reaxys.com/redir?pid=scp:85109294741" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;8</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-46"><a href="https://www.embase.com/#" class="showAbstract" data="46" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="46"></i> Abstract</a></li><li class="ui-tab" id="indexTab-46"><a href="https://www.embase.com/#" class="showIndexTerms" data="46" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="46"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.4103/2045-9912.318860" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="45">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-45"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Ischemia/reperfusion (I/R) <span class="hit">injury</span> is a phenomenon that the reperfusion of ischemic organs or tissues aggravates their damage, which poses a serious health threat and economic burden to the world. I/R gives rise to a series of physiological and pathological world, including inflammatory response, oxidative stress, brain edema, blood-brain barrier destruction, and <span class="hit">neuronal</span> death. Therefore, finding effective treatment measures is extremely important to the recovery of I/R patients and the improvement of long-term quality of life. <span class="hit">Sevoflurane</span> is an important volatile anesthetic which has been reported to reduce myocardial I/R damage and infarct size. <span class="hit">Sevoflurane</span> also has anti-inflammatory and neuroprotective effects. As reported <span class="hit">sevoflurane</span> treatment could reduce nerve function <span class="hit">injury</span>, cerebral infarction volume and the level of inflammatory factors. At the same time, there is evidence that <span class="hit">sevoflurane</span> can reduce neuron apoptosis and antioxidant stress. The protective effect of <span class="hit">sevoflurane</span> in brain <span class="hit">injury</span> has been proved to be existed in several aspects, so that a comprehensive understanding of its neuroprotective effect is helpful to exploit new treatment paths for I/R, provide clinicians with new clinical treatment decisions, contribute to the effective treatment of I/R patients and the improvement of quality of life after I/R healing.</p><p class="hitsHighlighted">© 2021 BMJ Publishing Group. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L636263621" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L636263621" type="checkbox" id="record_checkbox_L636263621"><label for="record_checkbox_L636263621" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">47</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=47&amp;page=1&amp;id=L636263621" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Intraoperative white cord syndrome following posterior spinal cord decompression</a><br><span class="author fn notranslate"><span class="family-name notranslate">Guay</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Flessa</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dejoy</span> <span class="given-name notranslate">S.</span></span><br><span class="journal-title">Journal of Neurosurgical Anesthesiology</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">33</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(384-385)</span>&nbsp;<span class="cited-by" id="CTB-L636263621"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-47"><a href="https://www.embase.com/#" class="showAbstract" data="47" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="47"></i> Abstract</a></li><li class="ui-tab" id="indexTab-47"><a href="https://www.embase.com/#" class="showIndexTerms" data="47" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="47"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ANA.0000000000000800" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="46">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-46"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Case Description: A 44-year old female with a medical history significant for obesity and cervical myelopathy presented for posterior spinal fusion and laminectomy of C2-T1. Initial outpatient neurological exam was noted to have full strength in all muscle groups, normal sensation, and gait, but spastic upper extremities and positive Lhermitte's sign. MRI of the cervical spine revealed multilevel degenerative disc disease with canal and foraminal narrowing with a moderate cord signal abnormality at C2-C6 representing edema versus myelomalacia. Preoperatively, the patient was noted to have significant progression of her symptoms, describing persistent upper extremity paresthesias, lower extremity weakness, and gait dysfunction. Intraoperatively, the patient was monitored with somatosensory evoked potentials (SSEPs) and electroencephalography (EEG). General anesthesia was maintained with <span class="hit">sevoflurane</span> and a remifentanil infusion. Following spinal cord decompression, there was an abrupt decrease in SSEP signals in the bilateral lower extremities, with greater than 10% increase in latency without perceptible technical cause. This was followed by decreases in bilateral lower extremity amplitudes and subsequent loss of upper extremity SSEP signals. To ensure adequate cord perfusion, mean arterial pressures were increased with a combination of crystalloid administration, vasopressors, and decreased anesthetic depth. The surgical site was closed and the patient promptly emerged from anesthesia for neurological examination which was notable for incomplete tetraplegia. Postoperative MRI revealed significantly improved cord compression, mild although improved cord impingement, and a faint T2/STIR hyperintensity present within the cord at C6-7 and possibly C3-4. Prior to discharge to PM&amp;R, her lower extremity neurologic function returned to baseline but continued to exhibit significant upper extremity motor dysfunction, right worse than left. Discussion: White cord syndrome is an extremely rare condition causing a rapid neurological decline following surgical decompression of a chronically compressed and ischemic spinal cord, with very few cases reported in the literature. It is classically defined by intramedullary hyperintense signal sequences on T2-weighted magnetic resonance imaging in a patient without other pathologic changes following spinal decompressive surgery. 1 The exact mechanism is unclear, but the main hypothesis describes an ischemia-reperfusion <span class="hit">injury</span> with disruption of the blood-spinal cord barrier leading to oxidative stress and <span class="hit">neuronal</span> apoptosis. High-dose glucocorticoids are thought to be of benefit for this condition by inhibiting the free oxygen radical damage. Riluzole, a benzothiazole anticonvulsant, may also have a role, has shown promising results via inhibition of glutaminergic transmission and diminishing neurological tissue destruction.2 Although rare, white cord syndrome should be included in the preoperative discussion between surgeon and patient prior to spinal surgery as this can be a devastating consequence. (Table Presented).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L636044055" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L636044055" type="checkbox" id="record_checkbox_L636044055"><label for="record_checkbox_L636044055" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">48</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=48&amp;page=1&amp;id=L636044055" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Hyperthermia-Induced Changes in EEG of Anesthetized Mice Subjected to Passive Heat Exposure</a><br><span class="author fn notranslate"><span class="family-name notranslate">de Labra</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pardo-Vazquez</span> <span class="given-name notranslate">J.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cudeiro</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rivadulla</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Frontiers in Systems Neuroscience</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">15</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 709337</span>&nbsp;<span class="cited-by" id="CTB-L636044055"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-48"><a href="https://www.embase.com/#" class="showAbstract" data="48" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="48"></i> Abstract</a></li><li class="ui-tab" id="indexTab-48"><a href="https://www.embase.com/#" class="showIndexTerms" data="48" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="48"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3389/fnsys.2021.709337" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="47">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-47"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Currently, the role of hypothermia in electroencephalography (EEG) is well-established. However, few studies have investigated the effect of hyperthermia on EEG, an important physiological parameter governing brain function. The aim of this work was to determine how <span class="hit">neuronal</span> activity in anesthetized mice is affected when the temperature rises above the physiological threshold mandatory to maintain the normal body functions. In this study, a temperature-elevation protocol, from 37 to 42°C, was applied to four female mice of 2–3 months old while EEG was recorded simultaneously. We found that hyperthermia reduces EEG amplitude by 4.36% when rising from 37 to 38 degrees and by 24.33% when it is increased to 42 degrees. Likewise, increasing the body temperature produces a very large impact on the EEG spectral parameters, reducing the frequency power at the delta, theta, alpha, and beta bands. Our results show that hyperthermia has a global effect on the EEG, being able to change the electrical activity of the brain.</p><p class="hitsHighlighted">© Copyright © 2021 de Labra, Pardo-Vazquez, Cudeiro and Rivadulla.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2013074356" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2013074356" type="checkbox" id="record_checkbox_L2013074356"><label for="record_checkbox_L2013074356" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">49</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=49&amp;page=1&amp;id=L2013074356" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroprotection of <span class="hit">sevoflurane</span> against ischemia/reperfusion-induced brain <span class="hit">injury</span> through inhibiting GluN2A/GluN2B-PSD-95-MLK3 module</a><br><span class="author fn notranslate"><span class="family-name notranslate">Jin</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bo</span> <span class="given-name notranslate">X.M.</span></span><br><span class="journal-title">Experimental Brain Research</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">239</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(2701-2709)</span>&nbsp;<span class="cited-by" id="CTB-L2013074356"><a href="https://lls.reaxys.com/redir?pid=scp:85109294387" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-49"><a href="https://www.embase.com/#" class="showAbstract" data="49" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="49"></i> Abstract</a></li><li class="ui-tab" id="indexTab-49"><a href="https://www.embase.com/#" class="showIndexTerms" data="49" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="49"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s00221-021-06157-x" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="48">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-48"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">To investigate the role of GluN2A and GluN2B in neuroprotective effect of sevoflurane preconditioning against cerebral ischemia–reperfusion injury (CIRI). Rats were randomly divided into five groups as follows: control, ischemia–reperfusion (I/R) 6&nbsp;h, sevoflurane preconditioning (SP), SP + amantadine, SP + NMDA. Immunoblot and immunoprecipitation were used to detect the tyrosine phosphorylation of GluN2A/GluN2B, the interaction of GluN2A/GluN2B-PSD-95-MLK3 and the expression of phosphorylation of MLK3, MKK7 and JNK3. Cresyl violet staining was employed to analyse neuronal injury in rat hippocampal CA1 subfields. Sevoflurane preconditioning inhibits the tyrosine phosphorylation of GluN2A/GluN2B, the interaction of GluN2A/GluN2B-PSD-95-MLK3 and the phosphorylation of MLK3, MKK7 and JNK3 in rat hippocampus. An N-methyl-d-aspartate receptor (NMDAR) antagonist amantadine reversed the MLK3-MKK7- JNK3 signal events. Such reversion was also realized by NMDA (60 and 80&nbsp;nmol) and low doses of NMDA (0–40&nbsp;nmol) could not change the inhibitory effect of sevoflurane preconditioning on MLK3-MKK7-JNK3 signal events. Finally, Cresyl violet staining also confirmed that low dose of NMDA reduced neuronal loss in rat hippocampal CA1 subfields. Sevoflurane preconditioning provides neuroprotection against CIRI by inhibiting NMDAR over-activation.</p><p class="hitsHighlighted">© 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L635745626" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L635745626" type="checkbox" id="record_checkbox_L635745626"><label for="record_checkbox_L635745626" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">50</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=50&amp;page=1&amp;id=L635745626" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> Inhibits Traumatic Brain <span class="hit">Injury</span>-Induced Neuron Apoptosis via EZH2-Downregulated KLF4/p38 Axis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yuan</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wei</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xing</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xing</span> <span class="given-name notranslate">N.</span></span><br><span class="journal-title">Frontiers in Cell and Developmental Biology</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">9</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 658720</span>&nbsp;<span class="cited-by" id="CTB-L635745626"><a href="https://lls.reaxys.com/redir?pid=scp:85113161642" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-50"><a href="https://www.embase.com/#" class="showAbstract" data="50" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="50"></i> Abstract</a></li><li class="ui-tab" id="indexTab-50"><a href="https://www.embase.com/#" class="showIndexTerms" data="50" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="50"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3389/fcell.2021.658720" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="49">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-49"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Traumatic brain <span class="hit">injury</span> (TBI) is characterized by physical damage to the brain tissues, ensuing transitory or permanent neurological dysfunction featured with <span class="hit">neuronal</span> loss and subsequent brain damage. <span class="hit">Sevoflurane</span>, a widely used halogenated anesthetic in clinical settings, has been reported to alleviate neuron apoptosis in TBI. Nevertheless, the underlying mechanism behind this alleviation remains unknown, and thus was the focus of the current study. First, Feeney models were established to induce TBI in rats. Subsequently, evaluation of the modified neurological severity scores, measurement of brain water content, Nissl staining, and TUNEL assay were employed to investigate the neuroprotective effects of <span class="hit">sevoflurane</span>. Immunofluorescence and Western blot analysis were further applied to detect the expression patterns of apoptosis-related proteins as well as the activation of the p38-mitogen-activated protein kinase (MAPK) signaling pathway within the lesioned cortex. Additionally, a stretch <span class="hit">injury</span> model comprising cultured neurons was established, followed by neuron-specific enolase staining and Sholl analysis. Mechanistic analyses were performed using dual-luciferase reporter gene and chromatin immunoprecipitation assays. The results demonstrated <span class="hit">sevoflurane</span> treatment brought about a decrease blood-brain barrier (BBB) permeability, brain water content, brain <span class="hit">injury</span> and neuron apoptosis, to improve neurological function. The neuroprotective action of <span class="hit">sevoflurane</span> could be attenuated by inactivation of the p38-MAPK signaling pathway. Mechanistically, <span class="hit">sevoflurane</span> exerted an inhibitory effect on neuron apoptosis by up-regulating enhancer of zeste homolog 2 (EZH2), which targeted Krüppel-like factor 4 (KLF4) and inhibited KLF4 transcription. Collectively, our findings indicate that <span class="hit">sevoflurane</span> suppresses neuron apoptosis induced by TBI through activation of the p38-MAPK signaling pathway via the EZH2/KLF4 axis, providing a novel mechanistic explanation for neuroprotection of <span class="hit">sevoflurane</span> in TBI.</p><p class="hitsHighlighted">© Copyright © 2021 Wang, Li, Wang, Wang, Wang, Yuan, Wei, Xing, Zhang and Xing.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2013270152" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2013270152" type="checkbox" id="record_checkbox_L2013270152"><label for="record_checkbox_L2013270152" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">51</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=51&amp;page=1&amp;id=L2013270152" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Participation of Mind Bomb-2 in <span class="hit">Sevoflurane</span> Anesthesia Induces Cognitive Impairment in Aged Mice via Modulating Ferroptosis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gong</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tuerhong</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xia</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">ACS Chemical Neuroscience</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">12</span><span class="journal-issue">:13</span><span class="journal-pages">&nbsp;(2399-2408)</span>&nbsp;<span class="cited-by" id="CTB-L2013270152"><a href="https://lls.reaxys.com/redir?pid=scp:85108599525" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;7</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-51"><a href="https://www.embase.com/#" class="showAbstract" data="51" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="51"></i> Abstract</a></li><li class="ui-tab" id="indexTab-51"><a href="https://www.embase.com/#" class="showIndexTerms" data="51" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="51"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1021/acschemneuro.1c00131" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="50">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-50"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Postoperative cognitive dysfunction (POCD) is a complication of the central nervous system (CNS) often occurred after surgery or anesthesia in the elder patients. Mind bomb-2 (MIB2) has been reported to modulate <span class="hit">neuronal</span> functions. Here, we aimed to study whether MIB2 exerts roles in the effects of <span class="hit">sevoflurane</span> anesthesia on mice hippocampal neurons and function, and how. Aging male C57BL/6 mice were subjected to <span class="hit">sevoflurane</span> administration, and primary hippocampal neurons were adopted to study <span class="hit">sevoflurane</span> effects in vitro. Western blotting and immunohistochemistry assay were used to study the protein expression of MIB2. CCK-8 assay and propidium iodide (PI) staining were performed to evaluate cell viability and cell death, respectively. Ferroptosis-related indicators malondialdehyde (MDA), glutathione (GSH), and iron levels were checked through indicated ELISA kits. Co-immunoprecipitation was adopted to study the binding effects of MIB2 to GPX4. We found that <span class="hit">sevoflurane</span> anesthesia increased MIB2 expression in mice hippocampus tissues and neurons. Knockdown of MIB2 alleviated neuron death and ferroptosis induced by <span class="hit">sevoflurane</span> exposure. Downregulated MIB2 enhanced GPX4 stability and reduced its ubiquitination. MIB2 was verified to bind to GPX4. The effects of MIB2 knockdown on the neuron death and ferroptosis can be reversed by further siGPX4 transfection. In vivo results also showed that MIB2 knockdown reduced hippocampal neuron death, ferroptosis, and cognitive impairments in the <span class="hit">sevoflurane</span>-exposed mice. Taking all together, downregulation of MIB2 could alleviate the <span class="hit">sevoflurane</span>-anesthesia-induced cognitive dysfunction and neuron <span class="hit">injury</span> through reducing ferroptosis via GPX4. Our results also provide novel directions for POCD treatment using anti-MIB2-related drugs or strategies.</p><p class="hitsHighlighted">© 2021 American Chemical Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2012011798" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2012011798" type="checkbox" id="record_checkbox_L2012011798"><label for="record_checkbox_L2012011798" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">52</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=52&amp;page=1&amp;id=L2012011798" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Circulating brain <span class="hit">injury</span> biomarkers increase after endoscopic surgery for pituitary tumors</a><br><span class="author fn notranslate"><span class="family-name notranslate">Hallén</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Olsson</span> <span class="given-name notranslate">D.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hammarstrand</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Farahmand</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Olofsson</span> <span class="given-name notranslate">A.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jakobsson Ung</span> <span class="given-name notranslate">E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jakobsson</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bergquist</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Blennow</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zetterberg</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Johannsson</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Skoglund</span> <span class="given-name notranslate">T.</span></span><br><span class="journal-title">Journal of Clinical Neuroscience</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">89</span><span class="journal-pages">&nbsp;(113-121)</span>&nbsp;<span class="cited-by" id="CTB-L2012011798"><a href="https://lls.reaxys.com/redir?pid=scp:85105707057" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-52"><a href="https://www.embase.com/#" class="showAbstract" data="52" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="52"></i> Abstract</a></li><li class="ui-tab" id="indexTab-52"><a href="https://www.embase.com/#" class="showIndexTerms" data="52" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="52"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.jocn.2021.04.030" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="51">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-51"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Pituitary tumors and subsequent treatment with endoscopic transsphenoidal surgery (ETSS) may cause <span class="hit">injury</span> to suprasellar structures, causing long-term fatigue and neurocognitive impairment. A method to quantify brain <span class="hit">injury</span> after ETSS is not available. In this prospective, exploratory study of patients undergoing ETSS for pituitary tumors, a novel approach to detect possible <span class="hit">neuronal</span> damage is presented. Plasma concentrations of brain <span class="hit">injury</span> biomarkers (glial fibrillary acidic protein [GFAP], tau, and neurofilament light [NFL]) were measured the day before surgery, immediately after surgery, at day 1 and 5, and at 6 and 12 months after surgery, using enzyme-linked immunosorbent assays. The association between the increase of biomarkers with preoperative tumor extension and postoperative patient-perceived fatigue was evaluated. Suprasellar tumor extension was assessed from MRI scans, and self-perceived fatigue was assessed using the Multidimensional Fatigue Inventory before and 6 months after surgery. Thirty-five patients were included in the analysis. Compared to baseline, GFAP showed a maximal increase at day 1 after surgery (p = 0.0005), tau peaked postoperatively on the day of surgery (p = 0.019), and NFL reached its maximum at day 5 after surgery (p &lt; 0.0001). The increase in GFAP correlated with preoperative chiasmal compression (p = 0.020). The increase in tau was correlated with preoperative chiasmal (p = 0.011) and hypothalamus compression (p = 0.016), and fatigue score 6 months after surgery (p = 0.016). In conclusion, the concentrations of brain <span class="hit">injury</span> biomarkers in blood increased after ETSS for pituitary tumors. The results indicate that postoperative plasma GFAP and tau might reflect astroglial and <span class="hit">neuronal</span> damage after ETSS.</p><p class="hitsHighlighted">© 2021 The Author(s)</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2012039215" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2012039215" type="checkbox" id="record_checkbox_L2012039215"><label for="record_checkbox_L2012039215" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">53</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=53&amp;page=1&amp;id=L2012039215" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">lncRNA Xist regulates <span class="hit">sevoflurane</span>-induced social and emotional impairment by modulating miR-98-5p/EDEM1 signaling axis in neonatal mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dai</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiao</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xie</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">Molecular Therapy - Nucleic Acids</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">24</span><span class="journal-pages">&nbsp;(939-950)</span>&nbsp;<span class="cited-by" id="CTB-L2012039215"><a href="https://lls.reaxys.com/redir?pid=scp:85105811935" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-53"><a href="https://www.embase.com/#" class="showAbstract" data="53" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="53"></i> Abstract</a></li><li class="ui-tab" id="indexTab-53"><a href="https://www.embase.com/#" class="showIndexTerms" data="53" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="53"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.omtn.2021.04.010" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="52">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-52"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Long non-coding RNA (lncRNA) X-inactive specific transcript (Xist) is involved in apoptosis and inflammatory <span class="hit">injury</span>. This study aimed to assess the role of lncRNA Xist in <span class="hit">sevoflurane</span>-induced social and emotional impairment and <span class="hit">neuronal</span> apoptosis in neonatal mice and hippocampal <span class="hit">neuronal</span> cells. The performance in social and emotional tests and the expression levels of lncRNA Xist and microRNA (miR)-98-5p after <span class="hit">sevoflurane</span> exposure were measured. Moreover, the effects of suppression of lncRNA Xist on <span class="hit">neuronal</span> apoptosis and endoplasmic reticulum (ER) stress were determined. Subsequently, the association among lncRNA Xist, miR-98-5p, and ER degradation-enhancing α-mannosidase-like 1 protein (EDEM1) was explored. Our results showed that lncRNA Xist increased, miR-98-5p decreased, and social and emotional impairment appeared after <span class="hit">sevoflurane</span> exposure. Furthermore, suppression of lncRNA Xist improved <span class="hit">sevoflurane</span>-induced social and emotional impairment and reduced <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis and ER stress in vivo and in vitro. Moreover, lncRNA Xist negatively regulated miR-98-5p expression, and it contributed to <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis and ER stress by sponging miR-98-5p. Additionally, EDEM1 was identified as a target of miR-98-5p. Our findings revealed that the knockdown of lncRNA Xist ameliorates <span class="hit">sevoflurane</span>-induced social and emotional impairment through inhibiting <span class="hit">neuronal</span> apoptosis and ER stress by targeting the miR-98-5p/EDEM1 axis.</p><p class="hitsHighlighted">© 2021 The Author(s)</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2011631699" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2011631699" type="checkbox" id="record_checkbox_L2011631699"><label for="record_checkbox_L2011631699" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">54</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=54&amp;page=1&amp;id=L2011631699" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of general anaesthesia during pregnancy on neurocognitive development of the fetus: a systematic review and meta-analysis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Bleeser</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Van Der Veeken</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fieuws</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Devroe</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Van de Velde</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Deprest</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rex</span> <span class="given-name notranslate">S.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">126</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(1128-1140)</span>&nbsp;<span class="cited-by" id="CTB-L2011631699"><a href="https://lls.reaxys.com/redir?pid=scp:85103943403" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;4</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-54"><a href="https://www.embase.com/#" class="showAbstract" data="54" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="54"></i> Abstract</a></li><li class="ui-tab" id="indexTab-54"><a href="https://www.embase.com/#" class="showIndexTerms" data="54" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="54"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bja.2021.02.026" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="53">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-53"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: The US Food and Drug Administration warned that exposure of pregnant women to general anaesthetics may impair fetal brain development. This review systematically evaluates the evidence underlying this warning. Methods: PubMed, EMBASE, and Web of Science were searched from inception until April 3, 2020. Preclinical and clinical studies were eligible. Exclusion criteria included case reports, in vitro models, chronic exposures, and exposure only during delivery. Meta-analyses were performed on standardised mean differences. The primary outcome was overall effect on learning/memory. Secondary outcomes included markers of <span class="hit">neuronal injury</span> (apoptosis, synapse formation, neurone density, and proliferation) and subgroup analyses. Results: There were 65 preclinical studies included, whereas no clinical studies could be identified. Anaesthesia during pregnancy impaired learning and memory (standardised mean difference −1.16, 95% confidence interval −1.46 to −0.85) and resulted in <span class="hit">neuronal injury</span> in all experimental models, irrespective of the anaesthetic drugs and timing in pregnancy. Risk of bias was high in most studies. Rodents were the most frequently used animal species, although their brain development differs significantly from that in humans. In a minority of studies, anaesthesia was combined with surgery. Monitoring and strict control of physiological homeostasis were below preclinical and clinical standards in many studies. The duration and frequency of exposure and anaesthetic doses were often much higher than in clinical routine. Conclusion: Anaesthesia-induced neurotoxicity during pregnancy is a consistent finding in preclinical studies, but translation of these results to the clinical situation is limited by several factors. Clinical observational studies are needed. Prospero registration number: CRD42018115194</p><p class="hitsHighlighted">© 2021 British Journal of Anaesthesia</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2012368628" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2012368628" type="checkbox" id="record_checkbox_L2012368628"><label for="record_checkbox_L2012368628" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">55</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=55&amp;page=1&amp;id=L2012368628" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Regulation of glial cell-derived neurotrophic factor in <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis by long non-coding RNA CDKN2B-AS1 as a ceRNA to adsorb miR-133</a><br><span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">American Journal of Translational Research</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">13</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(4760-4770)</span>&nbsp;<span class="cited-by" id="CTB-L2012368628"><a href="https://lls.reaxys.com/redir?pid=scp:85107030692" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-55"><a href="https://www.embase.com/#" class="showAbstract" data="55" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="55"></i> Abstract</a></li><li class="ui-tab" id="indexTab-55"><a href="https://www.embase.com/#" class="showIndexTerms" data="55" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="55"></i> Index Terms</a></li><li><span id="FTL-L2012368628" class="fulltext" data="{&quot;recno&quot;:&quot;L2012368628&quot;,&quot;issn&quot;:&quot;19438141&quot;,&quot;volume&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;startpage&quot;:&quot;4760&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="54">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-54"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: To investigate the regulatory mechanism of <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis through analyzing the expression of glial cell-derived neurotrophic factor (GDNF) mediated by miR-133, sponged by long non-coding RNA (lncRNA) CDKN2B-AS1. Methods: An in vitro cell <span class="hit">injury</span> model was established by using different concentrations of <span class="hit">sevoflurane</span> and primary hippocampal neurons. Cell proliferation was detected by Cell Counting Kit-8 (CCK-8); caspase-3 and caspase-9 activities were detected by colorimetry, and apoptotic cells were determined by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Fluorescence in situ hybridization (FISH) analysis was used to detect localized expression of CDKN2B antisense RNA 1 (CDKN2B-AS1), and dual-luciferase reporter assay was employed to verify the correlation of CDKN2B-AS1 and miR-133, and of miR-133 and GDNF. The expression of CDKN2B-AS1, miR-133, and GDNF mRNA in the cell <span class="hit">injury</span> model were measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Western blot was utilized to detect the expression of GDNF protein in the cell <span class="hit">injury</span> model. Results: In the cell <span class="hit">injury</span> model, CDKN2B-AS1 was highly expressed in the cytoplasm, and CDKN2B-AS1 and GDNF were downregulated and miR-133 was upregulated as detected by qRT-PCR (all P&lt;0.05). The connections between CDKN2B-AS1 and miR-133, and between miR-133 and GDNF were confirmed. That is, CDKN2B-AS1 regulated the expression of GDNF by adsorbing miR-133 (all P&lt;0.05). In cells treated with <span class="hit">sevoflurane</span>, overexpression of CDKN2B-AS1 could inhibit caspase-3 and caspase-9 activities and the degree of apoptosis. miR-133 could partially alleviate the effect of overexpressing CDKN2B-AS1 on cells, and si-GDNF the effect of miR-133 inhibitor (all P&lt;0.05). Conclusion: lncRNA CDKN2B-AS1 can up-regulate the expression of GDNF, inhibit <span class="hit">neuronal</span> apoptosis, and ease the toxic effect of <span class="hit">sevoflurane</span> on neural cells by acting as a sponge to adsorb miR-133.</p><p class="hitsHighlighted">© 2021 E-Century Publishing Corporation. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2010549576" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2010549576" type="checkbox" id="record_checkbox_L2010549576"><label for="record_checkbox_L2010549576" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">56</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=56&amp;page=1&amp;id=L2010549576" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">LncRNA Rian ameliorates <span class="hit">sevoflurane</span> anesthesia-induced cognitive dysfunction through regulation of miR-143-3p/LIMK1 axis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shao</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Human Cell</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">34</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(808-818)</span>&nbsp;<span class="cited-by" id="CTB-L2010549576"><a href="https://lls.reaxys.com/redir?pid=scp:85101676143" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-56"><a href="https://www.embase.com/#" class="showAbstract" data="56" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="56"></i> Abstract</a></li><li class="ui-tab" id="indexTab-56"><a href="https://www.embase.com/#" class="showIndexTerms" data="56" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="56"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s13577-021-00502-6" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="55">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-55"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> could stimulate neurotoxicity and result in postoperative cognitive dysfunction (POCD). Long non-coding RNAs (lncRNAs) have been implicated in the regulation of nervous system disease. This study was performed to investigate role and mechanism of lncRNA Rian (RNA imprinted and accumulated in nucleus) in <span class="hit">sevoflurane</span> anesthesia-induced cognitive dysfunction. Mice post-<span class="hit">sevoflurane</span> anesthesia showed cognitive impairments and <span class="hit">neuronal</span> damage and apoptosis. However, intracerebroventricularly injection with Adenovirus (Ad) for the over-expression of Rian ameliorated <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> damage and apoptosis. Cognitive impairments induced by <span class="hit">sevoflurane</span> were attenuated by injection with Ad-Rian. Moreover, transfection with Ad-Rian also protected isolated primary hippocampal neurons against <span class="hit">sevoflurane</span>-induced decrease of cell viability and increase of lactic acid dehydrogenase (LDH) and apoptosis. Mechanistically, Rian bind to miR-143-3p, and decreased expression of LIMK1 (Lim kinase 1) through negative regulation of miR-143-3p. Knockdown of LIMK1 aggravated <span class="hit">sevoflurane</span>-induced decrease of cell viability and increase of LDH and apoptosis in neurons, while over-expression attenuated LIMK1 silence-induced <span class="hit">neuronal</span> damage post-<span class="hit">sevoflurane</span> anesthesia. In conclusion, Rian demonstrated neuroprotective effects against <span class="hit">sevoflurane</span> anesthesia-induced cognitive dysfunction through regulation of miR-143-3p/LIMK1 axis, providing promising target for <span class="hit">sevoflurane</span> anesthesia-induced cognitive dysfunction.</p><p class="hitsHighlighted">© 2021, Japan Human Cell Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2011343001" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2011343001" type="checkbox" id="record_checkbox_L2011343001"><label for="record_checkbox_L2011343001" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">57</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=57&amp;page=1&amp;id=L2011343001" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effect of dexmedetomidine on <span class="hit">sevoflurane</span>-induced neurodegeneration in neonatal rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">J.-R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Joseph</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hofacer</span> <span class="given-name notranslate">R.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Upton</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">S.Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ewing</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Danzer</span> <span class="given-name notranslate">S.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Loepke</span> <span class="given-name notranslate">A.W.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">126</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(1009-1021)</span>&nbsp;<span class="cited-by" id="CTB-L2011343001"><a href="https://lls.reaxys.com/redir?pid=scp:85102439955" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;4</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-57"><a href="https://www.embase.com/#" class="showAbstract" data="57" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="57"></i> Abstract</a></li><li class="ui-tab" id="indexTab-57"><a href="https://www.embase.com/#" class="showIndexTerms" data="57" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="57"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bja.2021.01.033" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="56">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-56"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Structural brain abnormalities in newborn animals after prolonged exposure to all routinely used general anaesthetics have raised substantial concerns for similar effects occurring in millions of children undergoing surgeries annually. Combining a general anaesthetic with non-injurious sedatives may provide a safer anaesthetic technique. We tested dexmedetomidine as a mitigating therapy in a <span class="hit">sevoflurane</span> dose-sparing approach. Methods: Neonatal rats were randomised to 6 h of <span class="hit">sevoflurane</span> 2.5%, <span class="hit">sevoflurane</span> 1% with or without three injections of dexmedetomidine every 2 h (resulting in 2.5, 5, 10, 25, 37.5, or 50 μg kg<sup>−1</sup> h<sup>−1</sup>), or fasting in room air. Heart rate, oxygen saturation, level of hypnosis, and response to pain were measured during exposure. <span class="hit">Neuronal</span> cell death was quantified histologically after exposure. Results: <span class="hit">Sevoflurane</span> at 2.5% was more injurious than at 1% in the hippocampal cornu ammonis (CA)1 and CA2/3 subfields; ventral posterior and lateral dorsal thalamic nuclei; prefrontal, retrosplenial, and somatosensory cortices; and subiculum. Although <span class="hit">sevoflurane</span> 1% did not provide complete anaesthesia, supplementation with dexmedetomidine dose dependently increased depth of anaesthesia and diminished responses to pain. The combination of <span class="hit">sevoflurane</span> 1% and dexmedetomidine did not reliably reduce <span class="hit">neuronal</span> apoptosis relative to an equianaesthetic dose of <span class="hit">sevoflurane</span> 2.5%. Conclusions: A sub-anaesthetic dose of <span class="hit">sevoflurane</span> combined with dexmedetomidine achieved a level of anaesthesia comparable with that of <span class="hit">sevoflurane</span> 2.5%. Similar levels of anaesthesia caused comparable programmed cell death in several developing brain regions. Depth of anaesthesia may be an important factor when comparing the neurotoxic effects of different anaesthetic regimens.</p><p class="hitsHighlighted">© 2021 British Journal of Anaesthesia</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2011472932" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2011472932" type="checkbox" id="record_checkbox_L2011472932"><label for="record_checkbox_L2011472932" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">58</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=58&amp;page=1&amp;id=L2011472932" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Androgen is responsible for enhanced susceptibility of melatonin against traumatic brain <span class="hit">injury</span> in females</a><br><span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">S.-S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xie</span> <span class="given-name notranslate">L.-L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Z.-Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fan</span> <span class="given-name notranslate">Y.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qi</span> <span class="given-name notranslate">M.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xi</span> <span class="given-name notranslate">Y.-G.</span></span><br><span class="journal-title">Neuroscience Letters</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">752</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 135842</span>&nbsp;<span class="cited-by" id="CTB-L2011472932"><a href="https://lls.reaxys.com/redir?pid=scp:85103310944" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;3</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-58"><a href="https://www.embase.com/#" class="showAbstract" data="58" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="58"></i> Abstract</a></li><li class="ui-tab" id="indexTab-58"><a href="https://www.embase.com/#" class="showIndexTerms" data="58" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="58"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.neulet.2021.135842" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="57">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-57"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Numerous publications have demonstrated that melatonin administration is associated with mortality reduction and improvement in neurological outcomes after traumatic brain <span class="hit">injury</span> (TBI). However, there are significant sex differences in several diseases associated with melatonin. We aimed to determine whether androgen was responsible for enhanced susceptibility of melatonin against TBI in females, as well as potential molecular mechanisms. Methods: Weight-drop was used to establish a rodent model of TBI. Melatonin (10 mg/kg) and testosterone (1 mg/kg) were administered three times every day for three days after TBI using subcutaneous injection, respectively. Seven days after TBI, an open field assay was used to evaluate locomotor and exploratory activities. <span class="hit">Neuronal</span> amount, <span class="hit">neuronal</span> apoptosis, and expression of phosphorylated extracellularly regulated protein kinases 1/2 (ERK1/2), c-jun N-terminal kinase 1/2 (JNK1/2), and p38 mitogen-activated protein kinase (p38MAPK) in neurons were assessed using immunofluorescence assay seven days after TBI. The expression of caspase-3, Bax, and Bcl-2 in the frontal cortex was detected using western blot. Results: Compared with female rats, melatonin administration exhibited more neuroprotective effects (including improved locomotor and exploratory activities, elevated <span class="hit">neuronal</span> amount, and reduced <span class="hit">neuronal</span> apoptosis) in male rats exposed to TBI. Moreover, testosterone significantly improved locomotor and exploratory activities, elevated <span class="hit">neuronal</span> amount, decreased <span class="hit">neuronal</span> apoptosis, downregulated phosphorylation of JNK1/2- and p38MAPK-positive neurons, but upregulated phosphorylation of ERK1/2-positive neurons in the frontal cortex, and reduced the expressions of cleaved caspase-3, Bax, but increased Bcl-2 expressions in female rats exposed to TBI. Conclusions: Androgen was responsible for the enhanced susceptibility to TBI under melatonin supplementation in females through a mechanism that may be associated with MAPK pathway regulation.</p><p class="hitsHighlighted">© 2021 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2011091619" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2011091619" type="checkbox" id="record_checkbox_L2011091619"><label for="record_checkbox_L2011091619" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">59</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=59&amp;page=1&amp;id=L2011091619" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Analysis of the proportion and <span class="hit">neuronal</span> activity of excitatory and inhibitory neurons in the rat dorsal spinal cord after peripheral nerve <span class="hit">injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Motojima</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ueta</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sakai</span> <span class="given-name notranslate">A.</span></span><br><span class="journal-title">Neuroscience Letters</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">749</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 135707</span>&nbsp;<span class="cited-by" id="CTB-L2011091619"><a href="https://lls.reaxys.com/redir?pid=scp:85101370607" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;3</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-59"><a href="https://www.embase.com/#" class="showAbstract" data="59" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="59"></i> Abstract</a></li><li class="ui-tab" id="indexTab-59"><a href="https://www.embase.com/#" class="showIndexTerms" data="59" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="59"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.neulet.2021.135707" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="58">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-58"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The dorsal spinal cord contains projection neurons that transmit somatosensory information to the brain and interneurons which then modulate <span class="hit">neuronal</span> activity of these projection neurons and/or other interneurons. Interneurons can be subdivided into two groups: excitatory and inhibitory neurons. While inhibitory interneurons are thought to play a crucial role in analgesia, it is unclear whether they are involved in neuropathic pain. In the present study, we aimed to assess the proportion and <span class="hit">neuronal</span> activity of excitatory/inhibitory neurons in the dorsal spinal cord using a neuropathic pain model in rats. Following partial sciatic nerve ligation (PSNL), rats showed significant mechanical hyperalgesia, and subsequent immunohistochemical studies were conducted in laminae I–III of the dorsal spinal cord. We found that the number of FosB-immunoreactive cells was significantly higher; there was no change in the percentage of Pax2 positive/negative neurons in NeuN positive neurons; Pax2 negative neurons, but not Pax2 positive neurons, were predominantly activated in PSNL rats; and the immunofluorescence intensity of the calcium channel α2δ1 subunit was significantly higher. These results indicate that while peripheral nerve <span class="hit">injury</span> might not affect the proportion of excitatory and inhibitory neurons, it predominantly activates excitatory neurons in laminae I–III of the rat dorsal spinal cord.</p><p class="hitsHighlighted">© 2021 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2011159528" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2011159528" type="checkbox" id="record_checkbox_L2011159528"><label for="record_checkbox_L2011159528" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">60</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=60&amp;page=1&amp;id=L2011159528" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> alleviates oxygen-glucose deprivation/reoxygenation-induced <span class="hit">injury</span> in HT22 cells through regulation of the PI3K/AKT/GSK3β signaling pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dai</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zha</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">Experimental and Therapeutic Medicine</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">21</span><span class="journal-issue">:4</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 9807</span>&nbsp;<span class="cited-by" id="CTB-L2011159528"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-60"><a href="https://www.embase.com/#" class="showAbstract" data="60" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="60"></i> Abstract</a></li><li class="ui-tab" id="indexTab-60"><a href="https://www.embase.com/#" class="showIndexTerms" data="60" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="60"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/etm.2021.9807" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="59">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-59"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> (Sev), a volatile anesthetic, has been reported to exhibit beneficial effects on different ischemia/reperfusion (I/R)-injured organs. However, the neuroprotective effect of Sev on cerebral I/R <span class="hit">injury</span> is poorly understood. In the present study, the effects of Sev on HT22 cells exposed to oxygen-glucose deprivation/reperfusion (OGD/R) <span class="hit">injury</span> are investigated. The present study demonstrated that OGD/R suppressed the cell viability and increased lactate dehydrogenase (LDH) release from the cells, and these effects were attenuated by Sev treatment. The results also demonstrated that Sev alleviated OGD/R-induced cell apoptosis via flow cytometry and caspase-3 activity determination. Biochemical analysis results revealed that Sev significantly protected against OGD/R-induced oxidative stress by reducing ROS generation and improving antioxidant defense markers. Western blot analysis demonstrated that Sev reactivated the PI3K/AKT/glycogen synthase kinase-3β (GSK3β) signaling pathway, which was inhibited by OGD/R. In addition, wortmannin, a selective PI3K inhibitor was used to investigate the underlying pathways. Notably, the neuroprotective effect of Sev on apoptosis and reactive oxygen species production was found to be suppressed by wortmannin. Collectively, these results demonstrated that Sev may protect <span class="hit">neuronal</span> cells against OGD/R-induced <span class="hit">injury</span> through the activation of the PI3K/AKT/GSK3β signaling pathway. The findings from the present study provide a novel insight into understanding the neuroprotective effect of Sev on cerebral I/R <span class="hit">injury</span>.</p><p class="hitsHighlighted">© 2021 Spandidos Publications. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L629660243" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L629660243" type="checkbox" id="record_checkbox_L629660243"><label for="record_checkbox_L629660243" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">61</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=61&amp;page=1&amp;id=L629660243" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effect of General Anesthetics on Caspase-3 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage: A Preliminary Study</a><br><span class="author fn notranslate"><span class="family-name notranslate">Balasubramanian</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kuberan</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rawat</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dhandapani</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Panda</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kumar</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sahoo</span> <span class="given-name notranslate">A.K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kumar</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sharma</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Garcia</span> <span class="given-name notranslate">P.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bhagat</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Journal of Neurosurgical Anesthesiology</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">33</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(172-176)</span>&nbsp;<span class="cited-by" id="CTB-L629660243"><a href="https://lls.reaxys.com/redir?pid=scp:85073760501" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;3</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-61"><a href="https://www.embase.com/#" class="showAbstract" data="61" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="61"></i> Abstract</a></li><li class="ui-tab" id="indexTab-61"><a href="https://www.embase.com/#" class="showIndexTerms" data="61" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="61"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ANA.0000000000000648" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="60">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-60"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: General anesthesia has been associated with <span class="hit">neuronal</span> apoptosis and activation of caspases. Apoptosis is a crucial factor in early brain <span class="hit">injury</span> following aneurysmal subarachnoid hemorrhage (aSAH). We conducted a double-blind, prospective, randomized pilot study to evaluate the effect of 4 anesthetic agents on cerebrospinal fluid (CSF) and serum caspase-3 levels in aSAH patients. Materials and Methods: A total of 44 good-grade aSAH patients with preoperative lumbar drain scheduled for surgical clipping or endovascular coiling were randomized to receive maintenance of anesthesia with propofol, isoflurane, <span class="hit">sevoflurane</span>, or desflurane. Caspase-3 levels were measured in CSF and serum samples collected at baseline, 1 hour after induction, and 1 hour after cessation of anesthesia. Results: Compared with baseline, there was a decrease in CSF caspase-3 levels and an increase in serum caspase-3 levels 1 hour after exposure to all 4 anesthetic agents; levels returned to baseline values after cessation of anesthesia. Median CSF caspase-3 levels at baseline, 1 hour after anesthesia exposure, and 1 hour after cessation of anesthesia were 0.0679, 0.0004, and 0.0689 ng/mL, respectively (P&lt;0.05). Median serum caspase-3 levels at baseline, 1 hour after anesthesia exposure, and 1-hour after cessation of anesthesia were 0.0028, 0.0682, and 0.0044 ng/mL, respectively (P&lt;0.05). Conclusions: Propofol, isoflurane, <span class="hit">sevoflurane</span>, or desflurane have similar effects on CSF and serum caspase-3. The reduction of intraoperative CSF caspase-3 levels suggests a possible role for general anesthesia in neuroresuscitation by slowing the <span class="hit">neuronal</span> apoptotic pathway.</p><p class="hitsHighlighted">© 2021 Lippincott Williams and Wilkins. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2005972124" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2005972124" type="checkbox" id="record_checkbox_L2005972124"><label for="record_checkbox_L2005972124" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">62</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=62&amp;page=1&amp;id=L2005972124" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Changes in plasma glial fibrillary acidic protein in children receiving <span class="hit">sevoflurane</span> anesthesia: A preliminary randomized trial</a><br><span class="author fn notranslate"><span class="family-name notranslate">Kim</span> <span class="given-name notranslate">E.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jang</span> <span class="given-name notranslate">Y.-E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ji</span> <span class="given-name notranslate">S.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">J.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cho</span> <span class="given-name notranslate">S.-A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kim</span> <span class="given-name notranslate">J.-T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yoon</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kim</span> <span class="given-name notranslate">H.-S.</span></span><br><span class="journal-title">Journal of Clinical Medicine</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">10</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(1-8)</span>&nbsp;<span class="journal-artnr">Article Number 662</span>&nbsp;<span class="cited-by" id="CTB-L2005972124"><a href="https://lls.reaxys.com/redir?pid=scp:85114075172" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-62"><a href="https://www.embase.com/#" class="showAbstract" data="62" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="62"></i> Abstract</a></li><li class="ui-tab" id="indexTab-62"><a href="https://www.embase.com/#" class="showIndexTerms" data="62" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="62"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3390/jcm10040662" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="61">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-61"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">We investigated changes in plasma glial fibrillary acidic protein concentration during <span class="hit">sevoflurane</span> anesthesia induction in children &lt; 3 years old and determined the effect of co-administering dexmedetomidine. This preliminary randomized trial included 60 pediatric patients who received <span class="hit">sevoflurane</span> anesthesia for &gt;3 h. Patients were assigned to dexmedetomidine or control groups at a 1:1 ratio. The primary outcome was changes in plasma glial fibrillary acidic protein concentration of dexmedetomidine and control groups over time. Fifty-five patients were included in the final analysis. The median (interquartile range (IQR)) of the plasma glial fibrillary acidic protein level was 387.7 (298.9–510.8) pg·mL<sup>−1</sup> immediately after anesthetic induction, 302.6 (250.9–412.5) pg·mL<sup>−1</sup> at 30 min, and 321.9 (233.8–576.2) pg·mL<sup>−1</sup> at 180 min after the first sample. These values did not change over time (p = 0.759). However, plasma glial fibrillary acidic protein increased after 180 min of infusion of dexmedetomidine compared with values at 30 min infusion (p = 0.04, mean difference and 95% confidence interval of 221.6 and 2.2 to 441.0 pg·mL<sup>−1</sup>). In conclusion, three hours of <span class="hit">sevoflurane</span> anesthesia in pediatric patients &lt; 3 years old did not provoke <span class="hit">neuronal injury</span> assessed by the plasma biomarker. Further studies regarding the effect of prolonged dexmedetomidine infusion on anesthetic <span class="hit">neuronal injury</span> are required.</p><p class="hitsHighlighted">© 2021 by the authors. Licensee MDPI, Basel, Switzerland.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2007699520" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2007699520" type="checkbox" id="record_checkbox_L2007699520"><label for="record_checkbox_L2007699520" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">63</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=63&amp;page=1&amp;id=L2007699520" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Inhibiting PDE7A enhances the protective effects of neural stem cells on neurodegeneration and memory deficits in <span class="hit">sevoflurane</span>-exposed mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">S.</span></span><br><span class="journal-title">eNeuro</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">8</span><span class="journal-issue">:4</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number ENEURO.0071-21.2021</span>&nbsp;<span class="cited-by" id="CTB-L2007699520"><a href="https://lls.reaxys.com/redir?pid=scp:85109096292" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-63"><a href="https://www.embase.com/#" class="showAbstract" data="63" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="63"></i> Abstract</a></li><li class="ui-tab" id="indexTab-63"><a href="https://www.embase.com/#" class="showIndexTerms" data="63" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="63"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1523/ENEURO.0071-21.2021" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="62">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-62"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> is widely used in general anesthesia, especially for children. However, prolonged exposure to <span class="hit">sev-oflurane</span> is reported to be associated with adverse effects on the development of brain in infant monkey. Neural stem cells (NSCs), with potent proliferation, differentiation, and renewing ability, provide an encouraging tool for basic research and clinical therapies for neurodegenerative diseases. We aim to explore the functional effects of injecting NSCs with phosphodiesterase 7A (PDE7A) knock-down in infant mice exposed to <span class="hit">sevoflur-ane</span>. The effects of PDE7A in NSCs proliferation and differentiation were determined by cell counting kit-8 (CCK-8) assay and differentiation-related gene expression assay, respectively. The effects of NSCs with modi-fied PDE7A on mice’s long-term memory and learning ability were assessed by behavioral assays. Our data demonstrated that depleting PDE7A promoted, whereas forcing PDE7A suppressed the activation of cAMP/ cAMP-response element binding protein (CREB) signaling as well as cell proliferation and <span class="hit">neuronal</span> differentiation of NSCs. Inhibition of PDE7A in NSCs exhibited profound improved effects on long-term memory and learning ability of mice exposed to <span class="hit">sevoflurane</span>. Our results for the first time show that knock-down of PDE7A improves the neurogenesis of NSCs in vitro and in vivo, and is beneficial for alleviating <span class="hit">sevoflurane</span>-induced brain damage in infant mice.</p><p class="hitsHighlighted">© 2021 Huang et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2008575871" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2008575871" type="checkbox" id="record_checkbox_L2008575871"><label for="record_checkbox_L2008575871" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">64</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=64&amp;page=1&amp;id=L2008575871" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> increases intracellular calcium to induce mitochondrial <span class="hit">injury</span> and neuroapoptosis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yao</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">D.</span></span><br><span class="journal-title">Toxicology Letters</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">336</span><span class="journal-pages">&nbsp;(11-20)</span>&nbsp;<span class="cited-by" id="CTB-L2008575871"><a href="https://lls.reaxys.com/redir?pid=scp:85096199566" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;15</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-64"><a href="https://www.embase.com/#" class="showAbstract" data="64" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="64"></i> Abstract</a></li><li class="ui-tab" id="indexTab-64"><a href="https://www.embase.com/#" class="showIndexTerms" data="64" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="64"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.toxlet.2020.11.002" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="63">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-63"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> is commonly used in clinical anesthesia. However, some reports indicated that <span class="hit">Sevoflurane</span> could induce mitochondrial <span class="hit">injury</span> and neuroapoptosis. Although the mechanism remains unclear, evidence points to the increase of intracellular calcium after administration of <span class="hit">Sevoflurane</span>. Herein, we sought whether the increment of intracellular Ca<sup>2+</sup> caused by <span class="hit">Sevoflurane</span> administration could induce mitochondrial <span class="hit">injury</span> and apoptosis in primary neurons of the hippocampus. Fluo-4-acetoxymethyl ester Ca<sup>2+</sup> probe was used for measuring intracellular Ca<sup>2+</sup> concentrations. LDH assay, CCK-8 assay, and Western blotting were performed to confirm <span class="hit">Sevoflurane</span>-induced neuroapoptosis. ROS, mPTP, and ATP production were assayed to reveal mitochondrial <span class="hit">injury</span>. Our results indicated that <span class="hit">Sevoflurane</span> increased intracellular Ca<sup>2+</sup> and <span class="hit">neuronal</span> death. <span class="hit">Sevoflurane</span> also elevated ROS and the opening of mPTP, and decreased ATP production in neurons. The expression of cytochrome c, cleaved caspase-9, cleaved caspase-3, and the ratio of Bax/Bcl-2 were also increased. By using calcium channel blocker Nimodipine, the increase of intracellular Ca<sup>2+</sup> was attenuated, and the death rate of neurons, the ROS and opening of mPTP, decreased ATP production, the expressions of cytochrome c, cleaved caspase-9, cleaved caspase-3 and the ratio of Bax/Bcl-2 were alleviated. Our study suggested that <span class="hit">Sevoflurane</span> could increase intracellular Ca<sup>2+</sup> to induce mitochondrial <span class="hit">injury</span> and mitochondria-mediated neuroapoptosis in neurons.</p><p class="hitsHighlighted">© 2020</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2011564013" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2011564013" type="checkbox" id="record_checkbox_L2011564013"><label for="record_checkbox_L2011564013" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">65</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=65&amp;page=1&amp;id=L2011564013" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Post-treatment <span class="hit">sevoflurane</span> protects against hypoxic-ischemic brain <span class="hit">injury</span> in neonatal rats by downregulating histone methyltransferase g9a and upregulating nuclear factor erythroid 2-related factor 2 (NRF2)</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Medical Science Monitor</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">27</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 930042</span>&nbsp;<span class="cited-by" id="CTB-L2011564013"><a href="https://lls.reaxys.com/redir?pid=scp:85103488618" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-65"><a href="https://www.embase.com/#" class="showAbstract" data="65" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="65"></i> Abstract</a></li><li class="ui-tab" id="indexTab-65"><a href="https://www.embase.com/#" class="showIndexTerms" data="65" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="65"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.12659/MSM.930042" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="64">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-64"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Perinatal hypoxia and subsequent reduction of cerebral blood flow leads to neonatal hypoxic-ischemic brain <span class="hit">injury</span> (HIBI), resulting in severe disability and even death. Preconditioning or post-conditioning with <span class="hit">sevoflurane</span> protects against cerebral <span class="hit">injury</span>. This study investigated the mechanism of <span class="hit">sevoflurane</span> in HIBI. Material/Methods: The HIBI model of neonatal rats was established and the model rats were post-treated with <span class="hit">sevoflurane</span>. The oxygen-glucose deprivation (OGD) cell model was established, and the OGD cells were transfected with NRF2-siRNA plasmid and post-treated with <span class="hit">sevoflurane</span>. The Morris water maze test was used to detect the motor activity, spatial learning, and memory ability of HIBI rats. Histological stainings were performed to observe the area of cerebral infarction, record the number of neurons in the hippocampus, and assess neuron apoptosis. The levels of inflammatory factors were detected by ELISA. The protein levels of histone methyltransferase G9a and histone H3 lysine 9 (H3K9me2) were detected by western blot assay. The apoptosis was detected by flow cytometry. Results: <span class="hit">Sevoflurane</span> post-treatment significantly shortened the escape latency of HIBI neonatal rats, increased the density of neurons, reduced the area of cerebral infarction, and decreased the levels of inflammatory factors and <span class="hit">neuronal</span> apoptosis. <span class="hit">Sevoflurane</span> post-treatment decreased G9a and H3K9me2 levels, and G9a level was negatively correlated with NRF2 level. NRF2 silencing reversed the alleviation of <span class="hit">sevoflurane</span> post-treatment on OGD-induced cell <span class="hit">injury</span>. Conclusions: <span class="hit">Sevoflurane</span> post-treatment promotes NRF2 expression by inhibiting G9a and H3K9me2, thus alleviating HIBI in neonatal rats.</p><p class="hitsHighlighted">© Med Sci Monit, 2021; 27: e930042</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2013439482" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2013439482" type="checkbox" id="record_checkbox_L2013439482"><label for="record_checkbox_L2013439482" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">66</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=66&amp;page=1&amp;id=L2013439482" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Electroacupuncture pretreatment ameliorates anesthesia and surgery-induced cognitive dysfunction via activation of an α7-nachr signal in aged rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yin</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Q.</span></span><br><span class="journal-title">Neuropsychiatric Disease and Treatment</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">17</span><span class="journal-pages">&nbsp;(2599-2611)</span>&nbsp;<span class="cited-by" id="CTB-L2013439482"><a href="https://lls.reaxys.com/redir?pid=scp:85113134875" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-66"><a href="https://www.embase.com/#" class="showAbstract" data="66" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="66"></i> Abstract</a></li><li class="ui-tab" id="indexTab-66"><a href="https://www.embase.com/#" class="showIndexTerms" data="66" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="66"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.2147/NDT.S322047" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="65">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-65"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: Postoperative cognitive dysfunction (POCD) after anesthesia and surgery (AS) is a common complication in the elderly population. A cholinergic-dependent signal, the alpha7-nicotinic acetylcholine receptor (α7-nAChR), has been suggested to regulate cognitive processes in a variety of neurologic diseases. In the current study, we determined whether electroacupuncture (EA) pretreatment ameliorates AS-induced POCD in aged rats, as well as the underlying mechanism. Methods: Male Sprague-Dawley rats (20 months old) were randomly assigned to the following 5 groups (n=12): vehicle; POCD (tibial fracture surgery); EA plus POCD; EA plus POCD and alpha-bungarotoxin (α-BGT); and POCD plus α-BGT groups. Alphabungarotoxin (1 μg/kg), a selective antagonist of α7-nAChR, was administrated via intraperitoneal injection before EA. Thirty days post-AS, the Morris water maze and a novel objective recognition test were used to evaluate cognitive function. <span class="hit">Neuronal</span> amount, apoptosis, microglial activation, percentage of high mobility group box 1 (HMGB1)-and nuclear factor-κB (NF-κB)-positive microglia, and levels of HMGB-1 downstream factors, including NF-κB, interleukin-6 (IL-6), and IL-1β, were detected by Nissl staining, immunofluorescence, and Western blot assays. Results: EA pretreatment significantly increased crossing platform times and elevated the time with a novel object, restored the quantity of neurons, decreased TUNEL-positive neurons, alleviated activation of microglia, downregulated expression of HMGB1 and NF-κB in the microglia, and reduced levels of phosphor-NF-κB, IL-6, and IL-1β 35 days after AS, while α-BGT partially reversed these changes. Conclusion: EA pretreatment improved AS-induced POCD in aged rats, and the underlying mechanism may be associated with inhibition of HMGB1–NF-κB via an α7-nAChR signal in the microglia.</p><p class="hitsHighlighted">© 2021 Wang et al. php and incorporate.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2014424419" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2014424419" type="checkbox" id="record_checkbox_L2014424419"><label for="record_checkbox_L2014424419" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">67</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=67&amp;page=1&amp;id=L2014424419" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> protects against cerebral ischemia/reperfusion <span class="hit">injury</span> via microrna-30c-5p modulating homeodomain-interacting protein kinase 1</a><br><span class="author fn notranslate"><span class="family-name notranslate">Su</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Deng</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">Bioengineered</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">12</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(11858-11871)</span>&nbsp;<span class="cited-by" id="CTB-L2014424419"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-67"><a href="https://www.embase.com/#" class="showAbstract" data="67" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="67"></i> Abstract</a></li><li class="ui-tab" id="indexTab-67"><a href="https://www.embase.com/#" class="showIndexTerms" data="67" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="67"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1080/21655979.2021.1999551" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="66">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-66"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Sevoflurane (SEV) has been reported to be an effective neuroprotective agent for cerebral ischemia/reperfusion injury (CIRI). However, the precise molecular mechanisms of Sev preconditioning in CIRI remain largely unknown. Therefore, CIRI model was established via middle cerebral artery occlusion method. SEV was applied before modeling. after successful modeling, lentivirus was injected into the lateral ventricle of the brain. Neurological impairment score was performed in each group, and histopathologic condition, infarct volume, apoptosis, inflammation, oxidative stress, microRNA (miR)-30&nbsp;c-5p and homeodomain-interacting protein kinase 1 (HIPK1) were detected. Mouse hippocampal neuronal cell line HT22 cells were pretreated with SEV, and the in vitro model was stimulated via oxygen-glucose deprivation and reoxygenation. The corresponding plasmids were transfected, and the cell growth was detected, including inflammation and oxidative stress, etc. The targeting of miR-30&nbsp;c-5p with HIPK1 was examined. The results clarified that reduced miR-30&nbsp;c-5p and elevated HIPK1 were manifested in CIRI. SEV could improve CIRI and modulate the miR-30&nbsp;c-5p-HIPK1 axis in vitro and in vivo, and miR-30&nbsp;c-5p could target HIPK1. Depressed miR-30&nbsp;c-5p could eliminate the protection of SEV in vitro and in vivo. Repression of HIPK1 reversed the effect of reduced miR-30&nbsp;c-5p on CIRI. Therefore, it is concluded that SEV is available to depress CIRI via targeting HIPK1 through upregulated miR-30&nbsp;c-5p.</p><p class="hitsHighlighted">© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2017231290" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2017231290" type="checkbox" id="record_checkbox_L2017231290"><label for="record_checkbox_L2017231290" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">68</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=68&amp;page=1&amp;id=L2017231290" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">The protective effects of <span class="hit">sevoflurane</span> postconditioning mediated by SIRTl on learning and memory impairment in liemorrhagic shock and resuscitation mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">X.-T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">C.-X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">X.-W.</span></span><br><span class="journal-title">Chinese Pharmacological Bulletin</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">37</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(385-391)</span>&nbsp;<span class="cited-by" id="CTB-L2017231290"><a href="https://lls.reaxys.com/redir?pid=scp:85126752444" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-68"><a href="https://www.embase.com/#" class="showAbstract" data="68" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="68"></i> Abstract</a></li><li class="ui-tab" id="indexTab-68"><a href="https://www.embase.com/#" class="showIndexTerms" data="68" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="68"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3969/j.issn.1001-1978.2021.03.016" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="67">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-67"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Aim To explore the role of the silent information regulator (silent information regulation 1, SIRTl)-mediated apoptotic pathway in the protection of <span class="hit">sevoflurane</span> postconditioning in hippocampal <span class="hit">neuronal injury</span> of mice induced by hemorrhagic shock resuscitation (HSR). Methods A mouse model of HSR was established. The male C57BL/6J mice were randomly divided into; sham operation group (Sham group), HSR group (Shock group), <span class="hit">sevoflurane</span> treatment group (Sevo group), <span class="hit">sevoflurane</span> combined with SIRTl specific inhibitor treatment group (EX527 + Sevo group) and EX527 treatment group (EX527 group). The volume of cerebral infarction was detected by TTC staining method. The changes of hippocampal nerve cells in each group of mice were detected by TUNEL staining method. The learning and memory abilities were detected by Morris water maze test. The expression of SIRTl and apoptosis-related protein levels were delected by Western blot analysis. Results The latency of the model mice reaching the platform in Morris water maze test was prolonged, while the movement distance in the target quadrant was similarly reduced. Besides, the cerebral infarction volume remarkably increased. The number of TUNEL staining positive cells increased, and the expression of SIRTl and Bel-2 decreased while the pro-apoptosis protein Bax, and cleaved-caspase 3 expression level increased; <span class="hit">sevoflurane</span> treatment improved nerve <span class="hit">injury</span> in HSR. After combined treatment with <span class="hit">sevoflurane</span> and SIRTl inhibitor EX527, the protective effect of <span class="hit">sevoflurane</span> was attenuated on nerve <span class="hit">injury</span> in HSR. Conclusion <span class="hit">Sevoflurane</span> may play a protective role against hippocampal <span class="hit">neuronal injury</span> caused by HSR mediated by SIRTl apoptosis-related pathway.</p><p class="hitsHighlighted">© 2021 Publication Centre of Anhui Medical University. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L635224027" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L635224027" type="checkbox" id="record_checkbox_L635224027"><label for="record_checkbox_L635224027" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">69</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=69&amp;page=1&amp;id=L635224027" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Evaluation of the Neuroprotective Effect of Pycnogenol in a Hypoxic-Ischemic Brain <span class="hit">Injury</span> Model in Newborn Rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Çolak</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Celik</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Diniz</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Alkan Özdemir</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yilmaz</span> <span class="given-name notranslate">O.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Calkavur</span> <span class="given-name notranslate">S.</span></span><br><span class="journal-title">American Journal of Perinatology</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="cited-by" id="CTB-L635224027"><a href="https://lls.reaxys.com/redir?pid=scp:85107405092" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-69"><a href="https://www.embase.com/#" class="showAbstract" data="69" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="69"></i> Abstract</a></li><li class="ui-tab" id="indexTab-69"><a href="https://www.embase.com/#" class="showIndexTerms" data="69" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="69"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1055/s-0041-1730349" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="68">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-68"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective This study aimed to evaluate the efficacy of Pycnogenol (PYC) and its antioxidant and antiapoptotic effect in an experimental hypoxic-ischemic (HI) rat model. Study Design A total of 24 Wistar albino rats who were on the seventh postnatal day were divided into three groups with developed HI brain injury model under the sevoflurane anesthesia: 40 mg/kg PYC was given to Group A, saline was given to Group B, and the sham group was Group C. Neuronal apoptosis was investigated by terminal deoxynucleotidyl transferase dUTP nick end labeling and immunohistochemically stained manually with primer antibodies of tumor necrosis factor-α and interleukin-1β. Results The neuronal cell injury was statistically lower in the PYC treatment group. Conclusion This is the first study that investigates the role of PYC in the HI brain injury model. PYC reduces apoptosis and neuronal injury in the cerebral tissue of the rats. PYC may be a protective agent against hypoxic-ischemic encephalopathy. Key Points This is the first study that investigates the role of PYC in the HI brain injury model. PYC may be a protective agent against hypoxic-ischemic encephalopathy. Sevoflurane should not be preferred in rat studies where neuronal apoptosis will be investigated.
</p><p class="hitsHighlighted">© 2021. Thieme. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L637296629" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L637296629" type="checkbox" id="record_checkbox_L637296629"><label for="record_checkbox_L637296629" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">70</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=70&amp;page=1&amp;id=L637296629" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Intraoperative Electrophysiology during Deep Brain Surgeries in Disorders of Consciousness</a><br><span class="author fn notranslate"><span class="family-name notranslate">Coste</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sontheimer</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pontier</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lemaire</span> <span class="given-name notranslate">J.-J.</span></span><br><span class="journal-title">Stereotactic and Functional Neurosurgery</span>&nbsp;<span class="journal-publication-year">2021</span>&nbsp;<span class="journal-volume">99</span><span class="journal-issue">:SUPPL 1</span><span class="journal-pages">&nbsp;(97-)</span>&nbsp;<span class="cited-by" id="CTB-L637296629"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-70"><a href="https://www.embase.com/#" class="showAbstract" data="70" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="70"></i> Abstract</a></li><li class="ui-tab" id="indexTab-70"><a href="https://www.embase.com/#" class="showIndexTerms" data="70" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="70"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1159/000520618" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="69">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-69"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The efficacy on deep brain stimulation in disorders of consciousness (DC) is inconclusive. We investigated bilateral 30-Hz low-frequency stimulation designed to overdrive <span class="hit">neuronal</span> activity by dual pallido-thalamic targeting to promote conscious behavior in five patients. Five adult patients (mean age 38 years old) were included: one unresponsive-wakefulness-syndrome male (traumatic brain <span class="hit">injury</span>); and four patients in a minimally conscious state, one male (traumatic brain <span class="hit">injury</span>) and three females (two hemorrhagic strokes and one traumatic brain <span class="hit">injury</span>). Pallidothalamic electrode targeting were performed under <span class="hit">sevoflurane</span> general anesthesia with recording of extracellular muti-unit <span class="hit">neuronal</span> activity and local field potential (LFP). These data were compared with five GPi DBS implantations (three males) for Parkinson's disease (n=4) or dystonia (59 years old) and three VIM DBS surgeries (two males) for Parkinson's disease (n=1) or essential tremor (40 years old). The electrode implantation was realized after electrophysiological mapping using an intraoperative electrophysiological system for functional neurosurgery (MicroGuide Pro, Alpha Omega Eng., Israel). For each brain hemisphere, the mapping was performed using two exploration electrodes (Alpha Omega Eng.) steered by rigid guide tubes: one on the planned track and a second one on the parallel track located posteriorly at 2 mm. The characteristics of our electrophysiological approach were as follow: systematic recordings of the spontaneous <span class="hit">neuronal</span> activity every 1 mm during 30 seconds along the distal 8.2 mm (min: 5; max: 13 mm) in the pallidum and the thalamus previously labelled and manually outlined on stereotactic MRI. Spikes were encountered for 50 out of 130 recordings in the pallidum (38.46%) and for 43 out of 185 (23.24%) in the thalamus of patients with disorders of consciousness. Concerning motor disease (MD) patients implanted under general anesthesia, spikes were found in 52 out of 150 recordings in the pallidum (34.66%) and for 54 out of 82 (65.85%) in the thalamus. Mean firing rate of neurons in the pallidum was 9.84 +/-8.71 Hz and 11.95 +/-10.31 Hz during surgery for patients with DC and MD respectively. Concerning Thalamus, mean firing rate was 3.78 +/-4.87 Hz versus 2.25 +/-2.15 Hz (DC vs MD). Percentage of raw power spectral density of LFP was similar in GPi for patients with DC and MD. Delta (47.8%), Theta (19.5%) and Alpha (17.0%) bands were preponderant for DC, while Delta (37.2%), Alpha (29.1%) and Beta (17.0%) range were powerful for MD patients. Pallidal <span class="hit">neuronal</span> activity is similar for patients under general anesthesia suffering from DC or MD. Differences were encountered for Thalamus: higher 7-30 Hz frequency power was encountered for patients with MD and higher low (&gt;7 Hz) and high (&gt;30 Hz) band power was observed for DC. Thalamic <span class="hit">neuronal</span> activity differs between MD and DC patients. Few records have been obtained and published for patients with impaired consciousness. These results should be considered with caution given the small number of patients in the study.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2005180003" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2005180003" type="checkbox" id="record_checkbox_L2005180003"><label for="record_checkbox_L2005180003" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">71</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=71&amp;page=1&amp;id=L2005180003" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">AMPK-SIRT1-PGC1α Signal Pathway Influences the Cognitive Function of Aged Rats in <span class="hit">Sevoflurane</span>-Induced Anesthesia</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">X.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Q.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zheng</span> <span class="given-name notranslate">S.-Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qu</span> <span class="given-name notranslate">Z.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xi</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">G.</span></span><br><span class="journal-title">Journal of Molecular Neuroscience</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">70</span><span class="journal-issue">:12</span><span class="journal-pages">&nbsp;(2058-2067)</span>&nbsp;<span class="cited-by" id="CTB-L2005180003"><a href="https://lls.reaxys.com/redir?pid=scp:85086163326" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;7</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-71"><a href="https://www.embase.com/#" class="showAbstract" data="71" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="71"></i> Abstract</a></li><li class="ui-tab" id="indexTab-71"><a href="https://www.embase.com/#" class="showIndexTerms" data="71" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="71"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12031-020-01612-w" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="70">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-70"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">To understand the effect of AMP-activated protein kinase (AMPK)-SIRT1 (silent information regulator 1)-PPARγ coactivator-1α (PGC1α) signaling pathway on the cognitive function of <span class="hit">sevoflurane</span>-anesthetized aged rats. Aged rats were divided into Normal group, Sevo group (<span class="hit">Sevoflurane</span> anesthesia), Sevo + AICAR (the AMPK activator) group, Sevo + EX527 group (the AMPK inhibitor), and Sevo + AICAR + EX527 group. The cognitive function of rats was determined by the Morris water maze. Hippocampal <span class="hit">neuronal</span> apoptosis was evaluated by TUNEL and Fluoro-Jade C (FJC) staining, and the expression of cleaved caspase-3 was detected by immunohistochemistry. ROS, SOD, and MDA levels and the fluorescence intensity of GFAP in the hippocampus were assayed. The mitochondrial membrane potential (MMP), mitochondrial mass, ATP level, and the expression of AMPK-SIRT1-PGC1α were determined by the corresponding methods. Rats in the Sevo group manifested significant extension in the escape latency, with fewer platform crossings; and meanwhile, the apoptotic rate, the number of FJC-positive cells, and the fluorescence intensity of GFAP of neurons were elevated, with up-regulation of cleaved caspase-3. Moreover, the level of MDA and ROS was increased evidently, with significant down-regulation of SOD activity, ATP, mitochondrial mass and MMP levels, and AMPK, SIRT1 and PGC-1α protein expressions. However, <span class="hit">sevoflurane</span>-induced changes above were improved after the administration of AICAR, and EX527 could reverse AICAR-induced improvements in Sevo-anesthetized aged rats. Activating AMPK-SIRT1-PGC1α pathway can improve the cognitive function and mitigate the <span class="hit">neuronal injury</span> in Sevo-anesthetized aged rats by antagonizing the oxidative stress and maintaining the mitochondrial function.</p><p class="hitsHighlighted">© 2020, Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2007425481" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2007425481" type="checkbox" id="record_checkbox_L2007425481"><label for="record_checkbox_L2007425481" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">72</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=72&amp;page=1&amp;id=L2007425481" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Disruption of microRNA-214 during general anaesthesia prevents brain <span class="hit">injury</span> and maintains mitochondrial fusion by promoting Mfn2 interaction with Pkm2</a><br><span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qian</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Duan</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jia</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bai</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">Journal of Cellular and Molecular Medicine</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">24</span><span class="journal-issue">:23</span><span class="journal-pages">&nbsp;(13589-13599)</span>&nbsp;<span class="cited-by" id="CTB-L2007425481"><a href="https://lls.reaxys.com/redir?pid=scp:85096672059" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-72"><a href="https://www.embase.com/#" class="showAbstract" data="72" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="72"></i> Abstract</a></li><li class="ui-tab" id="indexTab-72"><a href="https://www.embase.com/#" class="showIndexTerms" data="72" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="72"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/jcmm.15222" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="71">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-71"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Duration of surgical general anaesthesia is associated with severe brain <span class="hit">injury</span> and neurological deficits. The specific mechanisms underlying post-general anaesthesia brain <span class="hit">injury</span>, however, still remain to be elucidated. Herein, we explore the role of microRNA-214 (miR-214) in the occurrence of brain <span class="hit">injury</span> after general anaesthesia and its underlying mechanism. Hippocampal tissues and neurons were isolated from rats exposed to 2% <span class="hit">sevoflurane</span>. TUNEL stains reflect hippocampal neuron apoptosis. Cultured hippocampal neurons stained with JC-1 and MitoTracker dyes were imaged by fluorescence microscope to visualize changes of mitochondrial membrane potential and mitochondrial fusion. Mitochondrial function was evaluated. Mitofusin 2 (Mfn2) binding to miR-214 or pyruvate kinase M2 (Pkm2) was confirmed by co-immunoprecipitation, immunofluorescence, dual luciferase reporter gene and RNA immunoprecipitation assays. After exposure to 2% <span class="hit">sevoflurane</span>, up-regulated miR-214 expression and impaired interaction between Mfn2 and Pkm2 were found in rat hippocampal tissues. Rats exposed to 2% <span class="hit">sevoflurane</span> also experienced <span class="hit">neuronal injury</span>, mitochondrial defects and deficits in the brain-derived neurotrophic factor (Bdnf) signalling. miR-214 was shown to target Mfn2 by impairing its binding with Pkm2. Inhibiting miR-214 expression using its specific inhibitor improved mitochondrial membrane potential, enhanced mitochondrial fusion, maintained mitochondrial function, restored interaction between Mfn2 and Pkm2, and activated the Bdnf signalling in cultured hippocampal neurons. Adenovirus infection of miR-214 inhibitor reduced neuron apoptosis and maintained mitochondrial function in the hippocampus of rats exposed to 2% <span class="hit">sevoflurane</span>. Taken together, the study demonstrates inhibition of miR-214 is cerebral protective against brain <span class="hit">injury</span> following general anaesthesia.</p><p class="hitsHighlighted">© 2020 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2005826969" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2005826969" type="checkbox" id="record_checkbox_L2005826969"><label for="record_checkbox_L2005826969" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">73</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=73&amp;page=1&amp;id=L2005826969" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">MicroRNA-203–mediated inhibition of doublecortin underpins cardioprotection conferred by <span class="hit">sevoflurane</span> in rats after myocardial ischaemia-reperfusion <span class="hit">injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Tan</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yuan</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Peng</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Journal of Cellular and Molecular Medicine</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">24</span><span class="journal-issue">:17</span><span class="journal-pages">&nbsp;(9825-9838)</span>&nbsp;<span class="cited-by" id="CTB-L2005826969"><a href="https://lls.reaxys.com/redir?pid=scp:85089250164" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;8</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-73"><a href="https://www.embase.com/#" class="showAbstract" data="73" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="73"></i> Abstract</a></li><li class="ui-tab" id="indexTab-73"><a href="https://www.embase.com/#" class="showIndexTerms" data="73" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="73"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/jcmm.15566" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="72">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-72"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Myocardial ischaemia-reperfusion (I/R) <span class="hit">injury</span> is a serious illness with high morbidity and mortality. Mounting evidence indicates the utility of <span class="hit">sevoflurane</span> (SEV) in the treatment of myocardial I/R <span class="hit">injury</span>. This study aimed to explore the molecular mechanisms underlying the protective action of SEV against myocardial I/R <span class="hit">injury</span>. A rat model of myocardial I/R <span class="hit">injury</span> was established, and I/R rats were treated with different concentrations of SEV. MicroRNA-203 (miR-203) and doublecortin (DCX) expression levels were determined using reverse transcription-quantitative polymerase chain reaction. Putative target relationship between miR-203 and DCX was explored using dual-luciferase reporter gene assay and RNA-binding protein immunoprecipitation assay. Ischaemia-reperfusion rats were treated with SEV, miR-203 antagomir or sh-DCX, followed by determination of oxidative stress- and inflammation-related factor levels using nitrite and enzyme-linked immunosorbent assays, and that of apoptosis-related factors using Western blot analysis. The apoptotic rate of myocardial tissues was determined using TdT-mediated dUTP-biotin nick end labeling (TUNEL) staining, and the infract area was evaluated using triphenyltetrazolium chloride staining. The results showed miR-203 was poorly expressed and DCX was highly expressed in myocardial tissues of I/R rats. <span class="hit">Sevoflurane</span> was found to elevate miR-203, and miR-203, in turn, could target and reduce DCX expression. <span class="hit">Sevoflurane</span>, miR-203 overexpression or DCX silencing resulted in declined oxidative stress, inflammation, apoptosis and infarct area, ultimately alleviating myocardial I/R <span class="hit">injury</span>. Collectively, these findings showed that SEV-activated miR-203 exhibited suppressive effects on myocardial I/R <span class="hit">injury</span> in rats and highlighted the SEV/miR-203/DCX axis as a promising therapeutic target for myocardial I/R <span class="hit">injury</span> management.</p><p class="hitsHighlighted">© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2006712559" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2006712559" type="checkbox" id="record_checkbox_L2006712559"><label for="record_checkbox_L2006712559" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">74</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=74&amp;page=1&amp;id=L2006712559" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Human plasma biomarker responses to inhalational general anaesthesia without surgery</a><br><span class="author fn notranslate"><span class="family-name notranslate">Deiner</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Baxter</span> <span class="given-name notranslate">M.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mincer</span> <span class="given-name notranslate">J.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sano</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hall</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mohammed</span> <span class="given-name notranslate">I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">O'Bryant</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zetterberg</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Blennow</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Eckenhoff</span> <span class="given-name notranslate">R.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">125</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(282-290)</span>&nbsp;<span class="cited-by" id="CTB-L2006712559"><a href="https://lls.reaxys.com/redir?pid=scp:85086359191" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;22</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-74"><a href="https://www.embase.com/#" class="showAbstract" data="74" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="74"></i> Abstract</a></li><li class="ui-tab" id="indexTab-74"><a href="https://www.embase.com/#" class="showIndexTerms" data="74" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="74"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bja.2020.04.085" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="73">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-73"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Postoperative neurocognitive disorders may arise in part from adverse effects of general anaesthetics on the CNS, especially in older patients or individuals otherwise vulnerable to neurotoxicity because of systemic disease or the presence of pre-existing neuropathology. Previous studies have documented cytokine and <span class="hit">injury</span> biomarker responses to surgical procedures that included general anaesthesia, but it is not clear to what degree anaesthetics contribute to these responses. Methods: We performed a prospective cohort study of 59 healthy volunteers aged 40–80 yr who did not undergo surgery. Plasma markers of neurological <span class="hit">injury</span> and inflammation were measured immediately before and 5 h after induction of general anaesthesia with 1 minimum alveolar concentration of <span class="hit">sevoflurane</span>. Biomarkers included interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-α), C-reactive protein (CRP), and neural <span class="hit">injury</span> (tau, neurofilament light [NF-L], and glial fibrillary acidic protein [GFAP]). Results: Baseline biomarkers were in the normal range, although NF-L and GFAP were elevated as a function of age. At 5 h after induction of anaesthesia, plasma tau, NF-L, and GFAP were significantly decreased relative to baseline. Plasma IL-6 was significantly increased after anaesthesia, but by a biologically insignificant degree (&lt;1 pg ml<sup>−1</sup>); plasma TNF-α and CRP were unchanged. Conclusions: <span class="hit">Sevoflurane</span> general anaesthesia without surgery, even in older adults, did not provoke an inflammatory state or <span class="hit">neuronal injury</span> at a concentration that is detectable by an acute elevation of measured plasma biomarkers in the early hours after exposure. Clinical trial registration: NCT02275026.</p><p class="hitsHighlighted">© 2020 British Journal of Anaesthesia</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2005420776" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2005420776" type="checkbox" id="record_checkbox_L2005420776"><label for="record_checkbox_L2005420776" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">75</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=75&amp;page=1&amp;id=L2005420776" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Protective effects and underlying mechanism of <span class="hit">sevoflurane</span> pretreatment on cerebral ischemia-reperfusion <span class="hit">injury</span> in mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">D.B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">He</span> <span class="given-name notranslate">H.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ying</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Journal of Biological Regulators and Homeostatic Agents</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">34</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(1479-1485)</span>&nbsp;<span class="cited-by" id="CTB-L2005420776"><a href="https://lls.reaxys.com/redir?pid=scp:85090873118" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="noAbstract">[No abstract available]</span></li><li class="ui-tab" id="indexTab-75"><a href="https://www.embase.com/#" class="showIndexTerms" data="75" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="75"></i> Index Terms</a></li><li><span id="FTL-L2005420776" class="fulltext" data="{&quot;recno&quot;:&quot;L2005420776&quot;,&quot;issn&quot;:&quot;17246083&quot;,&quot;volume&quot;:&quot;34&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;startpage&quot;:&quot;1479&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="74">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-74"><div class="abstractsContainer"></div></div></li></div></li><li>    <div id="embaseRecord_L2006934117" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2006934117" type="checkbox" id="record_checkbox_L2006934117"><label for="record_checkbox_L2006934117" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">76</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=76&amp;page=1&amp;id=L2006934117" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage</a><br><span class="author fn notranslate"><span class="family-name notranslate">Athiraman</span> <span class="given-name notranslate">U.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Aum</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Vellimana</span> <span class="given-name notranslate">A.K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Osbun</span> <span class="given-name notranslate">J.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dhar</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tempelhoff</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zipfel</span> <span class="given-name notranslate">G.J.</span></span><br><span class="journal-title">Journal of Neurosurgery</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">133</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(152-158)</span>&nbsp;<span class="cited-by" id="CTB-L2006934117"><a href="https://lls.reaxys.com/redir?pid=scp:85087962611" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-76"><a href="https://www.embase.com/#" class="showAbstract" data="76" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="76"></i> Abstract</a></li><li class="ui-tab" id="indexTab-76"><a href="https://www.embase.com/#" class="showIndexTerms" data="76" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="76"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3171/2019.3.JNS183512" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="75">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-75"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">OBJECTIVE Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) is characterized by large-artery vasospasm, distal autoregulatory dysfunction, cortical spreading depression, and microvessel thrombi. Large-artery vasospasm has been identified as an independent predictor of poor outcome in numerous studies. Recently, several animal studies have identified a strong protective role for inhalational anesthetics against secondary brain <span class="hit">injury</span> after SAH including DCI-a phenomenon referred to as anesthetic conditioning. The aim of the present study was to assess the potential role of inhalational anesthetics against cerebral vasospasm and DCI in patients suffering from an SAH. METHODS After IRB approval, data were collected retrospectively for all SAH patients admitted to the authors' hospital between January 1, 2010, and December 31, 2013, who received general anesthesia with either inhalational anesthetics only (<span class="hit">sevoflurane</span> or desflurane) or combined inhalational (<span class="hit">sevoflurane</span> or desflurane) and intravenous (propofol) anesthetics during aneurysm treatment. The primary outcomes were development of angiographic vasospasm and development of DCI during hospitalization. Univariate and logistic regression analyses were performed to identify independent predictors of these endpoints. RESULTS The cohort included 157 SAH patients whose mean age was 56 ± 14 (± SD). An inhalational anesthetic-only technique was employed in 119 patients (76%), while a combination of inhalational and intravenous anesthetics was employed in 34 patients (22%). As expected, patients in the inhalational anesthetic-only group were exposed to significantly more inhalational agent than patients in the combination anesthetic group (p &lt; 0.05). Multivariate logistic regression analysis identified inhalational anesthetic-only technique (OR 0.35, 95% CI 0.14-0.89), Hunt and Hess grade (OR 1.51, 95% CI 1.03-2.22), and diabetes (OR 0.19, 95% CI 0.06-0.55) as significant predictors of angiographic vasospasm. In contradistinction, the inhalational anesthetic-only technique had no significant impact on the incidence of DCI or functional outcome at discharge, though greater exposure to desflurane (as measured by end-tidal concentration) was associated with a lower incidence of DCI. CONCLUSIONS These data represent the first evidence in humans that inhalational anesthetics may exert a conditioning protective effect against angiographic vasospasm in SAH patients. Future studies will be needed to determine whether optimized inhalational anesthetic paradigms produce definitive protection against angiographic vasospasm; whether they protect against other events leading to secondary brain <span class="hit">injury</span> after SAH, including microvascular thrombi, autoregulatory dysfunction, blood-brain barrier breakdown, neuroinflammation, and <span class="hit">neuronal</span> cell death; and, if so, whether this protection ultimately improves patient outcome.</p><p class="hitsHighlighted">© 2020 AANS.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L632856721" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L632856721" type="checkbox" id="record_checkbox_L632856721"><label for="record_checkbox_L632856721" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">77</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=77&amp;page=1&amp;id=L632856721" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Protective effects and underlying mechanism of <span class="hit">sevoflurane</span> pretreatment on cerebral isch¬emia-reperfusion <span class="hit">injury</span> in mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">D.B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">He</span> <span class="given-name notranslate">H.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ying</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Journal of biological regulators and homeostatic agents</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">34</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(1479-1485)</span>&nbsp;<span class="cited-by" id="CTB-L632856721"><a href="https://lls.reaxys.com/redir?pid=scp:85090873118" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">MEDLINE</span></li><li><span class="noAbstract">[No abstract available]</span></li><li class="ui-tab" id="indexTab-77"><a href="https://www.embase.com/#" class="showIndexTerms" data="77" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="77"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.23812/20-253-L" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="76">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-76"><div class="abstractsContainer"></div></div></li></div></li><li>    <div id="embaseRecord_L2004103648" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2004103648" type="checkbox" id="record_checkbox_L2004103648"><label for="record_checkbox_L2004103648" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">78</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=78&amp;page=1&amp;id=L2004103648" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Role of Metallothionein-1 and Metallothionein-2 in the Neuroprotective Mechanism of <span class="hit">Sevoflurane</span> Preconditioning in Mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tan</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Luo</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Long</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mei</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tang</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Journal of Molecular Neuroscience</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">70</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(713-723)</span>&nbsp;<span class="cited-by" id="CTB-L2004103648"><a href="https://lls.reaxys.com/redir?pid=scp:85078275741" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;4</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-78"><a href="https://www.embase.com/#" class="showAbstract" data="78" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="78"></i> Abstract</a></li><li class="ui-tab" id="indexTab-78"><a href="https://www.embase.com/#" class="showIndexTerms" data="78" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="78"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12031-020-01481-3" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="77">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-77"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">This study investigated the protective effects and mechanisms of <span class="hit">sevoflurane</span> preconditioning (SPC) on neurons in ischemic mice. After SPC, mice were subjected to middle cerebral artery occlusion (MCAO). Cerebral infarction area, cell apoptosis, and metallothionein-1 (MT-1) and metallothionein-2 (MT-2) expressions in MCAO mice were analyzed. Mouse primary neurons were isolated and cultured to determine the location of metallothioneins (MTs) using immunofluorescence. Neurons transfected with MT-siRNA, exogenous MTs, or sh-MTF-1 were subjected to SPC and/or oxygen-glucose deprivation (OGD), and MT-1/MT-2 expression and neurotoxin release were assayed. Meanwhile, neurons were treated with the nitric oxide donor SNAP, degraded SNAP, or the peroxide initiator paraquat, and alterations in MT-1/MT-2 expression and neurotoxicity release were observed. SPC attenuated <span class="hit">neuronal injury</span> and apoptosis in MCAO mice. SPC could protect neurons against OGD <span class="hit">injury</span> and resulted in upregulated MT-1/MT-2 expression. MT-siRNA transfection led to the downregulated expression of MT-1/MT-2 and increased neurotoxicity, and the expression patterns of these neurons were different from those of neurons transfected with exogenous MTs. The knockdown of MTs could hinder the protective effect of SPC against OGD. Pretreatment with SNAP or paraquat could increase MTF-1 expression in the nucleus of neurons, protecting against OGD <span class="hit">injury</span>. The inhibition of nitric oxide and peroxide inhibited the protective role of SPC in OGD by downregulating MTF-1 expression. sh-MTF-1 transfection downregulated MT-1/MT-2 expression and enhanced neurotoxicity in neurons. SPC confers neuroprotection in focal cerebral ischemia mouse models by upregulating the expression of MT-1 and MT-2 by activating NO and peroxide and increasing MTF-1 expression in the nucleus.</p><p class="hitsHighlighted">© 2020, Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L631485982" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L631485982" type="checkbox" id="record_checkbox_L631485982"><label for="record_checkbox_L631485982" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">79</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=79&amp;page=1&amp;id=L631485982" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">HSP90 inhibitor 17AAG attenuates <span class="hit">sevoflurane</span>-induced neurotoxicity in rats and human neuroglioma cells via induction of HSP70</a><br><span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Journal of Translational Medicine</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">18</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 166</span>&nbsp;<span class="cited-by" id="CTB-L631485982"><a href="https://lls.reaxys.com/redir?pid=scp:85083412903" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-79"><a href="https://www.embase.com/#" class="showAbstract" data="79" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="79"></i> Abstract</a></li><li class="ui-tab" id="indexTab-79"><a href="https://www.embase.com/#" class="showIndexTerms" data="79" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="79"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1186/s12967-020-02332-w" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="78">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-78"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: 17AAG has been extensively studied for its antitumor effects that protect cells from lethal stress by maintaining protein stability. The role of 17AAG in <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal injury</span> has never been studied. We aim to investigate the effect of 17AAG on <span class="hit">sevoflurane</span>-induced neurotoxicity in vivo and in vitro. Methods: <span class="hit">Sevoflurane</span>-induced hippocampal neuron <span class="hit">injury</span> model was established in aged Sprague-Dawley rats. Pretreatment of vehicle or 17AAG was administered prior to <span class="hit">sevoflurane</span> inhalation. H4 neuroglioma cells were pretreated with vehicle or 17AAG and exposed to <span class="hit">sevoflurane</span>. Apoptosis, oxidative stress, expression of interleukin-6 (IL-6), and activation of the nuclear factor-κB (NF-κB) signaling pathway in H4 cells were examined by Hoechst assay, flow cytometry, Western blot, and immunofluorescent staining. RNA interference against HSPA1A was performed to test the function of HSP70 in neuroprotection. Results: Exogenous 17AAG reduced <span class="hit">sevoflurane</span>-induced apoptosis and oxidative stress in rat hippocampal neurons and in H4 cells. In H4 cells, 17AAG suppressed <span class="hit">sevoflurane</span>-induced upregulation of IL-6 and activation of NF-κB signaling. 17AAG enhanced <span class="hit">sevoflurane</span>-induced upregulation of HSP70 in rat hippocampal neurons and in H4 cells. Conversely, silencing of HSPA1A in H4 cells blocked the cytoprotective effect of 17AAG against <span class="hit">sevoflurane</span>-induced apoptosis and oxidative stress, and prevented upregulation of IL-6 and activation of NF-κB signaling. Conclusions: 17AAG protects against <span class="hit">sevoflurane</span>-induced neurotoxicity in vivo and in vitro via HSP70-dependent inhibition of apoptosis, oxidative stress, and pro-inflammatory signaling pathway.</p><p class="hitsHighlighted">© 2020 The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2005728554" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2005728554" type="checkbox" id="record_checkbox_L2005728554"><label for="record_checkbox_L2005728554" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">80</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=80&amp;page=1&amp;id=L2005728554" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Compound Porcine Cerebroside and Ganglioside Injection (CPCGI) attenuates <span class="hit">sevoflurane</span>-induced nerve cell <span class="hit">injury</span> by regulating the phosphorylation of p38 MAP kinase (p38MAPK)/ Nuclear Factor kappa B (NF-kB) Pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Song</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xun</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">He</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Duan</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Q.</span></span><br><span class="journal-title">Medical Science Monitor</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">26</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number e919600</span>&nbsp;<span class="cited-by" id="CTB-L2005728554"><a href="https://lls.reaxys.com/redir?pid=scp:85080840271" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-80"><a href="https://www.embase.com/#" class="showAbstract" data="80" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="80"></i> Abstract</a></li><li class="ui-tab" id="indexTab-80"><a href="https://www.embase.com/#" class="showIndexTerms" data="80" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="80"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.12659/MSM.919600" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="79">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-79"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Compound porcine cerebroside and ganglioside injection (CPCGI) has been widely applied in clinical practice in China to treat functional confusion caused by brain diseases. <span class="hit">Sevoflurane</span>, a frequently-used inhalational anesthetic, was discovered to have neurotoxicity that can cause neurological damage in patients. The present study was performed to investigate the protective effect of CPCGI on <span class="hit">sevoflurane</span>-induced nerve damage and to reveal the neuroprotective mechanisms of CPCGI. Material/Methods: Firstly, the hippocampal neurons were separated from Sprague-Dawley embryonic rats, and were stimulated by 3% <span class="hit">sevoflurane</span> for different times (0, 2, 4, and 6 h). Then, cell viability and cell apoptosis were assessed by thiazolyl blue tetrazolium bromide (MTT) and flow cytometry (FCM), respectively. Western blot analysis was used to determine the apoptosis-related protein expression levels. Results: The results demonstrated that 3% <span class="hit">sevoflurane</span> significantly inhibited cell viability but induced cell apoptosis in neurons in a time-dependent manner. Treatment with 3% <span class="hit">sevoflurane</span> also promoted the Bax [B cell leukemia/lymphoma 2 (Bcl2)-associated X protein] and cleaved caspase3 protein expressions, and suppressed Bcl-2 and pro-caspase3 expressions in hippocampal neurons. In addition, phosphorylated (p)-p38 and p-p65 expression and the ratio of p-p38/p38 and p-p65/p65 were upregulated in a time-dependent manner after 3% <span class="hit">sevoflurane</span> treatment. Further analysis indicated that all the effects of 3% <span class="hit">sevoflurane</span> on hippocampal neurons were reversed by CPCGI pre-treatment. Conclusions: We demonstrated the neuroprotective role of CPCGI in <span class="hit">sevoflurane</span>-stimulated <span class="hit">neuronal</span> cell damage via regulation of the MAPK/NF-kB signaling pathway.</p><p class="hitsHighlighted">© Med Sci Monit.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2003347041" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2003347041" type="checkbox" id="record_checkbox_L2003347041"><label for="record_checkbox_L2003347041" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">81</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=81&amp;page=1&amp;id=L2003347041" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care</a><br><span class="author fn notranslate"><span class="family-name notranslate">Prisco</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ganau</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Aurangzeb</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Moswela</span> <span class="given-name notranslate">O.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hallett</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Raby</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fitzgibbon</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kearns</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sen</span> <span class="given-name notranslate">A.</span></span><br><span class="journal-title">Seizure</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">75</span><span class="journal-pages">&nbsp;(153-164)</span>&nbsp;<span class="cited-by" id="CTB-L2003347041"><a href="https://lls.reaxys.com/redir?pid=scp:85073518711" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;18</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-81"><a href="https://www.embase.com/#" class="showAbstract" data="81" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="81"></i> Abstract</a></li><li class="ui-tab" id="indexTab-81"><a href="https://www.embase.com/#" class="showIndexTerms" data="81" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="81"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.seizure.2019.09.011" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="80">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-80"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Status epilepticus is a common neurological emergency, with overall mortality around 20%. Over half of cases are first time presentations of seizures. The pathological process by which spontaneous seizures are generated arises from an imbalance in excitatory and inhibitory <span class="hit">neuronal</span> networks, which if unchecked, can result in alterations in intracellular signalling pathways and electrolyte shifts, which bring about changes in the blood brain barrier, <span class="hit">neuronal</span> cell death and eventually cerebral atrophy. This narrative review focusses on the treatment of status epilepticus in adults. Anaesthetic agents interrupt <span class="hit">neuronal</span> activity by enhancing inhibitory or decreasing excitatory transmission, primarily via GABA and NMDA receptors. Intravenous anaesthetic agents are commonly used as second or third line drugs in the treatment of refractory status epilepticus, but the optimal timing and choice of anaesthetic drug has not yet been established by high quality evidence. Titration of antiepileptic and anaesthetic drugs in critically ill patients presents a particular challenge, due to alterations in drug absorbtion and metabolism as well as changes in drug distrubution, which arise from fluid shifts and altered protein binding. Furthermore, side effects associated with prolonged infusions of anaesthetic drugs can lead to multi-organ dysfunction and a need for critical care support. Electroencelography can identify patterns of burst suppression, which may be a target to guide weaning of intravenous therapy. Continuous elctroencephalography has the potential to directly impact clinical care, but despite its utility, major barriers exist which have limited its widespread use in clinical practice. A flow chart outlining the timing and dosage of anaesthetic agents used at our institution is provided.</p><p class="hitsHighlighted">© 2019 British Epilepsy Association</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2003472495" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2003472495" type="checkbox" id="record_checkbox_L2003472495"><label for="record_checkbox_L2003472495" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">82</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=82&amp;page=1&amp;id=L2003472495" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Theaflavins alleviate <span class="hit">sevoflurane</span>-induced neurocytotoxicity via Nrf2 signaling pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">International Journal of Neuroscience</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">130</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(1-8)</span>&nbsp;<span class="cited-by" id="CTB-L2003472495"><a href="https://lls.reaxys.com/redir?pid=scp:85077099123" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-82"><a href="https://www.embase.com/#" class="showAbstract" data="82" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="82"></i> Abstract</a></li><li class="ui-tab" id="indexTab-82"><a href="https://www.embase.com/#" class="showIndexTerms" data="82" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="82"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1080/00207454.2019.1667788" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="81">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-81"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Aim: <span class="hit">Sevoflurane</span> could induce apoptosis of rat hippocampal neurons, while theaflavins (TFs) have antioxidant and anti-inflammatory properties. This study aims to explore whether TFs could alleviate <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> cell <span class="hit">injury</span>. Materials and methods: Cells were treated by concentration gradient of <span class="hit">sevoflurane</span> and TFs. Cell viability, level of reactive oxygen species (ROS) and apoptosis rate were determined by cell counting kit-8 (CCK-8) and flow cytometry, respectively. Quantitative PCR (qPCR) and western blot were performed to determine mRNA and protein expressions. Results: TFs promoted viability of cells under the treatment of <span class="hit">sevoflurane</span>, while it suppressed apoptosis and down-regulated ROS level in a concentration-dependent manner. TFs could also down-regulate expression levels of caspase-3 and caspase-9 and cytosol and intranuclear nuclear factor E2-related factor 2 (Nrf2) in rat hippocampal nerve cells, while it up-regulated those of heme oxygenase 1 (HO-1), NADPH quinine oxidoreductase 1 (NQO1), glutamate cysteine ligase (GCL) and peroxiredoxin 1 (Prx1). Conclusions: Our study suggests that TFs exert protective effects on <span class="hit">sevoflurane</span>-induced neurocytotoxicity and therefore could be used as a potential drug for treatment of <span class="hit">neuronal injury</span>.</p><p class="hitsHighlighted">© 2019, © 2019 Informa UK Limited, trading as Taylor &amp; Francis Group.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2004978553" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2004978553" type="checkbox" id="record_checkbox_L2004978553"><label for="record_checkbox_L2004978553" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">83</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=83&amp;page=1&amp;id=L2004978553" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Exogenous carbon monoxide protects against mitochondrial DNA‑induced hippocampal pyroptosis in a model of hemorrhagic shock and resuscitation</a><br><span class="author fn notranslate"><span class="family-name notranslate">Fu</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">D.-X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Song</span> <span class="given-name notranslate">Y.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">F.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">X.-P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zheng</span> <span class="given-name notranslate">W.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">X.-D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gui</span> <span class="given-name notranslate">C.-X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kong</span> <span class="given-name notranslate">X.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kang</span> <span class="given-name notranslate">L.-Q.</span></span><br><span class="journal-title">International Journal of Molecular Medicine</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">45</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(1176-1186)</span>&nbsp;<span class="cited-by" id="CTB-L2004978553"><a href="https://lls.reaxys.com/redir?pid=scp:85079544951" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;14</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-83"><a href="https://www.embase.com/#" class="showAbstract" data="83" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="83"></i> Abstract</a></li><li class="ui-tab" id="indexTab-83"><a href="https://www.embase.com/#" class="showIndexTerms" data="83" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="83"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/ijmm.2020.4493" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="82">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-82"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Carbon monoxide-releasing molecule-3 (CORM-3), which is an exogenous carbon monoxide (CO) compound, slowly releases CO under physiological conditions; this exerts neuroprotective effects against incomplete ischemia/reperfusion <span class="hit">injury</span>. The objective of the present study was to investigate whether the administration of CORM-3 protects against nucleotide-binding oligomerization domain-like receptor pyrin domain‑3 (NLRP3) inflammasome formation and <span class="hit">neuronal</span> pyroptosis in the hippocampus following hemorrhagic shock and resuscitation (HSR). To establish this, an HSR model was created. Hemorrhagic shock was induced in adult male Sprague‑Dawley rats under <span class="hit">sevoflurane</span> anesthesia by bleeding using a heparinized syringe to maintain a mean arterial pressure of 30±5 mmHg for 60 min. Resuscitation was performed by reperfusion of the blood and, if necessary, administering sterile saline to achieve the baseline arterial pressure. Following resuscitation, CORM-3 (4 mg/kg) was injected via the femoral vein. <span class="hit">Neuronal</span> pyroptosis in the hippocampus, mitochondrial morphology, mitochondrial DNA (mtDNA), brain magnetic resonance imaging, expression levels of NLRP3 and the interaction of pro-caspase-1 and apoptosis-associated speck-like protein containing a CARD domain (ASC) were examined 12 h after HSR; locomotor activity was assessed 7 days after HSR. Compared with HSR-treated rats, CORM-3 administration resulted in a lower level of <span class="hit">neuronal</span> pyroptosis in the hippocampus, improved mitochondrial morphology, a lower mtDNA level, steadier levels of metabolites, decreased expression levels of NLRP3 and pro-caspase-1 interacting with ASC and enhanced locomotor activity. In conclusion, treatment with CORM-3 ameliorated impairments of locomotor and exploratory activities in a rat model of HSR. The mechanism may be associated with the inhibition of mitochondrial DNA-induced pyroptosis via improvements in cell metabolism.</p><p class="hitsHighlighted">© 2020 Spandidos Publications. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2005997561" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2005997561" type="checkbox" id="record_checkbox_L2005997561"><label for="record_checkbox_L2005997561" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">84</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=84&amp;page=1&amp;id=L2005997561" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroprotective effect of CTRP3 overexpression against <span class="hit">sevoflurane</span> anesthesia-induced cognitive dysfunction in aged rats through activating AMPK/SIRT1 and PI3K/AKT signaling pathways</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">L.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">Y.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">European Review for Medical and Pharmacological Sciences</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">24</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(5091-5100)</span>&nbsp;<span class="cited-by" id="CTB-L2005997561"><a href="https://lls.reaxys.com/redir?pid=scp:85085155311" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;10</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-84"><a href="https://www.embase.com/#" class="showAbstract" data="84" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="84"></i> Abstract</a></li><li class="ui-tab" id="indexTab-84"><a href="https://www.embase.com/#" class="showIndexTerms" data="84" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="84"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.26355/eurrev_202005_21202" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="83">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-83"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">OBJECTIVE: To investigate the effects of C1q/tumor necrosis factor-related protein-3 (CTRP3) on postoperative cognitive dysfunction (POCD) and elucidate the potential regulatory mechanism in <span class="hit">sevoflurane</span> anesthesia- induced aged rats. MATERIALS AND METHODS: A <span class="hit">sevoflurane</span> anesthesia-induced POCD aged rat model was established and hematoxylin and eosin (H&amp;E) staining was used to detect pathological changes of hippocampal neurons. Morris water maze task test was performed to determine the learning and memory ability of rats. Immunofluorescence, quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot were used to detect CTRP3 expression. Enzyme-linked immunosorbent assay (ELISA) or qRT-PCR assays were used to evaluate the changes of markers of brain damage and inflammatory cytokines. Terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) assay was used to assess the apoptosis of nerve cells in hippocampus. Western blot assay were used to measure the expression levels of apoptosis-related protein, and AMP-activated protein kinase (AMPK)/SIRT1 and PI3K/AKT pathway. RESULTS: <span class="hit">Sevoflurane</span> exposure led to brain <span class="hit">injury</span>, cognitive dysfunction in aged rats and decreased the expression of CTRP3. Overexpression of CTRP3 could suppress nerve cell apoptosis, inhibit <span class="hit">neuronal</span> inflammation, reduce brain tissue damage and improve cognitive dysfunction of aged rats after <span class="hit">sevoflurane</span> anesthesia. Further studies showed that CTRP3 may play a role in POCD by regulating AMPK/SIRT1 and PI3K/AKT signaling pathways. CONCLUSIONS: CTRP3 may effectively protect against <span class="hit">sevoflurane</span>-induced cognitive dysfunction and served as a potential predictive indicator and therapy target for POCD.</p><p class="hitsHighlighted">© 2020 Verduci Editore s.r.l. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2005997562" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2005997562" type="checkbox" id="record_checkbox_L2005997562"><label for="record_checkbox_L2005997562" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">85</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=85&amp;page=1&amp;id=L2005997562" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> inhibits <span class="hit">neuronal</span> apoptosis and expressions of HIF-1 and HSP70 in brain tissues of rats with cerebral ischemia/reperfusion <span class="hit">injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tong</span> <span class="given-name notranslate">L.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cai</span> <span class="given-name notranslate">D.-S.</span></span><br><span class="journal-title">European Review for Medical and Pharmacological Sciences</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">24</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(5082-5090)</span>&nbsp;<span class="cited-by" id="CTB-L2005997562"><a href="https://lls.reaxys.com/redir?pid=scp:85085157561" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;12</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-85"><a href="https://www.embase.com/#" class="showAbstract" data="85" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="85"></i> Abstract</a></li><li class="ui-tab" id="indexTab-85"><a href="https://www.embase.com/#" class="showIndexTerms" data="85" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="85"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.26355/eurrev_202005_21201" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="84">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-84"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">OBJECTIVE: To observe the influences of <span class="hit">sevoflurane</span> on <span class="hit">neuronal</span> apoptosis and expressions of hypoxia-inducible factor 1 (HIF-1), and heat-shock protein 70 (HSP70) in brain tissues of rats with cerebral ischemia/reperfusion (I/R) <span class="hit">injury</span>. MATERIALS AND METHODS: A total of 60 Sprague-Dawley rats were selected and divided into sham-operation group (Sham group, n=20), cerebral I/R model group (Model group, n=20), and 3% <span class="hit">sevoflurane</span> treatment group (<span class="hit">Sevoflurane</span> group, n=20). The rats in each group received neurological scoring, and the blood and brain tissues were collected to detect the concentrations of serum K+, Na+ and glucose (Glu). Enzyme-linked immunosorbent assay (ELISA) was adopted to measure the levels of inflammatory factors [tumor necrosis factor-β (TNF-β) and interleukin-6 (IL-6)] and oxidative stress [catalase (CAT), malondialdehyde (MDA) and superoxide dismutase (SOD)]. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to determine the nerve cell apoptosis in the brain tissues. The gene and protein expressions of Caspase-3, HIF-1, and HSP70 in the brain tissues were measured via quantitative Reverse Transcription-Polymerase Chain Reaction (qRTPCR) and Western blotting. RESULTS: In <span class="hit">Sevoflurane</span> group, the content of serum Glu and Na+ was decreased markedly, that of K+ was increased notably, and the levels of TNF-β, IL-1 and IL-6 were lowered remarkably compared with those in Model group (p&lt;0.05). Moreover, the neurological score was reduced evidently (p&lt;0.05). Model group had significantly strengthened the activity of MDA and CAT and decreased SOD content, while <span class="hit">Sevoflurane</span> group exhibited the opposite results. TUNEL staining showed that there were distinctly more apoptotic cells that were dominated by glial cells in Model group and fewer apoptotic cells in <span class="hit">Sevoflurane</span> group. It was indicated in gene assay that the messenger ribonucleic acid (mRNA) expression levels of HIF-1, HSP70, and Caspase-3 in Model group were remarkably higher than those in Sham group and <span class="hit">Sevoflurane</span> group (p&lt;0.05). According to the results of Western blotting, the protein expressions of HIF-1 and HSP70 in <span class="hit">Sevoflurane</span> group were markedly lower than those in Model group. CONCLUSIONS: <span class="hit">Sevoflurane</span> can reduce the content of inflammatory factors, inhibit apoptosis, and reduce the expressions of HIF-1 and HSP70 in the case of cerebral I/R <span class="hit">injury</span>, thus exerting protective effects on rats with cerebral I/R <span class="hit">injury</span>.</p><p class="hitsHighlighted">© 2020 Verduci Editore s.r.l. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2006993071" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2006993071" type="checkbox" id="record_checkbox_L2006993071"><label for="record_checkbox_L2006993071" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">86</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=86&amp;page=1&amp;id=L2006993071" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Autophagic Network Analysis of the Dual Effect of <span class="hit">Sevoflurane</span> on Neurons Associated with GABARAPL1 and 2</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lu</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rao</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liangpu Xu</span> </span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">BioMed Research International</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">2020</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 1587214</span>&nbsp;<span class="cited-by" id="CTB-L2006993071"><a href="https://lls.reaxys.com/redir?pid=scp:85087966623" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-86"><a href="https://www.embase.com/#" class="showAbstract" data="86" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="86"></i> Abstract</a></li><li class="ui-tab" id="indexTab-86"><a href="https://www.embase.com/#" class="showIndexTerms" data="86" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="86"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1155/2020/1587214" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="85">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-85"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background. <span class="hit">Sevoflurane</span> is commonly used as a general anesthetic in neonates to aged patients. Preconditioning or postconditioning with <span class="hit">sevoflurane</span> protects neurons from excitotoxic <span class="hit">injury</span>. Conversely, <span class="hit">sevoflurane</span> exposure induces neurotoxicity during early or late life. However, little is known about the underlying mechanism of the dual effect of <span class="hit">sevoflurane</span> on neurons. Autophagy is believed to control <span class="hit">neuronal</span> homeostasis. We hypothesized that autophagy determined the dual effect of <span class="hit">sevoflurane</span> on neurons. Methods. DTome was used to identify the direct protein target (DPT) of <span class="hit">sevoflurane</span>. The STRING database was employed to investigate the proteins associated with the DPTs. Protein-protein interaction was assessed using Cytoscape. WebGestalt was used to analyze gene set enrichment. The linkage between candidate genes and autophagy was identified using GeneCards. Results. This study found that 23 essential DPTs of <span class="hit">sevoflurane</span> interacted with 77 proteins from the STRING database. GABARAPL1 and 2, both of which are DPT- and autophagy-associated proteins, were significantly expressed in the brain and enriched in GABAergic synapses. Conclusions. Taken together, our findings showed that the network of <span class="hit">sevoflurane</span>-DPT-GABARAPL1 and 2 is related to the dual effect of <span class="hit">sevoflurane</span> on neurons.</p><p class="hitsHighlighted">© 2020 Guolin Lu et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2007611723" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2007611723" type="checkbox" id="record_checkbox_L2007611723"><label for="record_checkbox_L2007611723" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">87</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=87&amp;page=1&amp;id=L2007611723" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Non-anaesthetic effects of modern halogen-containing anaesthetics</a><br><span class="author fn notranslate"><span class="family-name notranslate">Grebenchikov</span> <span class="given-name notranslate">O.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Skripkin</span> <span class="given-name notranslate">Y.V.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gerasimenko</span> <span class="given-name notranslate">O.N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kadantseva</span> <span class="given-name notranslate">K.K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bachinskiy</span> <span class="given-name notranslate">A.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Berikashvili</span> <span class="given-name notranslate">L.B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Likhvantsev</span> <span class="given-name notranslate">V.V.</span></span><br><span class="journal-title">Patologiya Krovoobrashcheniya i Kardiokhirurgiya</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">24</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(26-45)</span>&nbsp;<span class="cited-by" id="CTB-L2007611723"><a href="https://lls.reaxys.com/redir?pid=scp:85090096080" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;3</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-87"><a href="https://www.embase.com/#" class="showAbstract" data="87" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="87"></i> Abstract</a></li><li class="ui-tab" id="indexTab-87"><a href="https://www.embase.com/#" class="showIndexTerms" data="87" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="87"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.21688/1681-3472-2020-2-26-45" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="86">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-86"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Many patients undergo surgery under general anaesthesia each day. One of the high-priority tasks for an anesthesiologist is to protect tissues from a systemic inflammatory reaction or oxidative distress (including ischaemia/reperfusion). This review aims to demonstrate the anti-inflammatory and antioxidant properties of general anaesthesia in experimental and clinical studies. Halogenated anaesthetics lead to the inactivation of glycogen synthase kinase-3β (GSK-3β), a key enzyme in the implementation of cellular damage mechanisms and systemic inflammatory response syndrome (SIRS). These mechanisms are implemented through the transcription factor nuclear factor (NF)-κB. As a result of NF-κB activation, gene expression responsible for proinflammatory cytokine synthesis follows, activating leukocytes and disrupts endothelial cell junctions, leading to a disruption of the endothelial barrier, leukocyte infiltration into tissues, and the development of SIRS. Furthermore, GSK-3β phosphorylation causes an increase in the level in <span class="hit">neuronal</span> cells and hepatocytes of transcription factor Nrf2, which is a master regulator of enzyme levels of antioxidant defence in the cell. Thus, halogenated anaesthetics interfere with different elements responsible for the implementation of SIRS and oxidative distress in addition to limiting disturbing factors during the development of multiorgan failure and endothelial dysfunction in experimental sepsis and a model of ischaemia/reperfusion. Understanding these processes can help to reduce many complications during the post-operative period.</p><p class="hitsHighlighted">Copyright: © 2020 Grebenchikov et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L626998834" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L626998834" type="checkbox" id="record_checkbox_L626998834"><label for="record_checkbox_L626998834" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">88</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=88&amp;page=1&amp;id=L626998834" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Subarachnoid Hemorrhage and <span class="hit">Sevoflurane</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Sorar</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Altay</span> <span class="given-name notranslate">O.</span></span><br><span class="journal-title">Turkish neurosurgery</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">30</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(354-360)</span>&nbsp;<span class="cited-by" id="CTB-L626998834"><a href="https://lls.reaxys.com/redir?pid=scp:85085229473" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;7</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-88"><a href="https://www.embase.com/#" class="showAbstract" data="88" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="88"></i> Abstract</a></li><li class="ui-tab" id="indexTab-88"><a href="https://www.embase.com/#" class="showIndexTerms" data="88" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="88"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.5137/1019-5149.JTN.24788-18.1" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="87">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-87"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">AIM: To examine whether post-treatment <span class="hit">sevoflurane</span> is protective against early brain <span class="hit">injury</span> (EBI) after subarachnoid hemorrhage (SAH) and how this neuroprotective effect occurs at different concentrations and durations of administration in mice. Furthermore, we tested whether the neuroprotective effect of post-treatment <span class="hit">sevoflurane</span> is associated with inhibition of apoptosis. MATERIAL AND METHODS: SAH was induced in mice by endovascular perforation. Animals were randomly assigned to five groups in each study. Study 1, sham-operated; SAH+vehicle-air; and SAH+1.5% <span class="hit">sevoflurane</span> for 30, 60, and 90 min. Study 2, SAH+3% <span class="hit">sevoflurane</span> for 30, 60, and 90 min. Study 3, SAH+4.5% <span class="hit">sevoflurane</span> for 30, 60, and 90 min. Neurobehavioral function and brain edema (brain water content) were evaluated 24 h after SAH. Neuroglial cell death was examined by terminal deoxynucleotidyl transferase-mediated uridine 5â€²-triphosphate-biotin nick end-labeling (TUNEL) staining. RESULTS: Administration of 1.5% <span class="hit">sevoflurane</span> for 60 min and 3% <span class="hit">sevoflurane</span> for 30 and 60 min significantly improved neurobehavioral function, brain edema, and attenuated <span class="hit">neuronal</span> cell death in the basal cortex at 24 h after SAH. CONCLUSION: Administration of 1.5% <span class="hit">sevoflurane</span> for 60 min and 3% for 30 and 60 min <span class="hit">sevoflurane</span> application attenuated the development of EBI after SAH, implying its use for anesthesia during acute aneurysm surgery or intervention.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L633101671" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L633101671" type="checkbox" id="record_checkbox_L633101671"><label for="record_checkbox_L633101671" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">89</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=89&amp;page=1&amp;id=L633101671" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Protective role of protocatechuic acid in <span class="hit">sevoflurane</span>-induced neuron apoptosis, inflammation and oxidative stress in mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Han</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Restorative Neurology and Neuroscience</span>&nbsp;<span class="journal-publication-year">2020</span>&nbsp;<span class="journal-volume">38</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(323-331)</span>&nbsp;<span class="cited-by" id="CTB-L633101671"><a href="https://lls.reaxys.com/redir?pid=scp:85092049368" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-89"><a href="https://www.embase.com/#" class="showAbstract" data="89" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="89"></i> Abstract</a></li><li class="ui-tab" id="indexTab-89"><a href="https://www.embase.com/#" class="showIndexTerms" data="89" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="89"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3233/RNN-201022" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="88">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-88"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: In neonatal mice, sevoflurane, inspired through the nasal cavity to act as anesthesia, triggers neuronal apoptosis, inflammation and oxidative injury that can hamper cognitive functions in the growth of the central nervous system in the later stages of life. Objective: Our study aimed to explore the potential neuroprotective effects of protocatechuic acid (PCA) to ameliorate neonatal sevoflurane-induced neurotoxicity. Methods: Male mice were pretreated with PCA (10 or 20 mg/kg) for half an hour before continuous treatment for 6 h with 3 % sevoflurane. TUNEL staining was performed to examine the apoptotic cells to record their count. ELISA was performed to evaluate the expressions of the proteins - IL-1β, IL-18 and TNF-α. Analysis of the Western blot and test of the Morris maze was determined and the results analyzed. Results: TUNEL findings assay showed a significant reduction with sevoflurane in neuronal apoptosis treated with PCA at 20 mg/kg. The expression of protein Caspase-3 showed significant changes in the group SEV + PCA (20 mg/kg). ELISA analysis showed that the levels of IL-18 and TNF-α were significantly reduced in the SEV + PCA (20 mg/kg) group as compared to SEV + PCA (10 mg/kg) group. MDA, ROS and SOD levels were noted to decrease significantly only in the SEV + PCA group (20 mg/kg) while IL-1β levels decreased in both SEV + PCA groups (10 or 20 mg/kg) respectively. Conclusions: Our findings imply that apoptosis, inflammation, and oxidative stress in the hippocampal region of neonatal mouse brain were significantly reduced by pre-treatment with PCA before sevoflurane exposure. Therefore, suggesting a role for PCA as a novel therapeutic agent in the treatment of sevoflurane anesthesia-induced neurobehavioral dysfunction.</p><p class="hitsHighlighted">© 2020 - IOS Press and the authors. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2002748257" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2002748257" type="checkbox" id="record_checkbox_L2002748257"><label for="record_checkbox_L2002748257" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">90</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=90&amp;page=1&amp;id=L2002748257" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Erythropoietin Reduces Neurodegeneration and Long-Term Memory Deficits Following <span class="hit">Sevoflurane</span> Exposure in Neonatal Rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Goyagi</span> <span class="given-name notranslate">T.</span></span><br><span class="journal-title">Neurotoxicity Research</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">36</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(817-826)</span>&nbsp;<span class="cited-by" id="CTB-L2002748257"><a href="https://lls.reaxys.com/redir?pid=scp:85068456443" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;8</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-90"><a href="https://www.embase.com/#" class="showAbstract" data="90" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="90"></i> Abstract</a></li><li class="ui-tab" id="indexTab-90"><a href="https://www.embase.com/#" class="showIndexTerms" data="90" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="90"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12640-019-00028-8" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="89">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-89"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Exposure to general anesthetics induces neural apoptosis and degeneration in the immature neonatal brain. Erythropoietin (EPO) has been shown to protect neonatal animals against hypoxic-ischemic injury and general anesthesia-induced developmental neurotoxicity. However, preventive strategy caused by EPO against neurotoxicity due to general anesthesia is still uncertain. This study examined the effects of EPO administration on brain cytology and cognitive function in adolescent rats exposed to 3% sevoflurane as neonates. Seven-day-old rats received intraperitoneal saline (EPO 0&nbsp;U group) or EPO (60, 120, or 600&nbsp;U) 30&nbsp;min before exposure to 3% sevoflurane with 21% oxygen for 4&nbsp;h. The rats only received 21% oxygen without EPO and sevoflurane as the sham group. The Morris water maze task was performed time-dependently among the groups, 3&nbsp;weeks post-anesthesia exposure. Escape latency and % quadrant in the EPO 600&nbsp;U group were significantly reduced and increased, respectively, compared with those in the EPO 0&nbsp;U group 6&nbsp;weeks post-exposure. In addition, freezing time in response to the conditioned stimulus and the number of NeuN-positive cells in the hippocampal CA1 region were significantly increased in the EPO 120 and 600&nbsp;U groups than in the EPO 0&nbsp;U group 6&nbsp;weeks after exposure. Moreover, the statistical parameter mapping of positive cell density was increased in the EPO-treated rats. These results support the observations that pretreatment with EPO reduced long-term cognitive deficits and neuronal degeneration in cortex and hippocampus induced by sevoflurane exposure with low oxygen concentration in neonatal rats.</p><p class="hitsHighlighted">© 2019, Springer Science+Business Media, LLC, part of Springer Nature.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2002152822" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2002152822" type="checkbox" id="record_checkbox_L2002152822"><label for="record_checkbox_L2002152822" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">91</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=91&amp;page=1&amp;id=L2002152822" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Mild hypothermia ameliorates anesthesia toxicity in the neonatal macaque brain</a><br><span class="author fn notranslate"><span class="family-name notranslate">Ikonomidou</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kirvassilis</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Swiney</span> <span class="given-name notranslate">B.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">S.H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huffman</span> <span class="given-name notranslate">J.N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Williams</span> <span class="given-name notranslate">S.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Masuoka</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Capuano</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brunner</span> <span class="given-name notranslate">K.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Crosno</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Simmons</span> <span class="given-name notranslate">H.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mejia</span> <span class="given-name notranslate">A.F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Turski</span> <span class="given-name notranslate">C.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brambrink</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Noguchi</span> <span class="given-name notranslate">K.K.</span></span><br><span class="journal-title">Neurobiology of Disease</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">130</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 104489</span>&nbsp;<span class="cited-by" id="CTB-L2002152822"><a href="https://lls.reaxys.com/redir?pid=scp:85067578632" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;14</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-91"><a href="https://www.embase.com/#" class="showAbstract" data="91" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="91"></i> Abstract</a></li><li class="ui-tab" id="indexTab-91"><a href="https://www.embase.com/#" class="showIndexTerms" data="91" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="91"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.nbd.2019.104489" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="90">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-90"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Sedatives and anesthetics can injure the developing brain. They cause apoptosis of neurons and oligodendrocytes, impair synaptic plasticity, inhibit neurogenesis and trigger long-term neurocognitive deficits. The projected vulnerable period in humans extends from the third trimester of pregnancy to the third year of life. Despite all concerns, there is no ethically and medically acceptable alternative to the use of sedatives and anesthetics for surgeries and painful interventions. Development of measures that prevent <span class="hit">injury</span> while allowing the medications to exert their desired actions has enormous translational value. Here we investigated protective potential of hypothermia against histological toxicity of the anesthetic <span class="hit">sevoflurane</span> in the developing nonhuman primate brain. Neonatal rhesus monkeys underwent <span class="hit">sevoflurane</span> anesthesia over 5 h. Body temperature was regulated in the normothermic (&gt;36.5 °C), mild hypothermic (35–36.5 °C) and moderately hypothermic (&lt;35 °C) range. Animals were euthanized at 8 h and brains examined immunohistochemically (activated caspase 3) and stereologically to quantify apoptotic <span class="hit">neuronal</span> and oligodendroglial death. <span class="hit">Sevoflurane</span> anesthesia was well tolerated at all temperatures, with oxygen saturations, end tidal CO<sub>2</sub> and blood gases remaining at optimal levels. Compared to controls, <span class="hit">sevoflurane</span> exposed brains displayed significant apoptosis in gray and white matter affecting neurons and oligodendrocytes. Mild hypothermia (35–36.5 °C) conferred significant protection from apoptotic brain <span class="hit">injury</span>, whereas moderate hypothermia (&lt;35 °C) did not. Hypothermia ameliorates anesthesia-induced apoptosis in the neonatal primate brain within a narrow temperature window (35–36.5 °C). Protection is lost at temperatures below 35 °C. Given the mild degree of cooling needed to achieve significant brain protection, application of our findings to humans should be explored further.</p><p class="hitsHighlighted">© 2019 Elsevier Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2002085448" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2002085448" type="checkbox" id="record_checkbox_L2002085448"><label for="record_checkbox_L2002085448" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">92</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=92&amp;page=1&amp;id=L2002085448" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroglobin protects offspring rats from <span class="hit">neuronal</span> damage induced by <span class="hit">sevoflurane</span> exposure to pregnant rats by inhibiting endogenous apoptosis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shan</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">International Journal of Developmental Neuroscience</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">76</span><span class="journal-pages">&nbsp;(17-24)</span>&nbsp;<span class="cited-by" id="CTB-L2002085448"><a href="https://lls.reaxys.com/redir?pid=scp:85066872597" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;7</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-92"><a href="https://www.embase.com/#" class="showAbstract" data="92" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="92"></i> Abstract</a></li><li class="ui-tab" id="indexTab-92"><a href="https://www.embase.com/#" class="showIndexTerms" data="92" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="92"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.ijdevneu.2019.06.001" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="91">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-91"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">As a general anesthesia drug, <span class="hit">sevoflurane</span> has been found to be potentially neurotoxic to the developing brain. Neuroglobin (Ngb) is a novel oxygen-carrying globulin that has been demonstrated to have neuroprotective effects in a variety of central nervous system disorders. However, it is unclear whether Ngb has a protective effect on nerve damage caused by <span class="hit">sevoflurane</span>. Therefore, this study was designed to investigate the effect and related mechanisms of Ngb on neural <span class="hit">injury</span> induced by <span class="hit">sevoflurane</span>. Pregnant rats on gestational day 20 (G20) were exposed to 3.5% <span class="hit">sevoflurane</span> for two hours, which led to an increase of Ngb on the 0-1st day after birth and decreased significantly on the 3rd day, while Cytochrome c increased from the 1 st day until the 7th day of offspring rats. Meanwhile, <span class="hit">sevoflurane</span> reduced Bcl-2 and Hif-1αand increased Bax and cleaved-caspase 3 in the third day after birth. Hemin inhibits endogenous apoptosis by increasing Ngb and Hif-1α. And increased Ngb improved the damage of long-term learning and memory induced by <span class="hit">sevoflurane</span> and increased the number of neurons in the hippocampus. We concluded that Ngb can improve the <span class="hit">neuronal injury</span> induced by <span class="hit">sevoflurane</span> exposure by inhibiting apoptosis and increasing the number of neurons. And this protective effect of Ngb may be related to Hif-1α signaling pathway. This finding may provide a novel therapeutic approach for <span class="hit">sevoflurane</span> -induced nerve damage.</p><p class="hitsHighlighted">© 2019</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001825495" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001825495" type="checkbox" id="record_checkbox_L2001825495"><label for="record_checkbox_L2001825495" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">93</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=93&amp;page=1&amp;id=L2001825495" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Quantitative ultrasound and apoptotic death in the neonatal primate brain</a><br><span class="author fn notranslate"><span class="family-name notranslate">Rosado-Mendez</span> <span class="given-name notranslate">I.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Noguchi</span> <span class="given-name notranslate">K.K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Castañeda-Martinez</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kirvassilis</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">S.H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Manzella</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Swiney</span> <span class="given-name notranslate">B.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Masuoka</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Capuano</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brunner</span> <span class="given-name notranslate">K.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Crosno</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guerrero</span> <span class="given-name notranslate">Q.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Whitson</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brambrink</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Simmons</span> <span class="given-name notranslate">H.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mejia</span> <span class="given-name notranslate">A.F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zagzebski</span> <span class="given-name notranslate">J.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hall</span> <span class="given-name notranslate">T.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ikonomidou</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Neurobiology of Disease</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">127</span><span class="journal-pages">&nbsp;(554-562)</span>&nbsp;<span class="cited-by" id="CTB-L2001825495"><a href="https://lls.reaxys.com/redir?pid=scp:85064213696" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-93"><a href="https://www.embase.com/#" class="showAbstract" data="93" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="93"></i> Abstract</a></li><li class="ui-tab" id="indexTab-93"><a href="https://www.embase.com/#" class="showIndexTerms" data="93" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="93"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.nbd.2019.03.032" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="92">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-92"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Apoptosis is triggered in the developing mammalian brain by sedative, anesthetic or antiepileptic drugs during late gestation and early life. Whether human children are vulnerable to this toxicity mechanism remains unknown, as there are no imaging techniques to capture it. Apoptosis is characterized by distinct structural features, which affect the way damaged tissue scatters ultrasound compared to healthy tissue. We evaluated whether apoptosis, triggered by the anesthetic <span class="hit">sevoflurane</span> in the brains of neonatal rhesus macaques, can be detected using quantitative ultrasound (QUS). Neonatal (n = 15) rhesus macaques underwent 5 h of <span class="hit">sevoflurane</span> anesthesia. QUS images were obtained through the sagittal suture at 0.5 and 6 h. Brains were collected at 8 h and examined immunohistochemically to analyze apoptotic <span class="hit">neuronal</span> and oligodendroglial death. Significant apoptosis was detected in white and gray matter throughout the brain, including the thalamus. We measured a change in the effective scatterer size (ESS), a QUS biomarker derived from ultrasound echo signals obtained with clinical scanners, after <span class="hit">sevoflurane</span>-anesthesia in the thalamus. Although initial inclusion of all measurements did not reveal a significant correlation, when outliers were excluded, the change in the ESS between the pre- and post-anesthesia measurements correlated strongly and proportionally with the severity of apoptotic death. We report for the first time in vivo changes in QUS parameters, which may reflect severity of apoptosis in the brains of infant nonhuman primates. These findings suggest that QUS may enable in vivo studies of apoptosis in the brains of human infants following exposure to anesthetics, antiepileptics and other brain <span class="hit">injury</span> mechanisms.</p><p class="hitsHighlighted">© 2019 Elsevier Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001796143" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001796143" type="checkbox" id="record_checkbox_L2001796143"><label for="record_checkbox_L2001796143" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">94</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=94&amp;page=1&amp;id=L2001796143" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Dexmedetomidine reduced <span class="hit">sevoflurane</span>-induced neurodegeneration and long-term memory deficits in neonatal rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Goyagi</span> <span class="given-name notranslate">T.</span></span><br><span class="journal-title">International Journal of Developmental Neuroscience</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">75</span><span class="journal-pages">&nbsp;(19-26)</span>&nbsp;<span class="cited-by" id="CTB-L2001796143"><a href="https://lls.reaxys.com/redir?pid=scp:85063940705" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;15</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-94"><a href="https://www.embase.com/#" class="showAbstract" data="94" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="94"></i> Abstract</a></li><li class="ui-tab" id="indexTab-94"><a href="https://www.embase.com/#" class="showIndexTerms" data="94" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="94"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.ijdevneu.2019.04.002" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="93">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-93"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Exposure to <span class="hit">sevoflurane</span> and other inhalational anesthetics can induce neurodegeneration in the developing brain. Although dexmedetomidine (DEX) has provided neuroprotection against hypoxic ischemic <span class="hit">injury</span>, relatively little is known about whether it has the neuroprotective effects against anesthetic-induced neurodegeneration. This study examined whether DEX improves the long-term cognitive dysfunction observed after exposure of neonatal rats to 3% <span class="hit">sevoflurane</span>. Seven-day-old rats received intraperitoneal saline (DEX 0) or DEX (6.6, 12.5, 25 μg/kg) 30 min before exposure to 3% <span class="hit">sevoflurane</span> with 21% oxygen for 4 h (n = 10 per group). The pups in the control group received only DEX 25 μg/kg without anesthesia. The escape latency in the Morris water maze was significantly increased in the DEX 0 group compared with the sham and control group, and the escape latency, but not the swimming path length, was significantly shorter at post-natal day 47 in the DEX 25 than in the DEX 0 group. The percent time spent in the quadrant was significantly decreased in the DEX 0 group compared with the sham and control group, and the percent time spent in the quadrant was significantly increased in the DEX 25 group compared with the DEX 0 groups. The freezing times of the DEX 0 and 6.6 groups were significantly decreased compared with those in the sham, control and DEX 25 groups. The number of NeuN-positive cells in the CA1 region was significantly decreased in the DEX 0 and 6.6 groups compared with the sham, control and DEX 25 groups. These findings indicate pre-treatment with DEX may improve long-term cognitive function and ameliorate the <span class="hit">neuronal</span> degeneration induced by <span class="hit">sevoflurane</span> exposure in neonatal rats.</p><p class="hitsHighlighted">© 2019 ISDN</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001421838" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001421838" type="checkbox" id="record_checkbox_L2001421838"><label for="record_checkbox_L2001421838" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">95</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=95&amp;page=1&amp;id=L2001421838" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span>-induced learning deficits and spine loss via nectin-1/corticotrophin-releasing hormone receptor type 1 signalling in neonatal mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Y.H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">G.L.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">122</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(e38-)</span>&nbsp;<span class="cited-by" id="CTB-L2001421838"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-95"><a href="https://www.embase.com/#" class="showAbstract" data="95" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="95"></i> Abstract</a></li><li class="ui-tab" id="indexTab-95"><a href="https://www.embase.com/#" class="showIndexTerms" data="95" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="95"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bja.2018.10.011" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="94">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-94"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> is one of the most commonly used volatile anaesthetics in general anaesthesia in children. <span class="hit">Sevoflurane</span> anaesthesia (2–2.5% for 4–6 h) can cause <span class="hit">neuronal</span> apoptosis and long-term learning and memory impairment in multiple brain regions of neonatal rats<sup>1,2</sup>. Therefore, it is necessary to study the acute and chronic mechanism of general anaesthetic-induced brain developmental <span class="hit">injury</span>. This study examined the changes in nectin-1 after exposure to <span class="hit">sevoflurane</span> in newborn mice in the hippocampal CA3 area. In addition, this study investigated the role of CRH/CRHR1 in <span class="hit">sevoflurane</span>-induced nectin-1 expression changes and assessed whether overexpression of nectin-1 in the adult hippocampus can reduce cognitive impairment and dendritic spine reduction caused by early <span class="hit">sevoflurane</span> exposure. Seven-day-old C57BL/6J mice were randomly assigned to either control or <span class="hit">sevoflurane</span> groups. Mice in the <span class="hit">sevoflurane</span> group were given 3% <span class="hit">sevoflurane</span> with a fresh airflow of 1 L min<sup>–1</sup> 100% O<sub>2</sub> for 6 h. The control group received 1 L min<sup>–1</sup> 100% O<sub>2</sub> for 6 h. A gas monitor was used to measure the concentration of <span class="hit">sevoflurane</span> inhalation. When the mice were 21 days old, AAV5-shNEC or AAV5-OE was injected into the ventricle or hippocampal CA3 region to knock down or overexpress nectin-1. The mice were allowed to recover for 4 weeks after injection to allow sufficient viral infection. The water maze was tested for spatial cognitive function from 50 to 57 days. The Y-maze short-term working memory experiment was performed at 58 days. The new object recognition test was conducted at 59 days. Hippocampal tissues were harvested before <span class="hit">sevoflurane</span> or 100% O<sub>2</sub> exposure, 1 h, 4 h, 8 h, 1 day (8 days old), 2 days (9 days old), 3 days (10 days old), and 53 days (60 days old) after <span class="hit">sevoflurane</span> or 100% O<sub>2</sub> exposure for western blot, Golgi impregnation, and immunofluorescence staining. <span class="hit">Sevoflurane</span> exposure in neonatal mice impaired learning and memory and decreased hippocampal nectin-1 protein level and spine number in adulthood. <span class="hit">Sevoflurane</span> inhalation for 6 h in neonatal mice impaired memory and learning in adulthood. In addition, <span class="hit">sevoflurane</span>-induced learning and memory impairment may be related to the decrease in nectin-1 and spine plasticity. <span class="hit">Sevoflurane</span> modulates nectin-1 expression by CRH/CRHR1 signalling in vitro and in vivo. CRH/CRHR1 signalling mediated nectin-1 protein expression through the MAPK pathway in the hippocampus. Suppression of hippocampal nectin-1 impairs cognitive function, indicating that nectin-1 is important for short-term and long-term spatial memory, which may be related to decreased spine density in CA3 neurones. Nectin-1 overexpression alleviated <span class="hit">sevoflurane</span>-induced learning deficits and spine loss. This study aimed to examine the mechanism of <span class="hit">sevoflurane</span>-induced neurotoxicity on learning and memory impairment. This study confirmed that 7 day old mice exposed to <span class="hit">sevoflurane</span> for 6 h could increase CRH levels in the hippocampus and activate CRHR1, thereby reducing the expression of nectin-1 in the hippocampal CA3 region. Decreased expression of nectin-1 in the hippocampus can lead to decreased dendritic spine formation and learning and memory deficits in adulthood. This study indicated that the CRH/CRHR1-nectin-1 pathway may be involved in <span class="hit">sevoflurane</span> neurotoxicity and provides new ideas for prevention and treatment of paediatric neurotoxicity via inhalation of general anaesthetics. References: 1. Kalkman CJ, Peelen L, Moons KG, et al. Anesthesiology 2009; 110: 805–12 2. Fang F, Xue Z, Cang J. Neurosci Bull 2012; 28: 499–508</p><p class="hitsHighlighted">© 2018</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001571826" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001571826" type="checkbox" id="record_checkbox_L2001571826"><label for="record_checkbox_L2001571826" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">96</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=96&amp;page=1&amp;id=L2001571826" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial</a><br><span class="author fn notranslate"><span class="family-name notranslate">McCann</span> <span class="given-name notranslate">M.E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Berde</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Soriano</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Marmor</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bellinger</span> <span class="given-name notranslate">D.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">de Graaff</span> <span class="given-name notranslate">J.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dorris</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bell</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Morton</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dorris</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Morton</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Disma</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Giribaldi</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Withington</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Grobler</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Stargatt</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hunt</span> <span class="given-name notranslate">R.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sheppard</span> <span class="given-name notranslate">S.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hartmann</span> <span class="given-name notranslate">P.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Frawley</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Davidson</span> <span class="given-name notranslate">A.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hunt</span> <span class="given-name notranslate">R.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Frawley</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Davidson</span> <span class="given-name notranslate">A.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Stargatt</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hunt</span> <span class="given-name notranslate">R.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Frawley</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Davidson</span> <span class="given-name notranslate">A.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hartmann</span> <span class="given-name notranslate">P.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hardy</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Izzo</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">von Ungern Sternberg</span> <span class="given-name notranslate">B.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">von Ungern Sternberg</span> <span class="given-name notranslate">B.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">von Ungern Sternberg</span> <span class="given-name notranslate">B.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lynn</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lynn</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wilton</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mueller</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Polaner</span> <span class="given-name notranslate">D.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Polaner</span> <span class="given-name notranslate">D.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Absalom</span> <span class="given-name notranslate">A.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Szmuk</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Szmuk</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Davidson</span> <span class="given-name notranslate">A.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Frawley</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hardy</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Arnup</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hunt</span> <span class="given-name notranslate">R.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Stargatt</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sheppard</span> <span class="given-name notranslate">S.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ormond</span> <span class="given-name notranslate">G.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hartmann</span> <span class="given-name notranslate">P.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Takagi</span> <span class="given-name notranslate">M.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Taylor</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Malarbi</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Doyle</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ragg</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Costi</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">von Ungern-Sternberg</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wilton</span> <span class="given-name notranslate">N.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Knottenbelt</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Furue</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gagnon</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mameli</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Giribaldi</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pini Prato</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mattioli</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wolfler</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Izzo</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bova</span> <span class="given-name notranslate">S.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Krachmalnicoff</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guuva</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">van der Werff</span> <span class="given-name notranslate">D.B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">van Gool</span> <span class="given-name notranslate">J.T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">van Loon</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kalkman</span> <span class="given-name notranslate">C.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">van Baar</span> <span class="given-name notranslate">A.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Absalom</span> <span class="given-name notranslate">A.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hoekstra</span> <span class="given-name notranslate">F.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Volkers</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Oostra</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bell</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dorris</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Morton</span> <span class="given-name notranslate">N.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pownall</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Waldman</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hind</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Symonds</span> <span class="given-name notranslate">J.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bagshaw</span> <span class="given-name notranslate">O.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">McCann</span> <span class="given-name notranslate">M.E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Berde</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Soriano</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sethna</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kovatsis</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cravero</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Marmor</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lynn</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ivanova</span> <span class="given-name notranslate">I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hunyady</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Verma</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Polaner</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Thomas</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mueller</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Haret</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Szmuk</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Steiner</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kravitz</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Farrow-Gillespie</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Suresh</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hays</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Taenzer</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Maxwell</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Williams</span> <span class="given-name notranslate">R.</span></span><br><span class="journal-title">The Lancet</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">393</span><span class="journal-issue">:10172</span><span class="journal-pages">&nbsp;(664-677)</span>&nbsp;<span class="cited-by" id="CTB-L2001571826"><a href="https://lls.reaxys.com/redir?pid=scp:85061349175" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;271</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-96"><a href="https://www.embase.com/#" class="showAbstract" data="96" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="96"></i> Abstract</a></li><li class="ui-tab" id="indexTab-96"><a href="https://www.embase.com/#" class="showIndexTerms" data="96" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="96"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/S0140-6736(18)32485-1" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="95">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-95"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: In laboratory animals, exposure to most general anaesthetics leads to neurotoxicity manifested by <span class="hit">neuronal</span> cell death and abnormal behaviour and cognition. Some large human cohort studies have shown an association between general anaesthesia at a young age and subsequent neurodevelopmental deficits, but these studies are prone to bias. Others have found no evidence for an association. We aimed to establish whether general anaesthesia in early infancy affects neurodevelopmental outcomes. Methods: In this international, assessor-masked, equivalence, randomised, controlled trial conducted at 28 hospitals in Australia, Italy, the USA, the UK, Canada, the Netherlands, and New Zealand, we recruited infants of less than 60 weeks' postmenstrual age who were born at more than 26 weeks' gestation and were undergoing inguinal herniorrhaphy, without previous exposure to general anaesthesia or risk factors for neurological <span class="hit">injury</span>. Patients were randomly assigned (1:1) by use of a web-based randomisation service to receive either awake-regional anaesthetic or <span class="hit">sevoflurane</span>-based general anaesthetic. Anaesthetists were aware of group allocation, but individuals administering the neurodevelopmental assessments were not. Parents were informed of their infants group allocation upon request, but were told to mask this information from assessors. The primary outcome measure was full-scale intelligence quotient (FSIQ) on the Wechsler Preschool and Primary Scale of Intelligence, third edition (WPPSI-III), at 5 years of age. The primary analysis was done on a per-protocol basis, adjusted for gestational age at birth and country, with multiple imputation used to account for missing data. An intention-to-treat analysis was also done. A difference in means of 5 points was predefined as the clinical equivalence margin. This completed trial is registered with ANZCTR, number ACTRN12606000441516, and ClinicalTrials.gov, number NCT00756600. Findings: Between Feb 9, 2007, and Jan 31, 2013, 4023 infants were screened and 722 were randomly allocated: 363 (50%) to the awake-regional anaesthesia group and 359 (50%) to the general anaesthesia group. There were 74 protocol violations in the awake-regional anaesthesia group and two in the general anaesthesia group. Primary outcome data for the per-protocol analysis were obtained from 205 children in the awake-regional anaesthesia group and 242 in the general anaesthesia group. The median duration of general anaesthesia was 54 min (IQR 41–70). The mean FSIQ score was 99·08 (SD 18·35) in the awake-regional anaesthesia group and 98·97 (19·66) in the general anaesthesia group, with a difference in means (awake-regional anaesthesia minus general anaesthesia) of 0·23 (95% CI −2·59 to 3·06), providing strong evidence of equivalence. The results of the intention-to-treat analysis were similar to those of the per-protocol analysis. Interpretation: Slightly less than 1 h of general anaesthesia in early infancy does not alter neurodevelopmental outcome at age 5 years compared with awake-regional anaesthesia in a predominantly male study population. Funding: US National Institutes of Health, US Food and Drug Administration, Thrasher Research Fund, Australian National Health and Medical Research Council, Health Technologies Assessment–National Institute for Health Research (UK), Australian and New Zealand College of Anaesthetists, Murdoch Children's Research Institute, Canadian Institutes of Health Research, Canadian Anesthesiologists Society, Pfizer Canada, Italian Ministry of Health, Fonds NutsOhra, UK Clinical Research Network, Perth Children's Hospital Foundation, the Stan Perron Charitable Trust, and the Callahan Estate.</p><p class="hitsHighlighted">© 2019 Elsevier Ltd</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L625609706" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L625609706" type="checkbox" id="record_checkbox_L625609706"><label for="record_checkbox_L625609706" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">97</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=97&amp;page=1&amp;id=L625609706" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effect of <span class="hit">sevoflurane</span> preconditioning on astrocytic dynamics and neural network formation after cerebral ischemia and reperfusion in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liang</span> <span class="given-name notranslate">W.-M.</span></span><br><span class="journal-title">Neural Regeneration Research</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">14</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(265-271)</span>&nbsp;<span class="cited-by" id="CTB-L625609706"><a href="https://lls.reaxys.com/redir?pid=scp:85058892464" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-97"><a href="https://www.embase.com/#" class="showAbstract" data="97" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="97"></i> Abstract</a></li><li class="ui-tab" id="indexTab-97"><a href="https://www.embase.com/#" class="showIndexTerms" data="97" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="97"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.4103/1673-5374.244790" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="96">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-96"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Astrocytes, the major component of blood-brain barriers, have presented paradoxical profiles after cerebral ischemia and reperfusion in vivo and in vitro. Our previous study showed that <span class="hit">sevoflurane</span> preconditioning improved the integrity of blood-brain barriers after ischemia and reperfusion <span class="hit">injury</span> in rats. This led us to investigate the effects of <span class="hit">sevoflurane</span> preconditioning on the astrocytic dynamics in ischemia and reperfusion rats, in order to explore astrocytic cell-based mechanisms of <span class="hit">sevoflurane</span> preconditioning. In the present study, 2,3,5-triphenyltetrazolium chloride staining and Garcia behavioral scores were utilized to evaluate cerebral infarction and neurological outcome from day 1 to day 3 after transient middle cerebral artery occlusion surgery. Using immunofluorescent staining, we found that <span class="hit">sevoflurane</span> preconditioning substantially promoted the astrocytic activation and migration from the penumbra to the infarct with microglial activation from day 3 after middle cerebral artery occlusion. The formation of astrocytic scaffolds facilitated neuroblasts migrating from the subventricular zone to the lesion sites on day 14 after <span class="hit">injury</span>. Neural networks increased in the infarct of <span class="hit">sevoflurane</span> preconditioned rats, consistent with decreased infarct volume and improved neurological scores after ischemia and reperfusion <span class="hit">injury</span>. These findings demonstrate that <span class="hit">sevoflurane</span> preconditioning confers neuroprotection, not only by accelerating astrocytic spatial and temporal dynamics, but also providing astrocytic scaffolds for neuroblasts migration to ischemic regions, which facilitates neural reconstruction after brain ischemia.</p><p class="hitsHighlighted">© 2019 Medknow Publications. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L625637625" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L625637625" type="checkbox" id="record_checkbox_L625637625"><label for="record_checkbox_L625637625" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">98</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=98&amp;page=1&amp;id=L625637625" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Metformin protects against <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis through the s1p1 and erk signaling pathways</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yue</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Luo</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">Experimental and Therapeutic Medicine</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">17</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(1463-1469)</span>&nbsp;<span class="cited-by" id="CTB-L625637625"><a href="https://lls.reaxys.com/redir?pid=scp:85082375288" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-98"><a href="https://www.embase.com/#" class="showAbstract" data="98" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="98"></i> Abstract</a></li><li class="ui-tab" id="indexTab-98"><a href="https://www.embase.com/#" class="showIndexTerms" data="98" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="98"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/etm.2018.7098" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="97">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-97"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The aim of the current study was to investigate whether metformin could counteract <span class="hit">sevoflurane</span>-induced neurotoxicity. In vitro experiments on the <span class="hit">sevoflurane</span>-induced nerve <span class="hit">injury</span> were performed using hippocampal neurons. <span class="hit">Neuronal</span> apoptosis was detected by an MTT assay. Protein expression levels of apoptosis-associated genes, including cleaved-caspase-3, apoptosis regulator BAX and apoptosis regulator Bcl-2 were detected by western blot analysis. The mechanism of the effect of metformin on <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis was investigated using a sphingosine 1-phosphate receptor 1 (S1P1) antagonist (VPC23019) and mitogen-activated protein kinase kinase inhibitor (U0126). The current study revealed that metformin may reduce <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis via activating mitogen-activated protein kinase (ERK)1/2 phosphorylation. VPC23019 and U0126 eliminated the neuroprotective effects of metformin on <span class="hit">neuronal</span> apoptosis, which suggests that metformin is able to protect against <span class="hit">sevoflurane</span>-induced neurotoxicity via activation of the S1P1-dependent ERK1/2 signaling pathway.</p><p class="hitsHighlighted">© 2018, Spandidos Publications. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001967610" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001967610" type="checkbox" id="record_checkbox_L2001967610"><label for="record_checkbox_L2001967610" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">99</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=99&amp;page=1&amp;id=L2001967610" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> post-conditioning alleviates neonatal rat hypoxic-ischemic cerebral <span class="hit">injury</span> via Ezh2-regulated autophagy</a><br><span class="author fn notranslate"><span class="family-name notranslate">Xue</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">Z.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">X.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Niu</span> <span class="given-name notranslate">J.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">Q.-S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">P.</span></span><br><span class="journal-title">Drug Design, Development and Therapy</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">13</span><span class="journal-pages">&nbsp;(1691-1706)</span>&nbsp;<span class="cited-by" id="CTB-L2001967610"><a href="https://lls.reaxys.com/redir?pid=scp:85066749189" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;29</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-99"><a href="https://www.embase.com/#" class="showAbstract" data="99" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="99"></i> Abstract</a></li><li class="ui-tab" id="indexTab-99"><a href="https://www.embase.com/#" class="showIndexTerms" data="99" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="99"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.2147/DDDT.S197325" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="98">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-98"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: When neonatal rats suffer hypoxic-ischemic brain <span class="hit">injury</span> (HIBI), autophagy is over-activated in the hippocampus, and inhibition of autophagy provides neuroprotection. The aim of this study was to investigate the possible roles of autophagy and Ezh2-regulated Pten/Akt/mTOR pathway in <span class="hit">sevoflurane</span> post-conditioning (SPC)-mediated neuroprotection against HIBI in neonatal rats. Methods: Seven-day-old Sprague–Dawley rats underwent left common artery ligation followed by 2 h hypoxia as described in the Rice–Vannucci model. The roles of autophagy and the Ezh2-regulated Pten/Akt/mTOR signaling pathway in the neuroprotection conferred by SPC were examined by left-side intracerebroventricular injection with the autophagy activator rapamycin and the Ezh2 inhibitor GSK126. Results: SPC was neuroprotective against HIBI through the inhibition of over-activated autophagy in the hippocampus as characterized by the rapamycin-induced reversal of <span class="hit">neuronal</span> density, <span class="hit">neuronal</span> morphology, cerebral morphology, and the expression of the autophagy markers, LC3B-II and Beclin1. SPC significantly increased the expression of Ezh2, H3K27me3, pAkt, and mTOR and decreased the expression of Pten induced by HI. The Ezh2 inhibitor, GSK126, significantly reversed the SPC-induced changes in expression of H3K27me3, Pten, pAkt, mTOR, LC3B-II, and Beclin1. Ezh2 inhibition also reversed SPC-mediated attenuation of <span class="hit">neuronal</span> loss and behavioral improvement in the Morris water maze. Conclusion: These results indicate that SPC inhibits excessive autophagy via the regulation of Pten/Akt/mTOR signaling by Ezh2 to confer neuroprotection against HIBI in neonatal rats.</p><p class="hitsHighlighted">© 2019 Xue et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L623016099" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L623016099" type="checkbox" id="record_checkbox_L623016099"><label for="record_checkbox_L623016099" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">100</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=100&amp;page=1&amp;id=L623016099" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> postconditioning protects against myocardial ischemia/reperfusion <span class="hit">injury</span> by restoring autophagic flux via an NO-dependent mechanism</a><br><span class="author fn notranslate"><span class="family-name notranslate">Qiao</span> <span class="given-name notranslate">S.-G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Qiu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hong</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">An</span> <span class="given-name notranslate">J.-Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">H.-L.</span></span><br><span class="journal-title">Acta Pharmacologica Sinica</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">40</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(35-45)</span>&nbsp;<span class="cited-by" id="CTB-L623016099"><a href="https://lls.reaxys.com/redir?pid=scp:85049779401" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;39</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-100"><a href="https://www.embase.com/#" class="showAbstract" data="100" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="100"></i> Abstract</a></li><li class="ui-tab" id="indexTab-100"><a href="https://www.embase.com/#" class="showIndexTerms" data="100" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="100"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1038/s41401-018-0066-y" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="99">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-99"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Volatile anesthetics improve postischemic cardiac function and reduce infarction even when administered for only a brief time at the onset of reperfusion. A recent study showed that <span class="hit">sevoflurane</span> postconditioning (SPC) attenuated myocardial reperfusion <span class="hit">injury</span>, but the underlying mechanisms remain unclear. In this study, we examined the effects of <span class="hit">sevoflurane</span> on nitric oxide (NO) release and autophagic flux during the myocardial ischemia/reperfusion (I/R) <span class="hit">injury</span> in rats in vivo and ex vivo. Male rats were subjected to 30 min ischemia and 2 h reperfusion in the presence or absence of <span class="hit">sevoflurane</span> (1.0 minimum alveolar concentration) during the first 15 min of reperfusion. We found that SPC significantly improved hemodynamic performance after reperfusion, alleviated postischemic myocardial infarction, reduced nicotinamide adenine dinucleotide content loss, and cytochrome c release in heart tissues. Furthermore, SPC significantly increased the phosphorylation of endothelial nitric oxide synthase (NOS) and <span class="hit">neuronal</span> nitric oxide synthase, and elevated myocardial NOS activity and NO production. All these effects were abolished by treatment with an NOS inhibitor NG-nitro-l-arginine methyl ester (l-NAME, 10 mg/kg, i.v.). We also observed myocardial I/R-induced accumulation of autophagosomes in heart tissues, as evidenced by increased ratios of microtubule-associated protein 1 light chain 3 II/I, up-regulation of Beclin 1 and P62, and reduced lysosome-associated membrane protein-2 expression. SPC significantly attenuated I/R-impaired autophagic flux, which were blocked by l-NAME. Moreover, pretreatment with the autophagic flux blocker chloroquine (10 mg/kg, i.p.) increased autophagosome accumulation in SPC-treated heart following I/R and blocked SPC-induced cardioprotection. The same results were also observed in a rat model of myocardial I/R <span class="hit">injury</span> ex vivo, suggesting that SPC protects rat hearts against myocardial reperfusion <span class="hit">injury</span> by restoring I/R-impaired autophagic flux via an NO-dependent mechanism.</p><p class="hitsHighlighted">© 2018, CPS and SIMM.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L631344272" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L631344272" type="checkbox" id="record_checkbox_L631344272"><label for="record_checkbox_L631344272" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">101</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=101&amp;page=1&amp;id=L631344272" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Anaesthetic neuroprotection in children: Does it exist or is it all just bad</a><br><span class="author fn notranslate"><span class="family-name notranslate">Marchesini</span> <span class="given-name notranslate">V.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Disma</span> <span class="given-name notranslate">N.</span></span><br><span class="journal-title">Current Opinion in Anaesthesiology</span>&nbsp;<span class="journal-publication-year">2019</span>&nbsp;<span class="journal-volume">32</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(363-369)</span>&nbsp;<span class="cited-by" id="CTB-L631344272"><a href="https://lls.reaxys.com/redir?pid=scp:85065510138" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;7</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-101"><a href="https://www.embase.com/#" class="showAbstract" data="101" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="101"></i> Abstract</a></li><li class="ui-tab" id="indexTab-101"><a href="https://www.embase.com/#" class="showIndexTerms" data="101" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="101"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ACO.0000000000000723" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="100">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-100"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Purpose of reviewIn the last 20 years, data from studies of laboratory animals, including nonhuman primates, have provided ample evidence that general anaesthetic drugs cause pathological changes in developing central nervous system (neurotoxicity). Recently, a new area of research has been developed in order to recognize any possible actions that can attenuate anaesthetics neurotoxicity. This review aims to provide an overview of the recent literature on neuroprotection.Recent findingsNeuroprotection includes a variety of actions that aim to preserve <span class="hit">neuronal</span> structures and/or function against insults caused by sedative and anaesthetic agents. Neuroprotective solutions include prevention of damage, such as postponing procedure, and counterbalance the damage. Mitigation of the neurotoxicity can be obtained through pharmacological protection, reducing cumulative dose or promoting neuroplasticity. Moreover, surgery and pain themselves might interfere with normal neurodevelopment in children and, in particular, treatment of pain plays a key role in preserving cortical activity and brain development.SummaryRecent literature largely explores a variety of solutions in order to preserve and reduce the damage caused by anaesthetic agents. At the moment, none of the presented solutions regarding neuroprotection is applicable in clinical setting. Further research studies are needed.</p><p class="hitsHighlighted">© 2019 Wolters Kluwer Health, Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L634519545" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L634519545" type="checkbox" id="record_checkbox_L634519545"><label for="record_checkbox_L634519545" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">102</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=102&amp;page=1&amp;id=L634519545" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Dexmedetomidine Ameliorates the Neurotoxicity of <span class="hit">Sevoflurane</span> on the Immature Brain Through the BMP/SMAD Signaling Pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Shan</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bi</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">H.</span></span><br><span class="article-in-press">[In Process] </span><span class="journal-title">Frontiers in Neuroscience</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">12</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 964</span>&nbsp;<span class="cited-by" id="CTB-L634519545"><a href="https://lls.reaxys.com/redir?pid=scp:85066841639" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;27</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-102"><a href="https://www.embase.com/#" class="showAbstract" data="102" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="102"></i> Abstract</a></li><li class="ui-tab" id="indexTab-102"><a href="https://www.embase.com/#" class="showIndexTerms" data="102" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="102"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3389/fnins.2018.00964" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="101">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-101"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Numerous studies have demonstrated that general anesthetics might damage the nervous system, thus, the effect of general anesthetics on the developing brain has attracted much attention. Dexmedetomidine (Dex) exhibits a certain neuroprotective effect, but the mechanism is obscure. In our study, pregnant rats on gestational day 20 (G20) were exposed to 3% <span class="hit">sevoflurane</span> for 2 h or 4 h, and the <span class="hit">neuronal</span> apoptosis in hippocampal CA1 region of the offspring rats was detected by quantification of TUNEL positive cells and cleaved-caspase3 (cl-caspase3). Different doses of Dex were intraperitoneally injected before <span class="hit">sevoflurane</span> anesthesia; then, the expression of apoptotic-related proteins including BCL-2, BAX and cl-caspase3 as well as amyloid precursor protein (APP, a marker of axonal <span class="hit">injury</span>), p-CRMP-2 and CRMP-2 were measured at postnatal days 0, 1and 3 (P0, P1, and P3, respectively). As an antagonist of the bone morphgenetic proteins (BMP) receptor, DMH1 was co-administered with <span class="hit">sevoflurane</span> plus Dex to investigate whether BMP/SMAD is associated with the neuroprotective effects of Dex. The results showed that prenatal <span class="hit">sevoflurane</span> anesthesia for 4 h activated apoptosis transiently, as manifested by the caspase3 activity peaked on P1 and disappeared on P3. In addition, the expressions of APP and p-CRMP-2/CRMP-2 in postnatal rat hippocampus were significantly increased, which revealed that prenatal <span class="hit">sevoflurane</span> anesthesia caused axonal <span class="hit">injury</span> of offspring. The long-term learning and memory ability of offspring rats was also impaired after prenatal <span class="hit">sevoflurane</span> anesthesia. These damaging effects of <span class="hit">sevoflurane</span> could be mitigated by Dex and DMH1 reversed the neuroprotective effect of Dex. Our results indicated that prenatal exposure to 3% <span class="hit">sevoflurane</span> for 4 h increased apoptosis and axonal <span class="hit">injury</span>, even caused long-term learning and memory dysfunction in the offspring rats. Dex dose-dependently reduced <span class="hit">sevoflurane</span>- anesthesia-induced the neurotoxicity by activating the BMP/SMAD signaling pathway.</p><p class="hitsHighlighted">© Copyright © 2018 Shan, Yang, Tang, Bi, Sun, Zhang and Liu.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2000597878" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2000597878" type="checkbox" id="record_checkbox_L2000597878"><label for="record_checkbox_L2000597878" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">103</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=103&amp;page=1&amp;id=L2000597878" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Lipidomics reveals a systemic energy deficient state that precedes neurotoxicity in neonatal monkeys after <span class="hit">sevoflurane</span> exposure</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Frisch-Daiello</span> <span class="given-name notranslate">J.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Martin</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Patterson</span> <span class="given-name notranslate">T.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Paule</span> <span class="given-name notranslate">M.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hanig</span> <span class="given-name notranslate">J.P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Slikker</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Crawford</span> <span class="given-name notranslate">P.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Han</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">Analytica Chimica Acta</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">1037</span><span class="journal-pages">&nbsp;(87-96)</span>&nbsp;<span class="cited-by" id="CTB-L2000597878"><a href="https://lls.reaxys.com/redir?pid=scp:85044398619" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;13</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-103"><a href="https://www.embase.com/#" class="showAbstract" data="103" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="103"></i> Abstract</a></li><li class="ui-tab" id="indexTab-103"><a href="https://www.embase.com/#" class="showIndexTerms" data="103" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="103"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.aca.2017.11.052" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="102">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-102"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Although numerous studies have raised public concerns regarding the safety of anesthetics including <span class="hit">sevoflurane</span> in children, the biochemical mechanisms leading to anesthetics-induced neurotoxicity remain elusive. Moreover, potential biomarker(s) for early detection of general anesthetics-induced brain <span class="hit">injury</span> are urgent for public health. We employed an enabling technology of shotgun lipidomics and analyzed nearly 20 classes and subclasses of lipids present in the blood serum of postnatal day (PND) 5 or 6 rhesus monkeys temporally collected after exposure to <span class="hit">sevoflurane</span> at a clinically relevant concentration or room-air as control. Lipidomics analysis revealed numerous significant anesthetic-induced changes of serum lipids and their metabolites as well as short chain acylcarnitines in the brain and cerebrospinal fluid after anesthetic exposure. These include decreased carnitine and acylcarnitines, unchanged triacylglycerol mass but accumulation of 16:0 and 18:1 fatty acyl chains in the triacylglycerol pool, losses of polyunsaturated fatty acids in both non-esterified fatty acid and phospholipid pools, and increased 4-hydroxynonenal content as early as 2 h after <span class="hit">sevoflurane</span> exposure. Importantly, the amounts of short chain acylcarnitines in the brain and cerebrospinal fluid were also significantly reduced after anesthetic exposure. We propose that this serum lipidomic profile can serve as indicative of <span class="hit">neuronal</span> damage. Our results reveal that <span class="hit">sevoflurane</span> exposure induces an energy deficient state in the brain evidenced by reduced free and acyl carnitine contents, as well as the presence of a pro-inflammatory state in the exposed animals, providing deep insights into the underlying mechanisms responsible for anesthetic-induced neurotoxicity.</p><p class="hitsHighlighted">© 2017 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001164627" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001164627" type="checkbox" id="record_checkbox_L2001164627"><label for="record_checkbox_L2001164627" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">104</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=104&amp;page=1&amp;id=L2001164627" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> induces neurotoxicity in the developing rat hippocampus by upregulating connexin 43 via the JNK/c-Jun/AP-1 pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Bi</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cai</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shan</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Biomedicine and Pharmacotherapy</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">108</span><span class="journal-pages">&nbsp;(1469-1476)</span>&nbsp;<span class="cited-by" id="CTB-L2001164627"><a href="https://lls.reaxys.com/redir?pid=scp:85054390148" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;27</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-104"><a href="https://www.embase.com/#" class="showAbstract" data="104" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="104"></i> Abstract</a></li><li class="ui-tab" id="indexTab-104"><a href="https://www.embase.com/#" class="showIndexTerms" data="104" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="104"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.biopha.2018.09.111" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="103">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-103"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">As one of the most popular anesthetics, <span class="hit">sevoflurane</span> is widely used in pediatric anesthesia. Unfortunately, an increasing number of studies have demonstrated that <span class="hit">sevoflurane</span> has potential neurotoxic effects on the developing brain and cognition, even in adolescence. Connexin 43 (Cx43) has been documented to contribute to cognitive dysfunction. The present study hypothesized that Cx43 may participate in <span class="hit">sevoflurane</span>-induced neuroinjury and investigated the underlying mechanisms in young Sprague Dawley (SD) rats. Seven-day-old SD rats (P7) were exposed to 3% <span class="hit">sevoflurane</span> for 4 h. The levels of Cx43,mitogen-activated protein kinase (MAPK) signaling pathway components(including total and phosphorylated p38, extracellular signal-regulated kinase (ERK), and c-Jun n-terminal kinase (JNK) and activator protein 1(AP-1) transcription factors (including total and phosphorylated c-Fos, and c-Jun) were assessed by Western blot analysis. <span class="hit">Neuronal</span> apoptosis was detected using immunohistochemistry (IHC). The Morris water maze (MWM) was performed to evaluate cognitive function from P28 to P33. The results showed that anesthesia with 3% <span class="hit">sevoflurane</span> for 4 h increased Cx43 levels in the rat hippocampus from 6 h to 3 d, and compared with <span class="hit">sevoflurane</span> exposure in the control group rats, exposure in P7 SD rats also increased the ratios of phosphorylated JNK to JNK and, phosphorylated c-Jun to c-Jun in the hippocampus from 6 h to 3 d. All these effects could be alleviated by pretreatment with the JNK inhibitor SP600125 (10 mg/kg). Neuroapoptosis was similarly increased from 6 h to 1 d after inhaled <span class="hit">sevoflurane</span> exposure. Finally, the MWM indicated that <span class="hit">sevoflurane</span> could increase the escape latency and, decrease the number of platform crossings from P28 to P33. Overall, our findings suggested that <span class="hit">sevoflurane</span> increased Cx43 expression and induced to apoptosis by activating the JNK/c-Jun signaling pathway in the hippocampus of P7 rats. This finding may reveal a new strategy for preventing <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> dysfunction.</p><p class="hitsHighlighted">© 2018</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L623380331" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L623380331" type="checkbox" id="record_checkbox_L623380331"><label for="record_checkbox_L623380331" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">105</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=105&amp;page=1&amp;id=L623380331" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Type 2 diabetes mellitus worsens neurological <span class="hit">injury</span> following cardiac arrest: an animal experimental study</a><br><span class="author fn notranslate"><span class="family-name notranslate">Vammen</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rahbek</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Secher</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Povlsen</span> <span class="given-name notranslate">J.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jessen</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Løfgren</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Granfeldt</span> <span class="given-name notranslate">A.</span></span><br><span class="journal-title">Intensive Care Medicine Experimental </span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">6</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 23</span>&nbsp;<span class="cited-by" id="CTB-L623380331"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-105"><a href="https://www.embase.com/#" class="showAbstract" data="105" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="105"></i> Abstract</a></li><li class="ui-tab" id="indexTab-105"><a href="https://www.embase.com/#" class="showIndexTerms" data="105" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="105"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1186/s40635-018-0193-2" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="104">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-104"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Cardiac arrest carries a poor prognosis. The typical cardiac arrest patient is comorbid, and studies have shown that diabetes mellitus is an independent risk factor for increased mortality after cardiac arrest. Despite this, animal studies lack to investigate cardiac arrest in the setting of diabetes mellitus. We hypothesize that type 2 diabetes mellitus in a rat model of cardiac arrest is associated with increased organ dysfunction when compared with non-diabetic rats. Methods: Zucker diabetic fatty (ZDF) rats (n = 13), non-diabetic Zucker lean control (ZLC) rats (n = 15), and non-diabetic Sprague Dawley (SprD) rats (n = 8), underwent asphyxia-induced cardiac arrest. Animals were resuscitated and monitored for 180&nbsp;min after return of spontaneous circulation (ROSC). Blood levels of neuron-specific enolase were measured to assess neurological injury. Cardiac function was evaluated by echocardiography. Results: No differences in cardiac output or neuron-specific enolase existed between the groups at baseline. Median levels of neuron-specific enolase 180&nbsp;min after ROSC was 10.8&nbsp;μg/L (Q<sub>25</sub>;Q<sub>75</sub>—7.6;11.3) in the ZDF group, which was significantly higher compared to the ZLC group at 2.0&nbsp;μg/L (Q<sub>25</sub>;Q<sub>75</sub>—1.7;2.3, p &lt; 0.05) and the SprD group at 2.8&nbsp;μg/L (Q<sub>25</sub>;Q<sub>75</sub>—2.3;3.4, p &lt; 0.05). At 180&nbsp;min after ROSC, cardiac output was 129&nbsp;mL/min/kg (SD 45) in the ZDF group, which was not different from 106&nbsp;mL/min/kg (SD 31) in the ZLC group or 123&nbsp;mL/min/kg (SD 26, p = 0.72) in the SprD group. Conclusions: In a cardiac arrest model, neuronal injury is increased in type 2 diabetes mellitus animals compared with non-diabetic controls. Although this study lacks to uncover the specific mechanisms causing increased neuronal injury, the establishment of a cardiac arrest model of type 2 diabetes mellitus lays the important foundation for further experimental investigations within this field.</p><p class="hitsHighlighted">© 2018, The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L627444948" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L627444948" type="checkbox" id="record_checkbox_L627444948"><label for="record_checkbox_L627444948" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">106</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=106&amp;page=1&amp;id=L627444948" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> reduces ischemic brain <span class="hit">injury</span> in rats with diet and streptozotocin-induced diabetes</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">L.</span></span><br><span class="journal-title">Journal of Receptors and Signal Transduction</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">38</span><span class="journal-issue">:5-6</span><span class="journal-pages">&nbsp;(448-454)</span>&nbsp;<span class="cited-by" id="CTB-L627444948"><a href="https://lls.reaxys.com/redir?pid=scp:85065075482" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;3</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-106"><a href="https://www.embase.com/#" class="showAbstract" data="106" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="106"></i> Abstract</a></li><li class="ui-tab" id="indexTab-106"><a href="https://www.embase.com/#" class="showIndexTerms" data="106" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="106"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1080/10799893.2019.1585451" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="105">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-105"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">To investigate the role of S100B, oxidative stress and the apoptosis signaling pathways in the <span class="hit">sevoflurane</span> induced neuroprotective effect on stroke. The brain <span class="hit">injury</span>, molecular and cellular damage, and functional recovery were investigated upon ischemic brain <span class="hit">injury</span> followed by <span class="hit">sevoflurane</span> treatment. Longa rodent stroke scales was used to quantify neurological deficits. TTC staining was used to measure infarct volume of brain tissue. Absolute brain water content was measured by wet/dry weight method. The <span class="hit">neuronal</span> morphological change was assessed by H and E staining. The spatial learning and memory ability were measured by water maze test. Serum proteins including S100B, GSH-PX, SOD, Bcl-2, Bax, Caspase-3 were measured by ELISA. The level of NOS and NO in serum was determined by colorimetric method. Compared with control, the serum proteins including S100B, Bax, NO, Caspase-3, and NOS activity in cerebral infarction rats increased significantly while SOD, GSH-PX, and Bcl-2 decreased significantly. Diabetic mellitus complicated with cerebral infarction rats showed more dramatic increase for S100B, Bax, NO, Caspase-3, and NOS activity and dramatic decrease for SOD, GSH-PX, and Bcl-2. Interestingly, <span class="hit">sevoflurane</span> reduced the changes significantly. The S100B level positively correlated with brain damage, NO, Bax, caspase-3, and NOS activity but negatively correlated with SOD, Bax, and GSH-PX. Brain damage in <span class="hit">sevoflurane</span> groups decreased while behavior outcomes including Longa neurologic score, learning, and memory increased significantly. The neuroprotective effect of <span class="hit">sevoflurane</span> is associated with defense mechanisms against free radical-induced oxidative stress and inhibition of apoptosis. S100B protein correlated with oxidative stress and the apoptosis signaling pathways.</p><p class="hitsHighlighted">© 2019, © 2019 Informa UK Limited, trading as Taylor &amp; Francis Group.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001073074" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001073074" type="checkbox" id="record_checkbox_L2001073074"><label for="record_checkbox_L2001073074" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">107</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=107&amp;page=1&amp;id=L2001073074" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> postconditioning improves the spatial learning and memory impairments induced by hemorrhagic shock and resuscitation through suppressing IRE1α-caspase-12-mediated endoplasmic reticulum stress pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Duan</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Neuroscience Letters</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">685</span><span class="journal-pages">&nbsp;(160-166)</span>&nbsp;<span class="cited-by" id="CTB-L2001073074"><a href="https://lls.reaxys.com/redir?pid=scp:85052631773" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;4</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-107"><a href="https://www.embase.com/#" class="showAbstract" data="107" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="107"></i> Abstract</a></li><li class="ui-tab" id="indexTab-107"><a href="https://www.embase.com/#" class="showIndexTerms" data="107" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="107"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.neulet.2018.08.035" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="106">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-106"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Severe hemorrhagic shock induces cognitive dysfunction by promoting cell death mediated by activating endoplasmic reticulum (ER) stress. <span class="hit">Sevoflurane</span> postconditioning prevents <span class="hit">neuronal</span> apoptosis against cerebral ischemia/reperfusion <span class="hit">injury</span>. It is unknown if this protective effect on hemorrhagic shock and resuscitation rats (HSR) is associated with ER stress attenuation. Male adult Sprague-Dawley rats were subjected HSR by removing 40% blood volume within 30 min, and 60 min later the animals were resuscitated with infusion of the removing blood in 30 min. <span class="hit">Sevoflurane</span> postconditioning was performed by inhaling <span class="hit">sevoflurane</span> at three different concentrations (0.5, 1.0, 1.5 MAC) at the onset of resuscitation for 30 min. Severe hypotension (mean arterial pressure 40–45 mmHg) occurred in the shock session for 60 min accompanying with significantly elevated lactate, decreased BE and pH values in arterial blood gas analysis. There were impaired spatial learning and memory following HSR indicated by persistently longer escape latency and lower correct rate, as well as less duration and crossing in the target quadrant by using Morris water maze and Y-maze tests. In the hippocampal CA1 region, there was significantly higher activity of caspase-3 induced by HSR. HSR also elevated the expression of inositol-requiring enzyme 1α (IRE1α) and caspase-12 in the hippocampus by western blot analysis. <span class="hit">Sevoflurane</span> postconditioning at 1.0 and 1.5 MAC significantly reversed these changes. These findings suggested that <span class="hit">sevoflurane</span> postconditioning could improve spatial learning and memory deficits induced by severe hemorrhagic shock and subsequent resuscitation. The suppression of endoplasmic reticulum stress provided critical contribution in neural apoptosis mediated by IRE1α-caspase-12 pathway.</p><p class="hitsHighlighted">© 2018 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2000827426" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2000827426" type="checkbox" id="record_checkbox_L2000827426"><label for="record_checkbox_L2000827426" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">108</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=108&amp;page=1&amp;id=L2000827426" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Postconditioning with <span class="hit">sevoflurane</span> ameliorates spatial learning and memory deficit via attenuating endoplasmic reticulum stress induced neuron apoptosis in a rat model of hemorrhage shock and resuscitation</a><br><span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Duan</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Brain Research</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">1696</span><span class="journal-pages">&nbsp;(49-55)</span>&nbsp;<span class="cited-by" id="CTB-L2000827426"><a href="https://lls.reaxys.com/redir?pid=scp:85048174536" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;10</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-108"><a href="https://www.embase.com/#" class="showAbstract" data="108" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="108"></i> Abstract</a></li><li class="ui-tab" id="indexTab-108"><a href="https://www.embase.com/#" class="showIndexTerms" data="108" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="108"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.brainres.2018.05.047" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="107">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-107"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Hemorrhage shock could initiate endoplasmic reticulum stress (ERS) and then induce <span class="hit">neuronal</span> apoptosis. The aim of this study was to investigate whether <span class="hit">sevoflurane</span> postconditioning could attenuate brain <span class="hit">injury</span> via suppressing apoptosis induced by ERS. Seventy male rats were randomized into five groups: sham, shock, low concentration (sevo1, 1.2%), middle concentration (sevo2, 2.4%) and high concentration (sevo3, 3.6%) of <span class="hit">sevoflurane</span> postconditioning. Hemorrhage shock was induced by removing 40% of the total blood volume during an interval of 30 min. 1 h after the completion of bleeding, the animals were reinfused with shed blood during the ensuing 30 min. The spatial learning and memory ability of rats were measured by Morris water maze (MWM) test three days after the operation. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) positive cells in the hippocampus CA1 region were assessed after the MWM test. The expression of C/EBP-homologousprotein (CHOP) and glucose-regulated protein 78 (GRP78) in the hippocampus were measured at 24 h after reperfusion. We found that <span class="hit">sevoflurane</span> postconditioning with the concentrations of 2.4% and 3.6% significantly ameliorated the spatial learning and memory ability, decreased the TUNEL-positive cells, and reduced the GRP78 and CHOP expression compared with the shock group. These results suggested that <span class="hit">sevoflurane</span> postconditioning with the concentrations of 2.4% and 3.6% could ameliorate spatial learning and memory deficit after hemorrhage shock and resuscitation <span class="hit">injury</span> via suppressing apoptosis induced by ERS.</p><p class="hitsHighlighted">© 2018</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L624589366" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L624589366" type="checkbox" id="record_checkbox_L624589366"><label for="record_checkbox_L624589366" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">109</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=109&amp;page=1&amp;id=L624589366" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Mild hypothermia ameliorates neurotoxicity of anesthesia in the neonatal brain</a><br><span class="author fn notranslate"><span class="family-name notranslate">Ikonomidou</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kirvassilis</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huffman</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Williams</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Capuano</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brunner</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Crosno</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Simmons</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Noguchi</span> <span class="given-name notranslate">K.</span></span><br><span class="journal-title">Annals of Neurology</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">84</span>&nbsp;<span class="journal-suppl">Supplement 22</span><span class="journal-pages">&nbsp;(S415-S416)</span>&nbsp;<span class="cited-by" id="CTB-L624589366"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-109"><a href="https://www.embase.com/#" class="showAbstract" data="109" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="109"></i> Abstract</a></li><li class="ui-tab" id="indexTab-109"><a href="https://www.embase.com/#" class="showIndexTerms" data="109" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="109"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1002/ana.25305" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="108">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-108"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: Sedative and anesthetic drugs can injure neurons and oligodendrocytes in the developing brain. They can cause widespread cell death, impair synaptic maturation and plasticity, inhibit neurogenesis in the brains of rodents and nonhuman primates (NHP) and trigger long term behavioral and cognitive deficits. Hypothermia (HT) is successfully applied in neonatal and pediatric medicine to minimize brain <span class="hit">injury</span> from perinatal asphyxia and during cardiac surgery. We investigated HT as a potential protective treatment of the developing primate brain against histological toxicity of the anesthetic <span class="hit">sevoflurane</span> in NHP infants. Methods: Neonatal rhesus monkeys underwent <span class="hit">sevoflurane</span> anesthesia over 5 hours. Body temperature was regulated to lie in the normothermic (&gt;37oC), mild hypothermic (35-36.5oC) and moderately hypothermic (&lt;35oC) range. Animals were euthanized at 8 hrs, brains collected and examined immunohistochemically (activated caspase 3) and stereologically to quantify apoptotic <span class="hit">neuronal</span> and glial death. Results: <span class="hit">Sevoflurane</span> anesthesia was well tolerated with oxygen saturation, end tidal CO2and electrolytes remaining at optimal levels throughout the procedures. Brains displayed significant apoptosis in both the white and gray matter. Areas predominantly affected included the visual, frontoparietal, cingulate and retrosplenial cortex, the thalamus, globus pallidum and putamen. Approximately 50% of the dying cells were glia and 50% were neurons. Mild hypothermia (mean 36.27oC) conferred significant protection from apoptotic <span class="hit">injury</span> whereas moderate hypothermia (&lt;35oC) did not. Conclusions: Our findings indicate that exposure of the infant rhesus macaque to <span class="hit">sevoflurane</span> for 5 hours is sufficient to cause widespread apoptosis of neurons and oligodendrocytes and that mild hypothermia is cytoprotective in the neonatal primate brain.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L623399880" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L623399880" type="checkbox" id="record_checkbox_L623399880"><label for="record_checkbox_L623399880" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">110</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=110&amp;page=1&amp;id=L623399880" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Lycium barbarum polysaccharides attenuates the apoptosis of hippocampal neurons induced by <span class="hit">sevoflurane</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Xie</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">Experimental and Therapeutic Medicine</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">16</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(1834-1840)</span>&nbsp;<span class="cited-by" id="CTB-L623399880"><a href="https://lls.reaxys.com/redir?pid=scp:85051142343" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-110"><a href="https://www.embase.com/#" class="showAbstract" data="110" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="110"></i> Abstract</a></li><li class="ui-tab" id="indexTab-110"><a href="https://www.embase.com/#" class="showIndexTerms" data="110" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="110"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/etm.2018.6426" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="109">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-109"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Following the application of inhalational anesthetics, including <span class="hit">sevoflurane</span>, patients may suffer from neural <span class="hit">injury</span>. The present study was conducted to explore the mechanism involved in Lycium barbarum polysaccharides (LBP) treatment of <span class="hit">sevoflurane</span> injured hippocampal neurons. Primary hippocampal neurons were isolated from Sprague Dawley embryonic rats. Th\e Cell Counting Kit‑8 (CCK‑8) assay was used to detect cell viability. Furthermore, flow cytometry (FCM) was used to determine cell proliferation and apoptosis rates. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis were applied to detect the expression levels of apoptosis‑related factors, including activated‑Caspase‑3, B‑cell lymphoma/leukemia‑2 (Bcl‑2) and Bcl‑2 associated X (Bax), phosphorylated extracellular signal‑regulated kinase 1/2 (p‑ERK1/2) and total ERK1/2. The results showed that LBP promoted cell viability and cell proliferation but inhibited cell apoptosis in neurons injured with 3% <span class="hit">sevoflurane</span>, in dose‑dependent manners (100, 200 and 400 μg/ml). LBP increased the expression levels of Bcl‑2 and p‑ERK1/2, and decreased levels of activated‑Caspase‑3 and Bax in a dose‑dependent manner in hippocampal neurons that were injured with <span class="hit">sevoflurane</span>. In addition, ERK1/2 inhibitor reversed the above phenomenon in 400 μg/ml LBP and 3% <span class="hit">sevoflurane</span>‑treated hippocampal neurons. Therefore, the present study indicated that LBP protected hippocampal neurons from <span class="hit">sevoflurane injury</span>, including aberrant cell apoptosis, via the ERK1/2 pathway.</p><p class="hitsHighlighted">© 2018, Spandidos Publications. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L624614363" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L624614363" type="checkbox" id="record_checkbox_L624614363"><label for="record_checkbox_L624614363" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">111</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=111&amp;page=1&amp;id=L624614363" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> preconditioning protects against spinal cord ischemia/ reperfusion <span class="hit">injury</span> by up-regulating miR-199a-5p in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Bao</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Chinese Pharmacological Bulletin</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">34</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(1230-1234)</span>&nbsp;<span class="cited-by" id="CTB-L624614363"><a href="https://lls.reaxys.com/redir?pid=scp:85055481941" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-111"><a href="https://www.embase.com/#" class="showAbstract" data="111" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="111"></i> Abstract</a></li><li class="ui-tab" id="indexTab-111"><a href="https://www.embase.com/#" class="showIndexTerms" data="111" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="111"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3969/j.issn.1001-1978.2018.09.010" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="110">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-110"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Aim To investigate the effect of <span class="hit">sevoflurane</span> preconditioning on spinal cord ischeniia-reperfusion <span class="hit">injury</span> (SCIRI) of miR-199a-5p in rats. Methods Twenty-four SD rats were randomly divided into: group of sham (Sham group) , group of ischemia-reperfusion (I/R group), and group of <span class="hit">sevoflurane</span> and control (SEVO +I/R group) . Sham group received the same operation, but did not inhale <span class="hit">sevoflurane</span> or close the aortic arch; SCIRI model was established after 14 min of the aortic arch of the non-invasive arterial clip in 1/ R group. SEVO + I/R group, before the establishment of SCIRI model, was inhaled 2.4% <span class="hit">sevoflurane</span> for 3 h. Basso Beattie Bresnahan scoring method was used to evaluate neuromotor function and TUNEL staining to observe apoptosis. Evans blue (EB) was used to determine blood-spinal cord barrier (BSCB) permeability; real-time qPCR to detect miR-199a-5p content; Western blot to measure the levels of caspase-9 and Bcl-2 in spinal cord tissues. Results Compared with sham group, the score of neuromotor function in I/R group decreased, cell apoptosis rate increased, BSCB permeability increased, miR-199a-5p expression decreased, caspase-9 expression increased, and Bcl-2 expression decreased; compared with I/R group, the neurological motor function score of SEVO + I/R group increased, the apoptotic rate decreased, the BSCB permeability decreased, the expression of miR-I99a-5p increased, the expression of caspase-9 decreased, and the expression of Bcl-2 increased. Conclusion <span class="hit">Sevoflurane</span> pretreatment may reduce BSCB permeability and <span class="hit">neuronal</span> apoptosis by up-regulation of miR- 199a-5p and protection of SCIRI in rats.</p><p class="hitsHighlighted">© 2018 Publication Centre of Anhui Medical University. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L623535225" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L623535225" type="checkbox" id="record_checkbox_L623535225"><label for="record_checkbox_L623535225" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">112</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=112&amp;page=1&amp;id=L623535225" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Collapsin response mediator protein-2 ameliorates <span class="hit">sevoflurane</span>-mediated neurocyte <span class="hit">injury</span> by targeting PI3K-mTOR-S6K pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">He</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">Medical Science Monitor</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">24</span><span class="journal-pages">&nbsp;(4982-4991)</span>&nbsp;<span class="cited-by" id="CTB-L623535225"><a href="https://lls.reaxys.com/redir?pid=scp:85051935905" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-112"><a href="https://www.embase.com/#" class="showAbstract" data="112" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="112"></i> Abstract</a></li><li class="ui-tab" id="indexTab-112"><a href="https://www.embase.com/#" class="showIndexTerms" data="112" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="112"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.12659/MSM.909056" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="111">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-111"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Collapsin response mediator protein-2 (CRMP-2) is the first member of the CRMP family that has been identified in primary <span class="hit">neuronal</span> cells; it was originally found and identified in the regulation of microtubule dimerization into microtubules. Material/Methods: In the present study, we aimed to investigate the roles and mechanisms of CRMP-2 in <span class="hit">sevoflurane</span>-induced neurocyte <span class="hit">injury</span>. Cell viability, proliferation, and apoptosis were measured by Cell Counting Kit-8 (CCK-8) assay and flow cytometry. Colorimetry was performed to measure the activity of caspase-3. Western blot and quantitative real-time reverse transcription assays were used to evaluate the related mRNAs and proteins expression. Results: We found that CRMP-2 reversed the inhibitory effect of <span class="hit">sevoflurane</span> on the viability of nerve cells. Moreover, CRMP-2 accelerated the proliferation and suppressed the apoptosis of <span class="hit">sevoflurane</span>-induced nerve cells. CRMP-2 modulated the expression levels of apoptosis-associated protein in <span class="hit">sevoflurane</span>-induced nerve cells. Furthermore, it was demonstrated that CRMP-2 impacted the PI3K-mTOR-S6K pathway. Conclusions: CRMP2 ameliorated <span class="hit">sevoflurane</span>-mediated neurocyte <span class="hit">injury</span> by targeting the PI3K-mTOR-S6K pathway. Thus, CRMP2 might be an effective target for <span class="hit">sevoflurane</span>-induced neurocyte <span class="hit">injury</span> therapies.</p><p class="hitsHighlighted">© Med Sci Monit.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L622215839" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L622215839" type="checkbox" id="record_checkbox_L622215839"><label for="record_checkbox_L622215839" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">113</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=113&amp;page=1&amp;id=L622215839" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Association of changes in plasma neurofilament light and tau levels with anesthesia and surgery: Results from the CAPACITY and ARCADIAN studies</a><br><span class="author fn notranslate"><span class="family-name notranslate">Evered</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Silbert</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Scott</span> <span class="given-name notranslate">D.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zetterberg</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Blennow</span> <span class="given-name notranslate">K.</span></span><br><span class="journal-title">JAMA Neurology</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">75</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(542-547)</span>&nbsp;<span class="cited-by" id="CTB-L622215839"><a href="https://lls.reaxys.com/redir?pid=scp:85047090784" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;76</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-113"><a href="https://www.embase.com/#" class="showAbstract" data="113" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="113"></i> Abstract</a></li><li class="ui-tab" id="indexTab-113"><a href="https://www.embase.com/#" class="showIndexTerms" data="113" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="113"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1001/jamaneurol.2017.4913" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="112">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-112"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">IMPORTANCE Anesthesia and surgery are believed to act on the central nervous system by a fully reversible mechanism innocuous to nerve cells. Evidence that neurological sequelae may follow would challenge this belief and would thereby suggest a need to reassess theories of the mechanism of anesthetic action or the response of the central nervous system to surgery. OBJECTIVE To measure 2 biomarkers of neurological <span class="hit">injury</span> (neurofilament light and tau) in plasma in a series of timed collections before and after anesthesia and surgery. DESIGN, SETTING, AND PARTICIPANTS These 2 related observational studies (CAPACITY and ARCADIAN) recruited patients 60 years and older who were undergoing general anesthesia for surgeries performed within a tertiary hospital. Blood samples were taken immediately before surgical anesthesia was administered and then sequentially after surgery at 30-minute, 6-hour, 24-hour, and 48-hour intervals. Sampling took place from January 2014 to August 2015. Data analysis took place from October 2016 to February 2017. MAIN OUTCOMES AND MEASURES Plasma neurofilament light and tau. RESULTS A total of 30 patients were enrolled (13 from the CAPACITY study and 17 from the ARCADIAN study). The mean (SD) age was 69.1 (7.0) years, and 18 members (59%) of the participant group were female; 22 (73%) were undergoing joint arthroplasty. Mean neurofilament light increased at each measurement from a combined baseline mean (SD) of 22.3 (20.4) pg/mL to a maximal combined mean (SD) level of 35.1 (28.7) pg/mL, a maximum increase of 67%(95%CI, 45%-89%; P &lt; .001), at 48 hours postoperatively. The level of tau increased significantly from baseline at every measurement, from a combined baseline mean (SD) of 3.1 (1.3) pg/mL to a maximal combined mean (SD) of 10.8 (9.5) pg/mL, a peak increase of 257%(95%CI, 154%-361%; P &lt; .001), at 6 hours postoperatively. After 6 hours, the mean level began to return to baseline but remained elevated after 48 hours. CONCLUSIONS AND RELEVANCE Neurofilament light is a specific marker of axonal <span class="hit">injury</span> and has been shown to indicate <span class="hit">neuronal</span> damage in a number of diseases. Tau proteins are an integral component of axonal integrity, and increased tau indicates <span class="hit">neuronal</span> damage. The increases in both neurofilament light and tau over 48 hours after surgery suggest that general anesthesia and surgerymay be associated with <span class="hit">neuronal</span> damage in the short term. Further investigations will be required to study any association with clinical outcomes. These preliminary findings demand that we question the prevailing assumption that anesthesia and surgery are innocuous, transient, and without injurious changes to the central nervous system.</p><p class="hitsHighlighted">© 2018 American Medical Association. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L622385026" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L622385026" type="checkbox" id="record_checkbox_L622385026"><label for="record_checkbox_L622385026" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">114</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=114&amp;page=1&amp;id=L622385026" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI3K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion after <span class="hit">Sevoflurane</span> Preconditioning</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">S.-B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">T.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Pu</span> <span class="given-name notranslate">G.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">B.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">X.-Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Han</span> <span class="given-name notranslate">X.-L.</span></span><br><span class="journal-title">Cellular Physiology and Biochemistry</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">46</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(1455-1470)</span>&nbsp;<span class="cited-by" id="CTB-L622385026"><a href="https://lls.reaxys.com/redir?pid=scp:85047776960" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;20</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-114"><a href="https://www.embase.com/#" class="showAbstract" data="114" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="114"></i> Abstract</a></li><li class="ui-tab" id="indexTab-114"><a href="https://www.embase.com/#" class="showIndexTerms" data="114" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="114"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1159/000489186" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="113">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-113"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background/Aims: Ischemic heart disease is a leading cause of death in cardiovascular diseases, and microRNAs (miRs) have been reported to be potential therapeutic targets in heart disease. Herein, this study aims to investigate the effects of microRNA (miR)-374 on myocardial ischemia-reperfusion (I/R) <span class="hit">injury</span> in rat models pretreated with <span class="hit">sevoflurane</span> by targeting SP1 through the PI3K/Akt pathway. Methods: SD rats were grouped into sham, I/R and <span class="hit">sevoflurane</span> + I/R (<span class="hit">sevoflurane</span> preconditioning and I/R) groups. The biochemical indicators, pathological changes, positive expression of SP1 protein, and apoptosis rates were measured using biochemical detection, Evans blue-TTC staining, immunohistochemistry and TUNEL staining. RT-qPCR and Western blotting were used to investigate the expression of miR-374 mRNA and the protein expression of SP1, PI3K, HO-1, p53, iNOS, c-fos, Akt/p-Akt, and GSK-3β/p-GSK-3β. Cardiomyocytes were treated with miR-374 mimics, miR-374 inhibitors, or siRNA-SP1. Cardiomyocyte proliferation and cycle distribution and apoptosis were studied by MTT and flow cytometry. Results: Compared with the I/R group, in the <span class="hit">sevoflurane</span> + I/R group, serum SOD and IL-10 increased, while MDA, LDH, CK, TNF-α, IL-6 and IL-10 decreased, as did the percentage of infarct area, the positive rate of SP1 and the apoptosis index. The expression of SP1, p53, iNOS and c-fos decreased, and the miR-374 expression of PI3K, HO-1, Akt/p-Akt, GSK-3β/p-GSK-3β increased. With the upregulation of miR-374 and the downregulation of SP1, the expression of SP1, p53, iNOS and c-fos decreased, as did the proportion of cells in G1 phase and the apoptosis rate; the expression of PI3K, HO-1, Akt/p-Akt, GSK-3β/p-GSK-3β increased. The results in the miR-374 inhibitor group contrasted with the above results. Conclusion: The results indicated that miR-374 could alleviate myocardial I/R damage in rat models pretreated with <span class="hit">sevoflurane</span> by targeting SP1 by activating the PI3K/Akt pathway.</p><p class="hitsHighlighted">© 2018 The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L622543302" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L622543302" type="checkbox" id="record_checkbox_L622543302"><label for="record_checkbox_L622543302" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">115</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=115&amp;page=1&amp;id=L622543302" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Identifying potential biomarkers, mechanisms and protective strategies for general anesthetic-induced neurotoxicity in the developing nonhuman primate</a><br><span class="author fn notranslate"><span class="family-name notranslate">Slikker</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Han</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Paterson</span> <span class="given-name notranslate">T.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Paule</span> <span class="given-name notranslate">M.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hanig</span> <span class="given-name notranslate">J.P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">FASEB Journal</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">32</span><span class="journal-issue">:1</span>&nbsp;<span class="journal-suppl">Supplement 1</span><span class="journal-pages"></span>&nbsp;<span class="cited-by" id="CTB-L622543302"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-115"><a href="https://www.embase.com/#" class="showAbstract" data="115" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="115"></i> Abstract</a></li><li class="ui-tab" id="indexTab-115"><a href="https://www.embase.com/#" class="showIndexTerms" data="115" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="115"></i> Index Terms</a></li><li><span id="FTL-L622543302" class="fulltext" data="{&quot;recno&quot;:&quot;L622543302&quot;,&quot;issn&quot;:&quot;15306860&quot;,&quot;volume&quot;:&quot;32&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;startpage&quot;:&quot;&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="114">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-114"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">It has been reported that commonly used general anesthetics such as <span class="hit">sevoflurane</span> induce neurotoxicity in developing brains. However, there has been limited research evaluating whether and how anesthetic agents affect bio-lipids, the most abundant components of the brain other than water. Thus, assessing lipid profiles from blood samples may assist in the early detection of general anesthesia-induced neurotoxic effects. Postnatalday (PND) 5 or 6 monkeys were randomly assigned to control (room-air; n=4) and <span class="hit">sevoflurane</span>-exposed(n=4) groups. <span class="hit">Sevoflurane</span> was delivered using an agent-specific vaporizer for 9 hours at a clinically-relevant concentration of 2.5%. Blood samples were collected at 0, 2, 4, 8 and 9 hours during exposure from both the control and <span class="hit">sevoflurane</span>-exposed groups. Lipid extractions and analyses were performed using a mass spectrometer. Four hours after completion of anesthetic exposures front alcortical tissue was collected for histochemical and Western blot analyses. In addition, to evaluate potential protective strategies monkey infants were exposed to <span class="hit">sevoflurane</span> in the presence or absence of acetyl-L-carnitine(mitochondrial stabilizer), and microPET scanning using [18F]-FEPPA was carried out to repeatedly visualize and quantify aspects of neurotoxicity. Serumlipidomic analyses demonstrated that the levels of critical lipid components including acylcarnitines, phosphatidylcholines and phosphatidylethanolamines were significantly decreased during prolongedexposure to <span class="hit">sevoflurane</span>. In contrast, the amounts of triglyceride and 4-hydroxynonenal were increased to abnormally high levels in <span class="hit">sevoflurane</span>-exposed monkeys. Consistently, histochemical staining and Western blot analyses of Bax protein revealed increased <span class="hit">neuronal</span> apoptotic damage after <span class="hit">sevoflurane</span> exposure. Co-administration of acetyl-L-carnitine effectively blocked the neural damage (increased [18F]-FEPPA signal)-induced by prolonged <span class="hit">sevoflurane</span> exposure. These data suggest that prolonged exposure of neonatal monkeys to a clinically-relevant concentration of <span class="hit">sevoflurane</span> resulted in significant changes in lipidmetabolism and subsequently, <span class="hit">neuronal</span> apoptotic damage. Monitoring specificlipid changes may provide insights into the molecular mechanism(s) underlying generalanesthetic-induced neurotoxicity and serve as sensitive biomarkers for the early detection of anesthetic-induced <span class="hit">neuronal</span> damage. Acetyl-L-carnitine may act to preserve cellular membrane integrity and play critical roles in mitochondrial oxidation of long-chain fatty acids, and thus protect neurons from <span class="hit">sevoflurane</span> induced damage.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L621477834" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L621477834" type="checkbox" id="record_checkbox_L621477834"><label for="record_checkbox_L621477834" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">116</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=116&amp;page=1&amp;id=L621477834" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> post-conditioning attenuates traumatic brain <span class="hit">injury</span>-induced <span class="hit">neuronal</span> apoptosis by promoting autophagy via the PI3K/AKT signaling pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">He</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Weng</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fu</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Drug Design, Development and Therapy</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">12</span><span class="journal-pages">&nbsp;(629-638)</span>&nbsp;<span class="cited-by" id="CTB-L621477834"><a href="https://lls.reaxys.com/redir?pid=scp:85044823425" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;42</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-116"><a href="https://www.embase.com/#" class="showAbstract" data="116" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="116"></i> Abstract</a></li><li class="ui-tab" id="indexTab-116"><a href="https://www.embase.com/#" class="showIndexTerms" data="116" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="116"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.2147/DDDT.S158313" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="115">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-115"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: <span class="hit">Sevoflurane</span> post-conditioning exerts nerve-protective effects through inhibiting caspase-dependent <span class="hit">neuronal</span> apoptosis after a traumatic brain <span class="hit">injury</span> (TBI). Autophagy that is induced by the endoplasmic reticulum stress plays an important role in the secondary neurological dysfunction after a TBI. However, the relationship between autophagy and caspase-dependent apoptosis as well as the underlying nerve protection mechanism that occurs with <span class="hit">sevoflurane</span> post-conditioning following a TBI remains unclear. Methods: The Feeney TBI model was used to induce brain <span class="hit">injury</span> in rats. Evaluation of the modified neurological severity scores, measurement of brain water content, Nissl staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling assay were used to determine the neuroprotective effects of the <span class="hit">sevoflurane</span> post-conditioning. Both immunofluorescence and Western blot analyses were used to detect the expression of autophagy-related proteins microtubule-associated protein 1 light chain 3-II and Beclin-1, pro-apoptotic factors, as well as the activation of the phosphatidylinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway within the lesioned cortex. Results: Autophagy and <span class="hit">neuronal</span> apoptosis were activated in the lesioned cortex following the TBI. <span class="hit">Sevoflurane</span> post-conditioning enhanced early autophagy, suppressed <span class="hit">neuronal</span> apoptosis, and alleviated brain edema, which improved nerve function after a TBI (all P &lt; 0.05). <span class="hit">Sevoflurane</span> post-conditioning induced the activation of PI3K/AKT signaling after the TBI (P &lt; 0.05). The neuroprotective effects of <span class="hit">sevoflurane</span> post-conditioning were reversed through the autophagy inhibitor 3-methyladenine treatment. Conclusion: <span class="hit">Neuronal</span> apoptosis and the activation of autophagy were involved in the secondary neurological <span class="hit">injury</span> following a TBI. <span class="hit">Sevoflurane</span> post-conditioning weakened the TBI-induced <span class="hit">neuronal</span> apoptosis by regulating autophagy via PI3K/AKT signaling.</p><p class="hitsHighlighted">© 2018 He et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L2001618661" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L2001618661" type="checkbox" id="record_checkbox_L2001618661"><label for="record_checkbox_L2001618661" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">117</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=117&amp;page=1&amp;id=L2001618661" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Dexmedetomidine protects the developing rat brain against the neurotoxicity wrought by <span class="hit">sevoflurane</span>: Role of autophagy and Drp1-Bax signaling</a><br><span class="author fn notranslate"><span class="family-name notranslate">Shan</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shang</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Drug Design, Development and Therapy</span>&nbsp;<span class="journal-publication-year">2018</span>&nbsp;<span class="journal-volume">12</span><span class="journal-pages">&nbsp;(3617-3624)</span>&nbsp;<span class="cited-by" id="CTB-L2001618661"><a href="https://lls.reaxys.com/redir?pid=scp:85056914983" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;29</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-117"><a href="https://www.embase.com/#" class="showAbstract" data="117" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="117"></i> Abstract</a></li><li class="ui-tab" id="indexTab-117"><a href="https://www.embase.com/#" class="showIndexTerms" data="117" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="117"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.2147/DDDT.S180343" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="116">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-116"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: The effect of <span class="hit">sevoflurane</span> on the nervous system is controversial. As an adjuvant anesthetic, dexmedetomidine has a protective role in various nerve-<span class="hit">injury</span> diseases. We investigated the effect of dexmedetomidine on <span class="hit">injury</span> to the developing brain induced by <span class="hit">sevoflurane</span> anesthesia, and if autophagy and mitochondrial damage are involved in the neuroprotective effects of dexmedetomidine. Methods: Pregnant rats on gestational day 20 were exposed to 3% <span class="hit">sevoflurane</span> for 4 hours. Saline and dexmedetomidine were injected intraperitoneally 15 minutes before exposure to <span class="hit">sevoflurane</span> or control gas. Bilateral hippocampi were harvested on postnatal day 1. Hippocampal morphology was observed by Nissl staining and expression of the microtubule-related protein LC3I/II, p62, Drp1, Bax, and Bcl2 were evaluated by Western blotting and immunohistochemistry. Results: Nissl staining showed that <span class="hit">sevoflurane</span> anesthesia during the third trimester caused <span class="hit">neuronal</span> damage to the hippocampi of rat pups. Western blotting and immunohistochemistry showed that pregnant rats exposed to <span class="hit">sevoflurane</span> during the third trimester led to pups having increased expression of LC3 and p62, suggesting that <span class="hit">sevoflurane</span> blocked autophagic flow in the hippocampus. Expression of Drp1 and Bax was increased after <span class="hit">sevoflurane</span> exposure, whereas Bcl2 expression was downregulated. All these effects were alleviated by pretreatment with dexmedetomidine. Conclusion: <span class="hit">Sevoflurane</span> exposure during the third trimester caused neurological <span class="hit">injury</span> to rat pups. Autophagy and abnormalities in mitochondrial dynamics were involved in this neurotoxic process and were antagonized by dexmedetomidine.</p><p class="hitsHighlighted">© 2018 Shan et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L619958331" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L619958331" type="checkbox" id="record_checkbox_L619958331"><label for="record_checkbox_L619958331" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">118</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=118&amp;page=1&amp;id=L619958331" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Roscovitine, a CDK5 Inhibitor, Alleviates <span class="hit">Sevoflurane</span>-Induced Cognitive Dysfunction via Regulation Tau/GSK3β and ERK/PPARγ/CREB Signaling</a><br><span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cai</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">Cellular Physiology and Biochemistry</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">44</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(423-435)</span>&nbsp;<span class="cited-by" id="CTB-L619958331"><a href="https://lls.reaxys.com/redir?pid=scp:85039073375" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;24</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-118"><a href="https://www.embase.com/#" class="showAbstract" data="118" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="118"></i> Abstract</a></li><li class="ui-tab" id="indexTab-118"><a href="https://www.embase.com/#" class="showIndexTerms" data="118" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="118"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1159/000485008" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="117">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-117"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background/Aims: Multiple exposures to anesthesia in children may increase the risk of developing cognitive impairment. <span class="hit">Sevoflurane</span> is an anesthetic that is commonly used in children during surgery. Cyclin-dependent kinase (CDK) 5 is involved in the regulation of <span class="hit">sevoflurane</span>-induced cognitive dysfunction, but the mechanistic details remain unclear. The present study evaluated the mechanism by which CDK5 mediates <span class="hit">sevoflurane</span>-induced cognitive dysfunction in mice. Methods: Hippocampal neurons were isolated from postnatal day 0 C57BL/6 mouse pups. Six-day-old wild-type mice were exposed to <span class="hit">sevoflurane</span> and then treated with the CDK5 inhibitor roscovitine. The effects on cognitive function were evaluated with the Morris water maze and <span class="hit">neuronal</span> damage in the hippocampus was assessed by immunohistochemical analysis. Results: CDK5 activation increased <span class="hit">neuronal</span> damage by inducing Tau/glycogen synthase kinase (GSK) 3β and suppressing extracellular signal-regulated kinase (ERK)/peroxisome proliferator-activated receptor (PPAR)γ/cyclic AMP response element-binding protein (CREB) signaling following exposure to <span class="hit">sevoflurane</span>. CDK5 inhibition by roscovitine administration alleviated <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> damage and cognitive impairment. Conclusions: Inhibiting CDK5 with roscovitine has neuroprotective effects against <span class="hit">neuronal injury</span> and cognitive dysfunction caused by <span class="hit">sevoflurane</span> anesthesia that are exerted via modulation of Tau/GSK3β and ERK/PPARγ/CREB signaling.</p><p class="hitsHighlighted">© 2017 The Author(s).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L618507464" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L618507464" type="checkbox" id="record_checkbox_L618507464"><label for="record_checkbox_L618507464" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">119</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=119&amp;page=1&amp;id=L618507464" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Panax Notoginseng Saponins attenuates <span class="hit">sevoflurane</span>-induced nerve cell <span class="hit">injury</span> by modulating AKT signaling pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hong</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guonian</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">Molecular Medicine Reports</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">16</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(7829-7834)</span>&nbsp;<span class="cited-by" id="CTB-L618507464"><a href="https://lls.reaxys.com/redir?pid=scp:85030122643" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;18</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-119"><a href="https://www.embase.com/#" class="showAbstract" data="119" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="119"></i> Abstract</a></li><li class="ui-tab" id="indexTab-119"><a href="https://www.embase.com/#" class="showIndexTerms" data="119" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="119"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/mmr.2017.7519" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="118">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-118"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">General anesthesia in patients with or at risk for <span class="hit">neuronal injury</span> remains challenging due to the neurotoxic effects of volatile anesthetics. One inhalation anesthetic, <span class="hit">sevo-flurane</span>, induces <span class="hit">neuronal</span> damage, including neuroapoptosis, and learning and memory impairment. Panax Notoginseng Saponins (PNS) is the active ingredient of Sanqui and has been reported to exert neuroprotective effects. In the current study, the protective effect of PNS on <span class="hit">sevoflurane</span>-induced nerve cell <span class="hit">injury</span> was explored. Cell proliferation was significantly reduced in a dose-dependent manner following stimulation with <span class="hit">sevoflurane</span>. Furthermore, cell apoptosis and the protein expression of caspase-3, caspase-9 and Bax were significantly increased, while the expression of Bcl-2 was decreased in the <span class="hit">sevoflurane</span> group compared with normal control. Furthermore, the protein level of Bace-1, APP and Aβ were elevated in the <span class="hit">sevoflurane</span> group compared with the control group. By contrast, PNS treatment significantly reduced the neurotoxicity induced by <span class="hit">sevoflurane</span>. Additionally, sevofu-rane reduced activation of the AKT signaling pathway, which was activated by PNS treatment. In conclusion, the results suggested that PNS attenuates <span class="hit">sevoflurane</span>-induced neurotox-icity through by stimulating cell proliferation and inhibiting cell apoptosis. These effects were mediated, at least in part, by activating the AKT signaling pathway.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L622265945" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L622265945" type="checkbox" id="record_checkbox_L622265945"><label for="record_checkbox_L622265945" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">120</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=120&amp;page=1&amp;id=L622265945" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Dexmedetomidine provides neuroprotection against <span class="hit">sevoflurane</span>-induced apoptosis in the brain of neonatal rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Perez-Zoghbi</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Grafe</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brambrink</span> <span class="given-name notranslate">A.</span></span><br><span class="journal-title">Journal of Neurosurgical Anesthesiology</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">29</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(546-)</span>&nbsp;<span class="cited-by" id="CTB-L622265945"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-120"><a href="https://www.embase.com/#" class="showAbstract" data="120" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="120"></i> Abstract</a></li><li class="ui-tab" id="indexTab-120"><a href="https://www.embase.com/#" class="showIndexTerms" data="120" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="120"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ANA.0000000000000452" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="119">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-119"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Introduction: Exposure of infant animals to clinically used anesthetics is associated with acute structural brain abnormalities including widespread <span class="hit">neuronal</span> apoptosis and behavioral alterations later in life. In addition, epidemiological studies in children suggest an association between early-life exposure to anesthesia and cognitive and behavioral impairments. Because anesthetics and sedatives are necessary for surgery and other procedures, a search for substances that could ameliorate the neurotoxic effects of anesthetics is of utmost clinical importance. The α2-adrenoceptor agonist dexmedetomidine (DEX) induces sedation, analgesia, and provides neuroprotection in experimental brain <span class="hit">injury</span> models. However, it is unknown whether DEX also affords protection in the developing brain against anesthesia using <span class="hit">sevoflurane</span> (SEVO), which is predominantly used in pediatric anesthesia. We hypothesize that DEX co-administration during SEVO anesthesia reduces brain cell apoptosis in experimental neonates. Methods: infant rats were exposed on postnatal day 7 for 6 hours to 2.5% SEVO in 30% oxygen (%Vol) or to 30% oxygen (control) and were given ip injections of saline or DEX (1 to 50 μg/kg) 3 times during the exposure. Anesthesia levels, respiratory rates, and blood gasses were assessed for each animal. Apoptosis was determined in brain slices immunostained for activated caspase-3 (AC-3) using a computerized approach. Results: SEVO alone induced a surgical plane of anaesthesia and all animals survived the study. SEVO induced an approximately 10-fold increase in AC-3 positive cells in several cortical and subcortical brain regions, compared with controls. Co-administration of DEX 1 μg/kg with SEVO significantly reduced apoptosis in all brain areas, affording the highest protection in the thalamus (84%) and lowest in the hippocampus and cortical areas (∼50%). However, DEX 5-25 μg/kg plus SEVO dose-dependently increased mortality of the neonatal rats. Conclusions: SEVO anesthesia-induced widespread apoptosis in the brain of neonatal rats and co-administration of DEX (1 μg/kg) provided significant protection against this <span class="hit">injury</span>. However, higher DEX doses (5 μg/ kg or higher) plus SEVO caused infant rat mortality. Our findings suggest that DEX may be an attractive therapeutic for future studies investigating its neuroprotective potential in a translational animal model.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L616286197" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L616286197" type="checkbox" id="record_checkbox_L616286197"><label for="record_checkbox_L616286197" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">121</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=121&amp;page=1&amp;id=L616286197" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Electroencephalographic monitoring during <span class="hit">sevoflurane</span> anaesthesia in an amyotrophic lateral sclerosis patient with locked-in state</a><br><span class="author fn notranslate"><span class="family-name notranslate">Hayashi</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Araki</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tanaka</span> <span class="given-name notranslate">A.</span></span><br><span class="journal-title">Journal of Clinical Neuroscience</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">43</span><span class="journal-pages">&nbsp;(126-128)</span>&nbsp;<span class="cited-by" id="CTB-L616286197"><a href="https://lls.reaxys.com/redir?pid=scp:85019451404" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-121"><a href="https://www.embase.com/#" class="showAbstract" data="121" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="121"></i> Abstract</a></li><li class="ui-tab" id="indexTab-121"><a href="https://www.embase.com/#" class="showIndexTerms" data="121" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="121"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.jocn.2017.04.042" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="120">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-120"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Recently, the cognitive abilities of patients with amyotrophic lateral sclerosis (ALS) have been found to be impaired along with the neurodegeneration of motor neurons. Electroencephalography (EEG) of end-stage ALS patients has reportedly shown specific features based on neuronal network modulations, differing from EEG of other patients with cognitive failure and dementia. However, EEG of end-stage ALS patients during anaesthesia has not yet been reported. A 64-year-old male ALS patient with locked-in state (LIS), supported by tracheostomy positive-pressure ventilation (TPPV) and enteral nourishment for 9&nbsp;years, underwent scheduled general anaesthesia for repair of a fractured mandible. He could blink and open his eyes, but seldom opened or closed his eyes on instruction. Sevoflurane anaesthesia was induced under continuous EEG monitoring with bispectral index (BIS), which is commonly used to examine the level of anaesthesia. Prominent alpha oscillations with lower peak frequency and high amplitude appeared during anaesthesia, differing from the characteristics of EEG seen in patients with general cognitive failure. Conversely, BIS reflected the sevoflurane concentration in this ALS patient, similar to healthy individuals, and BIS monitoring was useful for estimating the depth of anaesthesia. The prominent alpha oscillation revealed in this rare case report may suggest modulation of the functional neuronal network system during anaesthesia in patients with progressive ALS, in a manner quite different from typical dementia patients. EEG abnormalities in the present ALS patient did not influence the availability of BIS monitoring.</p><p class="hitsHighlighted">© 2017 Elsevier Ltd</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L618464642" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L618464642" type="checkbox" id="record_checkbox_L618464642"><label for="record_checkbox_L618464642" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">122</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=122&amp;page=1&amp;id=L618464642" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Alternative technique or mitigating strategy for <span class="hit">sevoflurane</span>-induced neurodegeneration: A randomized controlled dose-escalation study of dexmedetomidine in neonatal rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">J.-R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">E.P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hofacer</span> <span class="given-name notranslate">R.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Upton</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">S.Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ewing</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Joseph</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Loepke</span> <span class="given-name notranslate">A.W.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">119</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(492-505)</span>&nbsp;<span class="cited-by" id="CTB-L618464642"><a href="https://lls.reaxys.com/redir?pid=scp:85029788009" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;34</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-122"><a href="https://www.embase.com/#" class="showAbstract" data="122" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="122"></i> Abstract</a></li><li class="ui-tab" id="indexTab-122"><a href="https://www.embase.com/#" class="showIndexTerms" data="122" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="122"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1093/bja/aex219" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="121">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-121"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background. Brain <span class="hit">injury</span> in newborn animals from prolonged anaesthetic exposure has raised concerns for millions of children undergoing anaesthesia every yr. Alternative anaesthetic techniques or mitigating strategies are urgently needed to ameliorate potentially harmful effects. We tested dexmedetomidine, both as a single agent alternative technique and as a mitigating adjuvant for <span class="hit">sevoflurane</span> anaesthesia. Methods. Neonatal rats were randomized to three injections of dexmedetomidine (5, 25, 50, or 100 μg kg-1 every 2 h), or 6 h of 2.5% <span class="hit">sevoflurane</span> as a single agent without or with dexmedetomidine (1, 5, 10, or 20 μg kg-1 every 2 h). Heart rate, oxygen saturation, level of consciousness, and response to pain were assessed. Cell death was quantified in several brain regions. Results. Dexmedetomidine provided lower levels of sedation and pain control than <span class="hit">sevoflurane</span>. Exposure to either <span class="hit">sevoflurane</span> or dexmedetomidine alone did not cause mortality, but the combination of 2.5% <span class="hit">sevoflurane</span> and dexmedetomidine in doses exceeding 1 μg kg-1 did. <span class="hit">Sevoflurane</span> increased apoptosis in all brain regions; supplementation with dexmedetomidine exacerbated <span class="hit">neuronal injury</span>, potentially as a result of ventilatory or haemodynamic compromise. Dexmedetomidine by itself increased apoptosis only in CA2/3 and the ventral posterior nucleus, but not in prefrontal cortex, retrosplenial cortex, somatosensory cortex, subiculum, lateral dorsal thalamic nucleaus, or hippocampal CA1. Conclusions. We confirm previous findings of <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal injury</span>. Dexmedetomidine, even in the highest dose, did not cause similar <span class="hit">injury</span>, but provided lesser degrees of anaesthesia and pain control. No mitigation of <span class="hit">sevoflurane</span>-induced <span class="hit">injury</span> was observed with dexmedetomidine supplementation, suggesting that future studies should focus on anaesthetic-sparing effects of dexmedetomidine, rather than <span class="hit">injury</span>-preventing effects.</p><p class="hitsHighlighted">© 2017 The Author.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L613625096" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L613625096" type="checkbox" id="record_checkbox_L613625096"><label for="record_checkbox_L613625096" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">123</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=123&amp;page=1&amp;id=L613625096" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroinflammatory challenges compromise <span class="hit">neuronal</span> function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease</a><br><span class="author fn notranslate"><span class="family-name notranslate">Cortese</span> <span class="given-name notranslate">G.P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Burger</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Behavioural Brain Research</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">322</span><span class="journal-pages">&nbsp;(269-279)</span>&nbsp;<span class="cited-by" id="CTB-L613625096"><a href="https://lls.reaxys.com/redir?pid=scp:85002982878" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;36</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-123"><a href="https://www.embase.com/#" class="showAbstract" data="123" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="123"></i> Abstract</a></li><li class="ui-tab" id="indexTab-123"><a href="https://www.embase.com/#" class="showIndexTerms" data="123" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="123"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bbr.2016.08.027" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="122">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-122"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Alzheimer's disease (AD) is a progressive neurodegenerative disease that targets memory and cognition, and is the most common form of dementia among the elderly. Although AD itself has been extensively studied, very little is known about early-stage preclinical events and/or mechanisms that may underlie AD pathogenesis. Since the majority of AD cases are sporadic in nature, advancing age remains the greatest known risk factor for AD. However, additional environmental and epigenetic factors are thought to accompany increasing age to play a significant role in the pathogenesis of AD. Postoperative cognitive delirium (POD) is a behavioral syndrome that primarily occurs in elderly patients following a surgical procedure or <span class="hit">injury</span> and is characterized by disruptions in cognition. Individuals that experience POD are at an increased risk for developing dementia and AD compared to normal aging individuals. One way in which cognitive function is affected in cases of POD is through activation of the inflammatory cascade following surgery or <span class="hit">injury</span>. There is compelling evidence that immune challenges (surgery and/or <span class="hit">injury</span>) associated with POD trigger the release of pro-inflammatory cytokines into both the periphery and central nervous system. Thus, it is possible that cognitive impairments following an inflammatory episode may lead to more severe forms of dementia and AD pathogenesis. Here we will discuss the inflammation associated with POD, and highlight the advantages of using POD as a model to study inflammation-evoked cognitive impairment. We will explore the possibility that advancing age and immune challenges may provide mechanistic evidence correlating early life POD with AD. We will review and propose neural mechanisms by which cognitive impairments occur in cases of POD, and discuss how POD may augment the onset of AD.</p><p class="hitsHighlighted">© 2016 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L613962084" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L613962084" type="checkbox" id="record_checkbox_L613962084"><label for="record_checkbox_L613962084" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">124</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=124&amp;page=1&amp;id=L613962084" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroprotective effects of erythropoietin against <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> apoptosis in primary rat cortical neurons involving the EPOR-Erk1/2-Nrf2/Bach1 signal pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">D.-X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">Biomedicine and Pharmacotherapy</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">87</span><span class="journal-pages">&nbsp;(332-341)</span>&nbsp;<span class="cited-by" id="CTB-L613962084"><a href="https://lls.reaxys.com/redir?pid=scp:85008316364" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;29</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-124"><a href="https://www.embase.com/#" class="showAbstract" data="124" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="124"></i> Abstract</a></li><li class="ui-tab" id="indexTab-124"><a href="https://www.embase.com/#" class="showIndexTerms" data="124" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="124"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.biopha.2016.12.115" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="123">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-123"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective Erythropoietin (EPO)-induced activation of the EPO receptor (EPOR) against sevoflurane-induced neuronal apoptosis is an effective intervention, but the underlying mechanism is poorly understood. Previous studies have shown that alteration of the nuclear factor erythroid 2-related factor (Nrf2)/BTB-to-CNC homology 1 (Bach1) ratio by extracellular signal-related kinases (Erk) 1/2 ameliorates the oxidative stress which occurs in human macrophages. In this study, we determined whether or not EPO attenuates sevoflurane-induced neuronal apoptosis via the EPOR-Erk1/2-Nrf2/Bach1 signal pathway. Methods Primary rat cortical neurons were exposed to 4% sevoflurane for 6&nbsp;h. Neuronal viability, injury, apoptosis, and oxidative stress were assessed using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase (LDH), propidium iodide uptake (PI), malondialdehyde (MDA), and superoxide dismutase (SOD) assays. A real-time PCR assay was used to measure EPOR expression. Western blotting was used to assess Nrf2, Bach1, and heme oxygenase-1 (HO-1) expression. Results Sevoflurane exposure increased cell apoptosis, injury, and MDA (P&nbsp;&lt;&nbsp;0.05), but decreased cell viability and the Nrf2:Bach1 ratio (P&nbsp;&lt;&nbsp;0.05), and down-regulated superoxide dismutase (SOD; P&nbsp;&lt;&nbsp;0.05), while EPO partially rescued the neurotoxicity induced by sevoflurane (P&nbsp;&lt;&nbsp;0.05). Inhibition of EPOR via EPO-specific monoclonal antibody or Erk1/2 phosphorylation via PD98059 reversed the protective effect of EPO (P&nbsp;&lt;&nbsp;0.05). Conclusion The neuroprotective effects of EPO against sevoflurane-induced neuronal apoptosis in primary rat cortical neurons involves the EPOR-Erk1/2-Nrf2/Bach1 signal pathway.</p><p class="hitsHighlighted">© 2016 Elsevier Masson SAS</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L614585625" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L614585625" type="checkbox" id="record_checkbox_L614585625"><label for="record_checkbox_L614585625" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">125</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=125&amp;page=1&amp;id=L614585625" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> induces long-term memory impairment and increases MeCP2 phosphorylation in developing mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Han</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xue</span> <span class="given-name notranslate">Z.</span></span><br><span class="journal-title">International Journal of Clinical and Experimental Medicine</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">10</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(2897-2903)</span>&nbsp;<span class="journal-artnr">Article Number IJCEM0023347</span>&nbsp;<span class="cited-by" id="CTB-L614585625"><a href="https://lls.reaxys.com/redir?pid=scp:85014171705" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-125"><a href="https://www.embase.com/#" class="showAbstract" data="125" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="125"></i> Abstract</a></li><li class="ui-tab" id="indexTab-125"><a href="https://www.embase.com/#" class="showIndexTerms" data="125" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="125"></i> Index Terms</a></li><li><span id="FTL-L614585625" class="fulltext" data="{&quot;recno&quot;:&quot;L614585625&quot;,&quot;issn&quot;:&quot;19405901&quot;,&quot;volume&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;startpage&quot;:&quot;2897&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="124">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-124"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> is the most widely used volatile anesthetic in pediatric anesthesia. Some pediatric plastic surgery procedures (such as cleft lip repair, the repair of brachial plexus <span class="hit">injury</span>, etc.) may require multiple operations, requiring some children to repeatedly inhale this anesthetic. Evidence has suggested that <span class="hit">sevoflurane</span> may cause <span class="hit">neuronal</span> deficiency. We investigated the long-term effects of <span class="hit">sevoflurane</span> use and possible mechanisms underlying neurodegeneration induced by repeated <span class="hit">sevoflurane</span> exposure in the developing brain in the present study. Postnatal day 7 (P7) C57BL/6 mice were randomly exposed to either 1.5% <span class="hit">sevoflurane</span> or air control for 2 hours/day on 5 consecutive days. Methyl-CpG island binding protein 2 (MeCP2) phosphorylation and brain-derived neurotrophic factor (BDNF) expression in the hippocampus were measured by western blotting. Seven weeks after <span class="hit">sevoflurane</span> exposure, a fear conditioning test was used to evaluate associative learning processes. Repeated exposure to 1.5% <span class="hit">sevoflurane</span> resulted in increased MeCP2 phosphorylation and decreased BDNF expression in the hippocampus. This study demonstrates that P7 mice exposed to 1.5% <span class="hit">sevoflurane</span> for 2 hours on 5 consecutive days have significant contextual learning and memory impairment after 7 weeks. These data suggest that repeated <span class="hit">sevoflurane</span> exposure may cause neurotoxicity in the developing brain by increasing MeCP2 phosphorylation and decreasing BDNF expression in the hippocampus.</p><p class="hitsHighlighted">© 2017, E-Century Publishing Corporation. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L613367369" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L613367369" type="checkbox" id="record_checkbox_L613367369"><label for="record_checkbox_L613367369" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">126</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=126&amp;page=1&amp;id=L613367369" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> pre-conditioning increases phosphorylation of Erk1/2 and HO-1 expression via inhibition of mPTP in primary rat cortical neurons exposed to OGD/R</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">D.-X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">W.-B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">X.-J.</span></span><br><span class="journal-title">Journal of the Neurological Sciences</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">372</span><span class="journal-pages">&nbsp;(171-177)</span>&nbsp;<span class="cited-by" id="CTB-L613367369"><a href="https://lls.reaxys.com/redir?pid=scp:84997610592" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;9</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-126"><a href="https://www.embase.com/#" class="showAbstract" data="126" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="126"></i> Abstract</a></li><li class="ui-tab" id="indexTab-126"><a href="https://www.embase.com/#" class="showIndexTerms" data="126" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="126"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.jns.2016.11.055" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="125">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-125"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background As an indispensable clinical inhalation anesthetic, sevoflurane is widely used for peri-operative sedation. The neuroprotective effect of sevoflurane pre-conditioning against cerebral ischemia/reperfusion has been gradually realized, but the underlying mechanism during the early reperfusion period has not been established. Method Primary cultured cortical neurons were treated with 2% sevoflurane pre-conditioning for 30&nbsp;min, exposed to oxygen-glucose deprivation for 90&nbsp;min, and followed by 60&nbsp;min of reperfusion (OGD/R). Additionally, neuronal cells were treated with an inhibitor of extracellular signal–related kinases 1 and 2 (Erk1/2) phosphorylation (PD98059), a mPTP opener (atractyloside), or a mPTP opening inhibitor (cyclosporine A) before sevoflurane pre-conditioning. Result Sevoflurane pre-conditioning decreased neuronal apoptosis (assessed by TUNEL), oxidative stress (assessed by malondialdehyde [MDA], superoxide dismutase [SOD], and heme oxygenase [HO]-1), and opening of mitochondrial permeability transition pores [mPTPs] (assessed by calcein-cobalt), but increased neuronal viability (assessed by MTT) and mitochondrial membrane potential (assessed by JC-1) after OGD/R exposure compared with OGD/R treatment alone. Pre-treatment with the mPTP opener and inhibitor of Erk1/2 phosphorylation abolished the protective effect induced by sevoflurane pre-conditioning. Pre-treatment with the mPTP opener attenuated the phosphorylation of Erk1/2 in mitochondria of neuronal cultures exposed to OGD/R induced by sevoflurane pre-conditioning. The mPTP opening inhibitor, like sevoflurane pre-conditioning, increased phosphorylation of Erk1/2 after OGD/R exposure, while PD98059 failed to reverse inhibition of mPTP opening in cultures exposed to OGD/R induced by sevoflurane pre-conditioning. Conclusion The neuroprotective mechanism of sevoflurane pre-conditioning might be associated with increased Erk1/2 phosphorylation in mitochondria via inhibition of mPTP opening in the early reperfusion period.</p><p class="hitsHighlighted">© 2016 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L615579473" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L615579473" type="checkbox" id="record_checkbox_L615579473"><label for="record_checkbox_L615579473" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">127</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=127&amp;page=1&amp;id=L615579473" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Minocycline attenuates <span class="hit">sevoflurane</span>-induced cell <span class="hit">injury</span> via activation of Nrf2</a><br><span class="author fn notranslate"><span class="family-name notranslate">Tian</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wei</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">International Journal of Molecular Medicine</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">39</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(869-878)</span>&nbsp;<span class="cited-by" id="CTB-L615579473"><a href="https://lls.reaxys.com/redir?pid=scp:85018524900" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;14</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-127"><a href="https://www.embase.com/#" class="showAbstract" data="127" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="127"></i> Abstract</a></li><li class="ui-tab" id="indexTab-127"><a href="https://www.embase.com/#" class="showIndexTerms" data="127" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="127"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/ijmm.2017.2908" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="126">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-126"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Minocycline has been demonstrated to exert neuroprotective effects in various experimental models. In the present study, we investigated the mechanisms underlying the protective effects of minocycline on cell <span class="hit">injury</span> induced by the inhalation of the anesthetic, <span class="hit">sevoflurane</span>. In our in vivo experiments using rats, minocycline attenuated <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal</span> degeneration and apoptosis in the rat hippocampus, and this effect was associated with the minocycline-mediated suppression of oxidative stress in the hippocampus. In in vitro experiments, minocycline inhibited <span class="hit">sevoflurane</span>-induced apoptosis and the production of reactive oxygen species (ROS) in H4 human neuroglioma cells. In addition, minocycline suppressed the <span class="hit">sevoflurane</span>-induced upregulation of interleukin (IL)-6 and the activation of the nuclear factor-κB (NF-κB) signaling pathway in H4 cells. Furthermore, we found that nuclear factor E2-related factor 2 (Nrf2), an activator of the stress response, was upregulated and activated upon <span class="hit">sevoflurane</span> treatment both in the rat hippocampus and in H4 cells. In addition, minocycline further augmented the upregulation and activation of Nrf2 when used in conjunction with <span class="hit">sevoflurane</span>. Moreover, the knockdown of Nrf2 in H4 cells by small interfering RNA (siRNA) diminished the cytoprotective effect of minocycline, and attenuated the inhibitory effect of minocycline on ROS production, IL-6 upregulation and the activation of the NF-κB signaling pathway. On the whole, our findings indicate that minocycline may exert protective effects against <span class="hit">sevoflurane</span>-induced cell <span class="hit">injury</span> via the Nrf2-modulated antioxidant response and the inhibition of the activation of the NF-κB signaling pathway.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L615862223" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L615862223" type="checkbox" id="record_checkbox_L615862223"><label for="record_checkbox_L615862223" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">128</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=128&amp;page=1&amp;id=L615862223" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> preconditioning induced endogenous neurogenesis against ischemic brain <span class="hit">injury</span> by promoting microglial activation</a><br><span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Saiyin</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xie</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xue</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Q.</span></span><br><span class="journal-title">Oncotarget</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">8</span><span class="journal-issue">:17</span><span class="journal-pages">&nbsp;(28544-28557)</span>&nbsp;<span class="cited-by" id="CTB-L615862223"><a href="https://lls.reaxys.com/redir?pid=scp:85018445819" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;12</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-128"><a href="https://www.embase.com/#" class="showAbstract" data="128" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="128"></i> Abstract</a></li><li class="ui-tab" id="indexTab-128"><a href="https://www.embase.com/#" class="showIndexTerms" data="128" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="128"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.18632/oncotarget.15325" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="127">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-127"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Brain ischemia causes irreversible damage to functional neurons in cases of infarct. Promoting endogenous neurogenesis to replace necrotic neurons is a promising therapeutic strategy for ischemia patients. The neuroprotective role of <span class="hit">sevoflurane</span> preconditioning implies that it might also enhance endogenous neurogenesis and functional restoration in the infarct region. By using a transient middle cerebral artery occlusion (tMCAO) model, we discovered that endogenous neurogenesis was enhanced by <span class="hit">sevoflurane</span> preconditioning. This enhancement process is characterized by the promotion of neuroblast proliferation within the subventricular zone (SVZ), migration and differentiation into neurons, and the presence of astrocytes and oligodendrocytes at the site of infarct. The newborn neurons in the <span class="hit">sevoflurane</span> preconditioning group showed miniature excitatory postsynaptic currents (mEPSCs), increased synaptophysin and PSD95 staining density, indicating normal <span class="hit">neuronal</span> function. Furthermore, long-term behavioral improvement was observed in the <span class="hit">sevoflurane</span> preconditioning group consistent with endogenous neurogenesis. Further histological analyses showed that <span class="hit">sevoflurane</span> preconditioning accelerated microglial activation, including migration, phagocytosis and secretion of brain-derived neurotrophic factor (BDNF). Intraperitoneal injection of minocycline, a microglial inhibitor, suppressed microglial activation and reversed neurogenesis. Our data showed that <span class="hit">sevoflurane</span> preconditioning promoted microglial activities, created a favorable microenvironment for endogenous neurogenesis and accelerated functional reconstruction in the infarct region.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L620709066" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L620709066" type="checkbox" id="record_checkbox_L620709066"><label for="record_checkbox_L620709066" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">129</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=129&amp;page=1&amp;id=L620709066" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of TLR3 and TLR9 signaling pathway on brain protection in rats undergoing <span class="hit">sevoflurane</span> pretreatment during cardiopulmonary bypass</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cao</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">K.</span></span><br><span class="journal-title">BioMed Research International</span>&nbsp;<span class="journal-publication-year">2017</span>&nbsp;<span class="journal-volume">2017</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 4286738</span>&nbsp;<span class="cited-by" id="CTB-L620709066"><a href="https://lls.reaxys.com/redir?pid=scp:85042143058" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-129"><a href="https://www.embase.com/#" class="showAbstract" data="129" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="129"></i> Abstract</a></li><li class="ui-tab" id="indexTab-129"><a href="https://www.embase.com/#" class="showIndexTerms" data="129" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="129"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1155/2017/4286738" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="128">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-128"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective. To investigate the effects of TLR3 and TLR9 signaling pathway on brain <span class="hit">injury</span> during CPB in rats pretreated with <span class="hit">sevoflurane</span> and its possible molecular mechanism. Methods. SD rats were randomly assigned to sham group, CPB group, and Sev group. Brain tissue was obtained at before CPB (T0), at CPB for 30 minutes (T1), 1 hour after CPB (T3), and 3 hours after CPB (T5). ELISA was used to measure S100-ß and IL-6.Western blot was utilized to determine TLR3 and TLR9 expression. TUNEL was applied to detect <span class="hit">neuronal</span> apoptosis. Results. Compared with CPB group, at T1, at termination after 1 hour of CPB (T2), T3, 2 hours after CPB (T4) and T5, S100-ß and IL-6 decreased in Sev group. Compared with CPB group, IFN-ß were increased in Sev group, except T0. Compared with CPB group, TLR3 expression increased, and TLR9 and NF-κB decreased in Sev group. The apoptotic neurons were less in Sev group than in CPB group (P &lt; 0.05). Conclusion. <span class="hit">Sevoflurane</span> intervention can activate TLR3 and TLR9 signaling pathway, upregulate TLR3 expression and downstream TRIF expression, decrease TLR9 expression, and downregulate downstreamNF-κB expression in CPB ratmodels, therebymitigating brain <span class="hit">injury</span> induced by inflammatory response during CPB.</p><p class="hitsHighlighted">Copyright © 2017 Zhou Nan et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L613711571" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L613711571" type="checkbox" id="record_checkbox_L613711571"><label for="record_checkbox_L613711571" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">130</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=130&amp;page=1&amp;id=L613711571" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Pharmacological and pathological modulation of cerebral physiology</a><br><span class="author fn notranslate"><span class="family-name notranslate">Hirsch</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Taylor</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Anaesthesia and Intensive Care Medicine</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">17</span><span class="journal-issue">:12</span><span class="journal-pages">&nbsp;(635-640)</span>&nbsp;<span class="cited-by" id="CTB-L613711571"><a href="https://lls.reaxys.com/redir?pid=scp:85006013075" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-130"><a href="https://www.embase.com/#" class="showAbstract" data="130" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="130"></i> Abstract</a></li><li class="ui-tab" id="indexTab-130"><a href="https://www.embase.com/#" class="showIndexTerms" data="130" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="130"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.mpaic.2016.09.015" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="129">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-129"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Anaesthesia for neurosurgery aims to provide optimal surgical conditions whilst maintaining adequate cerebral blood flow in order to supply the brain with appropriate amounts of oxygen and glucose. Most anaesthetic drugs influence the normal cerebral physiology either directly or indirectly. They can cause changes in cerebral blood flow by influencing cerebral blood vessel calibre, by interfering with autoregulatory processes and by modifying cerebral metabolism. The brain's limited ability to store oxygen and glucose means that its supply must be continuous if <span class="hit">neuronal</span> damage is to be avoided. Ischaemic cerebral damage is the most important pathological mechanism in patients with stroke, subarachnoid haemorrhage and traumatic brain <span class="hit">injury</span>. Significant traumatic brain <span class="hit">injury</span> causes widespread derangement of cerebral physiology, including changes in cerebral blood flow, autoregulation and cerebral energy dynamics. This article outlines the effect of anaesthesia on cerebral physiology and reviews the pathophysiology of traumatic brain <span class="hit">injury</span> and subarachnoid haemorrhage.</p><p class="hitsHighlighted">© 2016</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L613852334" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L613852334" type="checkbox" id="record_checkbox_L613852334"><label for="record_checkbox_L613852334" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">131</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=131&amp;page=1&amp;id=L613852334" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> post-conditioning enhanced hippocampal neuron resistance to global cerebral ischemia induced by cardiac arrest in rats through PI3K/Akt survival pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ye</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huang</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">Q.</span></span><br><span class="journal-title">Frontiers in Cellular Neuroscience</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">10</span><span class="journal-issue">:NOV2016</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 271</span>&nbsp;<span class="cited-by" id="CTB-L613852334"><a href="https://lls.reaxys.com/redir?pid=scp:85007473613" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;19</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-131"><a href="https://www.embase.com/#" class="showAbstract" data="131" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="131"></i> Abstract</a></li><li class="ui-tab" id="indexTab-131"><a href="https://www.embase.com/#" class="showIndexTerms" data="131" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="131"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3389/fncel.2016.00271" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="130">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-130"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The purpose of this current study was to evaluate whether improvement of mitochondrial dysfunction was involved in the therapeutic effect of <span class="hit">sevoflurane</span> post-conditioning in global cerebral ischemia after cardiac arrest (CA) via the PI3K/Akt pathway. In the first experiment, animals were randomly divided into three groups: a sham group, a CA group, a CA+<span class="hit">sevoflurane</span> post-conditioning group (CA+SE). <span class="hit">Sevoflurane</span> post-conditioning was achieved by administration of 2.5% <span class="hit">sevoflurane</span> for 30 min after resuscitation. <span class="hit">Sevoflurane</span> post-conditioning has a significant neuroprotective effect by increasing survival rates and reducing <span class="hit">neuronal</span> apoptosis. Additionally, the gene and protein expression of PGC-1α, NRF-1, and TFAM, the master regulators of mitochondrial biogenesis, were up-regulated in the CA+SE group, when compared to the CA group. Similarly, in contrast to the CA group, mitochondria-specific antioxidant enzymes, including heat-shock protein 60 (HSP60), peroxiredoxin 3 (Prx3), and thioredoxin 2 (Trx2) were also increased in the CA+SE group. Finally, administration of <span class="hit">sevoflurane</span> ameliorated mitochondrial reactive oxygen species (ROS) formation and maintained mitochondrial integrity. In the second experiment, we investigated the relationship between the PI3K/Akt pathway and mitochondrial biogenesis and mitochondria-specific antioxidant enzymes in <span class="hit">sevoflurane</span>-induced neuroprotection. The selective PI3K inhibitor wortmannin not only eliminated the beneficial biochemical processes of <span class="hit">sevoflurane</span> by reducing the level of mitochondrial biogenesis-related proteins and aggravating mitochondrial integrity, but also reversed the elevation of mitochondria-specific antioxidant enzymes induced by <span class="hit">sevoflurane</span>. Therefore, our data suggested that <span class="hit">sevoflurane</span> post-conditioning provides neuroprotection via improving mitochondrial biogenesis and integrity, as well as increasing mitochondria-specific antioxidant enzymes by a mechanism involving the PI3K/Akt pathway.</p><p class="hitsHighlighted">© 2016 Wang, Ye, Huang, Wang, Wang and Guo.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L611412930" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L611412930" type="checkbox" id="record_checkbox_L611412930"><label for="record_checkbox_L611412930" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">132</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=132&amp;page=1&amp;id=L611412930" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of hypotension and/or hypocapnia during <span class="hit">sevoflurane</span> anesthesia on perfusion and metabolites in the developing brain of piglets—a blinded randomized study</a><br><span class="author fn notranslate"><span class="family-name notranslate">Ringer</span> <span class="given-name notranslate">S.K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ohlerth</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Carrera</span> <span class="given-name notranslate">I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mauch</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Spielmann</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bettschart-Wolfensberger</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Weiss</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">Paediatric Anaesthesia</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">26</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(909-918)</span>&nbsp;<span class="cited-by" id="CTB-L611412930"><a href="https://lls.reaxys.com/redir?pid=scp:84979533876" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;15</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-132"><a href="https://www.embase.com/#" class="showAbstract" data="132" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="132"></i> Abstract</a></li><li class="ui-tab" id="indexTab-132"><a href="https://www.embase.com/#" class="showIndexTerms" data="132" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="132"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/pan.12956" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="131">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-131"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Hypotension (HT) and/or hypocapnia (HC) are frequent complications occurring during pediatric anesthesia and may cause cerebral <span class="hit">injury</span> in the developing brain. Aim: The aim of this study is to investigate the effects of HT and/or HC on perfusion and metabolism in the developing brain. Methods: Twenty-eight piglets were randomly allocated to four groups: control (C), HT, HC, and hypotension and hyocapnia (HTC). Anesthesia was induced and maintained using <span class="hit">sevoflurane</span>. Fentanyl was added for instrumentation. Piglets were fully monitored and their lungs were artificially ventilated. Before treatment, conventional magnetic resonance imaging (MRI), dynamic susceptibility-contrast-enhanced T2*-weighted MRI (DSC-MRI), and single voxel proton MR spectroscopy (<sup>1</sup>H MRS) were performed. Hypotension (mean arterial blood pressure: 30 ± 3 mmHg) was induced by blood withdrawal and nitroprusside infusion, and hyperventilation was used to induce HC (PaCO<sub>2</sub>: 2.7–3.3 kPa). <sup>1</sup>H MRS and DSC-MRI were repeated immediately once treatment goals were achieved and 120 min later. Radiologists were blinded to the groups. DSCI-MRI and <sup>1</sup>H MRS analyses were performed in the thalamus, occipital and parietal lobe, hippocampus, and watershed areas. Results: In comparison to C, mean time to peak (TTP) increased with HTC in all brain areas as assessed with DSC-MRI (n = 26). Using <sup>1</sup>H MRS, a significant decrease in N-acetyl aspartate, choline, and myoinositol, as well as an increase in glutamine–glutamate complex (Glx) were detected independent of group. Compared to C, changes were more pronounced for Glx (due to an increase in glutamate) and myoinositol with HTC, for N-acetyl aspartate with HT, and for Glx with HC. No lactate signal was present. Conclusions: The combination of HT and HC during <span class="hit">sevoflurane</span> anesthesia resulted in alteration of cerebral perfusion with signs of <span class="hit">neuronal</span> dysfunction and early <span class="hit">neuronal</span> ischemia. HT and HC alone also resulted in signs of metabolic disturbances despite the absence of detectable cerebral perfusion alterations.</p><p class="hitsHighlighted">© 2016 John Wiley &amp; Sons Ltd</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L612173010" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L612173010" type="checkbox" id="record_checkbox_L612173010"><label for="record_checkbox_L612173010" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">133</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=133&amp;page=1&amp;id=L612173010" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Is there a role for regional anesthesia in the prevention of brain damage in the young?</a><br><span class="author fn notranslate"><span class="family-name notranslate">Ecoffey</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Regional Anesthesia and Pain Medicine</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">41</span><span class="journal-issue">:5</span>&nbsp;<span class="journal-suppl">Supplement 1</span><span class="journal-pages">&nbsp;(e23-e24)</span>&nbsp;<span class="cited-by" id="CTB-L612173010"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-133"><a href="https://www.embase.com/#" class="showAbstract" data="133" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="133"></i> Abstract</a></li><li class="ui-tab" id="indexTab-133"><a href="https://www.embase.com/#" class="showIndexTerms" data="133" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="133"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/AAP.0000000000000469" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="132">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-132"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">There are a large number of studies in the medical literature that have raised concern about the potential of neurotoxicity of sedation/anesthesia agents in young children (1, 2, 3), but few data exist in animals with regional anesthesia. Nonetheless, it is important to remember that many reflect work in animal models where translation to human applicability remains unknown or retrospective epidemiologic human studies in which some show a possible adverse effect and others do not. Observational studies on pediatric anesthesia neurotoxicity have been unable to distinguish long-term effects of general anesthesia from factors associated with the need for surgery. There is also potential for harm to direct brain toxicity from general anesthetic agents superimposed upon preexisting altered brain development in infants born at very to extreme preterm gestation. Finally, the possible increase in brain neurotoxicity in children exposed to general anesthesia cannot be attributed to the need for surgery or the surgery itself but must be due to some other reason (4). Regional anesthesia can be sometimes performed combined with general anesthesia or alone, i.e. spinal anesthesia in infants. For the combined technique of anesthesia, the amount of anesthetic agents is reduced (5, 6). It has been convincingly demonstrated that the effects of anesthetic agents on neurocognitive outcome are dose and duration dependent (3). Intuitively, if combining neuraxial techniques with general anesthesia can reduce exposure to general anesthetic agents, this approach could reduce the risk of brain neurotoxicity. On the other hand, spinal anesthesia is an alternative to general anesthesia for a variety of surgical procedures in infants. Although less commonly used than general anesthesia, it has an established record of safety (7) and has not been implicated in animal studies of neurotoxicity. An infant rat model was developed to study immediate and long-term behavioral responses and potential brain <span class="hit">neuronal</span> loss following spinal anesthesia (8). Spinal bupivacaine, 3.75 mg/kg, produced limb surgical anesthesia and did not induce apoptosis in either the brain or spinal cord. As in previous studies, short-term exposure to minimal alveolar concentrations of isoflurane appeared benign, while prolonged isoflurane exposure induced apoptosis, i.e. 6 h exposure to isoflurane in infant rats aged 7 days. Within the limitations imposed by extrapolation from rats to humans, these experiments support the expectation that spinal anesthesia in infants should have benign neurodevelopmental effects. However, today in the literature few clinical data exist comparing regional anesthesia and general anesthesia. A first study compared postoperative cognitive function in a similar cohort of children anesthetized with an alternative to general anesthesia, i.e. spinal anesthesia in infants (9). This is an interesting study separating the effects of exposure to general anesthesia from the need for surgery itself. The authors found no link between duration of surgery with infant spinal anesthesia and scores on academic achievement testing in elementary school. In the same way, the recent published GAS study compared spinal with general anesthesia in the repair of inguinal hernia (10). Outcome data were available for 238 children in the awake regional group and 294 in the general anesthesia group. The mean cognitive composite score was 98.6 ± 14.2 in the awake-regional group and 98.2 ± 14.7 in the general anesthesia group. There was equivalence in mean between groups. The median duration of anesthesia in the general anesthesia group was 54 min. The conclusion of this randomized study was no evidence that just less than 1 h of <span class="hit">sevoflurane</span> anesthesia in infancy increases the risk of adverse neurodevelopmental outcome at 2 years of age compared with awake-regional anesthesia. In conclusion, this highlights the clear need for the examination of neurodevelopmental outcomes in the context of large randomized controlled trials of general, compared with spinal, anesthesia or with combined techniques in infants.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L612648537" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L612648537" type="checkbox" id="record_checkbox_L612648537"><label for="record_checkbox_L612648537" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">134</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=134&amp;page=1&amp;id=L612648537" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroprotective effect of hydrogen gas on brain <span class="hit">injury</span> in a rat transient forebrain ischemia model</a><br><span class="author fn notranslate"><span class="family-name notranslate">Nagasaki</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Masaki</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Horiguchi</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Nishikawa</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Takahashi</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">123</span><span class="journal-issue">:3</span>&nbsp;<span class="journal-suppl">Supplement 2</span><span class="journal-pages">&nbsp;(206-)</span>&nbsp;<span class="cited-by" id="CTB-L612648537"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-134"><a href="https://www.embase.com/#" class="showAbstract" data="134" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="134"></i> Abstract</a></li><li class="ui-tab" id="indexTab-134"><a href="https://www.embase.com/#" class="showIndexTerms" data="134" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="134"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/01.ane.0000492562.00670.62" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="133">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-133"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background &amp; Objectives: Hydrogen gas is widely considered to be a novel antioxidant1). It has been demonstrated that inhalation of hydrogen gas reduced ischemic cerebral <span class="hit">injury</span> in several investigations. However, it remains unclear whether the neuroprotective effect of hydrogen gas is reproducible in a rat transient forebrain ischemia model (i.e. the Smith model). The current study was conducted to evaluate the effect of hydrogen gas on histological outcome after 7-day recovery period in rats subjected to transient forebrain ischemia. Materials &amp; Methods: After approval by the animal research committee, male Sprague-Dawley rats were randomly assigned to one of the following 2 groups: control group, or hydrogen gas group (n=6 in each group). In the hydrogen gas group, transient forebrain ischemia was induced by a combination of hemorrhagic hypotension (mean arterial pressure= 40 mmHg) and bilateral carotid artery occlusion following 2.5% of <span class="hit">sevoflurane</span> anesthesia. The brain was reperfused 10 minutes after the onset of ischemia, and after 1 hour, the <span class="hit">sevoflurane</span> anesthesia was discontinued. 1.3% hydrogen gas inhalation began 10 min prior to the onset of ischemia, and was continued until the discontinuation of the anesthesia. Temporalis muscle temperature was maintained at approximately 37.5 degrees throughout the procedure. In the control group, all treatments were the same as the hydrogen gas group except for the hydrogen gas inhalation. Seven days after ischemia, the rats were sacrificed for histological evaluation. The brain slices were stained with hematoxilin and eosin, and the coronal sections at hippocampal level were examined light-microscopically. The degree of <span class="hit">neuronal</span> damage in the CA1 subfield of the hippocampus was assessed using the following scale: 1 = no ischemic neurons; 2 = less than 20% ischemic neurons; 3 = 20∼50% ischemic neurons; 4 = 50∼80% ischemic neurons; 5 = more than 80% ischemic neurons; 6 = no intact neurons. Statistical analysis was performed with Mann-Whitney U test for group comparison. Results: The median hippocampal <span class="hit">injury</span> scale was greater in the control group than in the hydrogen gas group (5[0] vs. 4[2]; median [interquartile range], respectively, p=0.07). Conclusion: The current study indicates that the treatment with 1.3% hydrogen gas is likely to provide a modest neuroprotective effect in a rat transient forebrain ischemia model.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L611106837" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L611106837" type="checkbox" id="record_checkbox_L611106837"><label for="record_checkbox_L611106837" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">135</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=135&amp;page=1&amp;id=L611106837" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Inhibiting NADPH oxidase protects against long-term memory impairment induced by neonatal <span class="hit">sevoflurane</span> exposure in mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Satomoto</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Adachi</span> <span class="given-name notranslate">Y.U.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kinoshita</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Makita</span> <span class="given-name notranslate">K.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">117</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(80-86)</span>&nbsp;<span class="cited-by" id="CTB-L611106837"><a href="https://lls.reaxys.com/redir?pid=scp:84977091075" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;42</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-135"><a href="https://www.embase.com/#" class="showAbstract" data="135" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="135"></i> Abstract</a></li><li class="ui-tab" id="indexTab-135"><a href="https://www.embase.com/#" class="showIndexTerms" data="135" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="135"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1093/bja/aew064" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="134">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-134"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background Neonatal exposure to anaesthetics such as <span class="hit">sevoflurane</span> has been reported to result in behavioural deficits in rodents. However, while oxidative <span class="hit">injury</span> is thought to play an underlying pathological role, the mechanisms of neurotoxicity remain unclear. In the present study, we investigated whether the NADPH oxidase inhibitor apocynin protects against long-term memory impairment produced by neonatal <span class="hit">sevoflurane</span> exposure in mice. Methods Postnatal day six mice were divided into four groups; (1) non-anaesthesia, (2) intraperitoneal apocynin (50 mg kg<sup>-1</sup>) treatment, (3) 3% <span class="hit">sevoflurane</span> exposure for 6 h, and (4) apocynin treatment combined with <span class="hit">sevoflurane</span> exposure. Superoxide concentrations and NADPH oxidase expression in the brain were determined using dihydroethidium fluorescence and immunoblotting, respectively. Cleaved caspase-3 immunoblotting was used for the detection of apoptosis, and cytochrome c immunoblotting was performed to evaluate mitochondrial function. Long-term cognitive impairment was evaluated using the fear conditioning test in adulthood. Results <span class="hit">Sevoflurane</span> exposure increased concentrations of superoxide (109%) and the NADPH oxidase subunit p22phox (39%) in the brain, and apocynin abolished these increases. Neonatal <span class="hit">sevoflurane</span> exposure caused learning deficits in adulthood. Apocynin also maintained long-term memory function in mice given neonatal <span class="hit">sevoflurane</span> exposure, and it reduced apoptosis and decreased cytochrome c concentrations in the brains of these mice. Conclusions Apocynin reduces <span class="hit">neuronal</span> apoptosis and protects against long-term memory impairment in mice, neonatally exposed to <span class="hit">sevoflurane</span> by reducing superoxide concentrations. These findings suggest that NADPH oxidase inhibitors may protect against cognitive dysfunction resulting from neonatal anaesthesia.</p><p class="hitsHighlighted">© 2016 The Author 2016. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L72314548" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L72314548" type="checkbox" id="record_checkbox_L72314548"><label for="record_checkbox_L72314548" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">136</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=136&amp;page=1&amp;id=L72314548" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">In vivo monitoring of <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal injury</span> in neonatal nonhuman primates using small-animal positron emission tomography</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Newport</span> <span class="given-name notranslate">G.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Paule</span> <span class="given-name notranslate">M.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Thompson</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Berridge</span> <span class="given-name notranslate">M.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Apana</span> <span class="given-name notranslate">S.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Slikker</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Molecular Imaging and Biology</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">18</span><span class="journal-issue">:1</span>&nbsp;<span class="journal-suppl">SUPPL. 1</span><span class="journal-pages">&nbsp;(S343-)</span>&nbsp;<span class="cited-by" id="CTB-L72314548"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-136"><a href="https://www.embase.com/#" class="showAbstract" data="136" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="136"></i> Abstract</a></li><li class="ui-tab" id="indexTab-136"><a href="https://www.embase.com/#" class="showIndexTerms" data="136" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="136"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s11307-016-969-2" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="135">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-135"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: In surgical procedures for human infants, <span class="hit">sevoflurane</span> is the most widely used volatile general anesthetic. Early exposure to <span class="hit">sevoflurane</span> may induce <span class="hit">neuronal</span> cell death in the developing brain. In this study, in vivo microPET/CT imaging with <sup>18</sup>F-labeled fluoroethoxybenzyl-N-(4-phenoxypyridin-3-yl) acetamide (FEPPA), a sensitive biomarker for the detection of <span class="hit">neuronal</span> damage/inflammation, was utilized to monitor <span class="hit">sevoflurane</span>-induced <span class="hit">neuronal injury</span> in neonatal rhesus monkeys. Methods: On postnatal day (PND) 5 or 6, animals (4-6/group) were exposed to 2.5% <span class="hit">sevoflurane</span> mixed with oxygen, or acetyl-L-carnitine (ALC) (100mg/kg given i.p.) plus this mixture for 8 hours; control monkeys with and without ALC were exposed to room air only. One day later, [<sup>18</sup>F]-FEPPA (56 MBq) was injected into the lateral saphenous vein and microPET/CT images were obtained over the next 2 hours. MicroPET/CT scans were repeated for each monkey one week, three weeks and 6 months after the anesthetic exposure. Results: The radiotracer quickly distributed into the brains of both treated and control monkeys on all scan days. One day after anesthetic exposure the uptake of [<sup>18</sup>F]-FEPPA was significantly increased in the frontal and temporal lobes. One week after exposure the uptake of [<sup>18</sup>F]-FEPPA in the frontal lobe of treated animals was significantly greater than that in controls. <span class="hit">Sevoflurane</span>-induced neural damage was morphologically confirmed by EM observations. No significant increases were found in radiotracer uptake in the brains of treated monkeys three weeks or 6 months after exposure. Co-administration of ALC effectively blocked the increase in FEPPA uptake in both the temporal and frontal lobes. Conclusions: These findings suggest that early exposure to <span class="hit">sevoflurane</span> may trigger neurotoxicity in the nonhuman primate brain. Volatile anesthetic-induced brain damage in different brain regions can be dynamically detected using microPET imaging. In addition, ALC appears to be a potential protective agent against at least some of the adverse effects associated with such exposures.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L611614916" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L611614916" type="checkbox" id="record_checkbox_L611614916"><label for="record_checkbox_L611614916" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">137</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=137&amp;page=1&amp;id=L611614916" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> preconditioning revitalizes endogenous brain self-repairing ability in rats following cerebral ischemic <span class="hit">injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">L.I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Saiyin</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liang</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">Journal of Cerebral Blood Flow and Metabolism</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">36</span>&nbsp;<span class="journal-suppl">Supplement 1</span><span class="journal-pages">&nbsp;(323-)</span>&nbsp;<span class="cited-by" id="CTB-L611614916"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-137"><a href="https://www.embase.com/#" class="showAbstract" data="137" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="137"></i> Abstract</a></li><li class="ui-tab" id="indexTab-137"><a href="https://www.embase.com/#" class="showIndexTerms" data="137" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="137"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1177/0271678X16639008" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="136">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-136"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Purpose: Ischemic stroke causes irreversible <span class="hit">neuronal</span> death within the infarction region. Although an ideal therapy doesn't currently exist, it would target the affected region, ultimately restoring its function. <span class="hit">Sevoflurane</span> preconditioning has been demonstrated to play a neuroprotective role in penumbra region, whether it could promote neural regeneration and accelerate brain repair in infarct region remains unclear. Methods: Transient middle cerebral artery occlusion (MCAO) model was established in rats. Rats were randomly divided into sham group, MCAO group, Sevo + MCAO group and killed at 1, 3, 7, 14, 28d after surgery. TTC staining, immunofluorescent staining and confocal three dimensional reconstruction were used to observe brain repair process of different groups at different time. Results: <span class="hit">Sevoflurane</span> preconditioning not only enhanced proliferation of neural stem cells in SVZ at 3days, but also guaranteed those newborn neurons to survive in the infarct area. These benefits were achieved by accelerating BDNF secreted by microglia, and enhancing microglia phagocytic activity to swiftly clear the dead debris of infarct area. Early clearance of dead debris promoted astrocytes migration to infarct area, and provided a fine scaffold for neuroprogenitor cells migration into the cleared infarct area. Then neuroprogenitor cells quickly differentiated into mature neurons and different type of glial cells at 14days. The newborn neurons connected with each other by synapses, and built up a circuit with axons from the undamaged parts. Conclusions: These results demonstrated that <span class="hit">sevoflurane</span> preconditioning facilitated brain self-repair process by enhancing the systemic neurogenesis and synaptogenesis in the infarct region of cerebral ischemic <span class="hit">injury</span> model, which may provide a new strategy to the ischemic stroke patients.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L614034096" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L614034096" type="checkbox" id="record_checkbox_L614034096"><label for="record_checkbox_L614034096" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">138</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=138&amp;page=1&amp;id=L614034096" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Let us save the brain with cerebral oximetry</a><br><span class="author fn notranslate"><span class="family-name notranslate">Seker</span> <span class="given-name notranslate">I.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ozlu</span> <span class="given-name notranslate">O.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ozkan</span> <span class="given-name notranslate">A.</span></span><br><span class="journal-title">Journal of Neurosurgical Anesthesiology</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">28</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(S43-S44)</span>&nbsp;<span class="cited-by" id="CTB-L614034096"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-138"><a href="https://www.embase.com/#" class="showAbstract" data="138" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="138"></i> Abstract</a></li><li class="ui-tab" id="indexTab-138"><a href="https://www.embase.com/#" class="showIndexTerms" data="138" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="138"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ANA.0000000000000287" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="137">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-137"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: In newborns tracheal atresia and tracheoesophageal fistula surgery may result in hemodynamic instability leading to cerebral perfusion insufficiency because of pulmonary vessels and truncus brachiocephalic retraction. Case Report: A male newborn, 40 weeks gestational age and body weight 3150 g was delivered with cesarean section. He was meconium stained and was transferred from state hospital to the university hospital at the first postpartum day, because of tracheo-eosophageal atresia (EA/TEF). He has spontaneous ventilation with 70 to 80 breaths per minute and mild hypotonic and lethargic. A lot of white foamy oral secretion was aspirated. Respiratory rough ratles were auscultated. Hemodynamic parameters were stable. Thoracoscopic primary repair of EA/TEF by right thoracotomy was planned at the third day of birth. Anesthesia was induced using pentothal (5 mg/kg), fentanyl (4 μg), and rocuronium (0.5 mg/kg) intravenously. <span class="hit">Sevoflurane</span> 2%and 50% O<sub>2</sub>: in air were used for maintenance. The neonate positioned in a semiprone position, his right side elevated and right arm placed above his head. During right lung compression to expose posterior esophagus, no values was observed with pulse oximetry probe placed on right hand, and radial artery was not palpated. At the same time, oxygen saturation was observed as 96% to 97% by left foot probe. Because right cerebral oximetry values (rSO<sub>2</sub>) were decreased to 31% rapidly, the lung compression was ceased. Right pulse oximetry and right rSO<sub>2</sub> values were returned to baseline. Also pupillary anisocoria was observed (right/left: 3/1mm) during right lung compression. Whenever rSO<sub>2</sub>&lt;40%, operation was ceased throughout the procedure (Fig. 1). At the end of the operation he was transferred to the newborn intensive care unit. He was extubated at the ninth postoperative hour without any respiratory or hemodynamically instability. Discussion: During the newborn operations involving the great vessels, the cerebral perfusion could be preserved using cerebral oximetry. Learning Points: Cerebral oximetry is more efficient than pulse oximetry for detecting cerebral tissue oxygenation and could be helpful to minimize <span class="hit">neuronal</span> damage in newborn infant. (Figure Presented).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L607318273" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L607318273" type="checkbox" id="record_checkbox_L607318273"><label for="record_checkbox_L607318273" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">139</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=139&amp;page=1&amp;id=L607318273" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neurophysiological monitoring and spinal cord integrity</a><br><span class="author fn notranslate"><span class="family-name notranslate">Rabai</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sessions</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Seubert</span> <span class="given-name notranslate">C.N.</span></span><br><span class="journal-title">Best Practice and Research: Clinical Anaesthesiology</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">30</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(53-68)</span>&nbsp;<span class="cited-by" id="CTB-L607318273"><a href="https://lls.reaxys.com/redir?pid=scp:84950160789" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;21</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-139"><a href="https://www.embase.com/#" class="showAbstract" data="139" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="139"></i> Abstract</a></li><li class="ui-tab" id="indexTab-139"><a href="https://www.embase.com/#" class="showIndexTerms" data="139" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="139"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bpa.2015.11.006" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="138">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-138"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">An integral part of a major spine surgery is the intraoperative neurophysiological monitoring (IONM). By providing continuous functional assessment of specific anatomic structures, IONM allows the rapid detection of <span class="hit">neuronal</span> compromise and the opportunity for corrective action before an insult causes permanent neurological damage. Thus, IONM functions not just as a diagnostic tool but may also improve surgical outcomes. Effective clinical application requires a thorough understanding of the scope and limitations of IONM modalities not only by the monitoring team but also by the surgeon and anesthesiologist. Intraoperatively, collaboration and communication between monitorist, surgeon, and anesthesiologist are critical to the effectiveness of IONM. In this study, we review specific monitoring modalities, focusing on the relevant anatomy, physiology, and mechanisms of <span class="hit">neuronal injury</span> during major spine surgery. We discuss how these factors interact with anesthetic and surgical management. This review concludes with the current controversies surrounding the evidence in support of IONM and directions of future research.</p><p class="hitsHighlighted">© 2015 Elsevier Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L607129851" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L607129851" type="checkbox" id="record_checkbox_L607129851"><label for="record_checkbox_L607129851" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">140</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=140&amp;page=1&amp;id=L607129851" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Learning, memory and synaptic plasticity in hippocampus in rats exposed to <span class="hit">sevoflurane</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Xiao</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">International Journal of Developmental Neuroscience</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">48</span><span class="journal-pages">&nbsp;(38-49)</span>&nbsp;<span class="cited-by" id="CTB-L607129851"><a href="https://lls.reaxys.com/redir?pid=scp:84949035720" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;91</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-140"><a href="https://www.embase.com/#" class="showAbstract" data="140" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="140"></i> Abstract</a></li><li class="ui-tab" id="indexTab-140"><a href="https://www.embase.com/#" class="showIndexTerms" data="140" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="140"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.ijdevneu.2015.11.001" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="139">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-139"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Purpose: Developmental exposure to volatile anesthetics has been associated with cognitive deficits at adulthood. Rodent studies have revealed impairments in performance in learning tasks involving the hippocampus. However, how the duration of anesthesia exposure impact on hippocampal synaptic plasticity, learning, and memory is as yet not fully elucidated. Methods: On postnatal day 7(P7), rat pups were divided into 3 groups: control group (n= 30), 3% <span class="hit">sevoflurane</span> treatment for 1. h (Sev 1 h group, n= 30) and 3% <span class="hit">sevoflurane</span> treatment for 6. h (Sev 6. h group, n= 28). Following anesthesia, synaptic vesicle-associated proteins and dendrite spine density and synapse ultrastructure were measured using western blotting, Golgi staining, and transmission electron microscopy (TEM) on P21. In addition, the effects of <span class="hit">sevoflurane</span> treatment on long-term potentiation (LTP) and long-term depression (LTD), two molecular correlates of memory, were studied in CA1 subfields of the hippocampus, using electrophysiological recordings of field potentials in hippocampal slices on P35-42. Rats' neurocognitive performance was assessed at 2 months of age, using the Morris water maze and novel-object recognition tasks. Results: Our results showed that neonatal exposure to 3% <span class="hit">sevoflurane</span> for 6. h results in reduced spine density of apical dendrites along with elevated expression of synaptic vesicle-associated proteins (SNAP-25 and syntaxin), and synaptic ultrastructure damage in the hippocampus. The electrophysiological evidence indicated that hippocampal LTP, but not LTD, was inhibited and that learning and memory performance were impaired in two behavioral tasks in the Sev 6. h group. In contrast, lesser structural and functional damage in the hippocampus was observed in the Sev 1. h group. Conclusion: Our data showed that 6-h exposure of the developing brain to 3% <span class="hit">sevoflurane</span> could result in synaptic plasticity impairment in the hippocampus and spatial and nonspatial hippocampal-dependent learning and memory deficits. In contrast, shorter-duration exposure (1 h) results in less damage. These results provide further evidences that duration of anesthesia exposure could have differential effects on <span class="hit">neuronal</span> plasticity and neurocognitive performance.</p><p class="hitsHighlighted">© 2015 Elsevier Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L622531487" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L622531487" type="checkbox" id="record_checkbox_L622531487"><label for="record_checkbox_L622531487" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">141</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=141&amp;page=1&amp;id=L622531487" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Autophagy activation prevents <span class="hit">sevoflurane</span>-induced neurotoxicity in H4 human neuroglioma cells</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">Y.-F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Q.-X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">H.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">G.</span></span><br><span class="journal-title">Acta Pharmacologica Sinica</span>&nbsp;<span class="journal-publication-year">2016</span>&nbsp;<span class="journal-volume">37</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(580-588)</span>&nbsp;<span class="cited-by" id="CTB-L622531487"><a href="https://lls.reaxys.com/redir?pid=scp:85015601350" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;34</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-141"><a href="https://www.embase.com/#" class="showAbstract" data="141" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="141"></i> Abstract</a></li><li class="ui-tab" id="indexTab-141"><a href="https://www.embase.com/#" class="showIndexTerms" data="141" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="141"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1038/aps.2016.6" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="140">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-140"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Aim: The inhaled anesthetic <span class="hit">sevoflurane</span> may induce cognitive impairment in both animals and humans. Previous study has shown that <span class="hit">sevoflurane</span> triggers ER stress and may lead to apoptosis in rat hippocampal neurons. In this study, we examined whether <span class="hit">sevoflurane</span> caused autophagy and its contributions to <span class="hit">sevoflurane</span> induced <span class="hit">neuronal</span> cell <span class="hit">injury</span>. Methods: H4 human neuroglioma cells were exposed to 4.1% <span class="hit">sevoflurane</span> for 6 h. Cell viability and apoptosis ratio were assessed using a CCK8 kit and flow cytometry, respectively. Autophagosomes in the cells were detected using GFP-LC3 plasmid transfection or transmission electronic microscopy. The expression of LC3B, p62/SQSTM , C/EBP homologous protein (CHOP) and glucose-related protein 78 (GRP78) was assessed with Western blotting. Results: <span class="hit">Sevoflurane</span> treatment induced apoptosis and markedly increased the LC3-II level and GFP-LC3 puncta number, decreased p62 expression in H4 cells. Activation of autophagy by rapamycin (1 μmol/L) significantly reduced <span class="hit">sevoflurane</span>-induced apoptosis and increased cell viability, whereas inhibition of autophagy with 3-MA (5 mmol/L) caused the opposite effects. Furthermore, <span class="hit">sevoflurane</span> treatment markedly increased the expression of CHOP and GRP78, two hallmark proteins of ER stress. Inhibition of ER stress by 4-phenylbutyrate (500 μmol/L) abrogated <span class="hit">sevoflurane</span>-induced autophagy and apoptosis, and improved the viability. Moreover, <span class="hit">sevoflurane</span>-stimulated expression of CHOP and GRP78 was inhibited by rapamycin, but further enhanced by 3-MA. Conclusion: <span class="hit">Sevoflurane</span> treatment induces ER stress and activates autophagy, which antagonizes <span class="hit">sevoflurane</span>-induced apoptosis in H4 human neuroglioma cells. The results suggest that autophagy may be a potential therapeutic target in preventing <span class="hit">sevoflurane</span>-induced neurotoxicity.</p><p class="hitsHighlighted">© 2016 CPS and SIMM All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L606882795" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L606882795" type="checkbox" id="record_checkbox_L606882795"><label for="record_checkbox_L606882795" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">142</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=142&amp;page=1&amp;id=L606882795" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Role of the Toll-like receptor 3 signaling pathway in the neuroprotective effect of <span class="hit">sevoflurane</span> pre-conditioning during cardiopulmonary bypass in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhou</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">X.-N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cao</span> <span class="given-name notranslate">H.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">Y.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">T.-Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">K.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">D.-M.</span></span><br><span class="journal-title">Molecular Medicine Reports</span>&nbsp;<span class="journal-publication-year">2015</span>&nbsp;<span class="journal-volume">12</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(7859-7868)</span>&nbsp;<span class="cited-by" id="CTB-L606882795"><a href="https://lls.reaxys.com/redir?pid=scp:84946771425" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;7</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-142"><a href="https://www.embase.com/#" class="showAbstract" data="142" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="142"></i> Abstract</a></li><li class="ui-tab" id="indexTab-142"><a href="https://www.embase.com/#" class="showIndexTerms" data="142" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="142"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/mmr.2015.4420" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="141">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-141"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The aim of the present study was to explore the roles and possible molecular mechanism of the alleviating effect of <span class="hit">sevoflurane</span> pre-treatment on the extracorporeal circulation and to investigate the possible involvement of the Toll-like receptor (TLR3) signaling pathway. A total of 64 male Sprague Dawley rats were randomly divided into three groups: The sham operation group (H group; n=8), cardiopulmonary bypass (CPB) group (C group; n=24) and <span class="hit">sevoflurane</span> pre-conditioning group (S group; n=32). The C group was subjected to tracheal intubation and mechanical ventilation, vessel puncture and catheter placement in the right femoral artery and right internal jugular vein, while no CPB was performed in the H group. The S group was pre-treated with 2.4% <span class="hit">sevoflurane</span> for 1 h prior to establishing the CPB model. The CPB in the C and S groups was performed for 1 h. Blood of the rats was analyzed and clinical parameters were detected prior to, during and at various time-points after CPB. In addition, eight rats from the C and S groups each were sacrificed at these time-points and brain tissue samples were analyzed. The levels of the brain damage-specific protein S100- as well as IL-6 and IFN- in the serum were detected by ELISA; furthermore, the expression levels of TLR3 and TIR-domain-containing adapter-inducing interferon- (TRIF) in the left hippocampus were assessed by ELISA and/or western blot analysis. The right hippocampus was assessed for <span class="hit">neuronal</span> apoptosis by terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The mean arterial pressure, heart rate and hematocrit were significantly decreased following CPB (P&lt;0.05), while there was no significant changes in any other clinical parameters. The serum levels of S100- and IL-6 in the C group were significantly increased compared with those in the H group (P&lt;0.05), which was attenuated by <span class="hit">sevoflurane</span>-pre-treatment. Compared with the H group, the serum levels of IFN- as well as hippocampal protein levels of TLR3 and TRIF were significantly increased in the C group during and after CPB (P&lt;0.05), which was markedly aggravated in the S group (P&lt;0.05). The number of apoptotic hippocampal neurons, although being generally low, was significantly increased in the C group compared with that in the H group (P&lt;0.05), while apoptosis was significantly attenuated by <span class="hit">sevoflurane</span>-pre-treatment (P&lt;0.05). The present study therefore concluded that 2.4% <span class="hit">sevoflurane</span> pre-treatment has a protective effect on the rat brain against CPB-induced <span class="hit">injury</span>, which may be mediated via the TLR3 signaling pathway through upregulating the expression levels of anti-inflammatory and downregulating pro-inflammatory proteins.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L607347956" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L607347956" type="checkbox" id="record_checkbox_L607347956"><label for="record_checkbox_L607347956" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">143</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=143&amp;page=1&amp;id=L607347956" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Histopathological observations in the brains of children exposed to inhalational anesthetic agents: A retrospective autopsy-based study</a><br><span class="author fn notranslate"><span class="family-name notranslate">Green</span> <span class="given-name notranslate">M.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Aman</span> <span class="given-name notranslate">M.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Stevens</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Voralu</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Saththasivam</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mychaskiw</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Katsetos</span> <span class="given-name notranslate">C.D.</span></span><br><span class="journal-title">Minerva Anestesiologica</span>&nbsp;<span class="journal-publication-year">2015</span>&nbsp;<span class="journal-volume">81</span><span class="journal-issue">:12</span><span class="journal-pages">&nbsp;(1329-1337)</span>&nbsp;<span class="cited-by" id="CTB-L607347956"><a href="https://lls.reaxys.com/redir?pid=scp:84950320008" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-143"><a href="https://www.embase.com/#" class="showAbstract" data="143" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="143"></i> Abstract</a></li><li class="ui-tab" id="indexTab-143"><a href="https://www.embase.com/#" class="showIndexTerms" data="143" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="143"></i> Index Terms</a></li><li><span id="FTL-L607347956" class="fulltext" data="{&quot;recno&quot;:&quot;L607347956&quot;,&quot;issn&quot;:&quot;03759393&quot;,&quot;volume&quot;:&quot;81&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;startpage&quot;:&quot;1329&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="142">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-142"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background. Numerous animal models have demonstrated <span class="hit">neuronal</span> damage resulting from anesthetic exposure in the developing brain. Studies have shown a relationship between anesthetic exposure and brain hypoxia, neurodegeneration and apoptosis. The relevance of data derived from controlled experimental studies to human neuropathology is a subject of debate. This study compares histopathological findings in post-mortem brain tissue specimens from children with and without exposure to inhalational anesthetic agents. Methods. Autopsy reports were reviewed. Patients were divided into exposure and non-exposure groups defined as any procedure involving inhalational anesthetic agents. A retrospective chart review was performed collecting pathological findings of the brain. The autopsy results examined the presence of twelve different histopathological parameters reflecting morphologic changes in thirteen regions of interest in the central nervous system. Results. Post-mortem neuropathological findings were analyzed. Thirteen different areas were focused upon and changes were categorized into twelve histopathological parameters. Gliosis, which was confirmed by immunohistochemical staining for glial fibrillary acidic protein, was more prevalent in the exposure group (N.=48) compared to the non-exposure group (N.=20) (P&lt;0.05). Conclusion. The role of anesthetic neurotoxicity is not well understood. Numerous animal models have demonstrated <span class="hit">neuronal</span> apoptotic changes linked to anesthetic exposure, there is no tangible evidence supporting this relationship in humans. Our analysis demonstrates histopathological brain changes in children with anesthetic exposure not seen in the non-exposed group. Analysis was based on histopathological parameters representative of salient morphological findings of <span class="hit">injury</span>, which were encountered in anatomically divergent regions. Gliosis was the only statistically significant finding in post-mortem brain samples of patients who had received anesthetics.</p><p class="hitsHighlighted">© 2015 EDIZIONI MINERVA MEDICA.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L606316278" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L606316278" type="checkbox" id="record_checkbox_L606316278"><label for="record_checkbox_L606316278" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">144</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=144&amp;page=1&amp;id=L606316278" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Xenon for the prevention of postoperative delirium in cardiac surgery: Study protocol for a randomized controlled clinical trial</a><br><span class="author fn notranslate"><span class="family-name notranslate">Al Tmimi</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Van de Velde</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Herijgers</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Meyns</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Meyfroidt</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Milisen</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fieuws</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Coburn</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Poesen</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rex</span> <span class="given-name notranslate">S.</span></span><br><span class="journal-title">Trials</span>&nbsp;<span class="journal-publication-year">2015</span>&nbsp;<span class="journal-volume">16</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 449</span>&nbsp;<span class="cited-by" id="CTB-L606316278"><a href="https://lls.reaxys.com/redir?pid=scp:84943814146" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;13</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-144"><a href="https://www.embase.com/#" class="showAbstract" data="144" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="144"></i> Abstract</a></li><li class="ui-tab" id="indexTab-144"><a href="https://www.embase.com/#" class="showIndexTerms" data="144" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="144"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1186/s13063-015-0987-4" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="143">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-143"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Postoperative delirium (POD) is a manifestation of acute postoperative brain dysfunction that is frequently observed after cardiac surgery. POD is associated with short-term complications such as an increase in mortality, morbidity, costs and length of stay, but can also have long-term sequelae, including persistent cognitive deficits, loss of independence, and increased mortality for up to 2 years. The noble gas xenon has been demonstrated in various models of <span class="hit">neuronal injury</span> to exhibit remarkable neuroprotective properties. We therefore hypothesize that xenon anesthesia reduces the incidence of POD in elderly patients undergoing cardiac surgery with the use of cardiopulmonary bypass. Methods/Design: One hundred and ninety patients, older than 65 years, and scheduled for elective cardiac surgery, will be enrolled in this prospective, randomized, controlled trial. Patients will be randomized to receive general anesthesia with either xenon or <span class="hit">sevoflurane</span>. Primary outcome parameter will be the incidence of POD in the first 5 postoperative days. The occurrence of POD will be assessed by trained research personnel, blinded to study group, with the validated 3-minute Diagnostic Confusion Assessment Method (3D-CAM) (on the intensive care unit in its version specifically adapted for the ICU), in addition to chart review and the results of delirium screening tools that will be performed by the bedside nurses). Secondary outcome parameters include duration and severity of POD, and postoperative cognitive function as assessed with the Mini-Mental State Examination. Discussion: Older patients undergoing cardiac surgery are at particular risk to develop POD. Xenon provides remarkable hemodynamic stability and has been suggested in preclinical studies to exhibit neuroprotective properties. The present trial will assess whether the promising profile of xenon can be translated into a better outcome in the geriatric population. Trial registration: EudraCT Identifier: 2014-005370-11(13 May 2015).</p><p class="hitsHighlighted">© 2015 Al Tmimi et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L604917390" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L604917390" type="checkbox" id="record_checkbox_L604917390"><label for="record_checkbox_L604917390" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">145</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=145&amp;page=1&amp;id=L604917390" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> Post-conditioning Protects Primary Rat Cortical Neurons Against Oxygen–Glucose Deprivation/Resuscitation: Roles of Extracellular Signal-Regulated Kinase 1/2 and Bid, Bim, Puma</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">Neurochemical Research</span>&nbsp;<span class="journal-publication-year">2015</span>&nbsp;<span class="journal-volume">40</span><span class="journal-issue">:8</span><span class="journal-pages">&nbsp;(1609-1619)</span>&nbsp;<span class="cited-by" id="CTB-L604917390"><a href="https://lls.reaxys.com/redir?pid=scp:84939256240" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-145"><a href="https://www.embase.com/#" class="showAbstract" data="145" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="145"></i> Abstract</a></li><li class="ui-tab" id="indexTab-145"><a href="https://www.embase.com/#" class="showIndexTerms" data="145" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="145"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s11064-015-1639-5" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="144">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-144"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Temporal post-conditioning to induce neuroprotection against brain ischemia–reperfusion injury insult is considered to be an effective intervention, but the exact mechanisms of sevoflurane post-conditioning are poorly understood. Extracellular signal-related kinases 1/2 (Erk1/2) play a pivotal role in the cell growth and proliferation. The essential axis of activator Bid, Bim, Puma (BH3s) and BAX, BAK in activating the mitochondrial death program might offer common ground for cell death signal. We hypothesized that, sevoflurane post-conditioning might inhibit the expression of Bid, Bim and Puma and is activated by phosphor-Erk1/2 to reduce neuronal death. To test this hypothesis, we exposed primary cultured cortical neurons to oxygen–glucose deprivation for 1&nbsp;h and resuscitation for 24&nbsp;h (OGD/R). The assays of MTT, propidium iodide uptake, JC-1 fluorescence and western blot demonstrated that OGD/R exposure reduced cell viability, increased cell death, decreased mitochondrial membrane potential and the expressions of Bid, Bim, and Puma. Inhibition of Erk1/2 phosphorylation could partially attenuate 2&nbsp;% of sevoflurane post-conditioning mediated increase in neuronal viability and mitochondrial membrane potential, and also a decrease in cell death and expression of Bid, Bim and Puma after OGD/R treatment. The results demonstrated that, the protection of sevoflurane post-conditioning markedly reducing death of cortical neurons exposed to OGD/R could be correlated with down-regulation of Bid, Bim and Puma expression mediated by phosphorylation/activation of Erk1/2.</p><p class="hitsHighlighted">© 2015, Springer Science+Business Media New York.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L605087138" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L605087138" type="checkbox" id="record_checkbox_L605087138"><label for="record_checkbox_L605087138" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">146</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=146&amp;page=1&amp;id=L605087138" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> post-conditioning protects primary rat cortical neurons against oxygen-glucose deprivation/resuscitation via down-regulation in mitochondrial apoptosis axis of Bid, Bim, Puma-Bax and Bak mediated by Erk1/2</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">W.-B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">X.-J.</span></span><br><span class="journal-title">Journal of the Neurological Sciences</span>&nbsp;<span class="journal-publication-year">2015</span>&nbsp;<span class="journal-volume">357</span><span class="journal-issue">:1-2</span><span class="journal-pages">&nbsp;(80-87)</span>&nbsp;<span class="cited-by" id="CTB-L605087138"><a href="https://lls.reaxys.com/redir?pid=scp:84956580569" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;23</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-146"><a href="https://www.embase.com/#" class="showAbstract" data="146" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="146"></i> Abstract</a></li><li class="ui-tab" id="indexTab-146"><a href="https://www.embase.com/#" class="showIndexTerms" data="146" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="146"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.jns.2015.06.070" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="145">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-145"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Temporal post-conditioning helps provide neuroprotection against brain <span class="hit">injury</span> secondary to ischemia-reperfusion and is considered an effective intervention, but the exact mechanism of <span class="hit">sevoflurane</span> post-conditioning is unclear. The essential axis involves activator Bid, Bim, Puma (BH3s), Bax, and Bak; activates the mitochondrial death program; and might be involved in a cell death signal. Extracellular signal-related kinases 1/2 (Erk1/2) play a pivotal role in cell growth and proliferation. We hypothesized that <span class="hit">sevoflurane</span> post-conditioning might inhibit Bid, Bim, Puma, Bax, and Bak expression and is activated by phosphor-Erk1/2 to decrease <span class="hit">neuronal</span> death. To test this hypothesis, we exposed primary cortical neuron cultures to oxygen-glucose deprivation for 1 h, along with resuscitation for 24 h (OGD/R). MTT assays, propidium iodide uptake (PI), JC-1 fluorescence, and Western blot indicated the following: decreased cell viability (P &lt; 0.05); increased cell death (P &lt; 0.05); decreased mitochondrial membrane potential (P &lt; 0.05); and decreased Bid, Bim, Puma, Bax, and Bak expression with OGD/R exposure. Inhibition of Erk1/2 phosphorylation could attenuate <span class="hit">sevoflurane</span> post-conditioning that mediated an increase in <span class="hit">neuronal</span> viability and mitochondrial membrane potential, as well as a decrease in cell death and Bid, Bim, Puma, Bax, and Bak expression after OGD/R treatment. The results demonstrated that <span class="hit">sevoflurane</span> post-conditioning caused a marked decrease in cortical <span class="hit">neuronal</span> death secondary to OGD/R exposure through the downregulation of the mitochondrial apoptosis axis involving Bid, Bim, Puma, Bax, and Bak that was mediated by the phosphorylation/activation of Erk1/2.</p><p class="hitsHighlighted">© 2015 Elsevier B.V.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L601344812" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L601344812" type="checkbox" id="record_checkbox_L601344812"><label for="record_checkbox_L601344812" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">147</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=147&amp;page=1&amp;id=L601344812" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrest</a><br><span class="author fn notranslate"><span class="family-name notranslate">Bartos</span> <span class="given-name notranslate">J.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Matsuura</span> <span class="given-name notranslate">T.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sarraf</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Youngquist</span> <span class="given-name notranslate">S.T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">McKnite</span> <span class="given-name notranslate">S.H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rees</span> <span class="given-name notranslate">J.N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sloper</span> <span class="given-name notranslate">D.T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bates</span> <span class="given-name notranslate">F.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Segal</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Debaty</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lurie</span> <span class="given-name notranslate">K.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Neumar</span> <span class="given-name notranslate">R.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Metzger</span> <span class="given-name notranslate">J.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Riess</span> <span class="given-name notranslate">M.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yannopoulos</span> <span class="given-name notranslate">D.</span></span><br><span class="journal-title">Resuscitation</span>&nbsp;<span class="journal-publication-year">2015</span>&nbsp;<span class="journal-volume">87</span><span class="journal-pages">&nbsp;(7-13)</span>&nbsp;<span class="cited-by" id="CTB-L601344812"><a href="https://lls.reaxys.com/redir?pid=scp:84920931141" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;26</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-147"><a href="https://www.embase.com/#" class="showAbstract" data="147" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="147"></i> Abstract</a></li><li class="ui-tab" id="indexTab-147"><a href="https://www.embase.com/#" class="showIndexTerms" data="147" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="147"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.resuscitation.2014.10.019" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="146">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-146"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: Ischemic postconditioning (stutter CPR) and <span class="hit">sevoflurane</span> have been shown to mitigate the effects of reperfusion <span class="hit">injury</span> in cardiac tissue after 15. min of ventricular fibrillation (VF) cardiac arrest. Poloxamer 188 (P188) has also proven beneficial to <span class="hit">neuronal</span> and cardiac tissue during reperfusion <span class="hit">injury</span> in human and animal models. We hypothesized that the use of stutter CPR, <span class="hit">sevoflurane</span>, and P188 combined with standard advanced life support would improve post-resuscitation cardiac and neurologic function after prolonged VF arrest. Methods: Following 17. min of untreated VF, 20 pigs were randomized to Control treatment with active compression/decompression (ACD) CPR and impedance threshold device (ITD) (n= 8) or Bundle therapy with stutter ACD CPR + ITD + <span class="hit">sevoflurane</span> + P188 (n= 12). Epinephrine and post-resuscitation hypothermia were given in both groups per standard protocol. Animals that achieved return of spontaneous circulation (ROSC) were evaluated with echocardiography, biomarkers, and a blinded neurologic assessment with a cerebral performance category score. Results: Bundle therapy improved hemodynamics during resuscitation, reduced need for epinephrine and repeated defibrillation, reduced biomarkers of cardiac <span class="hit">injury</span> and end-organ dysfunction, and increased left ventricular ejection fraction compared to Controls. Bundle therapy also improved rates of ROSC (100% vs. 50%), freedom from major adverse events (50% vs. 0% at 48. h), and neurologic function (42% with mild or no neurologic deficit and 17% achieving normal function at 48. h). Conclusions: Bundle therapy with a combination of stutter ACD CPR, ITD, <span class="hit">sevoflurane</span>, and P188 improved cardiac and neurologic function after 17. min of untreated cardiac arrest in pigs. All studies were performed with approval from the Institutional Animal Care Committee of the Minneapolis Medical Research Foundation (protocol #12-11).</p><p class="hitsHighlighted">© 2014 Elsevier Ireland Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L602581781" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L602581781" type="checkbox" id="record_checkbox_L602581781"><label for="record_checkbox_L602581781" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">148</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=148&amp;page=1&amp;id=L602581781" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">General anesthetics as a factor of the effective neuroprotection in ischemic stroke models</a><br><span class="author fn notranslate"><span class="family-name notranslate">Laletin</span> <span class="given-name notranslate">V.S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bykov</span> <span class="given-name notranslate">Y.N.</span></span><br><span class="journal-title">Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry</span>&nbsp;<span class="journal-publication-year">2015</span>&nbsp;<span class="journal-volume">9</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(1-9)</span>&nbsp;<span class="cited-by" id="CTB-L602581781"><a href="https://lls.reaxys.com/redir?pid=scp:84923783520" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;2</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-148"><a href="https://www.embase.com/#" class="showAbstract" data="148" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="148"></i> Abstract</a></li><li class="ui-tab" id="indexTab-148"><a href="https://www.embase.com/#" class="showIndexTerms" data="148" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="148"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1134/S1990750815010059" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="147">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-147"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The success of experimental studies and failure of clinical trials of neuroprotective drugs proposed for the treatment of ischemic stroke determines the need for an analysis of existing models. Protocols of most laboratory models of stroke include general anesthesia. Inhalation and intravenous anesthetics affect the signaling pathways involved in the neuroprotective and neurotoxic mechanisms. Activation of ionotropic glutamatergic AMPA- and NMDA-receptors in the ischemic brain tissue is accompanied by necrosis and apoptosis of neurons. Certain anesthetics influence the activity of AMPA-receptors, including the phosphorylation and internalization/externalization of GluR-receptor subunits. Besides direct blockade of NMDA receptors several anesthetics affect expression and phosphorylation of NMDA receptor NR1 subunit. The mechanism of action of many inhalation and intravenous anesthetics is associated with activation of ionotropic GABA<sub>A</sub> receptors; this increases resistance of cells to excitotoxicity and reduces ischemic <span class="hit">neuronal</span> damage. In addition to the ionotropic receptors several anesthetics act through metabotropic transmembrane G-protein-coupled receptors. Anesthetic indirectly influence metabotropic GABA<sub>B</sub> and glutamate mGlureceptor by regulating protein-protein interactions and phosphorylation of receptor subunits. Some inhalation and intravenous anesthetics activate adenosine A1-receptor, increasing the concentration of extracellular adenosine. Anesthetic preconditioning may be accompanied by long-term neuroprotection coupled to activation of p38 MAPK, and mTOR and CREB transcription factors. A possible solution to the problem of the influence of anesthetics on the results of laboratory studies would be the use of parallel-group comparison of different general anesthetics. The effects of general anesthetics determine the need of studies of their neuroprotective potential in terms of ischemic stroke.</p><p class="hitsHighlighted">© 2015, Pleiades Publishing, Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L373422044" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L373422044" type="checkbox" id="record_checkbox_L373422044"><label for="record_checkbox_L373422044" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">149</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=149&amp;page=1&amp;id=L373422044" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Aging causes exacerbated ischemic brain <span class="hit">injury</span> and failure of <span class="hit">sevoflurane</span> post-conditioning: Role of B-cell lymphoma-2</a><br><span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lei</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">Neuroscience</span>&nbsp;<span class="journal-publication-year">2014</span>&nbsp;<span class="journal-volume">275</span><span class="journal-pages">&nbsp;(2-11)</span>&nbsp;<span class="cited-by" id="CTB-L373422044"><a href="https://lls.reaxys.com/redir?pid=scp:84903521029" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;14</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-149"><a href="https://www.embase.com/#" class="showAbstract" data="149" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="149"></i> Abstract</a></li><li class="ui-tab" id="indexTab-149"><a href="https://www.embase.com/#" class="showIndexTerms" data="149" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="149"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.neuroscience.2014.05.064" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="148">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-148"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Aging is associated with exacerbated brain <span class="hit">injury</span> after ischemic stroke. Herein, we explored the possible mechanisms underlying the age-associated exacerbated brain <span class="hit">injury</span> after ischemic stroke and determined whether therapeutic intervention with anesthetic post-conditioning would provide neuroprotection in aged rats. Male Fisher 344 rats (young, 4. months; aged, 24. months) underwent 2. h of middle cerebral artery occlusion (MCAO) followed by 24-h reperfusion, with or without <span class="hit">sevoflurane</span> post-conditioning for 15. min immediately at the onset of reperfusion. Compared with young rats, aged rats showed larger infarct size, worse neurological scores and more TUNEL-positive cells in the penumbral cerebral cortex at 24. h after MCAO. However, edema formation and motor coordination were similar in both groups. <span class="hit">Sevoflurane</span> reduced the infarct size, edema formation, and TUNEL-positive cells, and improved the neurological outcome in young rats but not in aged rats. Molecular studies revealed that basal expression of the anti-apoptotic molecule B-cell lymphoma-2 (Bcl-2) in the brain was lower in aged rats compared with young rats before MCAO, while basal expression of the pro-apoptotic molecule Bcl-2-associated X protein (Bax) showed similar levels in both groups. MCAO reduced Bcl-2 expression and increased Bax expression in both groups; however, Bax increase was more pronounced in aged rats. In young rats, <span class="hit">sevoflurane</span> reversed the above MCAO-induced changes. In contrast, <span class="hit">sevoflurane</span> failed to enhance Bcl-2 expression but decreased Bax expression in aged rats. These findings suggest that aging-associated reduction in basal Bcl-2 expression in the brain contributes to increased <span class="hit">neuronal injury</span> by enhancing cell apoptosis after ischemic stroke. <span class="hit">Sevoflurane</span> post-conditioning failed to provide neuroprotection in aged rats, probably due to its inability to increase Bcl-2 levels and prevent apoptosis in the brain. © 2014 IBRO.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L600027901" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L600027901" type="checkbox" id="record_checkbox_L600027901"><label for="record_checkbox_L600027901" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">150</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=150&amp;page=1&amp;id=L600027901" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> preconditioning ameliorates <span class="hit">neuronal</span> deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">X.-Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cao</span> <span class="given-name notranslate">X.-Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fang</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Tan</span> <span class="given-name notranslate">W.-F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Molecular Brain</span>&nbsp;<span class="journal-publication-year">2014</span>&nbsp;<span class="journal-volume">7</span><span class="journal-issue">:1</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 69</span>&nbsp;<span class="cited-by" id="CTB-L600027901"><a href="https://lls.reaxys.com/redir?pid=scp:84907052151" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;72</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-150"><a href="https://www.embase.com/#" class="showAbstract" data="150" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="150"></i> Abstract</a></li><li class="ui-tab" id="indexTab-150"><a href="https://www.embase.com/#" class="showIndexTerms" data="150" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="150"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1186/s13041-014-0069-7" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="149">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-149"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Microglia are the primary immune cells of the spinal cord that are activated in response to ischemia/reperfusion (IR) <span class="hit">injury</span> and release various neurotrophic and/or neurotoxic factors to determine <span class="hit">neuronal</span> survival. Among them, matrix metalloproteinase-9 (MMP-9), which cleaves various components of the extracellular matrix in the basal lamina and functions as part of the blood spinal cord barrier (BSCB), is considered important for regulating inflammatory responses and microenvironmental homeostasis of the BSCB in the pathology of ischemia. <span class="hit">Sevoflurane</span> has been reported to protect against <span class="hit">neuronal</span> apoptosis during cerebral IR. However, the effects of <span class="hit">sevoflurane</span> preconditioning on spinal cord IR <span class="hit">injury</span> remain unclear. In this study, we investigated the role of <span class="hit">sevoflurane</span> on potential genetic roles of microglial MMP-9 in tight junction protein breakdown, opening of the BSCB, and subsequent recruitment of microglia to apoptotic spinal cord neurons.</p><p class="hitsHighlighted">Results: The results showed significant upregulation of MMP-9 in rats with IR-induced inflammation of the BSCB compared to that of the sham group, manifested as dysfunctional BSCB with increased Evans blue extravasation and reduced expression of occludin protein. Increased MMP-9 expression was also observed to facilitate invasion and migration of activated microglia, imaging as high Iba-1 expression, clustered to neurons in the injured spinal cord, as shown by double immunofluorescence, and increased proinflammatory chemokine production (CXCL10, CCL2). Further, <span class="hit">sevoflurane</span> preconditioning markedly improved motor function by ameliorating <span class="hit">neuronal</span> apoptosis, as shown by reduced TUNEL-positive cell counts and expression of cleaved caspase-3. These protective effects were probably responsible for downregulation of MMP-9 and maintenance of normal expression of occludin protein indicating BSCB integrity from inflammatory damage, which was confirmed by decreased protein levels of Iba-1 and MMP-9, as well as reduced production of proinflammatory chemokines (CXCL10, CCL2) and proinflammatory cytokines (IL-1β). Intrathecal injection of specific siRNAs targeting MMP-9 had similar protective effects to those of <span class="hit">sevoflurane</span> preconditioning.</p><p class="hitsHighlighted">Conclusions: Preconditioning with 2.4% <span class="hit">sevoflurane</span> attenuated spinal cord IR <span class="hit">injury</span> by inhibiting recruitment of microglia and secretion of MMP-9; thus inhibiting downstream effects on inflammatory damage to BSCB integrity and <span class="hit">neuronal</span> apoptosis. © 2014 Li et al.; licensee BioMed Central Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L372749856" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L372749856" type="checkbox" id="record_checkbox_L372749856"><label for="record_checkbox_L372749856" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">151</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=151&amp;page=1&amp;id=L372749856" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroprotective effects of <span class="hit">sevoflurane</span> against electromagnetic pulse-induced brain <span class="hit">injury</span> through inhibition of <span class="hit">neuronal</span> oxidative stress and apoptosis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Deng</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Han</span> <span class="given-name notranslate">L.-C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">L.-Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wu</span> <span class="given-name notranslate">G.-L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hou</span> <span class="given-name notranslate">Y.-N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">G.-Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sang</span> <span class="given-name notranslate">H.-F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">L.-X.</span></span><br><span class="journal-title">PLoS ONE</span>&nbsp;<span class="journal-publication-year">2014</span>&nbsp;<span class="journal-volume">9</span><span class="journal-issue">:3</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number e91019</span>&nbsp;<span class="cited-by" id="CTB-L372749856"><a href="https://lls.reaxys.com/redir?pid=scp:84897549948" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;18</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-151"><a href="https://www.embase.com/#" class="showAbstract" data="151" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="151"></i> Abstract</a></li><li class="ui-tab" id="indexTab-151"><a href="https://www.embase.com/#" class="showIndexTerms" data="151" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="151"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1371/journal.pone.0091019" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="150">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-150"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Electromagnetic pulse (EMP) causes central nervous system damage and neurobehavioral disorders, and <span class="hit">sevoflurane</span> protects the brain from ischemic <span class="hit">injury</span>. We investigated the effects of <span class="hit">sevoflurane</span> on EMP-induced brain <span class="hit">injury</span>. Rats were exposed to EMP and immediately treated with <span class="hit">sevoflurane</span>. The protective effects of <span class="hit">sevoflurane</span> were assessed by Nissl staining, Fluoro-Jade C staining and electron microscopy. The neurobehavioral effects were assessed using the open-field test and the Morris water maze. Finally, primary cerebral cortical neurons were exposed to EMP and incubated with different concentration of <span class="hit">sevoflurane</span>. The cellular viability, lactate dehydrogenase (LDH) release, superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were assayed. TUNEL staining was performed, and the expression of apoptotic markers was determined. The cerebral cortexes of EMP-exposed rats presented <span class="hit">neuronal</span> abnormalities. <span class="hit">Sevoflurane</span> alleviated these effects, as well as the learning and memory deficits caused by EMP exposure. In vitro, cell viability was reduced and LDH release was increased after EMP exposure; treatment with <span class="hit">sevoflurane</span> ameliorated these effects. Additionally, <span class="hit">sevoflurane</span> increased SOD activity, decreased MDA levels and alleviated <span class="hit">neuronal</span> apoptosis by regulating the expression of cleaved caspase-3, Bax and Bcl-2. These findings demonstrate that <span class="hit">Sevoflurane</span> conferred neuroprotective effects against EMP radiation-induced brain damage by inhibiting <span class="hit">neuronal</span> oxidative stress and apoptosis. © 2014 Deng et al.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L372353264" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L372353264" type="checkbox" id="record_checkbox_L372353264"><label for="record_checkbox_L372353264" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">152</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=152&amp;page=1&amp;id=L372353264" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> postconditioning against cerebral ischemic <span class="hit">neuronal injury</span> is abolished in diet-induced obesity: Role of brain mitochondrial K<sub>ATP</sub> channels</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xu</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">Molecular Medicine Reports</span>&nbsp;<span class="journal-publication-year">2014</span>&nbsp;<span class="journal-volume">9</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(843-850)</span>&nbsp;<span class="cited-by" id="CTB-L372353264"><a href="https://lls.reaxys.com/redir?pid=scp:84893851391" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;19</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-152"><a href="https://www.embase.com/#" class="showAbstract" data="152" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="152"></i> Abstract</a></li><li class="ui-tab" id="indexTab-152"><a href="https://www.embase.com/#" class="showIndexTerms" data="152" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="152"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3892/mmr.2014.1912" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="151">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-151"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Obesity is associated with increased infarct volumes and adverse outcomes following ischemic stroke. However, its effect on anesthetic postconditioning-induced neuroprotection has not been investigated. The present study examined the effect of <span class="hit">sevoflurane</span> postconditioning on focal ischemic brain <span class="hit">injury</span> in diet-induced obesity. Sprague-Dawley rats were fed a high-fat diet (HF; 45% kcal as fat) for 12 weeks to develop obesity syndrome. Rats fed a low-fat diet (LF; 10% kcal as fat) served as controls. The HF or LF-fed rats were subjected to focal cerebral ischemia for 60 min, followed by 24 h of reperfusion. Postconditioning was performed by exposure to <span class="hit">sevoflurane</span> for 15 min immediately at the onset of reperfusion. The involvement of the mitochondrial K<sub>ATP</sub> (mitoK<sub>ATP</sub>) channel was analyzed by the administration of a selective inhibitor of 5-hydroxydecanoate (5-HD) prior to <span class="hit">sevoflurane</span> postconditioning or by administration of diazoxide (DZX), a mitoK<sub>ATP</sub> channel opener, instead of <span class="hit">sevoflurane</span>. The cerebral infarct volume, neurological score and motor coordination were evaluated 24 h after reperfusion. The HF-fed rats had larger infarct volumes, and lower neurological scores than the LF-fed rats and also failed to respond to neuroprotection by <span class="hit">sevoflurane</span> or DZX. By contrast, <span class="hit">sevoflurane</span> and DZX reduced the infarct volumes and improved the neurological scores and motor coordination in the LF-fed rats. Pretreatment with 5-HD inhibited <span class="hit">sevoflurane</span>-induced neuroprotection in the LF-fed rats, whereas it had no effect in the HF-fed rats. Molecular studies demonstrated that the expression of Kir6.2, a significant mitoKATP channel component, was reduced in the brains of the HF-fed rats compared with the LF-fed rats. The results of this study indicate that diet-induced obesity eliminates the ability of anesthetic <span class="hit">sevoflurane</span> postconditioning to protect the brain against cerebral ischemic <span class="hit">neuronal injury</span>, most likely due to an impaired brain mitoK<sub>ATP</sub> channel.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L373611350" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L373611350" type="checkbox" id="record_checkbox_L373611350"><label for="record_checkbox_L373611350" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">153</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=153&amp;page=1&amp;id=L373611350" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effect of combining anesthetics in neonates on long-term cognitive function</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">B.H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hazarika</span> <span class="given-name notranslate">O.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Quitoriano</span> <span class="given-name notranslate">G.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Leong</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brosnan</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chan</span> <span class="given-name notranslate">J.T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">May</span> <span class="given-name notranslate">L.D.V.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Alkhamisi</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Stratmann</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sall</span> <span class="given-name notranslate">J.W.</span></span><br><span class="journal-title">International Journal of Developmental Neuroscience</span>&nbsp;<span class="journal-publication-year">2014</span>&nbsp;<span class="journal-volume">37</span><span class="journal-pages">&nbsp;(87-93)</span>&nbsp;<span class="cited-by" id="CTB-L373611350"><a href="https://lls.reaxys.com/redir?pid=scp:84904750530" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;19</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-153"><a href="https://www.embase.com/#" class="showAbstract" data="153" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="153"></i> Abstract</a></li><li class="ui-tab" id="indexTab-153"><a href="https://www.embase.com/#" class="showIndexTerms" data="153" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="153"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.ijdevneu.2014.06.016" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="152">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-152"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: With growing evidence that anesthesia exposure in infancy affects cognitive development, it is important to understand how distinct anesthetic agents and combinations can alter long-term memory. Investigations of <span class="hit">neuronal</span> death suggest that combining anesthetic agents increases the extent of <span class="hit">neuronal injury</span>. However, it is unclear how the use of simultaneously combined anesthetics affects cognitive outcome relative to the use of a single agent. Methods: Postnatal day 7 (P7) male rats were administered either <span class="hit">sevoflurane</span> as a single agent or the combined delivery of <span class="hit">sevoflurane</span> with nitrous oxide at 1 Minimum Alveolar Concentration for 4. h. Behavior was assessed in adulthood using the forced alternating T-maze, social recognition, and context-specific object recognition tasks. Results: Animals exposed to either anesthetic were unimpaired in the forced alternating T-maze test and had intact social recognition. Subjects treated with the combined anesthetic displayed a deficit, however, in the object recognition task, while those treated with <span class="hit">sevoflurane</span> alone were unaffected. Conclusion: A combined <span class="hit">sevoflurane</span> and nitrous oxide anesthetic led to a distinct behavioral outcome compared with <span class="hit">sevoflurane</span> alone, suggesting that the simultaneous use of multiple agents may uniquely influence early neural and cognitive development and potentially impacts associative memory. © 2014.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L373831053" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L373831053" type="checkbox" id="record_checkbox_L373831053"><label for="record_checkbox_L373831053" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">154</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=154&amp;page=1&amp;id=L373831053" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Anesthesia-induced epilepsy: Causes and treatment</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhao</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">X.</span></span><br><span class="journal-title">Expert Review of Neurotherapeutics</span>&nbsp;<span class="journal-publication-year">2014</span>&nbsp;<span class="journal-volume">14</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(1099-1113)</span>&nbsp;<span class="cited-by" id="CTB-L373831053"><a href="https://lls.reaxys.com/redir?pid=scp:84906718477" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-154"><a href="https://www.embase.com/#" class="showAbstract" data="154" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="154"></i> Abstract</a></li><li class="ui-tab" id="indexTab-154"><a href="https://www.embase.com/#" class="showIndexTerms" data="154" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="154"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1586/14737175.2014.948851" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="153">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-153"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Epilepsy is a type of chronic brain disease that results from an abnormally high synchronization of <span class="hit">neuronal</span> discharge. The typical clinical features of epilepsy are paroxysms and transient and stereotyped brain dysfunction. Many cases of epileptic seizures occurring during anesthesia have been reportedx. Recently, risk assessment of epileptic seizures during surgery and anesthesia has gained increasing attention. In this review, we systematically summarize the influence of anesthesia on epileptic seizures; the types, durations and frequencies of seizures related to anesthesia; and the epidemiology, prevention, treatment and prognosis of epilepsy. We also explore the possible mechanism of epilepsy and provide guidance for anesthesia during surgeries. © Informa UK, Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L600686588" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L600686588" type="checkbox" id="record_checkbox_L600686588"><label for="record_checkbox_L600686588" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">155</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=155&amp;page=1&amp;id=L600686588" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Isoflurane but not <span class="hit">sevoflurane</span> or desflurane aggravates <span class="hit">injury</span> to neurons in vitro and in vivo via p75<sup>NTR</sup>-NF-κB Activation</a><br><span class="author fn notranslate"><span class="family-name notranslate">Schallner</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ulbrich</span> <span class="given-name notranslate">F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Engelstaedter</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Biermann</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Auwaerter</span> <span class="given-name notranslate">V.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Loop</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Goebel</span> <span class="given-name notranslate">U.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2014</span>&nbsp;<span class="journal-volume">119</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(1429-1441)</span>&nbsp;<span class="cited-by" id="CTB-L600686588"><a href="https://lls.reaxys.com/redir?pid=scp:84914094764" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;31</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-155"><a href="https://www.embase.com/#" class="showAbstract" data="155" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="155"></i> Abstract</a></li><li class="ui-tab" id="indexTab-155"><a href="https://www.embase.com/#" class="showIndexTerms" data="155" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="155"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/ANE.0000000000000488" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="154">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-154"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND: General anesthesia in patients with or at risk for <span class="hit">neuronal injury</span> remains challenging due to the controversial influence of volatile anesthetics on <span class="hit">neuronal</span> damage. We hypothesized that isoflurane, <span class="hit">sevoflurane</span>, and desflurane would exert variable degrees of neurotoxicity in vitro and in vivo via activation of the p75 neurotrophin receptor (p75<sub>NTR</sub>).</p><p class="hitsHighlighted">METHODS: SH-SY5Y cells were exposed to oxygen-glucose deprivation (OGD, 16 hours), preceded or followed by incubation with isoflurane, <span class="hit">sevoflurane</span>, or desflurane (1.2 minimal alveolar concentration, 2 hours). <span class="hit">Neuronal</span> cell death was analyzed by flow cytometry (mitochondrial membrane potential, Annexin V/propidium iodide [AV/Pi]) and quantification of lactate dehydrogenase release. We analyzed NF-κB activity by DNA-binding ELISA and luciferase assay. The role of p75<sub>NTR</sub> was studied using the p75<sub>NTR</sub>-blocking peptide TAT-pep5 and siRNA knockdown. The effect of isoflurane ±p75<sub>NTR</sub> inhibition on retinal ischemia-reperfusion <span class="hit">injury</span> (IRI) in adult Sprague-Dawley rats was assessed by analyzing retinal ganglion cell (RGC) density.</p><p class="hitsHighlighted">RESULTS: Isoflurane but not <span class="hit">sevoflurane</span> or desflurane postexposure aggravated OGD-induced <span class="hit">neuronal</span> cell death (AV/Pi positive cells: OGD 41.1% [39.0/43.3] versus OGD + isoflurane 48.5% [46.4/63.4], P = 0.001). Isoflurane significantly increased NF-κB DNA-binding and transcriptional activity of NF-κB (relative Luminescence Units: OGD 500 [499/637] versus OGD + isoflurane 1478 [1363/1643], P = 0.001). Pharmacological inhibition or siRNA knockdown of p75<sub>NTR</sub> counteracted the aggravating effects of isoflurane. Isoflurane increased RGC damage in vivo (IRI 1479 RGC/mm2 [1311/1697] versus IRI + isoflurane 1170 [1093/1211], P = 0.03), which was counteracted by p75<sub>NTR</sub>-inhibition via TAT-pep5 (P = 0.02).</p><p class="hitsHighlighted">CONCLUSIONS: Isoflurane but not <span class="hit">sevoflurane</span> or desflurane postexposure aggravates neurotoxicity in preinjured neurons via activation of p75<sub>NTR</sub> and NF-κB. These findings may have implications for the choice of volatile anesthetic being used in patients with or at risk for <span class="hit">neuronal injury</span>, specifically in patients with a stroke or history of stroke and in surgical procedures in which <span class="hit">neuronal injury</span> is likely to occur, such as cardiac surgery and neurovascular interventions. Copyright © 2014 International Anesthesia Research Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L369752681" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L369752681" type="checkbox" id="record_checkbox_L369752681"><label for="record_checkbox_L369752681" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">156</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=156&amp;page=1&amp;id=L369752681" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Pharmacological and pathological modulation of cerebral physiology</a><br><span class="author fn notranslate"><span class="family-name notranslate">Hirsch</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Taylor</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Anaesthesia and Intensive Care Medicine</span>&nbsp;<span class="journal-publication-year">2013</span>&nbsp;<span class="journal-volume">14</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(401-406)</span>&nbsp;<span class="cited-by" id="CTB-L369752681"><a href="https://lls.reaxys.com/redir?pid=scp:84883493614" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-156"><a href="https://www.embase.com/#" class="showAbstract" data="156" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="156"></i> Abstract</a></li><li class="ui-tab" id="indexTab-156"><a href="https://www.embase.com/#" class="showIndexTerms" data="156" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="156"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.mpaic.2013.05.017" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="155">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-155"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Anaesthesia for neurosurgery aims to provide optimal surgical conditions whilst maintaining adequate cerebral blood flow in order to supply the brain with appropriate amounts of oxygen and glucose. Most anaesthetic drugs influence the normal cerebral physiology either directly or indirectly. They can cause changes in cerebral blood flow by influencing cerebral blood vessel calibre, by interfering with autoregulatory processes and by modifying cerebral metabolism. The brain's limited ability to store oxygen and glucose means that its supply must be continuous if <span class="hit">neuronal</span> damage is to be avoided. Ischaemic cerebral damage is the most important pathological mechanism in patients with stroke, subarachnoid haemorrhage and traumatic brain <span class="hit">injury</span>. Significant traumatic brain <span class="hit">injury</span> causes widespread derangement of cerebral physiology, including changes in cerebral blood flow, autoregulation and cerebral energy dynamics. This article outlines the effect of anaesthesia on cerebral physiology and reviews the pathophysiology of traumatic brain <span class="hit">injury</span> and subarachnoid haemorrhage. © 2013 Elsevier Ltd. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L71367751" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L71367751" type="checkbox" id="record_checkbox_L71367751"><label for="record_checkbox_L71367751" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">157</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=157&amp;page=1&amp;id=L71367751" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">A miniature anesthetic vaporizer for status epilepticus (Stony's VAPO-JECT)</a><br><span class="author fn notranslate"><span class="family-name notranslate">Ishikita</span> <span class="given-name notranslate">N.</span></span><br><span class="journal-title">Epilepsia</span>&nbsp;<span class="journal-publication-year">2013</span>&nbsp;<span class="journal-volume">54</span>&nbsp;<span class="journal-suppl">SUPPL. 6</span><span class="journal-pages">&nbsp;(111-)</span>&nbsp;<span class="cited-by" id="CTB-L71367751"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-157"><a href="https://www.embase.com/#" class="showAbstract" data="157" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="157"></i> Abstract</a></li><li class="ui-tab" id="indexTab-157"><a href="https://www.embase.com/#" class="showIndexTerms" data="157" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="157"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/epi.12292" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="156">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-156"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Isoflurane/<span class="hit">sevoflurane</span> is widely used as anesthetic agent for its easy control of gas concentration. Isoflurane is also well known as a powerful anti convulsive drug which can stop seizure much faster than current intravenous or rectal medications during status epilepticus (SE) It is essential to stop seizure as fast as possible to protect the brain function from <span class="hit">neuronal</span> injuries. Isoflurane is useful, however, necessity of anesthesia machine makes it difficult to apply for the first line treatment of SEOur aim is to develop new anesthesia vaporization system which can be used without technical skills, and evaluate the applicability of the system for the treatment of SE. Method: We developed a miniature inhalational anesthesia attachment combined with 10 ml injector (STONY'S Vapo-Ject). VEO multigasmonitor was used to measure concentration every 100 ms for 15 min. Result: In most cases, the increase of concentration of anesthetic agentin the closed circuit was rapid and then declined gradually. After the initial therapeutic increase ET of isoflurane to 1% within 15 s, mode rate increase was kept in 2 min. Exhaled gas was removing 99.9% by attached filter in 15 min. Conclusion: Isoflurane was immediately rose to the therapeutic range, even faster than original method. Our APL valve worked as automatic ventilation to control pulmonary concentration and exhaled gas was cleaned by attached filter. This study indicates that Vapo-Ject is applicable to be clinical use and to treat SE with isoflurane as soon as possible to protect the brain function.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L369393996" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L369393996" type="checkbox" id="record_checkbox_L369393996"><label for="record_checkbox_L369393996" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">158</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=158&amp;page=1&amp;id=L369393996" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Anaesthetic neurotoxicity and neuroplasticity: An expert group report and statement based on the BJA Salzburg Seminar</a><br><span class="author fn notranslate"><span class="family-name notranslate">Jevtovic-Todorovic</span> <span class="given-name notranslate">V.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Absalom</span> <span class="given-name notranslate">A.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Blomgren</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brambrink</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Crosby</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Culley</span> <span class="given-name notranslate">D.J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fiskum</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Giffard</span> <span class="given-name notranslate">R.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Herold</span> <span class="given-name notranslate">K.F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Loepke</span> <span class="given-name notranslate">A.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Orser</span> <span class="given-name notranslate">B.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Planel</span> <span class="given-name notranslate">E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Slikker</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Soriano</span> <span class="given-name notranslate">S.G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Stratmann</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Vutskits</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xie</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hemmings</span> <span class="given-name notranslate">H.C.</span></span><br><span class="journal-title">British Journal of Anaesthesia</span>&nbsp;<span class="journal-publication-year">2013</span>&nbsp;<span class="journal-volume">111</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(143-151)</span>&nbsp;<span class="cited-by" id="CTB-L369393996"><a href="https://lls.reaxys.com/redir?pid=scp:84878601588" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;201</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-158"><a href="https://www.embase.com/#" class="showAbstract" data="158" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="158"></i> Abstract</a></li><li class="ui-tab" id="indexTab-158"><a href="https://www.embase.com/#" class="showIndexTerms" data="158" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="158"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1093/bja/aet177" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="157">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-157"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Although previously considered entirely reversible, general anaesthesia is now being viewed as a potentially significant risk to cognitive performance at both extremes of age. A large body of preclinical as well as some retrospective clinical evidence suggest that exposure to general anaesthesia could be detrimental to cognitive development in young subjects, and might also contribute to accelerated cognitive decline in the elderly. A group of experts in anaesthetic neuropharmacology and neurotoxicity convened in Salzburg, Austria for the BJA Salzburg Seminar on Anaesthetic Neurotoxicity and Neuroplasticity. This focused workshop was sponsored by the British Journal of Anaesthesia to review and critically assess currently available evidence from animal and human studies, and to consider the direction of future research. It was concluded that mounting evidence from preclinical studies reveals general anaesthetics to be powerful modulators of <span class="hit">neuronal</span> development and function, which could contribute to detrimental behavioural outcomes. However, definitive clinical data remain elusive. Since general anaesthesia often cannot be avoided regardless of patient age, it is important to understand the complex mechanisms and effects involved in anaesthesia-induced neurotoxicity, and to develop strategies for avoiding or limiting potential brain <span class="hit">injury</span> through evidence-based approaches. © The Author [2013]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L368565600" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L368565600" type="checkbox" id="record_checkbox_L368565600"><label for="record_checkbox_L368565600" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">159</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=159&amp;page=1&amp;id=L368565600" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Sleep and anesthesia: Common mechanisms of action</a><br><span class="author fn notranslate"><span class="family-name notranslate">Vacas</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kurien</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Maze</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">Sleep Medicine Clinics</span>&nbsp;<span class="journal-publication-year">2013</span>&nbsp;<span class="journal-volume">8</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(1-9)</span>&nbsp;<span class="cited-by" id="CTB-L368565600"><a href="https://lls.reaxys.com/redir?pid=scp:84875262251" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;12</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-159"><a href="https://www.embase.com/#" class="showAbstract" data="159" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="159"></i> Abstract</a></li><li class="ui-tab" id="indexTab-159"><a href="https://www.embase.com/#" class="showIndexTerms" data="159" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="159"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.jsmc.2012.11.009" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="158">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-158"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Appropriate sleep hygiene is crucial for repair in states of disease and <span class="hit">injury</span> and in restoring function especially in the central nervous and immune systems. Anesthetics have different action targets and ultimately different consequences. The effects of anesthetics on circadian rhythm possibly also lead to immune deregulation. α<sub>2</sub>-adrenergic agonists converge on sleep pathways within the brainstem and are associated with changes in <span class="hit">neuronal</span> activity similar to those seen in deeper stages of NREM sleep. Thoughtful attention must be made in selecting an anesthetic agent that best mimics natural sleep. Future studies will further elucidate the benefits of dexmedetomidine as a good anesthetic/sedative candidate. © 2013 Elsevier Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L52279288" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L52279288" type="checkbox" id="record_checkbox_L52279288"><label for="record_checkbox_L52279288" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">160</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=160&amp;page=1&amp;id=L52279288" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Should the STAIR Criteria Be Modified for Preconditioning Studies?</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">M.M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xi</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Keep</span> <span class="given-name notranslate">R.F.</span></span><br><span class="journal-title">Translational Stroke Research</span>&nbsp;<span class="journal-publication-year">2013</span>&nbsp;<span class="journal-volume">4</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(3-14)</span>&nbsp;<span class="cited-by" id="CTB-L52279288"><a href="https://lls.reaxys.com/redir?pid=scp:84872649179" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;14</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-160"><a href="https://www.embase.com/#" class="showAbstract" data="160" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="160"></i> Abstract</a></li><li class="ui-tab" id="indexTab-160"><a href="https://www.embase.com/#" class="showIndexTerms" data="160" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="160"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12975-012-0219-0" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="159">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-159"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Diverse preconditioning (PC) stimuli protect against a wide variety of <span class="hit">neuronal</span> insults in animal models, engendering enthusiasm that PC could be used to protect the brain clinically. Candidate clinical applications include cardiac and vascular surgery, after subarachnoid hemorrhage, and prior to conditions in which acute <span class="hit">neuronal injury</span> is anticipated. However, disappointments in clinical validation of multiple neuroprotectants suggest potential problems translating animal data into successful human therapies. Thus, despite strong promise of preclinical PC studies, caution should be maintained in translating these findings into clinical applications. The Stroke Therapy Academic Industry Roundtable working group and the National institute of Neurological Diseases and Stroke proposed working guidelines to improve the utility of preclinical studies that form the foundation of therapies for neurological disease. Here, we review the applicability of these consensus criteria to preconditioning studies and discuss additional considerations for PC studies. We propose that special attention should be paid to several areas, including (1) safety and dosage of PC treatments, (2) meticulously matching preclinical modeling to the human condition to be tested, and (3) timing of both the initiation and discontinuation of the PC stimulus relative to <span class="hit">injury</span> ictus. © 2012 Springer Science+Business Media New York (outside the USA).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L369167226" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L369167226" type="checkbox" id="record_checkbox_L369167226"><label for="record_checkbox_L369167226" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">161</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=161&amp;page=1&amp;id=L369167226" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of conditioning with <span class="hit">sevoflurane</span> before reperfusion on hippocampal ischemic <span class="hit">injury</span> and insulin-like growth factor-1 expression in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chiu</span> <span class="given-name notranslate">K.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sun</span> <span class="given-name notranslate">D.</span></span><br><span class="journal-title">Chinese Journal of Physiology</span>&nbsp;<span class="journal-publication-year">2013</span>&nbsp;<span class="journal-volume">56</span><span class="journal-issue">:4</span><span class="journal-pages"></span>&nbsp;<span class="cited-by" id="CTB-L369167226"><a href="https://lls.reaxys.com/redir?pid=scp:84879306591" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-161"><a href="https://www.embase.com/#" class="showAbstract" data="161" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="161"></i> Abstract</a></li><li class="ui-tab" id="indexTab-161"><a href="https://www.embase.com/#" class="showIndexTerms" data="161" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="161"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.4077/CJP.2013.BAB117" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="160">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-160"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted"><span class="hit">Sevoflurane</span> pre-conditioning before ischemia can reduce ischemia-reperfusion injuries in cardiac, pulmonary and cerebral tissues. It is uncertain whether <span class="hit">sevoflurane</span> conditioning before reperfusion has similar protective effects on <span class="hit">neuronal</span> injuries. In this study, we explored the effect of <span class="hit">sevoflurane</span> conditioning (at concentrations of 1.5%, 2.4% or 3.0%) on the morphology and molecular mechanisms of the hippocampal CA1 region in male Sprague-Dawley rats subjected to global cerebral ischemia. We determined the pathological results by hematoxylin and eosin (H&amp;E) staining and examined the mRNA levels of insulin-like growth factor-1 (IGF-1) and protein levels of p-JNK1/2 and p-Akt1 in the hippocampus at 24 h, 48 h and 72 h after global cerebral ischemia-reperfusion. Our data showed that O2 post-conditioning and lower dose (1.5%) of <span class="hit">sevoflurane</span> did not ameliorate ischemia-induced CA1 <span class="hit">injury</span>. However, higher doses of 2.4% and 3.0% <span class="hit">sevoflurane</span> post-conditioning alleviated the CA1 <span class="hit">injury</span> and enhanced the expression levels of IGF-1 mRNA. Furthermore, <span class="hit">sevoflurane</span> post-conditioning inhibited the activations of p-JNK1/2 and enhanced activation of p-Akt1. In conclusion, these results suggest that post-conditioning with <span class="hit">sevoflurane</span> at 2.4% and 3.0% ameliorates global cerebral ischemia induced hippocampal CA1 <span class="hit">injury</span> by up-regulating the expression of IGF-1 mRNA followed by the activation of p-Akt1 and inhibition of the activation of p-JNK1/2. © 2013 by The Chinese Physiological Society and Airiti Press Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L52754400" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L52754400" type="checkbox" id="record_checkbox_L52754400"><label for="record_checkbox_L52754400" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">162</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=162&amp;page=1&amp;id=L52754400" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Anesthetic neurotoxicity in the newborn and infant</a><br><span class="author fn notranslate"><span class="family-name notranslate">Olsen</span> <span class="given-name notranslate">E.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Brambrink</span> <span class="given-name notranslate">A.M.</span></span><br><span class="journal-title">Current Opinion in Anaesthesiology</span>&nbsp;<span class="journal-publication-year">2013</span>&nbsp;<span class="journal-volume">26</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(535-542)</span>&nbsp;<span class="cited-by" id="CTB-L52754400"><a href="https://lls.reaxys.com/redir?pid=scp:84888287919" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;46</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-162"><a href="https://www.embase.com/#" class="showAbstract" data="162" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="162"></i> Abstract</a></li><li class="ui-tab" id="indexTab-162"><a href="https://www.embase.com/#" class="showIndexTerms" data="162" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="162"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/01.aco.0000433061.59939.b7" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="161">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-161"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Purpose of review: Every year, millions of children undergo anesthesia. Emerging evidence from experimental in-vitro and in-vivo models supports a role for neuropathologic <span class="hit">injury</span> and neurobehavioral deficits at older age after early exposure to various anesthetic regimens. Clinical studies have sought to identify a phenotype of developmental anesthesia neurotoxicity in humans, but the current evidence is limited to data from retrospective studies with their associated confounders. Experimental models have been used to further define the <span class="hit">injury</span> and to help identify potential mechanisms of this neurotoxicity. Recent findings: A recent clinical trial from an Australian birth cohort suggests a single anesthesia exposure as a neonate or infant may increase the risk for language and abstract reasoning deficits later in life, though residual data confounders may remain. Several ongoing clinical trials like Mayo Safety in Kids, Pediatric Anesthesia NeuroDevelopment Assessment, and General Anesthesia and Apoptosis Study will likely offer more clear answers in the future. In the interim, experimental models have described roles for neuroinflammation, mitochondrial damage from reactive oxygen species, and the presence of several <span class="hit">neuronal</span> morphology changes from anesthesia exposure. Additionally, several potential neuroprotective agents and strategies have been tested in the laboratory. Summary: Whether anesthesia-associated neurotoxicity affects the developing human brain and whether this leads to clinically measurable deficits remains unclear. © 2013 Wolters Kluwer Health / Lippincott Williams &amp; Wilkins.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L71131888" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L71131888" type="checkbox" id="record_checkbox_L71131888"><label for="record_checkbox_L71131888" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">163</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=163&amp;page=1&amp;id=L71131888" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">16th Annual Meeting of the Japanese Society of Neuroanesthesia and Critical Care</a><br><br><span class="journal-title">Journal of Neurosurgical Anesthesiology</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="journal-volume">24</span><span class="journal-issue">:4</span><span class="journal-pages"></span>&nbsp;<span class="cited-by" id="CTB-L71131888"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-163"><a href="https://www.embase.com/#" class="showAbstract" data="163" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="163"></i> Abstract</a></li><li class="ui-tab" id="indexTab-163"><a href="https://www.embase.com/#" class="showIndexTerms" data="163" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="163"></i> Index Terms</a></li><li><span id="FTL-L71131888" class="fulltext" data="{&quot;recno&quot;:&quot;L71131888&quot;,&quot;issn&quot;:&quot;08984921&quot;,&quot;volume&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;startpage&quot;:&quot;&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="162">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-162"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The proceedings contain 17 papers. The topics discussed include: evaluation of optimal doses of <span class="hit">sevoflurane</span> and propofol with and without dexmedetomidine in rabbits; evaluation of feasibility and reliability of visual evoked potentials monitoring during neurosurgical procedures; morphine prevents postoperative cognitive dysfunction after anesthesia and surgery; case report: post-lung transplantation patient who developed cerebral vasospasm leading to infarction during administration of tacrolimus; study on the factors of intraoperative hyperthermia during neurosurgery; usefulness of droperidol on postoperative nausea and vomiting in patients after laparoscopic cholecystectomy; retrospective evaluation on patient satisfactory after brain tumor resection; severe pain induced by spinal anesthesia in a patient without preceding neuropathy; and mechanisms of <span class="hit">neuronal</span> migration regulated by a Rho-GTPase-activating protein and their possible applications to regenerative medicine for brain <span class="hit">injury</span>.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L52185707" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L52185707" type="checkbox" id="record_checkbox_L52185707"><label for="record_checkbox_L52185707" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">164</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=164&amp;page=1&amp;id=L52185707" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Activation of canonical notch signaling pathway is involved in the ischemic tolerance induced by <span class="hit">sevoflurane</span> preconditioning in mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yan</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Li</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hou</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xiong</span> <span class="given-name notranslate">L.</span></span><br><span class="journal-title">Anesthesiology</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="cited-by" id="CTB-L52185707"><a href="https://lls.reaxys.com/redir?pid=scp:84865428351" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-164"><a href="https://www.embase.com/#" class="showAbstract" data="164" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="164"></i> Abstract</a></li><li class="ui-tab" id="indexTab-164"><a href="https://www.embase.com/#" class="showIndexTerms" data="164" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="164"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ALN.0b013e31826cb469" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="163">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-163"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND: A wealth of evidence has demonstrated that <span class="hit">sevoflurane</span> preconditioning induces brain ischemic tolerance, but the mechanism remains poorly understood. This study was designed to investigate the role of canonical Notch signaling in the neuroprotection induced by <span class="hit">sevoflurane</span> preconditioning in a mouse model. METHODS: C57BL/6 mice were pretreated with 1-h <span class="hit">sevoflurane</span> exposure at a dose of 2.5% for 5 consecutive days. Twenty-four hours after the last exposure, all mice were subjected to focal cerebral ischemia by right middle cerebral artery occlusion for 60 min. Neurobehavioral scores, brain infarct volumes, and cellular apoptosis were determined at 72 h after reperfusion (n = 10 per group). The activation of Notch signaling was evaluated (n = 5 per group), and its role in ischemic tolerance was assessed by intraperitoneal administration of γ-secretase inhibitor DAPT (100 mg/kg, n = 10 per group) and conditional Notch-RBP-J knockout technique (n = 8 per group). RESULTS: <span class="hit">Sevoflurane</span> preconditioning reduced brain infarct volumes (42.5%), improved neurologic outcomes (P &lt; 0.01 vs. control), and attenuated <span class="hit">neuronal</span> cell apoptosis (cells positive for terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate nick-end labeling reduced to 21.2%). The expression of Notch1 intracellular domain (1.35 folds) and the transcriptions of Hes1 (1.95 times) and Hes5 (1.48 times) were up-regulated. DAPT augmented the brain infarcts (1.64-fold) and decreased neurologic scores (P = 0.43 vs. <span class="hit">sevoflurane</span>) in <span class="hit">sevoflurane</span>-preconditioned mice. Brain infarct volumes, neurobehavioral scores, and apoptotic cell numbers showed no significance between Notch knockout mice with <span class="hit">sevoflurane</span> preconditioning and wild-type mice without preconditioning. CONCLUSIONS: <span class="hit">Sevoflurane</span> preconditioning-induced protective effects against transient cerebral ischemic injuries are mediated by the activation of canonical Notch signaling pathway in mice.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L52025636" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L52025636" type="checkbox" id="record_checkbox_L52025636"><label for="record_checkbox_L52025636" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">165</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=165&amp;page=1&amp;id=L52025636" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> postconditioning involves an up-regulation of HIF-1α and HO-1 expression via PI3K/Akt pathway in a rat model of focal cerebral ischemia</a><br><span class="author fn notranslate"><span class="family-name notranslate">Ye</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Xia</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yuan</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Brain Research</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="journal-volume">1463</span><span class="journal-pages">&nbsp;(63-74)</span>&nbsp;<span class="cited-by" id="CTB-L52025636"><a href="https://lls.reaxys.com/redir?pid=scp:84861840455" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;78</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-165"><a href="https://www.embase.com/#" class="showAbstract" data="165" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="165"></i> Abstract</a></li><li class="ui-tab" id="indexTab-165"><a href="https://www.embase.com/#" class="showIndexTerms" data="165" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="165"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.brainres.2012.04.050" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="164">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-164"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Administration of <span class="hit">sevoflurane</span> at the onset of reperfusion has been confirmed to provide a cerebral protection. However, little is known about the mechanism. In this study, we tested the hypothesis that <span class="hit">sevoflurane</span> postconditioning induces neuroprotection through the up-regulation hypoxia inducible factor-1α (HIF-1α) and heme oxygenase-1 (HO-1) involving phosphatidylinositol-3-kinase (PI3K)/Akt pathway. In the first experiment, male Sprague-Dawley rats were subjected to focal cerebral ischemia. Postconditioning was performed by exposure to 2.5% <span class="hit">sevoflurane</span> immediately at the onset of reperfusion. The mRNA and protein expression of HIF-1α and its target gene, HO-1, intact neurons and the activity of caspase-3 was evaluated at 6, 24 and 72 h after reperfusion. In the second experiment, we investigated the relationship between PI3K/Akt pathway and the expression of HIF-1α and HO-1 in the neuroprotection induced by <span class="hit">sevoflurane</span>. Cerebral infarct volume, apoptotic neuron and the expression of HIF-1α, HO-1 and p-Akt were evaluated at 24 h after reperfusion. Compared with the control group, <span class="hit">sevoflurane</span> postconditiong significantly ameliorated <span class="hit">neuronal injury</span>, up-regulated mRNA and protein levels of HIF-1α and HO-1, inhibited the activity of caspase-3, and decreased the number of TUNEL-positive cells and infarct sizes. However, the selective PI3K inhibitor, wortmannin not only partly eliminated the neuroprotection of <span class="hit">sevoflurane</span> as shown by reducing infarct size and apoptotic <span class="hit">neuronal</span> cells, but also reversed the elevation of HIF-1α, HO-1 and p-Akt expression in the ischemic penumbra induced by <span class="hit">sevoflurane</span>. Therefore, our data demonstrate that the cerebral protection from <span class="hit">sevoflurane</span> postconditioning is partly mediated by PI3K/Akt pathway via the up-regulation of HIF-1α and HO-1. Crown Copyright © 2012 Published by Elsevier B.V. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L71793697" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L71793697" type="checkbox" id="record_checkbox_L71793697"><label for="record_checkbox_L71793697" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">166</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=166&amp;page=1&amp;id=L71793697" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Metabolic status in neonatal rat brain in response to general anesthesia differs from the young rat brain: The role of glutamate</a><br><span class="author fn notranslate"><span class="family-name notranslate">Makaryus</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jacob</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Feng</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Benveniste</span> <span class="given-name notranslate">H.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="journal-volume">114</span><span class="journal-issue">:5</span>&nbsp;<span class="journal-suppl">SUPPL. 1</span><span class="journal-pages">&nbsp;(S404-)</span>&nbsp;<span class="cited-by" id="CTB-L71793697"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-166"><a href="https://www.embase.com/#" class="showAbstract" data="166" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="166"></i> Abstract</a></li><li class="ui-tab" id="indexTab-166"><a href="https://www.embase.com/#" class="showIndexTerms" data="166" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="166"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/01.ane.0000431534.65496.1e" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="165">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-165"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Introduction : Proton magnetic resonance spectroscopy (1HMRS) can be used to detect abnormalities in the brain, which may reveal <span class="hit">neuronal</span> injuries, ischemia, inflammation, and even possibly neurogenesis and apoptosis. We previously showed that cerebral metabolomic patterns depend on anesthetic regimen used.1 The main differences seen in adult animals are an increase in the levels of glutamate and lactate in response to inhalational agents as compared to intravenous agents.1 We sought to determine if these differences would also be seen in younger animals, particularly those undergoing synaptogenesis (PND 6 - 11) and slightly older animals (PND 21 - 36). Methods : Following approval by the local IACUC, rats were divided into four groups based on age and anesthesia exposure: Neonatal <span class="hit">Sevoflurane</span> (n=11), Neonatal Propofol (n=10), Weaned <span class="hit">Sevoflurane</span> (n=8), and Weaned Propofol (n=9). All animals were monitored for respiratory rate, heart rate, temperature, and O2 sats while breathing 60% O2. The <span class="hit">sevoflurane</span> groups received 1 MAC <span class="hit">Sevoflurane</span>, while the propofol groups received 1 MAC equivalent doses. Total anesthesia duration for all animals was 6 hours; 1HMRS was performed in the hippocampus and thalamic regions using a 9.4T MRI. Results : Age and body weights were matched across groups. Metabolite milli-molar values attained via LCModel were compared across all four groups using two-way ANOVA analysis. Multiple metabolites differed by animal age; however, glutamate [glu] was the only one that differed by type of anesthesia with p &lt; 0.0001 for both brain regions. Post-hoc analysis revealed that glutamate was significantly higher in the weaned group; however, for the neonatal animals, there was no significant difference in glutamate between the two anesthetics. PLS-DA analysis showed a clear separation between the four groups with a significant Q2 value of &gt;0.3 for both regions, and confirmed our ANOVA results. Discussion : Although [Glu] trended to increase in the neonatal brain with <span class="hit">sevoflurane</span>, the baseline [glu] was lower compared to the young animals, which is probably related to brain maturity. Glutamate is the primary excitatory neurotransmitter in the brain and is also an essential intermediary in energy metabolism. Clearly from the point of view that [Glu] is representing metabolism, lower [Glu] in neonatal brain signifies lower metabolism and/or <span class="hit">neuronal</span> activity in agreement with neurophysiological data. The significance of the metabolic profiles in relation to potential neurotoxicity is currently being investigated (Table Presented).</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L51790669" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L51790669" type="checkbox" id="record_checkbox_L51790669"><label for="record_checkbox_L51790669" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">167</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=167&amp;page=1&amp;id=L51790669" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of surgery and/or remifentanil administration on the expression of pERK1/2, c-Fos and dynorphin in the dorsal root ganglia in mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Romero</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">González-Cuello</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Laorden</span> <span class="given-name notranslate">M.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Campillo</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Vasconcelos</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Romero-Alejo</span> <span class="given-name notranslate">E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Puig</span> <span class="given-name notranslate">M.M.</span></span><br><span class="journal-title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="journal-volume">385</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(397-409)</span>&nbsp;<span class="cited-by" id="CTB-L51790669"><a href="https://lls.reaxys.com/redir?pid=scp:84862889902" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;12</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-167"><a href="https://www.embase.com/#" class="showAbstract" data="167" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="167"></i> Abstract</a></li><li class="ui-tab" id="indexTab-167"><a href="https://www.embase.com/#" class="showIndexTerms" data="167" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="167"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s00210-011-0721-z" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="166">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-166"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Tissue <span class="hit">injury</span> and/or opioids induce plastic changes in the spinal cord resulting in pain hypersensitivity; the contribution of the dorsal root ganglia (DRG) is poorly understood. We evaluated DRG phenotypic changes induced by surgery and/or remifentanil in a mice model of postoperative pain using as <span class="hit">neuronal</span> markers ERK1/2 and c-Fos; prodynorphin mRNA and dynorphin levels were also determined. We hypothesized that a correlation between nociception and DRG reactivity would occur. Surgery and/or remifentanil induced mechanical hypersensitivity, correlated with ERK1/2 phosphorylation and c-Fos expression in the DRG; changes were greater in the remifentanil + incision group and still present on day 14 (p&lt;0.01 vs. control). Intrathecal PD98059 (ERK1/2 inhibitor) partially reversed the mechanical hypersensitivity (44%, p&lt;0.05) observed in the remifentanil+incision group. In this group, significant increases in prodynorphin mRNA (at 2, 7, and 14 days, p&lt;0.01) roughly coincided with increases in dynorphin (days 2 and 14, p&lt;0.001) in the DRG. Remifentanil or incision (alone) also induced an up-regulation in prodynorphin mRNA expression on days 7 and 14 (p&lt;0.01, p&lt;0.05, respectively), partially correlating with dynorphin levels. On day 21, all molecular changes returned to control levels in all experimental conditions, concurring with the complete recovery of nociceptive thresholds. Surgery and/or remifentanil induce up-regulation of c-Fos and pERK in the DRG, approximately correlating with nociceptive behavior, also associated with an increased expression of prodynorphin/ dynorphin. These changes support the role of the DRG in the development and maintenance of pain hypersensitivity after surgery. The findings could contribute to the development of new therapeutic agents focused on peripheral targets. © 2012 Springer-Verlag.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L364256002" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L364256002" type="checkbox" id="record_checkbox_L364256002"><label for="record_checkbox_L364256002" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">168</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=168&amp;page=1&amp;id=L364256002" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">A review of postoperative cognitive dysfunction and neuroinflammation associated with cardiac surgery and anaesthesia</a><br><span class="author fn notranslate"><span class="family-name notranslate">Van Harten</span> <span class="given-name notranslate">A.E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Scheeren</span> <span class="given-name notranslate">T.W.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Absalom</span> <span class="given-name notranslate">A.R.</span></span><br><span class="journal-title">Anaesthesia</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="journal-volume">67</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(280-293)</span>&nbsp;<span class="cited-by" id="CTB-L364256002"><a href="https://lls.reaxys.com/redir?pid=scp:84856942486" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;195</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-168"><a href="https://www.embase.com/#" class="showAbstract" data="168" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="168"></i> Abstract</a></li><li class="ui-tab" id="indexTab-168"><a href="https://www.embase.com/#" class="showIndexTerms" data="168" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="168"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/j.1365-2044.2011.07008.x" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="167">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-167"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Postoperative cognitive dysfunction is receiving increasing attention, particularly as it mainly affects the (growing) elderly population. Until recently, cognitive deficits after cardiac surgery were thought to be caused by physiological disturbances associated with the cardiopulmonary bypass technique. Although the technique of 'off-pump' coronary revascularisation may potentially be associated with improved outcome, long-term follow-up studies have failed to demonstrate a significant reduction in the incidence of postoperative cognitive dysfunction. The focus of research is thus shifting from cardiopulmonary bypass to other factors common to both techniques, such as surgery, anaesthesia and patient-related predisposing factors. Priming of the immune system by ageing and atherosclerosis may result in an exaggerated systemic and cerebral inflammatory response to cardiac surgery and anaesthesia, causing <span class="hit">neuronal</span> loss or dysfunction resulting in cognitive dysfunction. We briefly discuss the evidence for cardiopulmonary bypass-related <span class="hit">neuronal</span> injuries in adult cardiac surgery patients, and review the evidence that immune priming is a key factor in the pathogenesis of cognitive dysfunction after cardiac surgery. © 2012 The Association of Anaesthetists of Great Britain and Ireland.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L364085384" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L364085384" type="checkbox" id="record_checkbox_L364085384"><label for="record_checkbox_L364085384" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">169</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=169&amp;page=1&amp;id=L364085384" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Developmental disability in the young and postoperative cognitive dysfunction in the elderly after anesthesia and surgery: Do data justify changing clinical practice?</a><br><span class="author fn notranslate"><span class="family-name notranslate">Cottrell</span> <span class="given-name notranslate">J.E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hartung</span> <span class="given-name notranslate">J.</span></span><br><span class="journal-title">Mount Sinai Journal of Medicine</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="journal-volume">79</span><span class="journal-issue">:1</span><span class="journal-pages">&nbsp;(75-94)</span>&nbsp;<span class="cited-by" id="CTB-L364085384"><a href="https://lls.reaxys.com/redir?pid=scp:84855760620" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;18</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-169"><a href="https://www.embase.com/#" class="showAbstract" data="169" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="169"></i> Abstract</a></li><li class="ui-tab" id="indexTab-169"><a href="https://www.embase.com/#" class="showIndexTerms" data="169" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="169"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1002/msj.21283" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="168">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-168"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The assumption that anesthesia has no serious, long-term, adverse central nervous system consequences may be true for most patients between 6 months and 60 years of age. However, for patients younger than 6 months or older than 60 years, that status quo assumption is under challenge from a growing body of evidence. Fetuses and newborns appear to be at risk because systems that would enable them to fully recover from the effects of more than 2 hours of anesthesia are still in development. In distinction, the elderly appear to be at risk because systems that once enabled them to fully recover have ever-diminishing capacity. Even for those between the age of 6 months and 60 years, full recovery may require replacing apoptosed neurons and pruning overabundant dendritic spines ⋯ perhaps leaving patients not quite the same person that they were before they were anesthetized. © 2012 Mount Sinai School of Medicine.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L364923531" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L364923531" type="checkbox" id="record_checkbox_L364923531"><label for="record_checkbox_L364923531" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">170</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=170&amp;page=1&amp;id=L364923531" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">General anesthetics in pediatric anesthesia: Influences on the developing brain</a><br><span class="author fn notranslate"><span class="family-name notranslate">McCann</span> <span class="given-name notranslate">M.E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Soriano</span> <span class="given-name notranslate">S.G.</span></span><br><span class="journal-title">Current Drug Targets</span>&nbsp;<span class="journal-publication-year">2012</span>&nbsp;<span class="journal-volume">13</span><span class="journal-issue">:7</span><span class="journal-pages">&nbsp;(944-951)</span>&nbsp;<span class="cited-by" id="CTB-L364923531"><a href="https://lls.reaxys.com/redir?pid=scp:84861717404" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;64</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-170"><a href="https://www.embase.com/#" class="showAbstract" data="170" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="170"></i> Abstract</a></li><li class="ui-tab" id="indexTab-170"><a href="https://www.embase.com/#" class="showIndexTerms" data="170" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="170"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.2174/138945012800675768" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="169">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-169"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Millions of newborn and infants receive anesthetic, sedative and analgesic drugs for surgery and painful procedures on a daily basis. However, recent laboratory reports clearly demonstrate that anesthetic and sedative drugs induced both neuroapoptosis and neurocognitive deficits in laboratory models. This issue is of paramount interest to pediatric anesthesiologists and intensivists because it questions the safety of anesthetics used for fetal and neonatal anesthesia. Most clinically utilized anesthetic drugs have been found to induce <span class="hit">neuronal</span> cell death in the developing brain and to potentially cause long-term neurological impairment. Conversely, painful stimuli without analgesia and anesthesia have been implicated in triggering neuro-apoptosis in juvenile mammalian models. Published retrospective reviews demonstrate temporary neurological sequelae after prolonged anesthetic exposure in young children and larger studies identify long-term neurodevelopmental impairment after neonatal surgery and anesthesia. This paper examines the evidence for the effects of commonly used anesthetics on <span class="hit">neuronal</span> structure and neurocognitive function in laboratory models and reviews the relevant clinical human epidemiologic data. © 2012 Bentham Science Publishers.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L363008436" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L363008436" type="checkbox" id="record_checkbox_L363008436"><label for="record_checkbox_L363008436" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">171</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=171&amp;page=1&amp;id=L363008436" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span> postconditioning ameliorates oxygen-glucose deprivation-reperfusion <span class="hit">injury</span> in the rat hippocampus</a><br><span class="author fn notranslate"><span class="family-name notranslate">Peng</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kalikiri</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mychaskiw Ii</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">G.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">G.-L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Shen</span> <span class="given-name notranslate">Z.-Y.</span></span><br><span class="journal-title">CNS Neuroscience and Therapeutics</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">17</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(605-611)</span>&nbsp;<span class="cited-by" id="CTB-L363008436"><a href="https://lls.reaxys.com/redir?pid=scp:82355172757" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;21</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-171"><a href="https://www.embase.com/#" class="showAbstract" data="171" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="171"></i> Abstract</a></li><li class="ui-tab" id="indexTab-171"><a href="https://www.embase.com/#" class="showIndexTerms" data="171" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="171"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/j.1755-5949.2010.00193.x" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="170">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-170"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Introduction: <span class="hit">Sevoflurane</span> is well known to exert a neuroprotective effect through anesthetic preconditioning. However, its effects on postconditioning, a neuroprotective phenomenon following an insult, have not been well studied. Aims: In this study, we examined the ability of <span class="hit">sevoflurane</span> to induce postconditioning in rat hippocampal slices, in vitro. Results: 2%, 4%, and 6% <span class="hit">sevoflurane</span> reduced neurophysiologic and morphologic <span class="hit">neuronal injury</span> following oxygen-glucose deprivation (OGD) and reperfusion. The quantity of damaged neurons was significantly reduced on immunofluorescence staining; excitatory amino acids (Asp, Glu) increased and inhibitory amino acids (GABA) decreased significantly. The effect was concentration-dependent. Conclusion: Postconditioning with <span class="hit">sevoflurane</span> reduces <span class="hit">neuronal</span> damage after OGD-reperfusion <span class="hit">injury</span> in the CA1 area of rat hippocampus, in vitro. © 2010 Blackwell Publishing Ltd.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L51446424" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L51446424" type="checkbox" id="record_checkbox_L51446424"><label for="record_checkbox_L51446424" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">172</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=172&amp;page=1&amp;id=L51446424" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Dose-dependent influence of <span class="hit">sevoflurane</span> anesthesia on <span class="hit">neuronal</span> survival and cognitive outcome after transient forebrain ischemia in sprague-dawley rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lasarzik</span> <span class="given-name notranslate">I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Noppens</span> <span class="given-name notranslate">R.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wolf</span> <span class="given-name notranslate">T.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bauer</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Luh</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Werner</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Engelhard</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Thal</span> <span class="given-name notranslate">S.C.</span></span><br><span class="journal-title">Neurocritical Care</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">15</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(577-584)</span>&nbsp;<span class="cited-by" id="CTB-L51446424"><a href="https://lls.reaxys.com/redir?pid=scp:84856265753" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;7</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-172"><a href="https://www.embase.com/#" class="showAbstract" data="172" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="172"></i> Abstract</a></li><li class="ui-tab" id="indexTab-172"><a href="https://www.embase.com/#" class="showIndexTerms" data="172" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="172"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12028-011-9562-3" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="171">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-171"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background Volatile anesthetics reduce postischemic neurohistopathological <span class="hit">injury</span> and improve neurological outcome in various animal models. However, the isoflurane concentrations above 1 minimum alveolar concentration (MAC) have been associated with reduced <span class="hit">neuronal</span> survival and impaired functional outcome. The aim of this study was to evaluate if 1.8 MAC <span class="hit">sevoflurane</span> alters postischemic <span class="hit">neuronal</span> survival and neurologic outcome compared with 0.45 MAC <span class="hit">sevoflurane</span>. Methods In this study, 20 fasted male Sprague-Dawley rats were randomly assigned to treatment groups with 1 or 4 <span class="hit">vol.% sevoflurane</span> end-tidal concentration. Cerebral ischemia was induced by bilateral carotid artery occlusion and hemorrhagic hypotension (BCAO). The cognitive outcome was assessed after 7 days using the object recognition test. Animals were then re-anesthetized and brains were removed for neurohistopathological analysis of the hippocampus (CA1) and cortex using hematoxylin-eosin staining. Results Physiologic parameters were not different between both the treatment groups. The number of viable neurons (median [Q1, Q3]) in the CA1 region on postischemic day 7 was increased after high-dose <span class="hit">sevoflurane</span> compared with low-dose <span class="hit">sevoflurane</span> (1645 [453, 1825] vs. 3222 [2920, 3993] neurons/ROI, P &lt; 0.05). Results of the object recognition test were not different between both the treatment groups. Conclusions Postischemic <span class="hit">neuronal</span> survival was increased with 1.8 MAC compared with 0.45 MAC <span class="hit">sevoflurane</span>. Therefore, experimental models of cerebral ischemia should account for neuroprotective effects of <span class="hit">sevoflurane</span> with increasing concentrations. To ensure minimal interference of <span class="hit">sevoflurane</span> on <span class="hit">neuronal</span> survival, a low inspired concentration should be used and fluctuations in the depth of anesthesia should be limited. © Springer Science+Business Media, LLC 2011.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L51608221" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L51608221" type="checkbox" id="record_checkbox_L51608221"><label for="record_checkbox_L51608221" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">173</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=173&amp;page=1&amp;id=L51608221" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">The effects of anesthetic preconditioning with <span class="hit">sevoflurane</span> in an experimental lung autotransplant model in pigs</a><br><span class="author fn notranslate"><span class="family-name notranslate">Casanova</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Garutti</span> <span class="given-name notranslate">I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Simon</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Giraldez</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Martin</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gonzalez</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Azcarate</span> <span class="given-name notranslate">L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Garcia</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Vara</span> <span class="given-name notranslate">E.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">113</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(742-748)</span>&nbsp;<span class="cited-by" id="CTB-L51608221"><a href="https://lls.reaxys.com/redir?pid=scp:80053340432" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;44</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-173"><a href="https://www.embase.com/#" class="showAbstract" data="173" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="173"></i> Abstract</a></li><li class="ui-tab" id="indexTab-173"><a href="https://www.embase.com/#" class="showIndexTerms" data="173" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="173"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/ANE.0b013e3182288e01" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="172">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-172"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: Ischemia-reperfusion lung <span class="hit">injury</span> is doubly important in thoracic surgery because of the associated ventilation damage to 1 lung. In this study we evaluated the cytoprotective effects of <span class="hit">sevoflurane</span> in a pulmonary autotransplant model in pigs. Methods: Twenty Large White pigs undergoing pneumonectomy plus lung autotransplant were divided into 2 10-member groups on the basis of the anesthetic received (propofol or <span class="hit">sevoflurane</span>). Proinflammatory mediators, oxidative stress, nitric oxide metabolism, and hemodynamic and blood variables were measured at 5 different time points. Results: There was an increase of oxidative stress markers and proinflammatory mediators in the propofol group, whereas the hemodynamic variables were similar in both groups. Conclusions: We demonstrated that <span class="hit">sevoflurane</span> decreased the inflammatory response and oxidative stress in a live ischemia-reperfusion lung model. © 2011 International Anesthesia Research Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L362116693" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L362116693" type="checkbox" id="record_checkbox_L362116693"><label for="record_checkbox_L362116693" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">174</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=174&amp;page=1&amp;id=L362116693" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Emergent pharmacology of conscious experience: New perspectives in substance addiction</a><br><span class="author fn notranslate"><span class="family-name notranslate">Changeux</span> <span class="given-name notranslate">J.-P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lou</span> <span class="given-name notranslate">H.C.</span></span><br><span class="journal-title">FASEB Journal</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">25</span><span class="journal-issue">:7</span><span class="journal-pages">&nbsp;(2098-2108)</span>&nbsp;<span class="cited-by" id="CTB-L362116693"><a href="https://lls.reaxys.com/redir?pid=scp:79960155728" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;21</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-174"><a href="https://www.embase.com/#" class="showAbstract" data="174" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="174"></i> Abstract</a></li><li class="ui-tab" id="indexTab-174"><a href="https://www.embase.com/#" class="showIndexTerms" data="174" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="174"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1096/fj.11-0702ufm" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="173">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-173"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">We here review experimental findings relevant for the pharmacology of conscious experience, an issue largely neglected in pharmacological research. First, we focus on self-awareness, a pivotal component of conscious experience and its integration within the global <span class="hit">neuronal</span> network (GNW), a theoretical concept that unifies convergent approaches on the neural bases of conscious processing. We report recent evidence to show that self-awareness mobilizes a paralimbic circuitry of γ synchrony, and that such synchrony is, in particular, regulated by GABA interneurons under the control of acetylcholine and dopamine. Recent data illustrate that these neurotransmitters establish a causal relationship with the control of self-awareness. The hypothesis is presented that not only is self-awareness chemically regulated, but the reverse may be true. Long-term deficit in self-control of drug intake would result in compulsive substance use, accompanied, in particular, with lesions of the paralimbic circuitry of self-awareness, leading to aggravation of substance abuse, resulting in addiction in a vicious circle. Finally, we propose that the emergent pharmacology of conscious experience may provide new perspectives, not only in substance addiction but also in the many other pathological conditions with deficient self-awareness. © FASEB.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L70681292" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L70681292" type="checkbox" id="record_checkbox_L70681292"><label for="record_checkbox_L70681292" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">175</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=175&amp;page=1&amp;id=L70681292" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Gene expression profiles of <span class="hit">sevoflurane</span> and isoflurane in a rat model of focal cerebral ischemia: Preconditioning provide neuroprotection by inhibition of apoptosis</a><br><span class="author fn notranslate"><span class="family-name notranslate">Bedirli</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bagriacik</span> <span class="given-name notranslate">E.U.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Emmez</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yilmaz</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Unal</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zerrin</span> <span class="given-name notranslate">O.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Bayraktar</span> <span class="given-name notranslate">A.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kavutci</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">European Journal of Anaesthesiology</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">28</span>&nbsp;<span class="journal-suppl">SUPPL. 48</span><span class="journal-pages">&nbsp;(101-102)</span>&nbsp;<span class="cited-by" id="CTB-L70681292"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-175"><a href="https://www.embase.com/#" class="showAbstract" data="175" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="175"></i> Abstract</a></li><li class="ui-tab" id="indexTab-175"><a href="https://www.embase.com/#" class="showIndexTerms" data="175" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="175"></i> Index Terms</a></li><li><span id="FTL-L70681292" class="fulltext" data="{&quot;recno&quot;:&quot;L70681292&quot;,&quot;issn&quot;:&quot;02650215&quot;,&quot;volume&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;&quot;,&quot;startpage&quot;:&quot;101&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="174">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-174"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Aim and the Goal of Study: Volatile anaesthetics exert protective effects against ischemia-reperfusion (IR) <span class="hit">injury</span> in various organs however the mechanisms of organ protection by volatile anaesthetics are unclear. IR cause organ damage and triggers activation of several transcription factors which may alter the transcription of multiple genes associated with inflammatory response. The aim of this study was to investigate the effects of isoflurane and <span class="hit">sevoflurane</span> on IR <span class="hit">injury</span> and apoptotic genes in a rat model of focal cerebral IR. Materials and Methods: Twenty-four rats were randomly divided into three groups; control (n=8, no volatiles), <span class="hit">sevoflurane</span> (n=8, 2% <span class="hit">sevoflurane</span>), and isoflurane (n=8, 1.5% isoflurane) groups. The rats were anaesthetised by intramuscular injection of 150 mg/kg ketamine hydrochloride and 10 mg/kg xylazine and followed by endotracheal intubation. The rats in control, <span class="hit">sevoflurane</span> and isoflurane groups were exposed to 50 % O2, 2% <span class="hit">sevoflurane</span> and 1.5% isoflurane respectively for 30 min. Focal cerebral ischemia was produced by intraluminal MCA occlusion for 1 h followed by 6 h reperfusion. Blood samples were collected for blood gas, tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β) measurements and cerebral tissue samples were obtained for measurement of myeloperoxidase (MPO) and malondaldehyde (MDA) concentrations, histological examinations, and for isolation of total RNA. Results and Discussion: Blood gas analysis did not show any significant difference among the groups (p&gt;0.05). Serum cytokine levels and tissue MPO and MDA levels were significantly decreased in <span class="hit">sevoflurane</span> group compared to the both groups (p&lt; 0.05). Trp 53 and Trp 63 are proapoptotic proteins primarily expressed in the sympathetic nervous system and capable of promoting <span class="hit">neuronal</span> apoptosis was significantly down regulated while <span class="hit">neuronal</span> apoptosis inhibitory protein, Birc1b, was significantly up regulated in <span class="hit">sevoflurane</span> group compared to isoflurane and control groups (p&lt; 0.05). Both <span class="hit">sevoflurane</span> and isoflurane preconditioning up regulated the antiapoptotic gens bcl2, CD401g, prok 2 and decreased DNA fragmentation factor Dffb significantly compared to control rats (p&lt; 0.05). Conclusion(s): Treatment with <span class="hit">sevoflurane</span> ameliorates IR <span class="hit">injury</span> and down regulation of proapoptotic molecules and up regulation of antiapoptotic molecules could be responsible for this alleviation effect of the volatile anaesthetics.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L362208333" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L362208333" type="checkbox" id="record_checkbox_L362208333"><label for="record_checkbox_L362208333" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">176</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=176&amp;page=1&amp;id=L362208333" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of isoflurane and <span class="hit">sevoflurane</span> post conditioning and changes in JNK1/2 pathway activity on rat brain slices subjected to oxygen and glucose deprivation in vitro</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dai</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jiang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.</span></span><br><span class="journal-title">Neural Regeneration Research</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">6</span><span class="journal-issue">:14</span><span class="journal-pages">&nbsp;(1091-1096)</span>&nbsp;<span class="cited-by" id="CTB-L362208333"><a href="https://lls.reaxys.com/redir?pid=scp:79960710863" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;1</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-176"><a href="https://www.embase.com/#" class="showAbstract" data="176" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="176"></i> Abstract</a></li><li class="ui-tab" id="indexTab-176"><a href="https://www.embase.com/#" class="showIndexTerms" data="176" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="176"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3969/j.issn.1673-5374.2011.14.010" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="175">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-175"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Recent research shows that the JNK1/2 signaling pathway plays a neuroprotective role against ischemia-reperfusion <span class="hit">injury</span> by cross-talk with other pathways. The present study investigated the effects of isoflurane and <span class="hit">sevoflurane</span> postconditioning on JNK1/2 pathway activity and <span class="hit">neuronal</span> cell viability after oxygen and glucose deprivation <span class="hit">injury</span> in hippocampal slices in vitro. Techniques used included population spike analysis, propidium iodide fluorescent staining, western blot assay, and the use of JNK1/2-specific pharmacological tools such as anisomycin (agonist) and SP600125 (inhibitor). We found that both isoflurane and <span class="hit">sevoflurane</span> inhibited JNK pathway activity and had neuroprotective effects against oxygen and glucose deprivation <span class="hit">injury</span> in slices of rat hippocampus in vitro. Postconditioning with volatile anesthetics exerted neuroprotective effects on nerve cells and preserved the function of the CA1 region by inhibiting JNK1/2 phosphorylation. This suppression of JNK1/2 activity could underlie the observed synergistic neuroprotective effect produced by volatile anesthetic postconditioning.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L51125187" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L51125187" type="checkbox" id="record_checkbox_L51125187"><label for="record_checkbox_L51125187" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">177</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=177&amp;page=1&amp;id=L51125187" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Volatile anesthetics may not induce significant toxicity to human neuron-like cells</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Feng</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Cao</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zuo</span> <span class="given-name notranslate">Z.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">112</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(1194-1198)</span>&nbsp;<span class="cited-by" id="CTB-L51125187"><a href="https://lls.reaxys.com/redir?pid=scp:79955436534" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;23</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-177"><a href="https://www.embase.com/#" class="showAbstract" data="177" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="177"></i> Abstract</a></li><li class="ui-tab" id="indexTab-177"><a href="https://www.embase.com/#" class="showIndexTerms" data="177" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="177"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/ANE.0b013e3181fdf69d" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="176">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-176"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND: In vitro experiments and in vivo animal studies suggest detrimental effects of volatile anesthetics including isoflurane on brain cells. It is not clear whether volatile anesthetics can cause human brain cell <span class="hit">injury</span>. METHODS: The SH-SY5Y cells, a human neuroblastoma cell line, were induced to differentiate into terminal neuron-like cells. These differentiated cells and the HCN-2 cells, a human cortical <span class="hit">neuronal</span> cell line, were exposed to 2% to 5% isoflurane, 6% <span class="hit">sevoflurane</span>, or 12% desflurane for 48 hours at 37°C. Lactate dehydrogenase (LDH) release and the expression of caspase 3, synaptophysin, and drebrin were then measured. RESULTS: Exposure of the differentiated SH-SY5Y and HCN-2 cells to 2% to 4% isoflurane did not increase LDH release and the expression of caspase 3 whose activation leads to apoptosis. The expression of synaptophysin, a synaptic protein, and drebrin, a dendritic spine protein, in the differentiated SH-SY5Ycells was also not affected by 2% to 4% isoflurane. Exposure to 6% <span class="hit">sevoflurane</span> or 12% desflurane did not affect LDH release from differentiated SH-SY5Y cells. However, 5% isoflurane significantly increased LDH release from those cells. CONCLUSIONS: Our results suggest that volatile anesthetics at clinically relevant concentrations do not cause human neuron-like cell <span class="hit">injury</span>. Isoflurane also may not alter the quantity of dendritic spines and synapses in these human cells. Copyright © 2011 International Anesthesia Research Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L362857230" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L362857230" type="checkbox" id="record_checkbox_L362857230"><label for="record_checkbox_L362857230" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">178</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=178&amp;page=1&amp;id=L362857230" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effects of <span class="hit">sevoflurane</span> on <span class="hit">neuronal</span> cell damage after severe cerebral ischemia in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Park</span> <span class="given-name notranslate">H.-P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jeong</span> <span class="given-name notranslate">E.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kim</span> <span class="given-name notranslate">M.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hwang</span> <span class="given-name notranslate">J.-W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lim</span> <span class="given-name notranslate">Y.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Min</span> <span class="given-name notranslate">S.-W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kim</span> <span class="given-name notranslate">C.-S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jeon</span> <span class="given-name notranslate">Y.-T.</span></span><br><span class="journal-title">Korean Journal of Anesthesiology</span>&nbsp;<span class="journal-publication-year">2011</span>&nbsp;<span class="journal-volume">61</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(327-331)</span>&nbsp;<span class="cited-by" id="CTB-L362857230"><a href="https://lls.reaxys.com/redir?pid=scp:84930480160" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;12</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-178"><a href="https://www.embase.com/#" class="showAbstract" data="178" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="178"></i> Abstract</a></li><li class="ui-tab" id="indexTab-178"><a href="https://www.embase.com/#" class="showIndexTerms" data="178" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="178"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.4097/kjae.2011.61.4.327" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="177">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-177"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: The aim of this study was to investigate the neuroprotective effects of <span class="hit">sevoflurane</span> after severe forebrain ischemic <span class="hit">injury</span>. We also examined the relationship between the duration of ischemia and <span class="hit">neuronal</span> cell death. Methods: Male Sprague-Dawley rats (300-380 g) were subjected to 6 (each n = 6) or 10 min (each n = 10) of near-complete forebrain ischemia while anesthetized with either 50 mg/kg of zoletil given intraperitoneally or inhaled <span class="hit">sevoflurane</span> (2.3%). Ischemia was induced by bilateral common carotid artery occlusion plus hemorrhagic hypotension (26-30 mmHg). Histologic outcomes were measured 7 days after ischemia in CA1 pyramidal cells of the rat hippocampus. Results: The mean percentage of necrotic cells in the hippocampal CA1 area decreased in the <span class="hit">sevoflurane</span> group compared to the zoletil group (25% vs. 40% after 6 min ischemia, respectively: P = 0.004 and 44% vs. 54% after 10 min of ischemia, respectively P = 0.03). The percentage of apoptotic cells was similar in all groups. The percentage of necrotic cells in each anesthetic groups was significantly higher in the 10 min ischemia group compared to the 6 min ischemia group (P = 0.004 in the <span class="hit">sevoflurane</span> group, P = 0.03 in the zoletil group). Conclusions: The present data show that <span class="hit">sevoflurane</span> has neuroprotective effects in rats subjected to near-complete cerebral ischemia. Longer duration of ischemia is associated with more <span class="hit">neuronal injury</span> when compared to ischemia of shorter duration. © the Korean Society of Anesthesiologists, 2011.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L360073171" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L360073171" type="checkbox" id="record_checkbox_L360073171"><label for="record_checkbox_L360073171" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">179</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=179&amp;page=1&amp;id=L360073171" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Perioperative neuroprotection</a><br><span class="author fn notranslate"><span class="family-name notranslate">Klein</span> <span class="given-name notranslate">K.U.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Engelhard</span> <span class="given-name notranslate">K.</span></span><br><span class="journal-title">Best Practice and Research: Clinical Anaesthesiology</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">24</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(535-549)</span>&nbsp;<span class="cited-by" id="CTB-L360073171"><a href="https://lls.reaxys.com/redir?pid=scp:78649646802" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;15</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-179"><a href="https://www.embase.com/#" class="showAbstract" data="179" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="179"></i> Abstract</a></li><li class="ui-tab" id="indexTab-179"><a href="https://www.embase.com/#" class="showIndexTerms" data="179" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="179"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bpa.2010.10.008" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="178">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-178"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The endpoint of all cerebral injuries like stroke, global cerebral ischemia during cardiac arrest, cardiac, vascular, or brain surgery or head trauma is the inadequate supply of the brain with oxygen and glucose, which triggers a characteristic pathophysiologic cascade leading to <span class="hit">neuronal</span> death. Many methods and agents have been investigated to produce neuroprotection from cerebral ischemia along this cascade (e.g., hypothermia, anaesthetics, free radical scavengers, excitatory amino acid antagonists, calcium channel blockers, ionic pump modulators, growth factors, heparinization, antineutrophil/platelet factors, steroids, and gene products). However, essentially none of the pharmacological approaches was identified as useful in humans though most agents have been successfully tested in animal models. Expert opinion suggests that neuroprotective approaches have failed in human trials because there are multiple mechanisms of <span class="hit">injury</span> from local and cerebral ischemia. Furthermore, adequate timing might essential because of the temporal sequence of cerebral <span class="hit">injury</span>. However, because there are multiple mechanisms of <span class="hit">injury</span>, there are most likely also multiple mechanisms of neuroprotection. The most important strategy is profound knowledge on cerebral physiology and homeostasis in health and disease. This review discusses essential physiological mechanisms to warrant adequate supply of glucose and oxygen to the brain. In addition, the influence of potential neuroprotective strategies and agents are reviewed in the perioperative setting. © 2010 Elsevier Ltd. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L360163813" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L360163813" type="checkbox" id="record_checkbox_L360163813"><label for="record_checkbox_L360163813" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">180</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=180&amp;page=1&amp;id=L360163813" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Duplicate preconditioning with <span class="hit">sevoflurane</span> in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dai</span> <span class="given-name notranslate">Z.-G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Dong</span> <span class="given-name notranslate">X.-W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Guo</span> <span class="given-name notranslate">S.-X.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liu</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">Z.-P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zeng</span> <span class="given-name notranslate">Y.-M.</span></span><br><span class="journal-title">Neuroscience Bulletin</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">26</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(437-444)</span>&nbsp;<span class="cited-by" id="CTB-L360163813"><a href="https://lls.reaxys.com/redir?pid=scp:78650223954" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;28</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-180"><a href="https://www.embase.com/#" class="showAbstract" data="180" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="180"></i> Abstract</a></li><li class="ui-tab" id="indexTab-180"><a href="https://www.embase.com/#" class="showIndexTerms" data="180" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="180"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1007/s12264-010-6024-4" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="179">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-179"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objective: <span class="hit">Sevoflurane</span> preconditioning has been demonstrated to reduce cerebral ischemia-reperfusion (IR) <span class="hit">injury</span>, but the underlying mechanisms have not been fully elucidated. Besides, different protocols would usually lead to different results. The objective of this study was to determine whether dual exposure to <span class="hit">sevoflurane</span> improves the effect of anesthetic preconditioning against oxygen and glucose deprivation (OGD) <span class="hit">injury</span> in vitro. Methods: Rat hippocampal slices under normoxic conditions (95% O<sub>2</sub>/5% CO <sub>2</sub>) were pre-exposed to <span class="hit">sevoflurane</span> 1, 2 and 3 minimum alveolar concentration (MAC) for 30 min, once or twice, with 15-min washout after each exposure. The slices were then subjected to 13-min OGD treatment (95% N <sub>2</sub>/5% CO<sub>2</sub>, glucose-free), followed by 30-min reoxygenation. The population spikes (PSs) were recorded in the CA1 region of rat hippocampus. The percentage of PS amplitude at the end of 30-min reoxygenation to that before OGD treatment was calculated, since it could indicate the recovery degree of <span class="hit">neuronal</span> function. In addition, to assess the role of mitogen-activated protein kinases (MAPKs) in preconditioning, U0126, an inhibitor of extracellular signal-regulated protein kinase (MEK-ERK1/2, ERK1/2 MAPK), and SB203580, an inhibitor of p38 MAPK, were separately added 10 min before <span class="hit">sevoflurane</span> exposure. Results: Preconditioning once with <span class="hit">sevoflurane</span> 1, 2, and 3 MAC increased the percentage of PS amplitude at the end of 30-min reoxygenation to that before OGD treatment, from (15.13±3.79)% (control) to (31.88±5.36)%, (44.00±5.01)%, and (49.50±6.25)%, respectively, and twice preconditioning with <span class="hit">sevoflurane</span> 1, 2, and 3 MAC increased the percentage to (38.53±4.36)%, (50.74±7.05)% and (55.86±6.23)%, respectively. The effect of duplicate preconditioning with <span class="hit">sevoflurane</span> 3 MAC was blocked by U0126 [(16.23±4.62)%]. Conclusion: <span class="hit">Sevoflurane</span> preconditioning can induce neuroprotection against OGD <span class="hit">injury</span> in vitro, and preconditioning twice enhances this effect. Besides, the activation of extracellular signal-regulated protein kinase (MEK-ERK1/2, ERK1/2 MAPK) may be involved in this process. © 2010 Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag Berlin Heidelberg.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L361864184" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L361864184" type="checkbox" id="record_checkbox_L361864184"><label for="record_checkbox_L361864184" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">181</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=181&amp;page=1&amp;id=L361864184" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Brain connectivity in pathological and pharmacological coma</a><br><span class="author fn notranslate"><span class="family-name notranslate">Noirhomme</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Soddu</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lehembre</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Vanhaudenhuyse</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Boveroux</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Boly</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Laureys</span> <span class="given-name notranslate">S.</span></span><br><span class="journal-title">Frontiers in Systems Neuroscience</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">4</span><span class="journal-pages"></span>&nbsp;<span class="journal-artnr">Article Number 160</span>&nbsp;<span class="cited-by" id="CTB-L361864184"><a href="https://lls.reaxys.com/redir?pid=scp:79957923335" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;66</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-181"><a href="https://www.embase.com/#" class="showAbstract" data="181" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="181"></i> Abstract</a></li><li class="ui-tab" id="indexTab-181"><a href="https://www.embase.com/#" class="showIndexTerms" data="181" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="181"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3389/fnsys.2010.00160" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="180">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-180"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Recent studies in patients with disorders of consciousness (DOC) tend to support the view that awareness is not related to activity in a single brain region but to thalamo-cortical connectivity in the frontoparietal network. Functional neuroimaging studies have shown preserved albeit disconnected low-level cortical activation in response to external stimulation in patients in a "vegetative state" or unresponsive wakefulness syndrome. While activation of these "primary" sensory cortices does not necessarily reflect conscious awareness, activation in higher-order associative cortices in minimally conscious state patients seems to herald some residual perceptual awareness. PET studies have identified a metabolic dysfunction in a widespread frontoparietal "global <span class="hit">neuronal</span> workspace" in DOC patients including the midline default mode network ("intrinsic" system) and the lateral frontoparietal cortices or "extrinsic system." Recent studies have investigated the relation of awareness to the functional connectivity within intrinsic and extrinsic networks, and with the thalami in both pathological and pharmacological coma. In brain damaged patients, connectivity in all default network areas was found to be non-linearly correlated with the degree of clinical consciousness impairment, ranging from healthy controls and locked-in syndrome to minimally conscious, vegetative, coma, and brain dead patients. Anesthesia-induced loss of consciousness was also shown to correlate with a global decrease in cortico-cortical and thalamo-cortical connectivity in both intrinsic and extrinsic networks, but not in auditory, or visual networks. In anesthesia, unconsciousness was also associated with a loss of cross-modal interactions between networks. These results suggest that conscious awareness critically depends on the functional integrity of thalamo-cortical and cortico-cortical frontoparietal connectivity within and between "intrinsic" and "extrinsic" brain networks. © 2010 Noirhomme, Soddu, Lehembre, Vanhaudenhuyse, Boveroux, Boly and Laureys.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L51148852" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L51148852" type="checkbox" id="record_checkbox_L51148852"><label for="record_checkbox_L51148852" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">182</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=182&amp;page=1&amp;id=L51148852" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span>-induced preconditioning: Impact of protocol and aprotinin administration on infarct size and endothelial nitric-oxide synthase phosphorylation in the rat heart in vivo</a><br><span class="author fn notranslate"><span class="family-name notranslate">Frädorf</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Huhn</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Weber</span> <span class="given-name notranslate">N.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ebel</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wingert</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Preckel</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Toma</span> <span class="given-name notranslate">O.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Schlack</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hollmann</span> <span class="given-name notranslate">M.W.</span></span><br><span class="journal-title">Anesthesiology</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">113</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(1289-1298)</span>&nbsp;<span class="cited-by" id="CTB-L51148852"><a href="https://lls.reaxys.com/redir?pid=scp:78650180072" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;35</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-182"><a href="https://www.embase.com/#" class="showAbstract" data="182" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="182"></i> Abstract</a></li><li class="ui-tab" id="indexTab-182"><a href="https://www.embase.com/#" class="showIndexTerms" data="182" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="182"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ALN.0b013e3181f97fec" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="181">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-181"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: <span class="hit">Sevoflurane</span> induces preconditioning (SevoPC). The effect of aprotinin and the involvement of endothelial nitric-oxide synthase (NOS) on SevoPC are unknown. We investigated (1) whether SevoPC is strengthened by multiple preconditioning cycles, (2) whether SevoPC is blocked by aprotinin, and (3) whether endothelial NOS plays a crucial role in SevoPC. Methods: Anesthetized male Wistar rats were randomized to 15 groups (each n = 6) and underwent 25-min regional myocardial ischemia and 2-h reperfusion. Controls were not treated further. Preconditioning groups inhaled 1 minimum alveolar concentration of <span class="hit">sevoflurane</span> for 5 min (SEVO-I), twice for 5 min each (SEVO-II), three times for 5 min each (SEVO-III), or six times for 5 min each (SEVO-VI). Aprotinin was administered with and without <span class="hit">sevoflurane</span>. Involvement of endothelial NOS was determined with the nonspecific NOS blocker N-nitro-l-arginine-methyl-ester, the specific <span class="hit">neuronal</span> NOS blocker 7-nitroindazole, and the specific inducible NOS blocker aminoguanidine. Results: SevoPC reduced infarct size in all protocols (SEVO-I, 42 ± 6%; SEVO-II, 33 ± 4%; SEVO-III, 11 ± 5%; SEVO-VI, 16 ± 4%; all P &lt; 0.001 vs. control, 67 ± 3%) and was least after three and six cycles of <span class="hit">sevoflurane</span> (P &lt; 0.001 vs. SEVO-II and -I, respectively). Aprotinin alone had no effect on infarct size but blocked SevoPC. N-nitro-l-arginine-methyl-ester abolished SevoPC (67 ± 4%; P &lt; 0.05 vs. SEVO-III). Aminoguanidine and 7-nitroindazole blocked SevoPC only partially (25 ± 6 and 31 ± 6%, respectively; P &lt; 0.05 vs. SEVO-III and control). SevoPC induced endothelial NOS phosphorylation, which was abrogated by aprotinin. Conclusion: SevoPC is strengthened by multiple preconditioning cycles, and phosphorylation of endothelial NOS is a crucial step in mediating SevoPC. These effects are abolished by aprotinin. © 2010, the American Society of Anesthesiologists, Inc. Lippincott Williams &amp; Wilkins.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L51050061" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L51050061" type="checkbox" id="record_checkbox_L51050061"><label for="record_checkbox_L51050061" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">183</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=183&amp;page=1&amp;id=L51050061" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Postconditioning with <span class="hit">sevoflurane</span> protects against focal cerebral ischemia and reperfusion <span class="hit">injury</span> via PI3K/Akt pathway</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">J.-K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">L.-N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">F.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yang</span> <span class="given-name notranslate">M.-J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yan</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">G.</span></span><br><span class="journal-title">Brain Research</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">1357</span><span class="journal-pages">&nbsp;(142-151)</span>&nbsp;<span class="cited-by" id="CTB-L51050061"><a href="https://lls.reaxys.com/redir?pid=scp:77957270090" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;97</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-183"><a href="https://www.embase.com/#" class="showAbstract" data="183" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="183"></i> Abstract</a></li><li class="ui-tab" id="indexTab-183"><a href="https://www.embase.com/#" class="showIndexTerms" data="183" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="183"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.brainres.2010.08.009" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="182">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-182"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Emerging evidence has demonstrated that postconditioning with <span class="hit">sevoflurane</span> provided neuroprotection. In this study, we investigated the neuroprotective effect of different concentrations of <span class="hit">sevoflurane</span> in rats with middle cerebral artery occlusion (MCAO). Furthermore, we tested the hypothesis that the neuroprotective effect of postconditioning with <span class="hit">sevoflurane</span> is associated with inhibition of apoptosis and mediated by activation of the phosphoinositide-3- kinase/Akt (PI3K/Akt) pathway. Adult male Sprague-Dawley rats were subjected to MCAO for 90 min and then treated with <span class="hit">sevoflurane</span> at the beginning of reperfusion. The infarct volume, neurological deficit scores and brain edema were evaluated at 24 hours. Spatial learning and memory was examined by Morris water maze. Apoptosis and apoptosis-related proteins were studied by TUNEL, immunohistochemistry and western blot. The neuroprotective effect and the amount of p-Akt after <span class="hit">sevoflurane</span> administration with or without wortmannin were analyzed. Postconditioning with <span class="hit">sevoflurane</span> 1.0 minimum alveolar concentration (MAC) and 1.5 MAC significantly decreased neurological deficit scores, infarct volume and brain edema and markedly improved spatial learning and memory. Postconditioning also reduced apoptotic cells, upregulated Bcl-2 and downregulated P53 and Bax. Wortmannin abolished the neuroprotective effect and prevented the increasing of p-Akt. Our data suggest postconditioning with <span class="hit">sevoflurane</span> (1.0 MAC and 1.5 MAC) not only reduced infarct volume but also improved learning and memory. Our study further showed that this neuroprotective effect may be partly due to the activation of PI3K/Akt pathway and inhibiting <span class="hit">neuronal</span> apoptosis. © 2010 Elsevier B.V. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L359690242" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L359690242" type="checkbox" id="record_checkbox_L359690242"><label for="record_checkbox_L359690242" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">184</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=184&amp;page=1&amp;id=L359690242" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neuroprotections and mechanisms of inhalational anesthetics against brain ischemia.</a><br><span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liang</span> <span class="given-name notranslate">W.</span></span><br><span class="journal-title">Frontiers in bioscience (Elite edition)</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">2</span><span class="journal-pages">&nbsp;(1275-1298)</span>&nbsp;<span class="cited-by" id="CTB-L359690242"><a href="https://lls.reaxys.com/redir?pid=scp:77957338982" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;17</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-184"><a href="https://www.embase.com/#" class="showAbstract" data="184" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="184"></i> Abstract</a></li><li class="ui-tab" id="indexTab-184"><a href="https://www.embase.com/#" class="showIndexTerms" data="184" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="184"></i> Index Terms</a></li><li><span id="FTL-L359690242" class="fulltext" data="{&quot;recno&quot;:&quot;L359690242&quot;,&quot;issn&quot;:&quot;19450508&quot;,&quot;volume&quot;:&quot;2&quot;,&quot;issue&quot;:&quot;&quot;,&quot;startpage&quot;:&quot;1275&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="183">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-183"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">The new generation of inhalational anesthetics has been widely used for general anesthesia in both clinical and experimental settings because of their safety, reliability and potency. A neuroprotective role has recently been revealed for some of these anesthetics, including the volatile gases isoflurane, <span class="hit">sevoflurane</span>, and desflurane, as well as the inert gas xenon. In vivo and in vitro studies have demonstrated that these gases were able to protect brain against ischemic <span class="hit">injury</span>, indicated by the decreases in infarct volumes and <span class="hit">neuronal</span> apoptosis. In this review, we [Please see table 1] will briefly introduce the properties of these gases, and discuss in detail their effects on brain ischemia, effective treatment regimens, and neuroprotective mechanisms. Perspectives are also discussed on future study and use of inhalational anesthetics.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L359448496" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L359448496" type="checkbox" id="record_checkbox_L359448496"><label for="record_checkbox_L359448496" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">185</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=185&amp;page=1&amp;id=L359448496" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Pharmacological and pathological modulation of cerebral physiology</a><br><span class="author fn notranslate"><span class="family-name notranslate">Hirsch</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Taylor</span> <span class="given-name notranslate">C.</span></span><br><span class="journal-title">Anaesthesia and Intensive Care Medicine</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">11</span><span class="journal-issue">:9</span><span class="journal-pages">&nbsp;(349-354)</span>&nbsp;<span class="cited-by" id="CTB-L359448496"><a href="https://lls.reaxys.com/redir?pid=scp:77956141758" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-185"><a href="https://www.embase.com/#" class="showAbstract" data="185" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="185"></i> Abstract</a></li><li class="ui-tab" id="indexTab-185"><a href="https://www.embase.com/#" class="showIndexTerms" data="185" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="185"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.mpaic.2010.05.011" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="184">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-184"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Anaesthesia for neurosurgery aims to provide optimal surgical conditions whilst maintaining adequate cerebral blood flow in order to supply the brain with appropriate amounts of oxygen and glucose. Most anaesthetic drugs influence the normal cerebral physiology either directly or indirectly. They can cause changes in cerebral blood flow by influencing cerebral blood vessel calibre, by interfering with autoregulatory processes and by modifying cerebral metabolism. The brain's limited ability to store oxygen and glucose means that its supply must be continuous if <span class="hit">neuronal</span> damage is to be avoided. Ischaemic cerebral damage is the most important pathological mechanism in patients with stroke, subarachnoid haemorrhage and traumatic brain <span class="hit">injury</span>. Significant traumatic brain <span class="hit">injury</span> causes widespread derangement of cerebral physiology, including changes in cerebral blood flow, autoregulation and cerebral energy dynamics. This article outlines the effect of anaesthesia on cerebral physiology and reviews the pathophysiology of traumatic brain <span class="hit">injury</span> and subarachnoid haemorrhage. © 2010 Elsevier Ltd. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L50909775" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L50909775" type="checkbox" id="record_checkbox_L50909775"><label for="record_checkbox_L50909775" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">186</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=186&amp;page=1&amp;id=L50909775" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Cellular effects of helium in different organs</a><br><span class="author fn notranslate"><span class="family-name notranslate">Oei</span> <span class="given-name notranslate">G.T.M.L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Weber</span> <span class="given-name notranslate">N.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hollmann</span> <span class="given-name notranslate">M.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Preckel</span> <span class="given-name notranslate">B.</span></span><br><span class="journal-title">Anesthesiology</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">112</span><span class="journal-issue">:6</span><span class="journal-pages">&nbsp;(1503-1510)</span>&nbsp;<span class="cited-by" id="CTB-L50909775"><a href="https://lls.reaxys.com/redir?pid=scp:77953026048" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;40</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-186"><a href="https://www.embase.com/#" class="showAbstract" data="186" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="186"></i> Abstract</a></li><li class="ui-tab" id="indexTab-186"><a href="https://www.embase.com/#" class="showIndexTerms" data="186" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="186"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ALN.0b013e3181d9cb5e" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="185">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-185"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Experimental research in cardiac and <span class="hit">neuronal</span> tissue has shown that besides volatile anesthetics and xenon, the nonanesthetic noble gas helium also reduces ischemia-reperfusion damage. Even though the distinct mechanisms of helium-induced organ protection are not completely unraveled, several signaling pathways have been identified. Beside the protective effects on heart and brain that are mainly obtained by different pre- and postconditioning protocols, helium also exerts effects in the lungs, the immune system, and the blood vessels. Obviously, this noble gas is biochemically not inert and exerts biologic effects, although until today the question remains open on how these changes are mediated. Because of its favorable characteristics and the lack of hemodynamic side effects, helium is suitable for use also in critically ill patients. This review covers the cellular effects of helium, which may lead to new clinical strategies of tissue salvage in ischemia-reperfusion situations, both within and outside the perioperative setting. Copyright © 2010, the American Society of Anesthesiologists, Inc. Lippincott Williams &amp; Wilkins.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L358269864" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L358269864" type="checkbox" id="record_checkbox_L358269864"><label for="record_checkbox_L358269864" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">187</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=187&amp;page=1&amp;id=L358269864" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE"><span class="hit">Sevoflurane</span>-induced post-conditioning has no beneficial effects on neuroprotection after incomplete cerebral ischemia in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">H.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">D.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Choi</span> <span class="given-name notranslate">J.-H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">S.-R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Kim</span> <span class="given-name notranslate">Y.-W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jee</span> <span class="given-name notranslate">D.-L.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Do</span> <span class="given-name notranslate">H.-S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">H.-M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Park</span> <span class="given-name notranslate">S.-J.</span></span><br><span class="journal-title">Acta Anaesthesiologica Scandinavica</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">54</span><span class="journal-issue">:3</span><span class="journal-pages">&nbsp;(328-336)</span>&nbsp;<span class="cited-by" id="CTB-L358269864"><a href="https://lls.reaxys.com/redir?pid=scp:76349089301" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;6</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-187"><a href="https://www.embase.com/#" class="showAbstract" data="187" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="187"></i> Abstract</a></li><li class="ui-tab" id="indexTab-187"><a href="https://www.embase.com/#" class="showIndexTerms" data="187" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="187"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1111/j.1399-6576.2009.02129.x" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="186">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-186"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background: The aim of this study was to investigate whether <span class="hit">sevoflurane</span>-induced post-conditioning has a neuroprotective effect against incomplete cerebral ischemia in rats. Methods: After cerebral ischemia by right common carotid artery occlusion in combination with hemorrhagic hypotension (35 mmHg) for 30 min, 1.0 minimum alveolar concentration of <span class="hit">sevoflurane</span> was administered for 15 min (Post-C 15, n=8), 30 min (Post-C 30, n=8), or 60 min (Post-C 60, n=8) in rats. <span class="hit">Sevoflurane</span> was not administered in control (n=8) and sham control rats (n=8). Neurologic evaluations were performed at 24, 48, and 72 h after ischemia. Degrees of <span class="hit">neuronal</span> damage in ischemic hippocampal CA1 and the cortex were assessed by counting eosinophilic neurons, and detection of DNA fragmentation was performed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining. Results: Neurologic deficit scores in the Post-C 60 group were higher than in the control group at 48 and 72 h post-ischemia (P&lt;0.05). No differences were observed in the percentages of eosinophilic neurons among the control (CA1: 37.3 ± 25.4, cortex: 26.0 ± 8.9), Post-C 15 (CA1: 54.0 ± 21.4, cortex: 30.8 ± 19.9), or Post-C 30 (CA1: 68.4 ± 17.5, cortex: 38.0 ± 11.0) groups in ischemic CA1 and cortices. However, in the Post-C 60 group, the percentages of eosinophilic neurons were higher than in the control group in CA1 and cortices (P&lt;0.05). The percentages of TUNEL-positive cell were similar in the control group and the post-conditioned groups. Conclusion: These findings show that <span class="hit">sevoflurane</span> administration after ischemia does not provide neuroprotection in rats subjected to incomplete cerebral ischemia. © 2009 The Acta Anaesthesiologica Scandinavica Foundation.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L50747189" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L50747189" type="checkbox" id="record_checkbox_L50747189"><label for="record_checkbox_L50747189" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">188</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=188&amp;page=1&amp;id=L50747189" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Toxicity of a serotonin-derived neuromelanin</a><br><span class="author fn notranslate"><span class="family-name notranslate">Miller</span> <span class="given-name notranslate">E.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Fibuch</span> <span class="given-name notranslate">E.E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Seidler</span> <span class="given-name notranslate">N.W.</span></span><br><span class="journal-title">Biochemical and Biophysical Research Communications</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">391</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(1297-1300)</span>&nbsp;<span class="cited-by" id="CTB-L50747189"><a href="https://lls.reaxys.com/redir?pid=scp:73449134421" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;5</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-188"><a href="https://www.embase.com/#" class="showAbstract" data="188" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="188"></i> Abstract</a></li><li class="ui-tab" id="indexTab-188"><a href="https://www.embase.com/#" class="showIndexTerms" data="188" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="188"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.bbrc.2009.12.085" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="187">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-187"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Postoperative Cognitive Dysfunction (POCD) is associated with increased mortality in the elderly and may occur from lipid peroxidation in aging. We previously showed that <span class="hit">sevoflurane</span> sequesters acrolein, which promotes the formation of a novel species of a putative neuromelanin. The current study examined the properties of this serotonin-derived melanoid (SDM). The interaction of SDM with unilamellar vesicles (ULVs) was examined using lipid membrane probes. Vesicle disruption was investigated by leakage of dye from calcein-loaded ULVs. We observed that SDM decreased diphenyl-hexatriene fluorescence anisotropy and increased the temperature-dependent change in anisotropy. SDM changed the absorbance of merocyanin-bound ULVs. SDM increased detergent-mediated calcein leakage. SDM structure was dramatically altered upon interaction with ULVs. We also observed that SDM enhanced detergent-mediated leakage of loaded ULVs, suggesting that SDM may be neurotoxic. We propose that inhalational agents, which sequester acrolein, may promote the production of certain species of neuromelanin that depletes local serotonin and enhances <span class="hit">neuronal</span> vulnerability. © 2009 Elsevier Inc. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L358379394" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L358379394" type="checkbox" id="record_checkbox_L358379394"><label for="record_checkbox_L358379394" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">189</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=189&amp;page=1&amp;id=L358379394" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Beyond anesthetic properties: The effects of isoflurane on brain cell death, neurogenesis, and long-term neurocognitive function</a><br><span class="author fn notranslate"><span class="family-name notranslate">Stratmann</span> <span class="given-name notranslate">G.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sall</span> <span class="given-name notranslate">J.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">May</span> <span class="given-name notranslate">L.D.V.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Loepke</span> <span class="given-name notranslate">A.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lee</span> <span class="given-name notranslate">M.T.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">110</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(431-437)</span>&nbsp;<span class="cited-by" id="CTB-L358379394"><a href="https://lls.reaxys.com/redir?pid=scp:77649087875" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;62</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-189"><a href="https://www.embase.com/#" class="showAbstract" data="189" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="189"></i> Abstract</a></li><li class="ui-tab" id="indexTab-189"><a href="https://www.embase.com/#" class="showIndexTerms" data="189" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="189"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/ane.0b013e3181af8015" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="188">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-188"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Anesthetic drugs cause brain cell death and long-term neurocognitive dysfunction in neonatal rats. Recently, human data also suggest that anesthesia early in life may cause cognitive impairment. The connection between cell death and neurocognitive decline is uncertain. It is conceivable that mechanisms other than brain cell death contribute to neurocognitive outcome of neonatal anesthesia. In a series of experiments, we demonstrate that isoflurane exposure causes significant hypercarbia in postnatal day 7 rats and that exposure to isoflurane or carbon dioxide for 4 h provoked brain cell death. However, 1 h of isoflurane exposure was not sufficient to cause brain cell death. Moreover, only 4 h of isoflurane exposure, but not 1 or 2 h of exposure or 4 h of carbon dioxide, led to impaired hippocampal function, questioning the association between anesthesia-induced brain cell death and neurocognitive dysfunction. Neurogenesis both in the developing and adult dentate gyrus is important for hippocampal function, specifically learning and memory. γ-Amino-butyric- acid regulates proliferation and <span class="hit">neuronal</span> differentiation both in the developing and the adult brain. Inhaled anesthetics are γ-amino-butyric-acid-ergic and may therefore affect neurogenesis, which could be an alternative mechanism mediating anesthesia-induced neurocognitive decline in immature rats. Understanding the mechanism will help guide clinical trials aiming to define the scope of the problem in humans and may lead to preventive and therapeutic strategies. © 2010 International Anesthesia Research Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L360213926" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L360213926" type="checkbox" id="record_checkbox_L360213926"><label for="record_checkbox_L360213926" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">190</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=190&amp;page=1&amp;id=L360213926" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Studies in animal models of the effects of anesthetics on behavior, biochemistry, and <span class="hit">neuronal</span> cell death</a><br><span class="author fn notranslate"><span class="family-name notranslate">Mena</span> <span class="given-name notranslate">M.A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Perucho</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Rubio</span> <span class="given-name notranslate">I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">De Yébenes</span> <span class="given-name notranslate">J.G.</span></span><br><span class="journal-title">Journal of Alzheimer's Disease</span>&nbsp;<span class="journal-publication-year">2010</span>&nbsp;<span class="journal-volume">22</span><span class="journal-issue">:SUPPL. 3</span><span class="journal-pages">(S43-S48)</span>&nbsp;<span class="cited-by" id="CTB-L360213926"><a href="https://lls.reaxys.com/redir?pid=scp:78650487087" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;16</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-190"><a href="https://www.embase.com/#" class="showAbstract" data="190" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="190"></i> Abstract</a></li><li class="ui-tab" id="indexTab-190"><a href="https://www.embase.com/#" class="showIndexTerms" data="190" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="190"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.3233/JAD-2010-100822" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="189">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-189"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Recent clinical studies have suggested that there is an increased risk of Alzheimer's disease (AD) in patients undergoing surgical interventions, but it is unknown whether this effect is related to anesthesia, cardiovascular complications of surgery, or associated conditions such as hypothermia. In addition, many patients, especially the elderly, present persistent post-operative cognitive deterioration after anesthesia, without clear complications during surgery. Experimental studies in animals may be helpful to dissect the pathogenic role of the different factors involved in surgery. Here, we review studies on the effects of anesthesia on <span class="hit">neuronal</span> function performed in tissue culture and in experimental animals. Several studies have shown that a small inhalation of anesthetics induces activation of caspases and cell toxicity on glioma and pheochromocitoma cells in culture, which is prevented by treatment with the metal chelating agent clioquinol. Exposure of old rodents to anesthesia produced memory deficits and increased levels of amyloid-β (Aβ) peptide and phosphorylated tau in brain. The effects of long term or short term repetitive exposure to small molecular weight anesthetics are more severe in transgenic AβPPswe than in wild type mice. In the former, low molecular weight increased the number of TUNEL<sup>+</sup> apoptotic cells and the ratio of pro-apoptotic proteins in hippocampus; reduced astroglial and increased microglial responses; increased Aβ aggregates and high molecular weight peptides; abnormal chaperone responses and reduced autophagy. In conclusion, anesthetic gases induce changes which may reproduce AD pathology in mice with mutations which produced AD. It would be interesting to know whether anesthetics are risky for subjects with special genetic risk factors. © 2010 IOS Press and the authors. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L358816581" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L358816581" type="checkbox" id="record_checkbox_L358816581"><label for="record_checkbox_L358816581" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">191</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=191&amp;page=1&amp;id=L358816581" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Protective effects of <span class="hit">sevoflurane</span> preconditioning on cerebral ischemia-reperfusion <span class="hit">injury</span> in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lin</span> <span class="given-name notranslate">H.F.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhu</span> <span class="given-name notranslate">Z.R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hu</span> <span class="given-name notranslate">Z.Y.</span></span><br><span class="journal-title">Zhonghua yi xue za zhi</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">89</span><span class="journal-issue">:41</span><span class="journal-pages">&nbsp;(2943-2945)</span>&nbsp;<span class="cited-by" id="CTB-L358816581"><a href="https://lls.reaxys.com/redir?pid=scp:77952315350" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;0</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-191"><a href="https://www.embase.com/#" class="showAbstract" data="191" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="191"></i> Abstract</a></li><li class="ui-tab" id="indexTab-191"><a href="https://www.embase.com/#" class="showIndexTerms" data="191" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="191"></i> Index Terms</a></li><li><span id="FTL-L358816581" class="fulltext" data="{&quot;recno&quot;:&quot;L358816581&quot;,&quot;issn&quot;:&quot;03762491&quot;,&quot;volume&quot;:&quot;89&quot;,&quot;issue&quot;:&quot;41&quot;,&quot;startpage&quot;:&quot;2943&quot;}"></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="190">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-190"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">OBJECTIVE: To investigate if <span class="hit">sevoflurane</span> preconditioning attenuate <span class="hit">neuronal</span> apoptosis induced by ischemia-reperfusion. METHODS: Thirty-six male SD rats weighing 250 - 300 g were randomly divided into three groups (n = 12 each): control group (group C), ischemia-reperfusion group (group IR) (rats were established cerebral artery clamped and reperfusion model), <span class="hit">sevoflurane</span> preconditioning group (group S) (rats were established cerebral artery clamped and reperfusion model after 1 h 2.4% <span class="hit">sevoflurane</span> preconditioning). Apoptosis neurons were observed by Hematoxylin and Eosin (HE) staining and transmission electron microscope, TdT mediated Dutp nick end labeling (TUNEL) method was used to count apoptosis neurons density, fresh ischemic brain tissue was taken out, while Caspase-3 zymogen and 20 000 segment were checked by Western blot. RESULTS: apoptosis neurons in group IR were more than ones in group S under HE staining and light microscope and transmission electron microscope, and apoptosis neurons density (cell number/0.1 mm(2)) by TUNEL staining: group C, 13.0 +/- 1.4; group IR, 189.8 +/- 6.8; group S, 110.5 +/- 4.3, the relative gray values of the contents of procaspase-3 and its 20 000 cleavage fragment were 16.72 +/- 3.0, 76.1 +/- 3.4, 51.2 +/- 3.1 and 8.2 +/- 2.3, 59.0 +/- 6.3, 31.2 +/- 5.4 respectively. CONCLUSIONS: <span class="hit">Sevoflurane</span> pretreatment can protect neuron on ischemia-reperfusion <span class="hit">injury</span> by attenuating <span class="hit">neuronal</span> apoptosis in rats.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L358123284" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L358123284" type="checkbox" id="record_checkbox_L358123284"><label for="record_checkbox_L358123284" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">192</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=192&amp;page=1&amp;id=L358123284" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Mild hypothermia has no long-term impact on postischemic neurogenesis in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Lasarzik</span> <span class="given-name notranslate">I.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Winkelheide</span> <span class="given-name notranslate">U.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Thal</span> <span class="given-name notranslate">S.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Benz</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lörscher</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Jahn-Eimermacher</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Werner</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Engelhard</span> <span class="given-name notranslate">K.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">109</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(1632-1639)</span>&nbsp;<span class="cited-by" id="CTB-L358123284"><a href="https://lls.reaxys.com/redir?pid=scp:70350707920" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;26</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-192"><a href="https://www.embase.com/#" class="showAbstract" data="192" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="192"></i> Abstract</a></li><li class="ui-tab" id="indexTab-192"><a href="https://www.embase.com/#" class="showIndexTerms" data="192" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="192"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/ANE.0b013e3181bab451" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="191">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-191"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND:: Postischemic improvement of functional outcome by therapeutic hypothermia may be related to cerebral regeneration by postischemic neurogenesis. We investigated whether mild peri-ischemic hypothermia leads to a long-term increase in postischemic neurogenesis. METHODS:: Seventy male <span class="hit">sevoflurane</span>-anesthetized Sprague Dawley rats were randomly assigned to the following treatment groups: normothermic ischemia, intraischemic hypothermia, and postischemic hypothermia with corresponding sham-operated controls. Fifteen naïve rats were investigated as reference for natural neurogenesis. Forebrain ischemia was induced by bilateral common carotid artery occlusion and hemorrhagic hypotension. In normothermic groups, the pericranial temperature was maintained at 37.5°C. Animals in the hypothermic groups were cooled to a pericranial temperature of 33°C for 45 min. All animals received 5-bromo-2-deoxyuridine for 7 days. Histopathological damage and 5-bromo-2-deoxyuridine-positive neurons of the hippocampus were analyzed after 28 days. RESULTS:: Hypothermia had no impact on natural neurogenesis. Cerebral ischemia increased the number of new neurons regardless of pericranial temperature. Forty-five minutes of hypothermia beginning before ischemia diminished hippocampal <span class="hit">injury</span> to &lt;10% in the CA1 and CA3 regions, whereas 45 min of postischemic hypothermia beginning after reperfusion did not reduce <span class="hit">neuronal injury</span> compared with normothermia. CONCLUSIONS:: Neither intraischemic nor postischemic hypothermia affected the ischemia-induced increase in endogenous neurogenesis. Intraischemic hypothermia reduced hippocampal damage, whereas postischemic hypothermia as applied here did not prevent formation of histopathological <span class="hit">injury</span>. This indicates that, 28 days after cerebral ischemia, postischemic neurogenesis is not significantly increased by mild peri-ischemic hypothermia and not affected by the severity of histopathological damage. Copyright © 2009 International Anesthesia Research Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L355269985" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L355269985" type="checkbox" id="record_checkbox_L355269985"><label for="record_checkbox_L355269985" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">193</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=193&amp;page=1&amp;id=L355269985" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">What is new in pediatric traumatic brain <span class="hit">injury</span>?</a><br><span class="author fn notranslate"><span class="family-name notranslate">Sookplung</span> <span class="given-name notranslate">P.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Vavilala</span> <span class="given-name notranslate">M.S.</span></span><br><span class="journal-title">Current Opinion in Anaesthesiology</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">22</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(572-578)</span>&nbsp;<span class="cited-by" id="CTB-L355269985"><a href="https://lls.reaxys.com/redir?pid=scp:70349112716" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;24</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-193"><a href="https://www.embase.com/#" class="showAbstract" data="193" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="193"></i> Abstract</a></li><li class="ui-tab" id="indexTab-193"><a href="https://www.embase.com/#" class="showIndexTerms" data="193" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="193"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ACO.0b013e3283303884" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="192">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-192"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Purpose of review: Pediatric traumatic brain <span class="hit">injury</span> (TBI) is associated with significant morbidity and mortality. The purpose of this review is to discuss emerging concepts and to provide an update on the clinical evaluation, management, and predictors of outcome after pediatric TBI. Recent findings: We review the epidemiology, patterns of <span class="hit">injury</span>, and pathophysiology of pediatric TBI and focus on selective 'hot topics' such as biomarkers, glucose control, and the potential benefits of hypothermia after pediatric TBI. Summary: As TBI is the leading cause of death in children, research in this area is needed to advance our knowledge of the sequelae after and improve outcomes of children with TBI. © 2009 Wolters Kluwer Health | Lippincott Williams &amp; Wilkins.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L70030614" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L70030614" type="checkbox" id="record_checkbox_L70030614"><label for="record_checkbox_L70030614" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">194</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=194&amp;page=1&amp;id=L70030614" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Effect of the anesthetic regimen during experimental brain trauma on histological outcome and cerebral inflammation</a><br><span class="author fn notranslate"><span class="family-name notranslate">Thal</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ricken</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gierth</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Timaru-Kast</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Werner</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Engelhard</span> <span class="given-name notranslate">K.</span></span><br><span class="journal-title">Journal of Cerebral Blood Flow and Metabolism</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">29</span>&nbsp;<span class="journal-suppl">SUPPL. 1</span><span class="journal-pages">&nbsp;(S34-S35)</span>&nbsp;<span class="cited-by" id="CTB-L70030614"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-194"><a href="https://www.embase.com/#" class="showAbstract" data="194" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="194"></i> Abstract</a></li><li class="ui-tab" id="indexTab-194"><a href="https://www.embase.com/#" class="showIndexTerms" data="194" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="194"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1038/jcbfm.2009.119" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="193">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-193"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Objectives: Application of different anesthetics for 1h following traumatic brain <span class="hit">injury</span> (TBI) alters the extent of <span class="hit">neuronal injury</span> and influences functional outcome.<sup>1</sup> The question therefore arises, if already the use of anesthetics for a short period during induction of an experimental TBI influences secondary pathophysiological mechanisms. Knowledge about the effect of anesthetics on experimental data is essential for the selection of an appropriate anesthetic agent. The present study therefore compares the effect of two volatile and one intraperitoneal anesthesia on histological damage, functional outcome and expression of inflammatory marker genes after experimental brain trauma. Methods: Male C57Bl/6 mice were randomly assigned to an anesthesia with 1.4 vol% isoflurane (iso), 3.5 vol% <span class="hit">sevoflurane</span> (sevo) or an i.p. injection (comb) of midazolam (5mg/kg), fentanyl (0.05 mg/kg) and medetomidine (0.5 mg/kg). A pneumatic brain trauma was induced on the right parietal cortex (controlled cortical impact, CCI). 15 mins and 24 h after CCI brain contusion volume was determined in cresyl violet stained sections. mRNA expression of TNFα, IL1β, IL6, COX2 and iNOS was determined in contused brain tissue and normalized against Cyclophilin A as control gene. Neurological function was evaluated with a 10-point-neurological severity score. Statistics: ANOVA on ranks, P&lt;0.05. Results: 15 mins after CCI brain contusion volume was not different between the anesthesia regimens. Within 24 h histological brain damage increased significantly in all groups (15 mins: 19.4 mm<sup>3</sup>±4.5; 24 h: sevo = 45.3 mm<sup>3</sup>±9.0; iso = 31.5 mm<sup>3</sup>±4.0; comb = 44.2 mm<sup>3</sup>±6.2). Sevo and comb anesthesia resulted in a significantly larger contusion volume compared to iso. After 24h neurological function was significantly better in animals anesthetized with iso in comparison to comb (sevo: 4.6 pts.±1.3; iso: 3.9 pts.±0.8; comb: 5.1 pts.±1.6). The expression of inflammatory marker genes increased significantly from 15 min to 24 h after CCI, but without differences between the anesthesia protocols. Conclusion: The data demonstrate that a short anesthesia during the induction of a brain trauma has a profound impact on extent of secondary brain damage. Despite differences in histological brain damage, cerebral inflammation was similar between the anesthetic regimens. Differences in histological brain damage are therefore not mediated by variation in cerebral inflammation. Differences in post-traumatic cerebral perfusion or influence on apoptotic processes might account of the observed effects. In conclusion, in order to investigate the pathophysiological mechanisms of brain trauma selection of the anesthetic agent may influence results and interpretation of a study.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L70031099" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L70031099" type="checkbox" id="record_checkbox_L70031099"><label for="record_checkbox_L70031099" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">195</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=195&amp;page=1&amp;id=L70031099" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Preconditioning or postconditioning with <span class="hit">sevoflurane</span> can induce neuroprotection against focal cerebral ischemia in rats</a><br><span class="author fn notranslate"><span class="family-name notranslate">Wang</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Lu</span> <span class="given-name notranslate">S.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">Q.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Liang</span> <span class="given-name notranslate">W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Chen</span> <span class="given-name notranslate">J.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gao</span> <span class="given-name notranslate">Y.</span></span><br><span class="journal-title">Journal of Cerebral Blood Flow and Metabolism</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">29</span>&nbsp;<span class="journal-suppl">SUPPL. 1</span><span class="journal-pages">&nbsp;(S433-)</span>&nbsp;<span class="cited-by" id="CTB-L70031099"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-195"><a href="https://www.embase.com/#" class="showAbstract" data="195" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="195"></i> Abstract</a></li><li class="ui-tab" id="indexTab-195"><a href="https://www.embase.com/#" class="showIndexTerms" data="195" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="195"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1038/jcbfm.2009.156" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="194">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-194"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Background and purpose: The phenomenon of ischemic tolerance in the heart was first reported by Murry et al in 1986,and that of ischemic preconditioning (PC) in the brain was reported by Kitagawa et al four years later. Since then, studies on the mechanism and pharmacological agents to mimic ischemic preconditioning have been intense. Zhao et al elucidated firstly that ischemic postconditioning could improve the outcomes of cardio ischemia/reperfusion insult in 2003. Recent data demonstrate that the PC effect of <span class="hit">sevoflurane</span> (Sevo), a comprehensively used volatile anesthetics clinically, is valid in vitro. It's unknown that the impact of Sevo pretreatment or post-administration in vivo and the precise mechanism. In this study, we preconditioned or postconditioned with Sevo to investigate the neuroprotective effect of Sevo against ischemic <span class="hit">neuronal injury</span>. Methods: Male Sprague-Dawley rats were allocated to sham, vehicle, Sevo PC, Sevo postconditoning groups (n=8 to 10/group). In the PC groups, the Sevo 1 and Sevo 2 groups received 0.5 or 1 minimum alveolar concentration (MAC) Sevo PC in air 30 min/d after 15 mins equilibrium for 4 consecutive days, whereas postconditioning animals inhaled 1MAC Sevo in air once for 30 mins at 10 mins, 30 mins or 2h after reperfusion. Animals were subjected to focal ischemia for 60 mins by filament occlusion of the middle cerebral artery with the monitor of regional cerebral blood flow at 24 h after Sevo pretreatment or before Sevo post-intervention. Rectal temperature was servo-controlled at 37°C to 38°C and physiological parameters were detected and maintained according to baseline status throughout the experiment. Neurologic assessment was performed 3 days after ischemia. The volume of cerebral infarction were determined by image analysis of cresyl voilet-stained coronal brain sections. Animals were euthanized at 0, 6, 12 and 24h after reperfusion for detecting caspase3, caspase9 and apoptosis inducing factor (AIF) by immunofluorescence and Western blotting tests. Results: Infarction volume was less in the Sevo 1 and Sevo 2 groups (13.6% ± 13.3% and 13.9 ± 5.7 respectively, mean ± s.d.) than in vehicle group (46.6 ± 9.3, P &lt; 0.01and P &lt; 0.001), but there were no significant difference between Sevo 1and Sevo 2 groups (P&gt;0.05). In comparison with the vehicle, the postadministration of <span class="hit">sevoflurane</span> at 10 and 30 mins after reperfusion significantly decreased infarction volume (19.8 ± 14.3, 26.4 ± 18.3, P &lt; 0.05). Similarly, the <span class="hit">sevoflurane</span> pre- and post-treatment at 10 and 30 mins after reperfusion groups demonstrated better neurologic function than the vehicle group (P &lt; 0.05). Brains with ischemic insult without Sevo-treatment showed increase in caspase3, caspase9 and AIF, otherwise, Pre- or post-intervention with Sevo restored the levels of those factors. Conclusion: The repeated preconditioning of <span class="hit">sevoflurane</span> may provide neuroprotection against focal cerebral ischemia in dose-independent manner and the effect of <span class="hit">sevoflurane</span> postconditioning is available in a short therapeutic window. Suppression of apoptosis responses may contribute to neuroprotection of <span class="hit">sevoflurane</span>.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L70034513" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L70034513" type="checkbox" id="record_checkbox_L70034513"><label for="record_checkbox_L70034513" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">196</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=196&amp;page=1&amp;id=L70034513" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Neurological function deteriorates while extent of secondary brain damage remains unaltered after brain trauma in old versus young mice</a><br><span class="author fn notranslate"><span class="family-name notranslate">Timaru-Kast</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Engelhard</span> <span class="given-name notranslate">K.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Werner</span> <span class="given-name notranslate">C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Thal</span> <span class="given-name notranslate">S.C.</span></span><br><span class="journal-title">Journal of Neurosurgical Anesthesiology</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">21</span><span class="journal-issue">:4</span><span class="journal-pages">&nbsp;(410-)</span>&nbsp;<span class="cited-by" id="CTB-L70034513"></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-196"><a href="https://www.embase.com/#" class="showAbstract" data="196" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="196"></i> Abstract</a></li><li class="ui-tab" id="indexTab-196"><a href="https://www.embase.com/#" class="showIndexTerms" data="196" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="196"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/01.ana.0000358102.35410.08" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="195">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-195"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Introduction: After traumatic brain <span class="hit">injury</span> (TBI) elderly patients show a higher morbidity and mortality compared to young patients.<sup>1</sup> It is unclear whether this is caused by an extended secondary brain damage<sup>2</sup> or a reduced capability to compensate neurological deficits.<sup>3</sup> Therefore, lesion volume and neurological deficits after brain trauma in young and aged mice were compared. Methods: Young (Y = 2mo) and old (O = 21 mo) male C57Bl6N mice were anesthetized with <span class="hit">sevoflurane</span> and were subjected to a pneumatic brain trauma on the right parietal cortex (controlled cortical impact, CCI). Animals of both ages were randomly assigned to 15 minutes (O+Y: each n = 6), 24 h (O+Y: each n = 7) and 72 h (O: n = 9, Y: n = 7) survival. Contusion volume was measured in Nissl stained brain sections. Neurological outcome was assessed at 24 hours and 72 hours after CCI by the Neurological Severity Score (NSS: Assessment of neuromotor functions, no impairment = 0, highest neuromotor deficit = 10 points). Results: 2 of 9 (22%) old animals in the 72 hours survival group died, whereas all young mice and all old mice in the 24 hours and 15 minutes groups survived. 24 hours after CCI neurological function was comparable between both groups while after 72 hours it deteriorated in old animals and improved in young animals (Fig. 1A). Histological brain damage was not different between old and young animals at any time point (Fig. 1B). According to volumetric assessment the aged brains were in average 8% smaller compared to the brains of the young mice (eg, naïve ipsi: 155± 6 vs. 167 ±4mm<sup>3</sup>). Discussion: In the present study old animals show worse neurological function or even die after CCI compared to young mice, although this does not correlate with histopathological damage as contusion volume was equal in both age groups. One possible cause for diminished functional recovery of the aged is a substantially increased and long lasting cerebral inflammatory response, which leads to scar tissue generation impeding axon and blood vessel formation.<sup>3-5</sup> Moreover, brains of the old naïve mice are about 8% smaller compared to young naïve brains, suggesting an age-related cerebral atrophy with decline in plasticity of the brain. This may be an additional explanation for the poor functional recovery of old animals. Therefore, the ability of the aged brain to compensate <span class="hit">neuronal</span> loss after brain trauma is largely reduced, which may have a major impact on recovery from TBI in the elderly.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L355551082" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L355551082" type="checkbox" id="record_checkbox_L355551082"><label for="record_checkbox_L355551082" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">197</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=197&amp;page=1&amp;id=L355551082" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Children with infantile <span class="hit">neuronal</span> ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during Anesthesia</a><br><span class="author fn notranslate"><span class="family-name notranslate">Miao</span> <span class="given-name notranslate">N.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Levin</span> <span class="given-name notranslate">S.W.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Baker</span> <span class="given-name notranslate">E.H.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Caruso</span> <span class="given-name notranslate">R.C.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Zhang</span> <span class="given-name notranslate">Z.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Gropman</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Koziol</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Wesley</span> <span class="given-name notranslate">R.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Mukherjee</span> <span class="given-name notranslate">A.B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Quezado</span> <span class="given-name notranslate">Z.M.N.</span></span><br><span class="journal-title">Anesthesia and Analgesia</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">109</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(372-378)</span>&nbsp;<span class="cited-by" id="CTB-L355551082"><a href="https://lls.reaxys.com/redir?pid=scp:67849106639" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;18</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-197"><a href="https://www.embase.com/#" class="showAbstract" data="197" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="197"></i> Abstract</a></li><li class="ui-tab" id="indexTab-197"><a href="https://www.embase.com/#" class="showIndexTerms" data="197" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="197"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1213/ane.0b013e3181aa6e95" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="196">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-196"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND: <span class="hit">Neuronal</span> ceroid lipofuscinoses (NCLs) are a group of autosomal recessive neurodegenerative diseases characterized by lysosomal accumulation of autofluorescent material in neurons and other cell types. The infantile NCL (INCL) subtype is rare (1 in &gt;100,000 births), the most devastating of childhood subtypes, and is caused by mutations in the gene CLN1, which encodes palmitoyl-protein thioesterase-1. METHODS: To investigate the incidence of hypothermia and bradycardia during general anesthesia in patients with INCL, we conducted a case-control study to examine the perianesthetic course of patients with INCL and of controls receiving anesthesia for diagnostic studies. RESULTS: Eight children with INCL (mean age 25 mo [range, 10-32] at first anesthetic) and 25 controls (mean age 44 mo [range, 18-92]) underwent 62 anesthetics for nonsurgical procedures. Patients with INCL had neurologic deficits including developmental delay, myoclonus, and visual impairment. Patients with INCL had lower baseline temperature (36.4 ± 0.1 vs 36.8 ± 0.1, INCL versus controls, P &lt; 0.007), and during anesthesia, despite active warming techniques, had significantly more hypothermia (18 vs 0 episodes, P &lt; 0.001) and sinus bradycardia (10 vs 1, P &lt; 0.001) compared with controls. INCL diagnosis was significantly associated with temperature decreases during anesthesia (P &lt; 0.001), whereas age, sex, and duration of anesthesia were not (P = NS). CONCLUSIONS: We report that patients with INCL have lower baseline body temperature and during general anesthesia, despite rewarming interventions, are at increased risk for hypothermia and bradycardia. This suggests a previously unknown INCL phenotype, impaired thermoregulation. Therefore, when anesthetizing these children, careful monitoring and routine use of warming interventions are warranted. Copyright © 2009 International Anesthesia Research Society.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L355123705" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L355123705" type="checkbox" id="record_checkbox_L355123705"><label for="record_checkbox_L355123705" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">198</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=198&amp;page=1&amp;id=L355123705" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Is Anesthesia Bad for the Newborn Brain?</a><br><span class="author fn notranslate"><span class="family-name notranslate">McCann</span> <span class="given-name notranslate">M.E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Soriano</span> <span class="given-name notranslate">S.G.</span></span><br><span class="journal-title">Anesthesiology Clinics</span>&nbsp;<span class="journal-publication-year">2009</span>&nbsp;<span class="journal-volume">27</span><span class="journal-issue">:2</span><span class="journal-pages">&nbsp;(269-284)</span>&nbsp;<span class="cited-by" id="CTB-L355123705"><a href="https://lls.reaxys.com/redir?pid=scp:68949110163" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;23</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-198"><a href="https://www.embase.com/#" class="showAbstract" data="198" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="198"></i> Abstract</a></li><li class="ui-tab" id="indexTab-198"><a href="https://www.embase.com/#" class="showIndexTerms" data="198" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="198"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1016/j.anclin.2009.05.007" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="197">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-197"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Although certain data suggest that common general anesthetics may be neurotoxic to immature animals, there are also data suggesting that these same anesthetics may be neuroprotective against hypoxicischemic <span class="hit">injury</span>, and that inadequate analgesia during painful procedures may lead to increased <span class="hit">neuronal</span> cell death in animals and long-term behavioral changes in humans. The challenge for the pediatric anesthesia community is to design and implement studies in human infants to ascertain the safety of general anesthesia. In this article, the authors review the relevant preclinical and clinical data that are currently available on this topic. © 2009 Elsevier Inc. All rights reserved.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L354635615" class="resultPreviewItem"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L354635615" type="checkbox" id="record_checkbox_L354635615"><label for="record_checkbox_L354635615" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">199</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=199&amp;page=1&amp;id=L354635615" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Xenon and <span class="hit">Sevoflurane</span> Protect against Brain <span class="hit">Injury</span> in a Neonatal Asphyxia Model</a><br><span class="author fn notranslate"><span class="family-name notranslate">Luo</span> <span class="given-name notranslate">Y.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ma</span> <span class="given-name notranslate">D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Ieong</span> <span class="given-name notranslate">E.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Sanders</span> <span class="given-name notranslate">R.D.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Yu</span> <span class="given-name notranslate">B.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Hossain</span> <span class="given-name notranslate">M.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Maze</span> <span class="given-name notranslate">M.</span></span><br><span class="journal-title">Anesthesiology</span>&nbsp;<span class="journal-publication-year">2008</span>&nbsp;<span class="journal-volume">109</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(782-789)</span>&nbsp;<span class="cited-by" id="CTB-L354635615"><a href="https://lls.reaxys.com/redir?pid=scp:56149093066" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;93</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-199"><a href="https://www.embase.com/#" class="showAbstract" data="199" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="199"></i> Abstract</a></li><li class="ui-tab" id="indexTab-199"><a href="https://www.embase.com/#" class="showIndexTerms" data="199" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="199"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ALN.0b013e3181895f88" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="198">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-198"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">BACKGROUND:: Perinatal hypoxia-ischemia causes significant morbidity and mortality. Xenon and <span class="hit">sevoflurane</span> may be used as inhalational analgesics for labor. Therefore, the authors investigated the potential application of these agents independently and in combination to attenuate perinatal <span class="hit">injury</span>. METHODS:: Oxygen-glucose deprivation <span class="hit">injury</span> was induced in pure <span class="hit">neuronal</span> or <span class="hit">neuronal</span>-glial cocultures 24 h after preconditioning with xenon and/or <span class="hit">sevoflurane</span>. Cell death was assessed by lactate dehydrogenase release or staining with annexin V-propidium iodide. The mediating role of phosphoinositide-3-kinase signaling in putative protection was assessed using wortmannin, its cognate antagonist. In separate in vivo experiments, perinatal asphyxia was induced 4 hours after preconditioning with analgesic doses alone and in combination; infarct size was assessed 7 days later, and neuromotor function was evaluated at 30 days in separate cohorts. The role of phosphorylated cyclic adenosine monophosphate response element binding protein in the preconditioning was assessed by immunoblotting. RESULTS:: Both anesthetics preconditioned against oxygen-glucose deprivation in vitro alone and in combination. The combination increased cellular viability via phosphoinositide-3- kinase signaling. In in vivo studies, xenon (75%) and <span class="hit">sevoflurane</span> (1.5%) alone as well as in combination (20% xenon and 0.75% <span class="hit">sevoflurane</span>) reduced infarct size in a model of neonatal asphyxia. Preconditioning with xenon and the combination of xenon and <span class="hit">sevoflurane</span> resulted in long-term functional neuroprotection associated with enhanced phosphorylated cyclic adenosine monophosphate response element binding protein signaling. CONCLUSIONS:: Preconditioning with xenon and <span class="hit">sevoflurane</span> provided long-lasting neuroprotection in a perinatal hypoxic-ischemic model and may represent a viable method to preempt <span class="hit">neuronal injury</span> after an unpredictable asphyxial event in the perinatal period. © 2008, the American Society of Anesthesiologists, Inc. Lippincott Williams &amp; Wilkins, Inc.</p></div></div></div></li></div></li><li>    <div id="embaseRecord_L352482586" class="resultPreviewItem parity1"><div class="resultPreviewInner"><div class="selectable cur-d"><input class="checkbox" name="record_id" value="L352482586" type="checkbox" id="record_checkbox_L352482586"><label for="record_checkbox_L352482586" class="emb-checkbox emb-checkbox-result"></label><!-- this should be fixed throught the css --><span class="result-number">200</span></div><div class="resultInfo"><a href="https://www.embase.com/search/results?subaction=viewrecord&amp;rid=200&amp;page=1&amp;id=L352482586" class="hitsHighlighted" data-counter-investigation="RECORD_TITLE">Hyperglycaemia and neurological <span class="hit">injury</span></a><br><span class="author fn notranslate"><span class="family-name notranslate">Prakash</span> <span class="given-name notranslate">A.</span></span>, <span class="author fn notranslate"><span class="family-name notranslate">Matta</span> <span class="given-name notranslate">B.F.</span></span><br><span class="journal-title">Current Opinion in Anaesthesiology</span>&nbsp;<span class="journal-publication-year">2008</span>&nbsp;<span class="journal-volume">21</span><span class="journal-issue">:5</span><span class="journal-pages">&nbsp;(565-569)</span>&nbsp;<span class="cited-by" id="CTB-L352482586"><a href="https://lls.reaxys.com/redir?pid=scp:53549126971" target="_blank" title="Cited by in Scopus" data-counter-investigation="SCOPUS_LINK">Cited by:&nbsp;34</a></span><br> <div class="previewNav clearfix"><div class="previewNavInner clearfix"><ul class="ui-tabs-nav"><li><span class="source">Embase</span></li><li><span class="source">MEDLINE</span></li><li class="ui-tab ui-tabs-selected" id="abstractTab-200"><a href="https://www.embase.com/#" class="showAbstract" data="200" data-counter-investigation="ABSTRACT"><i class="abs-ind-icon" data="200"></i> Abstract</a></li><li class="ui-tab" id="indexTab-200"><a href="https://www.embase.com/#" class="showIndexTerms" data="200" data-counter-investigation="INDEX_TERMS"><i class="abs-ind-icon" data="200"></i> Index Terms</a></li><li><span><a href="http://dx.doi.org/10.1097/ACO.0b013e32830f44e4" class="fullText external" data-counter-investigation="FULL_TEXT_LINK" target="_blank" title="View Full Text at Publisher"><i class="vft-icon"></i> View Full Text</a></span></li><!-- open url linking --></ul><a class="similarRecordsLink" href="https://www.embase.com/#" data-idx="199">Similar records <i class="vft-icon"></i></a></div></div></div></div></div><div id="tabsheet"><li>    <div class="ui-tabs-panel" id="abstract-199"><div class="abstractsContainer"><div class="innerPpanel"><p class="hitsHighlighted">Purpose of review: Clinical and experimental data suggest that hypergylcaemia lowers the ischaemic <span class="hit">neuronal</span> threshold and worsens outcome in the presence of neurological <span class="hit">injury</span> from trauma, stroke and subarachnoid haemorrhage. This review aims to appraise the evidence for tight glycaemic control in patients with neurological <span class="hit">injury</span>. Recent findings: Hyperglycaemia can adversely affect outcome in critically ill patients. Intensive insulin therapy with tight glycaemic control has been advocated for improving outcome in these patients. However, the extent to which intensive insulin therapy and tight control of blood glucose improve outcome after ischaemic neurological insults remains unclear. The benefit of such treatment regimes may be negated by the increased frequency of hypoglycaemic episodes, which may aggravate neurological <span class="hit">injury</span>. Although it seems sensible to control hyperglycaemia in patients with neurological <span class="hit">injury</span>, the treatment must account for potential hypoglycaemic episodes. Summary: Clinical and experimental data suggest that hyperglycaemia lowers the ischaemic <span class="hit">neuronal</span> threshold in the presence of neurological <span class="hit">injury</span>. Tight glycaemic control may result in hypoglycaemia, which in itself can be detrimental. Therefore, it seems sensible that we should accept slightly less tight blood glucose control than in the critically ill patient without neurological <span class="hit">injury</span>. © 2008 Wolters Kluwer Health | Lippincott Williams &amp; Wilkins.</p></div></div></div></li></div></li></ul></div><div id="resultsLoadingBar" style="display: none;"><img src="./Embase  neuronal injury 01_files/spinner.gif" class="resultsLoadingBar-img"></div><!-- edged container --><div class="resultHeader actionBar"><ul><li class="checkAllbox"><input title="Select all on page" type="checkbox" class="checkbox" id="selectAllOnPage" name="selectAllOnPage"><label for="selectAllOnPage" class="emb-checkbox emb-checkbox-result"></label></li><li class="headerLabel"><span class="section-headings">Results</span></li><li class=" viewSubmit"><a class="textButton" href="javascript:void(0);" id="viewSubmitAction">View</a> |</li><li><span class="exportSubmit textButton" data="false">Export</span> |</li><li><span class="emailSubmit textButton" data="false">Email</span> |</li><li><a class="textButton" href="javascript:void(0);" id="addToClipboardAction">Add to Clipboard</a></li></ul><div class="hitcount-abstract"><div class="extraNav"></div></div></div><!--// edged container --></div></form><div class="pageIndex"><div id="search-results-pagesize-selector" class="pageIndex">Records per page<select name="pageSize" id="pageSizeSelector"><option value="25">25</option><option value="50">50</option><option value="100">100</option><option value="200" selected="">200</option></select></div><div id="hans"><label for="pager" id="pagerLabel">Go to page: </label><input type="text" id="pager" name="pager" size="5" value="1"><span>  of </span><span id="pageAmount">2  </span><input type="submit" id="go" name="go" value="Go" title="Go to page" alt="Go to page"><span class="textAlignment"><a style="text-decoration:none;" class="emb-btn-result-ft-nav next" id="goNext" href="javascript:void(0);"><span class="btn-result-ft-nxt"></span></a></span></div></div></div>			</div>		</div>		<!--// col2 -->	</div></div></div>
        </div>
        <div id="footer" style="display: block;"><footer id="pageFooter"><nav id="footer-nav"><div class="column"><h2 class="column-title">Life Science Solutions</h2><ul class="column-list"><li><a href="https://www.elsevier.com/solutions/professional-services" target="_blank">Professional Services™</a></li><li><a href="https://www.elsevier.com/solutions/pathway-studio-biological-research" target="_blank">Pathway Studio™</a></li><li><a href="https://www.elsevier.com/solutions/reaxys/reaxys-medicinal-chemistry" target="_blank">Reaxys® Medicinal Chemistry</a></li><li><a href="https://www.elsevier.com/solutions/reaxys" target="_blank">Reaxys®</a></li><li><a href="https://www.elsevier.com/solutions/pharmapendium-clinical-data" target="_blank">PharmaPendium®</a></li><li><a href="https://www.elsevier.com/solutions/embase-biomedical-research" target="_blank">Embase®</a></li><li><a href="https://www.elsevier.com/solutions/quosa-scientific-literature" target="_blank">QUOSA™</a></li></ul></div><div class="column"><h2 class="column-title">Support</h2><ul class="column-list"><li><a href="https://service.elsevier.com/app/home/supporthub/embase/" target="_blank">Help</a></li><li><a href="https://service.elsevier.com/app/answers/detail/a_id/29878/supporthub/embase/kw/webinar/" target="_blank">Webinars</a></li><li><a href="https://service.elsevier.com/app/answers/list/c/10545/supporthub/embase/" target="_blank">Guides and videos</a></li><li><a href="https://service.elsevier.com/app/contact/supporthub/embase/" target="_blank">Contact Support Team</a></li></ul></div><div class="column"><h2 class="column-title">Product</h2><ul class="column-list"><li><a class="last-child" href="https://www.elsevier.com/solutions/embase-biomedical-research" target="_blank">About Embase</a></li><li><a class="last-child" href="https://service.elsevier.com/app/answers/detail/a_id/29534/p/10882/supporthub/embase/related/1/" target="_blank">News</a></li><li><a class="last-child" href="https://service.elsevier.com/app/home/supporthub/embase/" target="_blank">Upcoming webinars</a></li><li><a class="last-child" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions" target="_blank">Terms and Conditions</a></li><li><a class="last-child" href="https://www.elsevier.com/legal/privacy-policy" target="_blank">Privacy Policy</a></li></ul></div></nav><div id="footer-disclaimer"><a class="footer-els-logo" href="http://www.elsevier.com/">Elsevier logo</a><a class="footer-relx-logo" href="http://www.relxgroup.com/" target="_blank">RELX group logo</a><div class="footer-disclaimer-content"><p>Copyright © 2022 Elsevier Limited except certain content provided by third parties. Embase is a trademark of Elsevier Limited.</p><p class="cookiesNotice">We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the <a href="https://www.embase.com/legal/cookies" target="blank">use of cookies</a>.</p></div></div></footer></div>
        <div id="tip" class="infoTip" style="display:none" onmouseout="hideInfoTip(event)"></div>
        <!-- Process time: 1.25 mSec. -->

    </div>

<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"errorBeacon":"bam.nr-data.net","licenseKey":"3c836f97d2","agent":"","beacon":"bam.nr-data.net","applicationTime":5,"applicationID":"1572543444","transactionName":"blRRMUVQC0JWVhJaV1ceYBFFRBFCdlYSWldXHlAKWh8AXURQEFpdSx9fEEBQDh9WRRZAFlxcUQREVEtCUkcQX11NQh0LVkcMVlZBD1xWF3NSBlxTCl9ScQNVWUxdRyRURQxeWQ==","queueTime":0}</script>

<audio controls="controls" style="display: none;"></audio><div data-action="feedbackBox" class="feedbackBox" style="display: none;"><div data-action="feedbacBoxClass"><div data-action="feedbacBoxIcon" class="icon"><span class="text" data-action="feedbackMessage"></span></div><div data-action="box-control" class="close_button"></div></div></div><script type="text/javascript" async="" src="https://translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><script>_satellite["_runScript1"](function(event, target, Promise) {
!function(){try{pendoData={visitor:{},account:{}},pageData&&(pageDataTracker&&(pendoData.visitor.id=pageDataTracker.getVisitorId()),pageData.visitor&&pageData.visitor.userId&&(pendoData.visitor.webuserID=pageData.visitor.userId),pageData.visitor&&pageData.visitor.accessType&&(pendoData.visitor.accessType=pageData.visitor.accessType),pageData.page&&pageData.page.name&&pageData.page.productName&&(pendoData.visitor.pageName=pageData.page.productName+":"+pageData.page.name),pageData.page&&pageData.page.type&&(pendoData.visitor.pageType=pageData.page.type),pageData.page&&pageData.page.productName&&(pendoData.visitor.pageProduct=pageData.page.productName),pageData.page&&pageData.page.language&&(pendoData.visitor.pageLanguage=pageData.page.language),pageData.page&&pageData.page.environment&&(pendoData.visitor.pageEnvironment=pageData.page.environment),pageData.visitor&&pageData.visitor.accountId&&(pendoData.account.id=pageData.visitor.accountId),pageData.visitor&&pageData.visitor.accountName&&(pendoData.account.name=pageData.visitor.accountName)),pendoData.visitor.id&&pendoData.visitor.pageName&&pendoData.visitor.pageProduct?(pendo.initialize(pendoData),_satellite.logger.log("pendo initialized with pageData.")):_satellite.logger.log("couldn't initialize pendo.")}catch(a){_satellite.logger.log("exception during pendo init. "),_satellite.logger.log(a)}}();
});</script><script>_satellite["_runScript2"](function(event, target, Promise) {
pageDataTracker.mapAdobeVars(s);
});</script><script>_satellite["_runScript3"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script><script>_satellite["_runScript4"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script><div class="daterangepickerContainer"></div><script>_satellite["_runScript5"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script><script>_satellite["_runScript6"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script><ul class="vakata-context"></ul><div id="jstree-marker" style="display: none;">&nbsp;</div><div id="pendo-base" data-layout="lightboxBlank" class="_pendo-step-container _pendo-guide-tt_" style="overflow: visible; height: auto; width: auto; position: fixed; z-index: 300000; left: 184px; top: 15px; display: block;"><style type="text/css" scoped="scoped" style="white-space: pre-wrap;">#pendo-close-guide-8c219693:hover{color:#007398!important;}div[tabindex=-1]:focus{}</style><div id="pendo-g-FzMiHKF3XRLRfdrkuwQu3DP8tR4" data-vertical-alignment="Relative to Element" data-relative-alignment="true" class="_pendo-step-container-size" style="z-index: 300000; position: absolute; width: 90px; animation: 0s ease 0s 1 normal none running none; float: none; vertical-align: baseline; display: block; visibility: visible; margin-right: 0px; height: 0px;"><div aria-modal="false" tabindex="-1" id="pendo-guide-container" data-caret-enabled="true" data-caret-height="15px" data-caret-width="15px" class="_pendo-step-container-styles" style="background-color: rgba(255, 255, 255, 0); border-radius: 0px; padding: 0px; position: relative; border: 0px solid rgb(187, 187, 187); box-shadow: rgba(190, 190, 190, 0.8) 0px 0px 0px 0px; float: none; vertical-align: baseline; display: none; max-width: none; max-height: none;"><div id="pendo-code-fe23853a" class=" pendo-code-block" style="display: block; float: none; vertical-align: baseline;"></div></div><div class="pendo-tooltip-caret" style="position: absolute; z-index: 11; border-top: 15px solid transparent; border-bottom: 15px solid transparent; top: 10px; border-right: 15px solid rgba(255, 255, 255, 0); left: -15px;"></div></div></div><script>_satellite["_runScript7"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script><script>_satellite["_runScript8"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script><script>_satellite["_runScript9"](function(event, target, Promise) {
_satellite.logger.log("eventDispatcher: clearing tracking state");try{s.events="",s.linkTrackVars="",s.linkTrackEvents=""}catch(e){_satellite.logger.log("eventDispatcher: s object - could not reset state.")}try{dispatcherData=JSON.parse(event.detail),window.ddqueue=window.ddqueue||[],window.ddqueue.push(dispatcherData),window.eventData=dispatcherData.eventData,window.pageData=dispatcherData.pageData,_satellite.track(dispatcherData.eventName)}catch(e){_satellite.logger.log("eventDispatcher: exception"),_satellite.logger.log(e)}
});</script></body><style type="text/css">#yddContainer{display:block;font-family:Microsoft YaHei;position:relative;width:100%;height:100%;top:-4px;left:-4px;font-size:12px;border:1px solid}#yddTop{display:block;height:22px}#yddTopBorderlr{display:block;position:static;height:17px;padding:2px 28px;line-height:17px;font-size:12px;color:#5079bb;font-weight:bold;border-style:none solid;border-width:1px}#yddTopBorderlr .ydd-sp{position:absolute;top:2px;height:0;overflow:hidden}.ydd-icon{left:5px;width:17px;padding:0px 0px 0px 0px;padding-top:17px;background-position:-16px -44px}.ydd-close{right:5px;width:16px;padding-top:16px;background-position:left -44px}#yddKeyTitle{float:left;text-decoration:none}#yddMiddle{display:block;margin-bottom:10px}.ydd-tabs{display:block;margin:5px 0;padding:0 5px;height:18px;border-bottom:1px solid}.ydd-tab{display:block;float:left;height:18px;margin:0 5px -1px 0;padding:0 4px;line-height:18px;border:1px solid;border-bottom:none}.ydd-trans-container{display:block;line-height:160%}.ydd-trans-container a{text-decoration:none;}#yddBottom{position:absolute;bottom:0;left:0;width:100%;height:22px;line-height:22px;overflow:hidden;background-position:left -22px}.ydd-padding010{padding:0 10px}#yddWrapper{color:#252525;z-index:10001;background:url(chrome-extension://eopjamdnofihpioajgfdikhhbobonhbb/ab20.png);}#yddContainer{background:#fff;border-color:#4b7598}#yddTopBorderlr{border-color:#f0f8fc}#yddWrapper .ydd-sp{background-image:url(chrome-extension://eopjamdnofihpioajgfdikhhbobonhbb/ydd-sprite.png)}#yddWrapper a,#yddWrapper a:hover,#yddWrapper a:visited{color:#50799b}#yddWrapper .ydd-tabs{color:#959595}.ydd-tabs,.ydd-tab{background:#fff;border-color:#d5e7f3}#yddBottom{color:#363636}#yddWrapper{min-width:250px;max-width:400px;}</style></html>